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ABSTRACT 
Processing effects on soy storage proteins, glycinin and (3-conglycinin, as well as 
isoflavones and group B soyasaponins, protein-associated phytochemicals, were evaluated. 
It was hypothesized that the physicochemical characteristics of these molecules, such as 
protein native state, hydrophobicity, or ionization, would affect their partitioning during 
processing and, for the proteins, affect functional properties. 
A pilot-scale soy protein fractionation process, yielding glycinin, (3-conglycinin, and an 
intermediate fraction comprised of a mixture of these proteins, was scaled up from 15 kg to 
50 kg of defatted soy white flake starting material in order to produce larger quantities of 
protein products. The scaled-up process recovered 12% less of the initial protein in the 
product fractions compared to the 15-kg process, but 2.4 times more total protein were 
recovered in the scaled-up process product fractions. The insoluble fraction, a waste stream, 
retained 59, 67, and 75% of the protein, isoflavones, and saponins, respectively. The whey 
contained 6% of the protein and 12% of the isoflavones, but almost no saponins. The 
saponin to isoflavone ratio was about 2:1 in the (3-conglycinin, but about 1:1 in the glycinin. 
These data demonstrate differences in phytochemical partitioning, possibly due to 
physicochemical characteristics such as hydrophobicity and ionization. The isoflavone 
profile shifted from malonylglucosides toward aglucon forms, possibly due to the action of 
native (3-glucosidases. 
Solubilization temperature and pH influenced protein and phytochemical recovery and 
partitioning during bench-scale soy protein isolate production. Increasing temperature from 
25 to 60 °C and pH from 8.5 to 10.5 increased extraction of phytochemicals from the soy 
flakes. Saponin concentration increased in the isolate. Neutralizing samples prior to 
phytochemical extraction significantly increased measured saponin concentrations in the 
isolate and measured isoflavone concentrations in the insoluble fraction. Increasing 
temperature and pH shifted isoflavone profile from malonylglucosides to glucosides and 
saponin profile from DDMP saponins to non-DDMP saponins. 
vii 
Extraction pH, ethanol concentration, water-to-soy flake ratio, and temperature were 
evaluated during bench-scale protein fractionation for ability to improve protein and 
phytochemical solubilization and recovery. A 10:1 water-to-flake ratio and 45 °C were 
selected as optimized solubilization conditions. When compared to the control (15:1 water-
to-flake ratio and 20 °C) under pilot-scale conditions, the optimized method produced more 
(3-conglycinin, but at the expense of purity. The optimized method displayed increased 
saponin extraction from the soy flakes. A portion of the malonylglucoside isoflavones were 
converted to p-glucoside and aglucon forms. 
Protein products from the optimized and control pilot-scale fractionation processes were 
compared for functionality. Optimized process intermediate and (3-conglycinin fractions, 
which had higher surface hydrophobicity than the corresponding control fractions, exhibited 
significantly better emulsification activity compared to those for the control process. 
Because the (3-conglycinin fractions had a lower denaturation temperature than the glycinin 
fractions, and denaturation of the protein is required as a first step in gel formation, the (3-
conglycinin fractions gelled at a lower temperature than did glycinin. The (3-conglycinin 
fractions made firmer gels than did glycinin fractions at pH 3 and 7. The intermediate 
fractions, which contained little native-state protein, demonstrated higher apparent viscosities 
than the soy protein isolate and other process fractions, probably due to the increased 
molecular interaction of the unfolded, non-native state protein. 
1 
CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
Soybeans are an extremely valuable agricultural resource, providing oil with both food 
and industrial applications and a concentrated source of high-quality food protein with a 
myriad of functional applications in food systems. Some functional aspects of soy 
ingredients are foaming, emulsification, solubility, hydrophobicity, water binding, fat 
binding, and gelling. While soybeans have certain anti-nutritional aspects, such as trypsin 
inhibitors and oligosaccharides, mounting evidence suggests that several components, such 
as isoflavones, saponins, and even the soy proteins, acting alone or in a synergistic fashion, 
may be important factors providing positive health consequences when consumed as part of a 
healthy diet. 
Developing an in-depth understanding of the soy proteins is critically important. 
Physicochemical properties of glycinin and P-conglycinin, the major storage proteins in soy 
and major components of the 11S and 7S soy protein fractions, respectively, influence the 
quality and characteristics of traditional soy foods, such as tofu, as well as the functionality 
of commercially-produced soy ingredients, such as soy concentrates and soy protein isolates. 
A considerable body of research has been directed toward isolating and characterizing these 
proteins to better understand how each of these proteins influences food systems and to 
evaluate how each protein or combinations of the proteins, whether modified or unmodified, 
could provide useful, unique functionalities in food systems. 
One early study (Briggs and Mann 1950) characterized soy storage proteins using 
electrophoretic analysis. The authors found evidence that the globulin termed "glycinin" by 
Osborne and Campbell (1898), commonly considered to be the principle soy storage protein, 
was actually a mixture of components and the composition of the components differed 
depending on method of isolation. Wolf and Sly (1967), Eldridge and Wolf (1967), and 
Wolf and Briggs (1959) have described bench-scale methods to isolate 1 IS proteins. Roberts 
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and Briggs (1965) have described what they termed a "large-scale preparation", starting with 
1300 g of defatted soy flakes, to isolate 7S proteins. These methods did permit the isolation 
of enriched or purified fractions and provided information concerning protein 
characterization, but the methods were not convenient for sequential fractionation of the 11S 
and 7S proteins. However, Thanh and others (1975), Thanh and Shibasaki (1976), O'Keefe 
and others (1991), and Nagano and others (1992) have all described bench-scale methods for 
the sequential fractionation of 11S and 7S proteins and include some protein characterization 
information. Pilot-scale methods for sequential fractionation of these proteins have been 
disclosed in U.S. patents awarded to Davidson and others (1979), Lehnhart and others 
(1983), and Howard and others (1983). The advantage of pilot-scale fractionation is that 
production of kilogram quantities of material permits more exhaustive evaluation of protein 
functionality characteristics, nutritional aspects, and product applications of the protein 
fractions. 
Significant advances have been made toward developing a commercially feasible 
glycinin and P-conglycinin fractionation process at Iowa State University. Previously, Dr. 
Shaowen Wu developed a bench-scale process, a modification of the process used by Nagano 
and others (1992), for fractionation of glycinin and (3-conglycinin from defatted soy flakes. 
Wu's process was scaled up for use in the Iowa State University Center for Crops Utilization 
Research Pilot Plant (Wu and others 1999), using 15 to 20 kilograms of starting material. 
Subsequent scale-up, from 20 kg of starting material to 50 kg of starting material, was 
performed in the same facility to produce a sufficient quantity of P-conglycinin such that the 
protein could be used in a human feeding study to evaluate the effects of P-conglycinin on 
serum cholesterol and lipid levels. 
These pilot-scale fractionation runs have provided topics for further research. One 
obvious shortcoming of the pilot-scale fractionation processes was the poor initial 
solubilization of protein from the starting material and low yield of protein end products, so 
improving initial protein solubilization has been a priority. Since soybean isoflavones and 
saponins, soy protein-associated phytochemicals, may have significant, positive influences 
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on human health, there is interest in determining the concentrations of these valuable 
isoflavones and saponins being partitioned into the fractionation process streams and end 
products, and how the concentrations in end products differ from that in commercially-
available products, such as soy protein isolate. Of course functionality aspects of the protein 
fractions produced in the pilot plant are of interest: 1) from a research point of view to 
develop additional understanding how glycinin and P-conglycinin may each affect or 
contribute to food systems and 2) from an industrial point of view to identify end-products 
with potential as new, unique ingredients. 
A central hypothesis dealing with the above issues can be stated as follows. 
Physicochemical properties of the soy storage proteins, glycinin and P-conglycinin, and the 
protein-associated soy phytochemicals, isoflavones and saponins, will influence the solubility 
and recovery of these co-products during soy protein fractionation and soy protein isolate 
production, and changes in protein structure due to process parameters will affect partitioning 
and functionality of the protein products. 
Four main research questions will be addressed in this body of work. First, do 
isoflavones and saponins partition differently during bench-scale isolate production, bench-
scale protein fractionation, and pilot-scale protein fractionation processes, and how can 
partitioning be influenced or directed? Secondly, can the bench-scale protein fractionation 
process be optimized with respect to initial protein recovery, protein end-product 
partitioning, and phytochemical recovery? Third, how does scale up affect the partitioning of 
the soy proteins and the protein-associated phytochemicals? And finally, how do pilot-scale 
protein fractionation process end-products produced by the original and optimized methods, 
as well as soy protein isolate produced in the pilot plant from the same starting material, 
differ among one another in terms of protein functionality? 
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Dissertation Organization 
This dissertation consists of a literature review, in the format of the Journal of Food 
Science, and four papers, each paper being presented as a chapter. The first paper, "Soy 
Protein, Isoflavone, and Saponin Partitioning During Pilot-Scale Fractionation of Glycinin 
and P-Conglycinin," will be submitted to the Journal of the American Oil Chemists ' Society. 
The second paper, "Isoflavone and Saponin Partitioning During Bench-Scale Soy Isolate 
Production: Effects of Temperature and pH," will be submitted to the Journal of Food 
Science. The third paper, to be submitted to the Journal of Agricultural and Food Chemistry, 
is "Pilot-Scale Fractionation of Glycinin and p-Conglycinin: Process Improvement." Desired 
process improvement outcomes included increased recoveries of total protein and 
phytochemicals in product fractions without sacrificing purity of the glycinin- and (3-
conglycinin-rich protein fractions. The fourth paper, "Pilot-Scale Fractionation of Soy 
Storage Proteins: Functional Properties," evaluates the functionality of protein products from 
a control fractionation process, an optimized fractionation process, and a soy protein isolate 
process, all produced from the same starting material. The fourth paper will be submitted to 
the Journal of Food Science. A general conclusion follows the four papers. Appendix A 
displays ANOVA tables for isoflavone and saponin concentration comparisons for Chapter 3. 
Appendix B shares data about the microbial load of the protein products prepared in the pilot 
plant as described in Chapter 4. 
Literature Review 
A. Soybean Production, Soy Food Sales, and Perception of Soy 
World soybean production has increased from about 132 million metric tons in 1996-97 
to about 184 million metric tons in 2001-02 (Soya & Oilseed Bluebook 2003). During this 
same time frame, U.S. production increased from about 65 to 79 million metric tons. In 
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2000, the U.S. produced 45% of the world soybean crop, with Brazil, Argentina, and China 
producing 21, 15, and 9%, respectively (United Soybean Board 2001). Approximately 98% 
of the 43 million metric tons of soybean meal produced each year is primarily used for 
animal feed. The other two percent receives additional processing to prepare soy food 
ingredients and soy products. 
Consumption of traditional soy foods and foods prepared with soy ingredients has 
increased dramatically in the U.S., with U.S. soyfood sales totaling $2.77 billion in 2000 and 
increasing by 16.8% in 2001 to $3.2 billion according to a study by SPINS and Soyatech, 
Inc. (2002). Soyfoods: Trends and Developments, a study by Business Communications Co. 
Inc., Norwalk, Conn. (2001), predicts that soy food sales will top $6.9 billion in 2005. They 
also project that the soy ingredient market, which includes soy protein, soy fiber, and soy 
isoflavones, will grow from $523.3 million in 2000 to $659.2 million in 2005. Soymilk 
sales exceeded $550 million in 2001 and meat alternative sales experienced about $440 
million in retail sales in 2000 (Wrick 2003). LMC International (1999) projected that the soy 
sports supplements and powders market segment will grow 20% per year from 2000 to 2005. 
LMC also reports that sales of nutritional beverages, nutraceuticals and supplements, 
nutrition bars, soymilks, and meat analogs are all growing at over 10% per year. 
Clearly, there is an enthusiastic market for soy foods and soy ingredients. There are 
several reasons for this popularity. First, soy has long been recognized as an abundant source 
of high-quality protein that is generally cost efficient on a protein basis, promoting its use in 
foods needing protein fortification or in regions whose populations have chronic dietary 
protein deficiency. The protein digestibility corrected amino acid score (PDCAAS), the 
official assay of the World Health Organization and the United States Department of 
Agriculture for evaluating protein quality, for soy protein is 1.0. A food with a score of 1.0 
or higher indicates that it is capable of meeting the amino acid requirements for 2- to 5-year-
old children, the segment of the population having the highest requirement. This means that 
soy protein can meet the protein needs of adults when it is consumed at the recommended 
intake of 0.6 g/kg body wt. (Young 1991). Friedman and Brandon (2001) do express 
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concerns, however, that methionine and lysine levels may be marginal in some instances. 
Methionine availability in some plant proteins is low, probably due to lower digestibility 
(Begbie and Pusztai 1989). Another factor that may affect methionine availability is 
chemical modification during storage and processing (Oste 1991). Fortification of a soymilk 
formula with methionine increased nitrogen retention in malnourished children (de Oliviera 
and others 1998). Lysine availability may also be lost during storage and processing due to 
Maillard reactions (Friedman 1982) and during processing at high pH due to formation of 
lysinoalanine (Mao and others 1993). 
Second, a wide variety of soy ingredients is available, and they have useful functional 
properties that have permitted food manufacturers to select a soy ingredient for a specific 
functional purpose or as an inexpensive replacement for other food proteins. Functional 
properties of proteins in food were defined by Kinsella (1976) as "those physical and 
chemical properties that affect the behavior of proteins in food systems during processing, 
storage, preparation and consumption." Functional roles of food proteins include foaming, 
emulsification, solubility, viscosity, cohesion, adhesion, water binding, fat binding, flavor 
binding, and gelling. 
Third, traditional soy foods are more available in grocery stores and consumers are now 
more accepting of soy ingredients in foods. Factors influencing this availability and 
acceptance may be the increase in popularity of Asian foods in the U.S., increase of Asians 
comprising the U.S. population, and the increase in people choosing plant-based foods. 
Soyfoods.com (2003) reported data from consumer surveys showing that 55% of participants 
in 1991 said they were aware of soy protein in foods, compared with 79% in 1996, while 
other data from that website stated that 25.4% of consumers surveyed plan to use more soy 
foods in the future than they now use. 
Possibly the most significant reason consumers are choosing soy is that soy has become 
recognized as a nutraceutical or functional food. A functional food is a food or food 
ingredient that may provide a health benefit beyond simple nutrition, whereas a nutraceutical 
may be defined as a food or food component that provides medical or health benefits, such as 
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the prevention or treatment of a disease (ISU University Extension 2000). Such components 
in soy may be isoflavones and saponins, phytochemicals found in soy, or even the soy 
proteins themselves. Aging baby boomers, a significant portion of the population, may be 
more interested in living a healthy lifestyle than previous generations. Ten percent of 
shoppers surveyed in 1998, versus three percent in 1996, were including soy as part of a 
healthy diet because they felt it might reduce the risk of disease (Henkel 2000). 
B. Composition of Soybeans and Soy Products, Advances in Soybean Composition 
This section provides basic information about the chemical composition of soybeans and 
a few major soybean products. Liu (1997) provides more detailed information. Tables 1-4 
contain soybean composition information. 
Table 1. Soybean and soybean component proximate analyses presented on a dry weight 
basis 
Component Yield 
(%) 
Protein 
(%) 
Fat 
(%) 
Ash 
(%) 
Carbohydrates 
(%) 
Whole 
soybeans 100.0 40.3 21.0 4.9 33.9 
Cotyledon 90.3 42.8 22.8 5.0 29.4 
Hull 7.3 8.8 1.0 4.3 85.9 
Hypocotyl 2.4 40.8 11.4 4.4 43.4 
Source: Perkins (1995) 
It is important to note that plant breeders have been making progress toward altering the 
compositional analysis of soybeans. Liu (1997) includes a chapter titled "Soybean 
Improvements Through Plant Breeding and Genetic Engineering," which provides references 
and comments on breeding to increase oil content and profile; to increase protein content; to 
alter 11S/7S storage protein ratio; to alter amino acid composition for protein quality; to 
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reduce the concentration of trypsin inhibitors, oligosaccharides, phytates, and lipoxygenase; 
and to increase isoflavone content. 
Table 2. Proximate analyses of soybeans and soybean products 
Material Moisture Protein Fat Fiber Ash 
(%) (%) (%) (%) (%) 
Soybeans 11.0 37.9 17.8 4.7 4.5 
Defatted meal dehulled 10.7 47.5 0.5 3.5 6.0 
Full-fat soy flour 5.0 44.3 21.0 2.0 4.9 
Soy protein concentrate 7.5 66.6 - 3.5 5.5 
Soy protein isolate 5.0 93.1 - 0.2 4.0 
Adapted from Perkins (1995) 
Table 3. Carbohydrate content of dehulled, defatted soybean flakes from cotyledons 
Carbohydrate % wt 
Monosaccharides 
Glucose trace 
Oligosaccharides 
Sucrose 5.7 
Raffinose 4.1 
Stachyose 4.6 
Polysaccharides 
Arabinan 1.0 
Arabinogalactan 8-10 
Acidic polysaccharides 5-7 
Adapted from Smith (1972) 
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Table 4. Primary inorganic components of soybeans: ranges from 12 selected varieties 
Potassium 1.5 to 1.92% 
Sodium 0.4 to 0.61% 
Phosphorous 0.352 to 0.733% 
Magnesium 0.094 to 0.208% 
Calcium 0.024 to 0.063% 
Iron 0.0044 to 0.0163% 
Source: Perkins (1995) 
High sucrose beans are an example of a potentially successful and economically 
beneficial alteration of soybean composition. High sucrose beans contain 40% more sucrose 
and 90% less raflmose and stachyose than regular soybeans. Drastically reduced 
concentrations of these oligosaccharides that cause flatulence and intestinal discomfort in 
humans could revolutionize soy protein ingredient manufacturing. There were 4500 acres of 
high sucrose beans contracted for production in Iowa for the 2003 season by Protein 
Technologies International (Illinois Specialty Farm Products 2003). These beans are 
reported to yield 85-90% of normal soybean yields, but farmers receive a $0.90/bu premium. 
New soybean compositions, produced by traditional and genetically engineered plant 
breeding, will undoubtedly open niche markets for specialty soybeans that will further 
increase the demand for soy products and soy ingredients. 
C. Soy Foods, Soy Ingredient Production, and Cost of Some Soy Ingredients 
Wang and Murphy (1994) divided soy foods into three categories: soy ingredients, 
traditional soy foods, and second-generation soy foods. Murphy and Hendrich (2001) 
suggest a fourth category, foods with soy as a functional ingredient. Examples of traditional 
soy foods are soymilk, tofu, miso, natto, and tempeh. These products are generally made 
from whole soybeans, but some soymilk and tofu processes are exceptions to this and may 
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use soy flakes as the starting material. Unprocessed soybeans, soy flours, soy protein 
concentrates, soy protein isolates, and textured soy protein are examples of soy ingredients. 
Second-generation soy foods may be described as those food items containing significant 
amounts of soy and manufactured to resemble the traditional food item in appearance, 
texture, taste, and flavor. Examples are soy-based hot dogs and hamburgers, other soy-based 
meats, and soy-based cheese. The final category, foods with soy as a functional ingredient, 
covers applications where soy protein is used to replace other food proteins, such as 
replacing milk protein in infant formula and wheat protein in baked goods. 
The starting material for soy ingredients, second-generation soy foods, and in some cases 
functional ingredients is defatted soy flakes. The flakes are a by-product of the soy oil 
recovery process. In brief, soybeans are cleaned, conditioned to about 10-11% moisture, 
cracked to remove the hulls, milled to produce grits, and then the grits are rolled into flakes. 
The crude oil is then extracted from the flakes, usually using an organic solvent. Removal of 
the solvent from the flakes is a critical step and greatly influences the usefulness of the 
desolventized flakes. Flakes that will be used for animal feeds are toasted to remove residual 
solvent. However, this denatures the proteins, greatly reducing protein solubility, and 
imparts undesirable odor, flavor, and appearance characteristics. White flakes, the usual 
starting material for defatted soy flours, soy protein concentrates, and soy protein isolates, are 
produced by employing super-heated streams of hexane vapors and vacuum to quickly 
remove the solvent. This rapid removal of the solvent limits the exposure of the flakes to 
heat and produces flakes with a higher protein dispersibility index (PDI), meaning that the 
proteins in the flakes can be more easily solubilized during additional processing of the 
flakes. Flakes having a PDI as high as 90-95 (high protein solubility) and as low as 20 (low 
protein solubility) are commercially available. High PDI white flakes are used where high 
solubility of the protein is desired, such as in the preparation of soy protein isolate. Low PDI 
flakes will have low protein solubility, but the protein is still able to bind fat and water. 
These characteristics are useful in some meat applications. The object is to produce soy 
ingredients with the desired functional characteristics. Examples of functional characteristics 
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are solubility, foaming capacity, foaming stability, emulsification capacity, emulsification 
stability, water and fat binding capacities, gel strength, and viscosity. 
Soy flour is generally produced by grinding the defatted flakes, and it is used as a protein 
supplement and functional ingredient. High enzyme flours with viable lipoxygenase, 
produced from defatted flakes with a minimum heat treatment, are used in baking 
applications to increase dough mixing tolerance and promote bleaching in bread products. 
On a moisture-free basis defatted soy flour is about 52-54% protein. Defatted flours receive 
varying moist heat treatments to provide products with a range of solubility, depending on 
desired application. Soy flour may also be made from dehulled soybeans, producing a full-
fat flour. The protein content of these flours is generally about 40% on a moisture-free basis, 
and they are used primarily in the baking industry and for the production of soy milks. 
Soy protein concentrate is produced by removing soluble carbohydrates, such as raffinose 
and stachyose, from defatted soy flakes. The carbohydrates are leached from the flakes using 
a weak acid solution at about pH 4.5, a 70-90% aqueous alcohol solution, or moist heat 
followed by hot water. Each process provides a concentrate with different functional 
properties and flavor profile. Concentrates must be at least 65% protein (6.25 correction 
factor multiplied by nitrogen content) on a moisture-free basis. They are used in systems 
requiring emulsifiers, emulsion stabilizers, and water and fat binders. Food system examples 
are meat systems, gravies, and baked goods. 
Soy protein isolates are also made from defatted soy flakes. Isolates are the highest 
protein soy ingredient product, produced by the removal of most of the fiber, soluble 
carbohydrates, and ash. The protein is solubilized from flakes as they are mixed in a mild 
alkali solution at pH 8 to 9 at up to 80 °C. Insoluble material is removed by centrifugation. 
The soluble soy protein is then precipitated by lowering the pH of the solution to 
approximately 4.5, near the isoelectric point of most soy proteins. The resulting precipitate, 
or curd, is removed by centrifugation, eliminating soluble carbohydrates. The curd may then 
be neutralized with NaOH or KOH to enhance solubility and functionality after spray drying. 
Soy protein isolates must be at least 90% protein on a moisture free basis and using a 6.25 
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correction factor. They are used in a wide variety of food systems requiring emulsifiers, 
emulsion stabilizers, water and fat absorption, and fiber-forming properties. 
Textured vegetable proteins (TVP) are produced by thermoplastic extrusion or steam 
texturization of soy flours or soy protein concentrates; extrusion of concentrates yielding 
different sized and shaped pieces; or extrusion of isolate into an acid or salt bath that 
coagulates protein into fibers. If binders are present in the acid or salt baths the fibers can be 
formed into fiber bundles or structured isolates. TVP must be 50% protein on an "as is" 
basis and contain no more than 10% moisture. TVP may be used as an ingredient in ground 
meat products, providing texture as well as water and fat binding capability. The structured 
isolates are often used as food analogs. 
When a soy protein product can fill the functional and nutritional role of another protein 
source, such as egg whites, meat, milk, or wheat proteins, cost also becomes a driving factor 
for the replacement. Whereas wheat flour costs only $228 per ton compared to $289 per ton 
for defatted soy flour (American Soybean Association 2003a), the cost on a price per pound 
of protein basis is $1.00 vs. $0.25, respectively. Price per ton and price per pound of protein 
for soy protein concentrate, soy isolate, and soy TVP are $2150 and $1.39 (American 
Soybean Association 2003b), $2750 and $1.36 (American Soybean Association 2003c), and 
$396 and $0.30 (American Soybean Association 2003d), respectively. This should not imply 
that all soy products are inexpensive. Soymilk may be as much as 2-3 times as expensive as 
dairy milk, and many of the meat analogs are quite expensive compared to the conventional 
products with which they are competing. 
The large variety of soy foods and soy ingredients described above display a means by 
which soy has been incorporated into the U.S. diet. However, the reported health benefits of 
soy have been an influential component of the recent enthusiasm for consumers to seek out 
soy foods or foods containing soy ingredients and for food manufacturers to gladly meet the 
resulting increased demand for soy by incorporating soy ingredients into their product 
formulations. The nutraceutical, functional food, and phytochemical aspects of soy, all 
related to the potential health benefits of soy, are covered in the next section. 
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D. Soy Consumption: Concerns and Potential Benefits 
This section will provide a very brief overview of the potentially harmful and beneficial 
aspects of soy components in the human diet. 
Soy Allergen 
Soybeans are included in the list of major food allergens, as are cow's milk, egg, fish, 
crustacean shellfish, tree nuts, wheat, and peanuts. Glycinin and p-conglycinin, as well as 
nearly all of the subunits that comprise these soy proteins, have been implicated in eliciting 
an allergenic response in some humans. Use of infant soy formula is quite common in the 
U.S. Concern has been expressed that exposure to soy at an early age could lead to an 
increase in soy allergies. However, at least one study has shown that soy formulas rarely 
elicit allergic reactions in infants (Cantani and Lucenti 1997). Inducement of allergic 
response in children can occur, but cost and use for those infants suffering from cow's milk 
allergenic response drive the popularity of soy-based infant formulas as a breast-milk 
alternative. As mentioned above, soy is becoming more prevalent as an ingredient in foods 
such as bread, muffins, cake mixes, cookies and bars, cereals, cooking spray, frozen desserts, 
meat and meat substitutes, pancake mixes, sauces and toppings, and soups, making it 
increasingly difficult for someone with a soy allergy to avoid soy. Perkin (1990) offers a 
short list of examples of common, brand name food items, which contain soy proteins. 
Protease Inhibitors 
The Kunitz (MW 20 kDa) and Bowman-Birk (MW 6-10 kDa) protease inhibitors bind to 
and inactivate trypsin and trypsin plus chymotrypsin, respectively. Table 5 shows the 
concentration of Kunitz and Bowman-Birk inhibitors in a few soy ingredients and products. 
Since trypsin and chymotrypsin are bound by the inhibitors and inactivated, exogenous 
dietary protein absorption declines. Rats fed diets with soy protease inhibitors showed poor 
weight gain and hyperplasia of the pancreas, in some cases leading to pancreatic cancer. For 
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rats, binding of trypsin leads to excessive excretion of cholecystokinin (CCK) by the 
intestinal mucosa, stimulating the pancreas to release even more proteolytic enzymes. These 
enzymes are high in sulfur amino acids and are not readily re-absorbed, potentially leading to 
sulfur amino acid deficiency. Schneeman and Gallaher (1986) showed that rats, chickens, 
and growing guinea pigs display such pancreatic hyperplasia, but dogs, pigs, calves, and 
monkeys do not. 
Table 5. Kunitz and Bowman-Birk inhibitors in selected soy protein products. 
Sample 
Kunitz Inhibitor 
(mg/g sample) 
Bowman-Birk Inhibitor 
(mg/g sample) 
Flours 1.1-19.6 <0.2-4.9 
Concentrates <0.5-6.1 <0.2-1.0 
Isolates <0.5-3.6 0.3-2.0 
Dehydrated Soymilk 11.3 1.9 
Wheat-soy pancake mix 1.0 0.4 
Source: DiPietro and Liener (1989). Quantification of Kunitz and Bowman-Birk 
inhibitors is by rocket Immunoelectrophoresis and chymotrypsin inhibition, respectively. 
Heat treatment, especially moist heat, inactivates the Kunitz inhibitor (KI) and 
substantially inactivates Bowman-Birk inhibitor (BBI). Rackis and Gumbmann (1982) 
indicate that about 80% of the inhibitor activity is lost during the processing and preparation 
of soy foods. However, Liener (1986) warns that excessive heat treatment and processing 
may damage the nutritional value and functionality characteristics of the other soy proteins. 
Human gastric juice has a greater inactivation effect on KI than BBI (Liener 1986). Liener 
(1986) states that there is minimal evidence for concern from protease inhibitors for adults 
consuming soy, although there may be some concern for infants consuming soy-based infant 
formulas, adults consuming vegetarian diets very high in legumes, and those replacing meat 
protein with soy protein to help control hyperlipidemia. Kennedy (1995) reviews a body of 
evidence that suggests that hyperplasia, hypertrophy, adenoma, or cancer development in 
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humans from soy and other dietary sources of trypsin inhibitors in the diet is unlikely and 
points out that populations with high intakes of trypsin inhibitors have not displayed an 
increased risk of pancreatic cancer. 
A growing body of information suggests that BBI may have anticarcinogenic properties. 
Kennedy (1995) reviews some of this research and contends that the most important index of 
tumorigenicity is whether an organism develops tumors or cancers. She presents a table 
reviewing the success of isolated soybean constituents, including BBI, phytic acid, and (3-
sitosterol, toward having a suppressive effect on carcinogenesis. Of these three constituents, 
BBI had the most dramatic results. Three of the four studies concerning BBI resulted in 
greater than 60% suppression of benign and malignant tumors. Kennedy shares additional 
data supporting the hypothesis that BBI can suppress malignant transformation in the liver 
and mammary tissue, and in animal models using 125I-PBBI (purified BBI) Kennedy 
showed that up to 40% of the BBI is taken up in the gastrointestinal tract and transported to 
liver and mammary tissues. Friedman and Brandon (2001) review research suggesting that 
the cancer preventative action of this protein is due to the trapping of free radicals by the 
cystine-rich BBI or BBI-protease complexes in tissues or by adsorbing carcinogens in the 
digestive tract like a dietary fiber, preventing colon cancer. In evaluating the results of these 
studies, as with any other studies evaluating the health effects of soybean components, it is 
important to consider the concentration of other soy components in the diets or treatments 
that may provide health benefits, such as isoflavones, saponins, and soy storage proteins. 
As will be clear with other components of soy, the protease inhibitors are able to exert 
positive and negative effects on animal and, possibly, human health. It is the responsibility 
of the scientific community and the consumer to consider available research data and make 
reasonable dietary recommendations or choices. 
Dehydroalanine and Formation of Lysinoalanine 
Alkaline solubilization (pH >8.5-9) of soy proteins in the presence of heat can react 
cysteine with serine phosphate, forming dehydroalanine. Dehydroalanine can then react with 
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water, ammonia, L-lysine (via the s-amino group), cysteine, or histidine forming D, L-serine, 
(3-aminoalanine, L-lysino-D, L-alanine, lanthionine, and histidinoalanine, respectively (Finot 
1997). For lysinoalanine this leads to a loss of lysine, though usually negligible, e.g. 0.1% 
loss of total lysine in casein-based milk products rich in serine phosphate and levels of 
lysinoalanine near 1200 ppm. Reactions with dehydroalanine also create cross-linking that 
can lead to decreased digestibility. Friedman (1999) reviewed publications that demonstrated 
that free and protein-bound lysinoalanine could cause nephrocytomegaly in rats. Studies by 
De Weck-Gaudard and others (1988) and Langhendries and others (1992) diminished 
toxicological concerns about lysinoalanine by showing that protein-bound lysinoalanine was 
not well absorbed and that infants fed commercially processed formulas containing up to 
1000 ppm lysinoalanine experienced no abnormal kidney functioning. This again 
demonstrates the importance of thoroughly considering and evaluating results from studies 
concerning the intake of a dietary substance or component. 
Oligosaccharides 
Soybean oligosaccharides of importance are sucrose, raffinose, and stachyose, and their 
usual percentage by weight in soybeans is 5.7,4.1, and 4.6%, respectively (Perkins 1995). 
The concentration of raffinose and stachyose is about 60 mg/g of defatted soybean meal (Kuo 
and others 1988). Raffinose and stachyose are not digested in the human gut due to the 
absence of endogenously produced a-galactosidase. They are however fermented in the gut 
by microbes, producing flatulence and intestinal discomfort. Consequently, the goal of most 
soy ingredient manufacturing processes is the removal of these oligosaccharides. 
A growing body of evidence is suggesting that maintenance of high numbers of 
fermentative organisms in the human gut is desirable. In the large intestine, these 
fermentative organisms may out compete and displace pathogenic organisms, thought to be 
at least partially responsible for ulcerative colitis, bowel cancer and irritable bowel 
syndrome. Gibson and Macfarlane (1995) address such health issues. The oligosaccharides 
in soybeans may be considered prebiotics, non-digestible food ingredients that beneficially 
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affect the host by improving the growth or activity of one or more types of bacteria in the 
host and in turn improve the health of the host (Gibson 2002). Hayakawa and others (1990) 
showed that oligosaccharides promoted the growth of bifidobacteria, nonpathogenic, 
fermentative gut microorganisms thought to be beneficial for human gut health. Healthy 
populations of bifidobacteria may reduce the incidence of colon cancer (Koo and Rao 1991). 
So, raffinose and stachyose may be undesirable at high levels in soy foods and soy food 
products, but at low concentrations they may have a beneficial effect on human health. 
Phytate 
Phytate, or inositol hexaphosphate, binds iron, zinc, calcium, and other minerals. In this 
bound state the minerals are poorly absorbed. Table 6 shows the phytic acid content of 
soybeans, selected processed soy protein products, and selected soy foods. Phytic acid is 
stable at food preparation conditions and is probably not degraded by extrusion during 
preparation of texturized vegetable protein. Washing soy precipitates at pH 5.0 has been 
shown to remove up to 75% of the phytates (Rhee and Choi 1981). 
Phytate may have beneficial health implications. Hirose and others (1991) used a rat 
model to demonstrate that a 2% supplement of phytic acid inhibited development of 
neoplasmatic lesions in the pancreas and liver. Shamsuddin and others (1992 and 1996) used 
in vitro models to show that phytic acid reduced cell proliferation rate in erythroleukemia and 
human mammary cancer cell lines. Graf and Eaton (1993) showed that phytic acid may play 
a role in colon cancer suppression. Thompson and Zhang (1991) proposed that the 
anticarcinogenic properties of phytic acid may be due to its antioxidant capabilities. 
However, Rimbach and Pallauf (1999) indicated that phytic acid did not have any significant 
effect on liver oxidant or antioxidant status in growing rats. Other evidence suggests that 
phytic acid may be able to reduce serum cholesterol levels (Jariwalla and others 1990). 
The mechanisms for the observed beneficial effects of phytic acid are not well 
understood. More research will need to be done to build a better understanding about the 
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actions of phytic acid. For most human populations the diet is varied enough that the dietary 
phytic acid encountered in some foods will not cause mineral deficiency. 
Table 6. Phytic acid in soybeans, soy protein products, and traditional soy foods 
Sample Phytic acid content (g/100g, dry basis) 
Soybeans 1.00-2.30 
Soybean Hulls 0.12-0.50 
Hypocotyl 0.88 
Cotyledons 1.58 
Full-fat Flour 1.51-1.81 
Defatted Flour 1.30-1.85 
Textured Flour 1.10-2.02 
Texture Soy Protein Concentrate 1.25-2.17 
Soy Protein Isolate 0.97-2.00 
Spun Isolate Fiber 1.48 
Soymilk 1.68-1.83 
Tofu 1.5-2.88 
Okara 0.5-1.2 
Tempeh 0.69-0.73 
Adapted from Anderson and Wolf (1995) 
Saponins 
Saponins are present in a wide variety of plants, and the chemical structures of the 
saponins number in the thousands. However, there are two central building block structures 
for saponins, triterpenoid or steroid aglucons. Saponin aglucons are referred to as 
sapogenins. When sugars or sugar chains are added to the sapogenins, the resulting 
compounds are called glycosides. There are three classes of saponin glycosides: triterpene, 
steroid, and steroid alkaloid. The most common sugars that are added to the sapogenins to 
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form glycosides are glucose, arabinose, glucuronic acid, and xylose. Soybean saponins are 
oleanene-type triterpenoid glycosides and can be further categorized into sapogenols A, B, 
and E, each category having their respective glycosides. On a dry weight basis soybean 
saponin concentration is about 0.2% (Tsukamoto and others 1995), while soy ingredients 
may contain up to 0.76% (Ireland and others 1986). Traditional soyfoods, such as tofu, miso, 
and tempeh contain from 0.15 to 0.30 % saponins (Kitagawa 1984). Ireland and others 
(1986) reported that whole soybeans contain about 75% group B saponins and 25% group A 
saponins. Figures 1 and 2 show group A and group B saponin glycosides, respectively. The 
group B saponins have a 2,3-dihydro-2, 5-dihydroxy-6-methyl-4//-pyran-4-one or DDMP 
moiety attached to C-22 of the sapogenol. This DDMP saponin bond is labile. Loss of the 
moiety from soy saponins pg, 0a, yg, ya, and ag yields soy saponins I, II, III, IV, and V, 
respectively. Group A saponins, identified as Aa through Ah, do not contain the DDMP 
moiety. Hu (2000) contains a more complete review of saponin nomenclature, presence in 
other plants, and their impact on livestock and other animals. 
Tables 7 and 8 reveal that saponin content and profile vary among soybean seed 
components and among soy foods and soy ingredients. Soybean flour primarily contains Pg 
and pa saponins, while soy products and ingredients that have received significant heat 
treatment contain primarily saponins I and II, demonstrating that heat treatment cleaves the 
DDMP moiety. Novasoy® is a dried extract resulting from soy ingredient preparation, and 
due to the processing conditions contains exclusively non-DDMP forms of saponins. As 
described above, soy protein concentrates may be prepared using an ethanol wash strategy to 
remove the unwanted oligosaccharides. Table 7 shows that the acid-washed soy concentrates 
have 9.41 p.mol/g group B saponins while ethanol-washed concentrates have only 0.20 
(j.mol/g. This demonstrates that organic solvents are capable of leaching saponins out of soy 
meal as the oligosaccharides are being removed. 
On a g/g basis, the germ, or hypocotyl, contains six to seven times as much group B 
saponin as the cotyledons. Table 8 shows that Kennong 16 variety soybeans from the 1997 
crop year contained 23.89 pmol/g group A saponins in the hypocotyl compared to none 
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Soyasaponin RI R2 R3 
Aa = acetyl A4 CH2OH P-D-Glc H 
Ab = acetyl A, CH2OH 0-D-Glc CH2OAc 
Ac CH2OH a-L-Rha CH2OAC 
Ad H P-D-Glc CH2OAC 
Ae = acetyl A5 CH2OH H H 
Af = acetyl A2 CH2OH H CH2OAc 
Ag = acetyl Ae H H H 
Ah = acetyl A3 H H CH2OAc 
Figure 1 - Group A acetylated soyasaponin structures. 
Glc: glucosyl; Rha: rhamnosyl; Ac: acetyl 
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HO 
saponin RI R2 DDMP 
Pg CH2OH a-L-Rha Y 
I CH2OH a-L-Rha N 
pa H a-L-Rha Y 
II H a-L-Rha N 
Yg CH2OH H Y 
III CH2OH H N 
ya H H Y 
IV H H N 
ag CH2OH p-D-Glc Y 
V CH2OH p-D-GIc N 
Figure 2. Structures of group B soyasaponins. 
Rha: rhamnosyl; Glc: glucosyl; Y: yes; N: no 
DDMP: 2,3-dihydro-2,5-dihydroxy-6-methyl-4//-
pyran-4-one 
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Table 7. HPLC analysis of group B saponin content and profile of selected 
jimol/g, as is basis 
Product V I II ag Pg pa Total 
Soybean flour1 0.00 0.28 0.21 0.17 2.19 0.47 3.31 
Tofu2 0.00 0.31 0.13 0.01 0.11 0.03 0.59 
Tempeh3 0.00 0.76 0.39 0.01 0.28 0.09 1.53 
Soymilk4 0.00 0.22 0.12 0.00 0.09 0.04 0.47 
Acid-washed concentrates5 0.00 2.41 1.05 0.19 4.90 0.86 9.41 
Ethanol-washed concentrates5 0.00 0.08 0.12 0.00 0.00 0.00 0.20 
Isolated soy protein 500E6 0.87 5.73 2.39 0.10 1.20 0.31 10.60 
Isolated soy protein Supro 670s 0.00 5.59 2.50 0.07 1.01 0.33 9.51 
Textured vegetable protein5 0.00 1.89 0.87 0.11 1.26 0.38 4.51 
Soy hypocotyl7 4.41 5.80 0.00 4.71 12.53 0.00 27.46 
Novasoy®5 0.00 77.55 36.48 0.00 0.00 0.00 114.02 
Adapted from Hu and others (2002) 
'VintonSl, 1994 crop 
2Mori-nu, firm 
3Quong Hop & Company 
^Vhite Wave, Inc. 
5Archer Daniels Midland Company 
6Protein Technologies International 
7Schouten USA Inc., toasted 
Table 8. LC-MS analysis of group A saponin content and profile of selected 
commercial soy products 
pmol/g, as is basis 
Product Aa Ab Ac Ad Ae Af Ag Ah Total 
Soy hypocotyl1 5.16 4.65 1.08 0.00 1.80 1.14 0.17 0.08 23.89 
Soy cotyledon1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Defatted soy meal2 0.00 0.74 0.25 0.19 0.00 0.30 0.00 0.07 1.55 
Molasses3 8.38 8.14 1.22 0.00 2.71 1.02 0.24 0.00 21.71 
Adapted from Gu and others (2002) 
'Kennong 16, 1997 crop 
Jilin 3, 1997 crop 
3 Shanghai Liantang Food Factory 
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in the cotyledons. The relative concentration of the saponins, secondary metabolites, in the 
hypocotyls suggests that they may play a role in defense against oxidative stress, insects, 
fungi, and bacteria. The hypothesis for this role has been supported by other saponin 
research. Yoshiki and Okubo (1995) reported that DDMP saponins display oxygen 
scavenging activity in soybean seeds. Saponin extracts from some plants have been found to 
be inhibitory against the fungi Fusarium solani (Timbekova and others 1996) and the 
bacteria Agrobacterium tumefaciens (Timbekova and others 1996). Tava and Odoardi (1996) 
demonstrated that a saponin-containing diet led to a rise in larval mortality and a decrease in 
body weight in grass grabs, locusts, and flour beetles. Since saponins are found in the stems 
and leaves of plants, as well as seeds, it has been hypothesized that saponins may have been 
developed by plants as a defense against herbivores, as well as the fungi and insects 
mentioned above. Cheeke (1996) indicated that swine, poultry, and cattle displayed an 
aversion to dietary saponins. Some saponins are extremely toxic to fish and some cold­
blooded animals (Price and others 1987). Klita and others (1996) showed alfalfa root 
saponins decreased ruminai protozoal populations and reduced ruminai and total tract 
apparent digestibilities in sheep. The saponins were introduced into duodenally cannulated 
wethers, with doses so high that in a preliminary study that one of the wethers did not 
survive. It is questionable how useful their data is. Malinow and others (1981, 1982) 
showed that consumption of alfalfa saponins by rats and monkeys (Macaca fascicularis) 
caused no adverse effects. Ishaaya (1969) showed that soyasaponin consumption by chicks, 
rats, and mice caused no adverse effects. Average daily saponin soy and non-soy saponin 
intakes for a Western-style diet and Asian vegetarians are about 10 mg/day and 200 mg/day, 
respectively (Ridout and others 1988). Anti-nutritional effects of soyasaponins in humans 
are evidently minimal, as no significant health concern has arisen in regard to their 
consumption. 
There does seem to be mounting evidence that soyasaponins may deliver 
hypocholesterolemic, anticarcinogenic, and immunostimulatory benefits to humans. 
However, soybean isofiavones, Bowman-Birk inhibitor, and the soy proteins themselves 
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confound efforts to elucidate the true impact of soyasaponins in these roles. Further 
confounding these efforts are the extensive use of animal models rather than clinical trials, 
use of differing animal models, type of diet used in animal trials, and use of different 
saponins. 
The cholesterol-lowering effects of soy protein have reportedly been known for more 
than 90 years (Anderson and others 1995). There is currently much debate about what 
component or components of soy are responsible for this effect. More than 20 years ago 
Potter and others (1979) advanced the hypothesis that the hypercholesterolemic action of soy 
protein was due to the soyasaponins. They cited the following rationale. First, cholesterol 
lowering of foods and fibers is due the binding of bile acids or cholesterol, leading to reduced 
absorption. With reduced absorption and reduced enterohepatic circulation of bile acids 
there is an increase in bile acid production from cholesterol in the liver. Saponins had been 
shown to reduce serum cholesterol in animals. An acid hydrolysis of proteins retained 
hypocholesterolemic activity, an acid hydrolysis of saponins increased their activity, and a 
mixture of amino acids that matched the profile of the intact proteins did not have activity. 
Consequently, they stated that the hypocholesterolemic action of soy was due to the saponins 
rather than the protein. 
A review by Oakenfull and Sidu (1990) revealed that saponin-fed animal models, 
including monkeys, mice, rats, chicks, rabbits, pigs, and hamsters, led to a reduction in 
hypercholesterolemia in 14 of 20 experiments. They added that of the other six experiments, 
four did not use a hypocholesterolemic diet and in two the source of saponins was not 
identified. Thirteen of the 14 experiments employed hypocholesterolemic diets. Proposed 
mechanisms for the hypocholesterolemic action of saponins were binding of cholesterol and 
saponins leading to inhibited absorption (Gestetner and others 1972); binding of saponins to 
enterocrine cells leading to modulation of gastric emptying, intestinal mobility and 
permeability, nutrient absorption, and appetite (Cooke 1986); binding of bile acids leading to 
excretion in the feces; and formation of large saponin-bile acid micelles that block 
reabsorption (Oakenfull 1986). 
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Oakenfull and Sidhu (1990) also reviewed nine experiments in which saponin-containing 
materials were consumed by humans, generally at a level of300-500 mg saponins/d. The 
sources of the saponins were chickpea, soy, yucca, alfalfa, and ginseng. Plasma cholesterol 
decreased in six of the nine studies, but of the three studies that used soyasaponins only one 
study showed a significant decrease. 
Some studies to evaluate the effect of saponins on hypercholesterolemia have evaluated 
incorporation of saponins into the diet material. Oakenfull (1984) added saponins to a casein 
diet for rats and observed cholesterol-lowering effects coupled with increased fecal bile 
excretion. Topping and others (1980) spiked saponins into a soy protein-based diet and 
observed no beneficial effect. Potter and others (1993) built on this work by adding quillaja 
saponins to soy protein isolate- and casein-based diets. The authors observed a positive 
effect for the casein diet, a decrease in LDL cholesterol and LDL/HDL cholesterol levels, but 
not with the soy protein diet. They also observed that the saponins rapidly complexed with 
the soy protein. They concluded that the effect of saponins on serum lipid profiles was 
affected by the source of dietary protein. 
The Sirtori research group has been aggressive in promoting the 7S soy protein fraction 
as the component in soy responsible for altering serum cholesterol levels. They point out that 
soy protein might reduce the risk of coronary heart disease by activating the LDL receptors 
in liver cells or by modulating synthesis and catabolism of LDL by consuming specific 
proportions of amino acids corresponding to soy protein. Recent studies by this group have 
used a human hepatoma cell line (Hep G2) to show that the a'-subunit of P-conglycinin was 
more effective than whole P-conglycinin, a + a' subunit combination, or the P-subunit for 
up-regulating LDL receptor activity (Lovati and others 1998, Manzoni and others 1998). 
Since whole subunits cannot be absorbed and passed into the circulatory system, Lovati and 
others (2000) evaluated the effectiveness of synthetic sequences, a digestion of an 
isofiavone-poor soy protein isolate, and undigested isolate. The digest up-regulated the LDL 
receptor more than the undigested isolate. A synthetic peptide corresponding to the 127-150 
positions of the 7S globulin showed a marked up-regulation of LDL activity. The MW of 
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this unit was 2271 Da, and the authors suggest they have evidence that peptides of >3000 Da 
can cross the intestinal wall at a percentage of 0.20. 
The picture is not clear whether saponins, soy protein, other soy components, or a 
combination of these is responsible for the hypocholesterolemic effect of soy. Lacaille-
Dubois (2000) lists other beneficial saponin activities as cytotoxic, anti-tumoral, and 
chemopreventive for cancer-related activities and as immunostimulants and 
immunoadjuvants for immune system activities. Other activities include anti-inflammatory, 
hepatoprotective, cardiovascular, hypoglycemic, antiviral, antimicrobial, and antifungal. 
Obviously, a complete review of these properties is beyond the scope of this literature 
review, but a few a given below. Also, it is important to note that dietary intake of soy may 
not reap many of these benefits since saponins are generally thought to be poorly absorbed 
by the digestive system 
Hayashi and others (1997) evaluated the in vitro antiviral activities of soyasaponin I and 
II against herpes simplex virus type 1. Soyasaponin II was found to be more potent than 
soyasaponin I. Soyasaponin II was also inhibitory toward replication of human 
cytomegalovirus, influenza virus, and human immunodeficiency virus type 1. The authors 
claim that the inhibition was due to a virucidal effect rather than inhibition of virus 
penetration into the cell or inhibition of viral protein synthesis. 
Kinjo and others (1998) utilized soyasaponins I, II, II, and IV to evaluate their in vitro 
hepatoprotective actions towards immunologically induced liver injury on primary cultured 
rat hepatocytes. Effectiveness was soyasaponin III and IV> II and I. The authors 
hypothesize that the sugar moiety linked at C-3 may have an important role in 
hepatoprotective actions. 
Antimutagenic activity of 2-acetoxyacetylaminofluorene (2AAAF) in Chinese hamster 
ovary cells was repressed by a concentrated mixture of soyasaponins II, III, IV, V, pg, pa, yg, 
ya and Be (Berhow and others 2000). Purified soyasapogenol aglycone had a significant 
activity against 2AAAF. The authors suggest that this is the first time antimutagenic activity 
of soybean saponins has been demonstrated in mammalian cells. 
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Oh and Sung (2001) evaluated the effect of soy saponins on HT-29 cell proliferation, 
differentiation, and apoptosis. The crude soybean saponin extract had only a slight apoptotic 
effect at the highest concentrations, 240 and 600 ppm. The saponin treatment decreased cell 
growth in a concentration-dependent manner. 
Jun and others (2002) compared the ability of saponins and other antioxidants to inhibit 
anatoxin B1 (AFBl)-induced mutagenicity and DNA-adduct formation. Antimutagenicity 
was found to be butylated hydroxytoluene>saponins>alpha-tocopherol>L-ascorbic acid. The 
saponins inhibited the mutagenicity of AFB1 by 52, 64, and 81% at concentrations of600, 
900, and 1200 p,g/plate, respectively. The authors hypothesized that the saponins blocked 
initiation of carcinogenesis. 
Protection against colon cancer may be the most likely and plausible anticarcinogenic 
activity of soyasaponins. Koratkar and others (1997) fed soybean saponins to mice at a 
concentration of 3 g/100 g feed. They observed a decrease in aberrant crypts induced with 
azoxymethane. It should be noted that this concentration is much higher than the 0.3-0.4% 
found in soy foods. 
More research is needed to further elucidate the exact role of soyasaponins in decreasing 
serum cholesterol, as well as their potential role in inhibiting colon cancer. Clearly, further 
investigation is warranted to understand their chemopreventative, antitumoral, and cytotoxic 
activities as we search for drugs to combat cancer. 
Isoflavones 
Isoflavones are a subclass of the isoflavonoids, which are themselves a subclass of the 
flavanoids. Harbome (1994) indicated that at least 364 known aglucons of isoflavones had 
been reported. However, few of these isoflavones occur in plants commonly consumed by 
humans. Genistein, daidzein, and glycitein are the aglucons of soy isoflavones. For each of 
these aglucons there are three additional major isomeric forms: the p-glucosides (genistin, 
daidzin, and glycitin), the 6"-Omalonylglucosides, and the 6"-0-acetylglucosides (Figure 3). 
Isoflavone data from Wang and Murphy (1994b), using high performance liquid 
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Ri 
Isoflavone Ri R2 
Daidzein H H 
Gerastein H OH 
Glycitein OCH3 H 
isoflavone Ri Rz Rs 
Genistin H OH H 
Glycitin OCH3 H H 
Daidzin H H H 
Malonylgenistin H OH COCH2COOH 
Malonylglycitin OCH3 H COCH2COOH 
Malonyldaidzin H H COCH2COOH 
Acetylgenistin H OH COCH3 
Acetylglycitin OCH3 H COCH3 
Acetyldaidzin H H COCH3 
Figure 3. Isoflavone structures 
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chromatography analysis (HPLC), showed that the prevalence of isoflavones in whole 
soybeans on an aglucon basis was genistein=daidzein»glycitein on a mole basis, and 
relative prevalence of forms within an aglucon family generally was malonylglucoside>P~ 
glucoside>aglycone >acetylglucoside. Wang and Murphy (1994b) also were able to show 
that genetic differences dramatically affected isoflavone profile. American varieties had 
malonylglucoside/glucoside ratios of 1-3 compared to 4-6 for Japanese varieties. Crop year 
was shown to have a greater effect than crop location on overall isoflavone content. 
The soy germ isoflavone profile is different from that of whole soybeans, and the 
concentration of isoflavones in soy germ is about 10 times that in whole soybeans. Tabular 
data from Hendrich and Murphy (2001) shows that on an aglucon basis the profile for whole 
soybeans is 42:51:7 and soy germ is 45:15:40 for daidzein, genistein, and glycitein, 
respectively. If the health benefit differs among the soy isoflavones this may be significant 
since soy germ is an isoflavone-rich starting material that may be used in the production of 
isoflavone supplements. 
Soy isoflavones have received considerable investigation during the last 20 years, as data 
suggests that they may have beneficial effects on cardiovascular disease, carcinogenesis, and 
osteoporosis. The different aglucons and isomeric forms display different biological 
activities. Consequently, the quantification of these forms in foods and food ingredients is 
critical to better understand their impact on human health, maintain quality control, and 
permit accurate labeling and marketing statements. 
Much of the literature expresses isoflavone concentrations in ng/g of sample. Since the 
molecular weights of the (3-glucosides, malonylglucosides, and acetylglucosides are 
substantially different from the aglucons, concentrations should be normalized and expressed 
in terms of each aglucon or the sum of the aglucons. Murphy and others (1997) indicated 
that without this correction, summed concentrations may overestimate isoflavone 
concentrations by almost a factor of two for soymilk samples, but extent of isoflavone 
overestimations of different samples will vary according to the isomeric profile. In 
retrospect, it would have been better for authors to express data as jimol/g. Isoflavone 
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contents of soybeans, soy ingredients, and soy foods are shown in Tables 9,10, and 11. 
Table 12 shows isoflavone contents of commercial products on a |j.mol/g basis, thus enabling 
a direct comparison to saponins on a molecular basis. 
Obviously, the various types of soy foods contain widely varying concentrations of 
isoflavones. It has been generalized (Messina 1997) that raw soybeans contain 2-4 mg 
isoflavones/g while soyfoods contain 1-3 mg/g on a dry weight basis. It is difficult to 
accurately measure isoflavone intake in the U.S. However, the estimated daily median intake 
of soy isoflavones by postmenopausal women participating in the Framingham Heart Study 
ranged from 52-177 p.g, comprised of genistein and daidzein at 24-57 jo.g and 28-120 |ig (de 
Kleijn and others 1999), respectively. Kirk and others (1999), using a food frequency 
questionnaire, estimated that U.S. adults consume 7-10 and 4-6 mg per day of genistein and 
daidzein, respectively. Estimated dietary intake of isoflavones in Korea was estimated to 
total 14.88 mg/d, comprised of 7.32 mg/d genistein, 5.81 mg/d daidzein and 1.75 mg/d 
glycitein (Kim and Kwon 2001). Native Japanese adults have been estimated to consume 30-
40 mg (aglucon units) of isoflavones per day (Wakai and others 1999). This demonstrates 
the disparity of soy isoflavone intake between traditional U.S. diets and Asian diets. 
Whereas the consumption of traditional soyfoods, such as soymilk and tofu, are rapidly 
increasing in the U.S., much of the soy isoflavone intake is from soy in the form of 
ingredients in processed foods. 
Bioavailability of isoflavones for humans is affected by their absorption. Hendrich and 
Murphy (2001) suggested that evidence supports the hypothesis that isoflavone glucosides 
are not well absorbed in the gut and that human intestinal or gut microflora (i-glucosidases 
must convert the glucosides to aglucons before the isoflavones are absorbed. Brown (1988) 
reported that the glucosides are poorly hydrolyzed by mammalian intestinal digestive 
enzymes. Coward and others (1996), employing HPLC analysis, found that isoflavones from 
soy protein isolate were absorbed more slowly than those in soymilk. It was noted that in 
isolate the glucoside isoflavone distribution was pre-dominantly malonyl- and 
acetylglucosides, compared to a predominance of glucosides in the soymilk. It was 
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hypothesized that the glucosides were more readily hydrolyzed by P-glucosidases than the 
malonyl- and acetylglucosides. Since individuals may differ in the concentration 
Table 9. Isoflavone content (pg/g, as is basis) of soybeans and soy ingredients1,2 
p-glucoside malonyl acetyl Aglucon 
Totals6 Product Din Gin Glin Din Gin Glin Din Gin Glin Dein Gein Glein 
Vinton 81 
90H3 690" 852" 56d 300" 743" 50" Ie 
9= 
nd 26" 29e 20f 1636 
Vinton 81 
91I3 180e 394de 53def 241° 738" 61' tr 2C 35dc 7f 17f 20rf 995 
Green 
soybean 451d 430d 48f 515a 851" 57* tr 2C nd 10dc 16f 188 1354 
Soy flour 147f 407dc 418 261bc 1023' 57a tr Ie 32e 48 22e 19* 1124 
Soy granule 12T 870" 132" 106d 193" 60a 72e 135d 48e 12= 27d 22d 1464 
TVP A4 507° 634" 146a 93d 192cd 60* 187" 320" 90a 12e 29=0 25e 1382 
TVPB4 463d 552c 93° 129d 256° 58a 23 r 355' 68" 8* 22" 26" 1342 
Soy Isolate 
A4 tr 137s 34" 20e 100d 39e 6e nd 33e 63a 136a 53' 466 
Soy Isolate 
B4 88* 301f 49rf 18e 88d 36e 74e 215e 46e IIe" 36" 25bc 610 
Soy Isolate 
C4 133f 382e 55de 19e 95d 3 r 36d 122d 40d 12= 36" 22de 615 
Soy 
concentrate tr 18" 31" nd tr nd tr Ie nd nd nd 23d 56 
Lsd5 31 47 6 41 117 7 14 34 2 2 2 1 
Source: Wang and Murphy (1994a) 
'Data from three replications. Values in column with different letters were significantly 
different at a=0.05; dry samples. 
2Abbreviations: Din, daidzin; Gin, genistin; Glin, glycitin; Dein, daidzein; Gein, genistein; 
Glein, glycitein; tr, trace; nd, not detected. 
390 and 91, 1990 and 1991 crop years; H and I, different locations. 
4Different commercial sources. 
5Least significant difference. 
^Totals are sums of isomers after normalization to aglucon forms. 
of P-glucosidases in their gut, possibly due to differences in gut microflora, isoflavone 
distribution pattern may have dietary significance. Consequently, understanding how 
soybean storage and processing can affect isoflavone profile and distribution is of interest. 
Heat, moisture, and glucosidases are the most important factors in changing isoflavone 
distribution. Table 9 shows that soybeans and soy flour are high in malonylglucosides, but 
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heat processed soy products, such as the roasted soybeans and TVP, have distributions 
shifted substantially from malonylglucosides toward acetylglucosides. The fermented foods, 
such as tempeh and miso, have their isoflavone distributions shifted toward the aglucons 
Table 10. Isoflavone content (ng/g, as is basis) of traditional soy foods1,2 
p-glucoside malonyl acetyl Aglucon 
Totals6 Product Din Gin Glin Din Gin Glin Din Gin Glin Dein Gein Glein 
Roast 
soybeans 460b 55 ld 68" 45b 63f 72' 397" 743' 102" 39e 69e 52a 1625 
Instant 
beverage 
A3 444" 775' 76' 39b 144d 40c 5b 24b 33" 18g 44s 20d 1037 
Instant 
beverage 
B3 404° 718b IT 58b 202b 43b 8b 27" 33b 156 38h 20d 1014 
Instant 
beverage 
C3 468b 674" 68" 61" 179' 42be 9b 22b 33b 15e 32' 20d 1001 
Instant 
beverage 
D3 525" 745ab 75' 98" 259a 44" 12b 26b 33b 30f 50f 21ed 1183 
Tofu 25e 84f 8e 159ab 108e nd 8b lb 29b 46d 52f 12f 337 
Tempeh 2e 65f 14d 255' 164° nd l l b  nd nd 137e 193b 24b 625 
Bean paste nd 96ef 21° nd nd 19e lb 2b nd 271' 183e 54' 593 
Honsukuri 
miso4 72d 123e 18° nd nd 22d lb 11" nd 34f 93d 15e 390 
Fermented 
bean curd nd tr nd nd nd nd nd nd nd 143b 223' 23bc 294 
Lsd5 35 32 3 127 16 3 23 38 8 4 5 2 
Source: Wang and Murphy (1994a) 
'See Table 9.2See Table 9. 3Different commercial sources, dry powder. 4Made of rice and 
soybeans. 5Least significant difference. ^Totals are sums of isomers after normalization to 
aglucon forms. 
due to the action of fungal P-glucosidases. Coward and others (1998), using HPLC analysis, 
evaluated effects of cooking on isoflavones in soyfoods. They found that baking processed 
soy products led to conversion of malonylglucosides to P-glucosides, but frying tended to 
promote the conversion of malonylglucosides to acetylglucosides, due to decarboxylation of 
the malonylglucosides. They indicated that as food received excessive heat treatment, 
aglucon concentration increased and total isoflavone content decreased. They also suggested 
that diy heat tends to transform malonylglucosides to acetylglucosides, while moist heat 
tends to transform malonylglucosides to P-glucosides. In their case, however, the moist 
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heating was relatively mild, probably less than 100 °C, and under these conditions 
conversion from malonylglucosides to P-glucosides would be expected. 
Wang and Murphy (1996) published the first true mass balance paper for isoflavones, 
evaluating the effect of tempeh, soymilk, and tofu processing on isoflavone concentration 
Table 11. Foods containing significant concentrations (#g/g, as is basis) of isoflavones 
Food Concentration Range Reference 
Soybeans 720-2370 1 
Soy flours, defatted 610-2440 1 
Soy sprouts 250-530 1 
Soy protein isolate 456-1993 1 
Soy Protein Concentrate, 
water washed 20-318 1 
Soy Protein Concentrate, 
ethanol washed 612-1670 1 
Texturized soy protein 44-2956 1 
Hydrolyzed soy protein (HSP) 127-1621 2 
Tuna (packed in water with HSP) 22 2 
Doughnuts 85-100 2 
Pancake mix 171 2 
Soymilk 13-211 1 
Low fat soymilk 17-86 
Tofu 79-635 1 
Low fat tofu 194-200 
Tempeh 69-625 1 
Miso 227-892 1 
Natto 464-870 1 
Soy-based infant formula 202-316 1 
Edamame 1354-1860 1 
Soybean (vegetable) oil 0 1 
Bacon, meatless 121 1 
Chicken analog 146 1 
Harvestburgers® 82.2 1 
Soy cheeses 33-593 1 
Soy hotdog and breakfast sausage 34-150 1 
Soy sauce 12.7-23.0 1 
Commodity hamburgers with soy 5.5-29 1 
Adapted from Murphy and Hendrich (2002) 
'Beecher and others (1999) 
2Liggans and others (2000) 
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and profile. During tempeh production, 12% of the isoflavones were leached from the 
soybeans during the soaking/dehulling step and 49% were lost during cooking. Soaked 
soybeans had isoflavone distributions that were proportionally higher in daidzein and 
genistein glucosides and lower concentrations of these malonylglucosides. The P-glucosides 
and malonylglucosides decreased substantially during cooking, mostly due to leaching with 
Table 12. Isoflavone and saponin concentrations in commercial soy products 
Isoflavone Saponin 
Product (nmol/g, as is) (pmol/g, as is) 
Soymilk 0.5 0.5 
Tempeh 5.0 1.6 
Textured vegetable protein 8.4 4.8 
Soybean flour, 1994 4.2 3.5 
Tofu 1.0 0.6 
Isolated soy protein Supro 670 7.4 10.1 
Isolated soy protein 500E 4.2 11.2 
Acid-washed soy concentrate 2.4 10.0 
Ethanol-washed soy concentrate 0.6 0.2 
Soy hypocotyls 558 30 
Novasoy 925 115 
Source: Hu (2000) 
some conversion to acetylglucosides. Fermentation dramatically shifted the isoflavone 
profile toward aglucon forms. During soymilk and subsequent tofu manufacture, the most 
notable changes in isoflavone concentration were losses in the soaking water, okara, and 
whey fractions. Substantial profile changes occurred during the cooking step, with 
malonylglucosides being transformed to aglucon and P-glucoside forms. 
Franke and others (1999) used HPLC analysis to evaluate 25 multiethnic foods for 
isoflavone content and distribution. Their results support the leaching and processing trends 
mentioned in this section. In their summary, they noted that different laboratories measuring 
the same foods may get different results, due in part to differing analytical techniques, and 
they emphasized the need for careful quality assurance using external and internal standards 
as those described by Song and others (1998). Careful choice of extraction solvent is also 
important to maximize recovery of all soy isoflavone forms. 
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Murphy and others (2002) evaluated acetonitrile, acetone, ethanol, and methanol as 
extraction solvents for soy flour, tempeh, tofu, TVP, and soy germ. Acetonitrile, at 
approximately 53% in water, was determined to be the best choice in most cases. Murphy 
and others (2002) reported that 53% methanol was significantly less efficient than 53% 
acetonitrile, acetone, or ethanol in extracting isoflavones and saponins from tofu and textured 
vegetable protein (TVP). For TVP, 53% methanol was reported to underestimate 
acetylglucosides by 30-35% and p-glucosides and malonylglucosides by 25%. 
The following authors used 80% methanol rather than the 53% acetonitrile solution 
suggested by Murphy and others (2002). They also did not have standards for all 12 
isoflavones, most using just the aglucons and the P-glucosides to prepare HPLC standard 
curves. Singletary and others (2000) and Mahungu and others (1999) reported the effect of 
extrusion on corn/soy mixtures was that malonylglucosides decreased while acetylglucosides 
increased. The glucoside concentrations decreased, but aglucon concentrations did not 
increase. Total isoflavone concentrations were reduced 24-38% in the extruded material 
compared to the starting material. Simmone and others (2000) evaluated the impact of 
processing on isoflavone content and distribution in edamame. They also found that 
blanching/boiling caused a considerable loss in isoflavones, with the hypothesis that the loss 
was largely due to leaching of isoflavones. Boiling the immature soybeans caused a 
substantial increase in genistein and the glucosides daidzin and genistin at the expense of the 
malonylglucosides. Grim and others (2001) measured changes in isoflavone profile during 
thermal processing of tofu, Wang and others (1998) measured changes in isoflavone profile 
during processing of soy protein isolates, and Coward and others (1998) evaluated 
modification of isoflavones in soyfoods during cooking and processing. 
There is interest in isoflavone profile due to reported differences in their bioavailability 
for humans. Hendrich and Murphy (2001) have reviewed the absorption of soy isoflavones. 
Glycosidic isoflavones, the malonyl-, acetyl-, and P-glucosides, have not been detected in 
human blood plasma or urine, suggesting that these forms are transformed by glycosidases in 
the gut before being passively absorbed. The isoflavones are probably glucuronidated in the 
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gastrointestinal mucosa and in the liver. About 1/3 of adult humans can metabolize daidzein 
to equol, another isoflavone, in the gut (Murphy and Hendrich 2002). Setchell and others 
(1998) determined the plasma half-life of daidzein and genistein to be 7.9 h in adults with 
peak concentrations occurring in 6-8 hours after consumption. Plasma concentrations of 
daidzein, genistein, and equol range from 50-800 ng/mL may be achieved when food with 
about 50 mg/d is consumed. Isoflavones are excreted in urine and feces, but mass balance 
indicates that further metabolism of isoflavones occurs in the gut due to the actions of 
microbes (Hendrich and Murphy 2001). 
Information concerning the negative health aspects of soy isoflavones is limited. Zhang 
and others (1999) showed that 10 p.M genistein inhibited human natural killer cell activity in 
vitro. Kulling and others (1999) showed that 25 p.M genistein caused chromosomal 
abnormalities in human peripheral blood lymphocytes, but daidzein as high as 100 p,M did 
not yield these abnormalities. It should be noted that these concentrations are much higher 
than can be obtained through normal dietary means. It does however leave room for concern 
about abuse of isoflavone supplements. Certainly, isoflavones have been consumed by large 
numbers of humans for centuries without dramatic detrimental health impacts. However, two 
population groups, infants and breast cancer survivors, have been suggested to be at risk from 
soy isoflavones due to their mild estrogenic properties. Isoflavones have been estimated to 
possess between 10 ~5 and 10 ~2 the activity of 17 ^-estradiol on a molar basis (Messina and 
Lopronzi 2001). 
Sheehan (1997) has expressed concerns about the consumption of soybean 
phytoestrogens by infants and their potential effect on reproductive systems. He calculated 
that mothers living in Hong Kong and consuming soy in their diet deliver approximately 4 pg 
isoflavone/kg infant body weight per day. Infants fed soy-based formulas may consume as 
much as 4000 ng/kg/d. Adults consuming 50 g of soy protein per day might consume 700 
Hg/kg/d. The author notes that this amount has been shown to cause hormonal effects in 
premenopausal women. It is mentioned that little is known about the conversion of glucoside 
forms to aglucon forms in the infant gut. However, Setchell and others (1997) indicated that 
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(3-glucosidase activity is high enough by four months of age to hydrolyze isoflavone 
glycosides to aglucons. Murphy and others (1997) showed that several major soy-based 
infant formulas contained isoflavones that were primarily in the glucoside or 
malonylglucoside forms. 
The American Academy of Pediatrics recommends breast feeding or cow's milk-based 
formulas, but states that soy protein-based formulas are a safe and effective alternative. It 
has been estimated that approximately 25% of the nearly 4 million newborns in the U.S. 
consume infant formula (AAPCN 1998). Badger and others (2002) cited several studies that 
demonstrated normal growth and development of soy formula-fed infants. Strom and others 
(2001) followed up on a small cohort of 811 male and female subjects, now aged 20-34 
years, that had consumed either cow's milk or soy-based formula as infants. No statistically 
significant differences were found for growth, development, puberty, reproductive function 
and pregnancy outcomes. Clearly larger cohorts will need to be followed to calm fears about 
potential estrogenic and reproductive effects on infants. 
Part of the basis for this reproductive and developmental concern relates to the observed 
effects of a clover diet on Australian sheep. The isoflavone formononetin was high in that 
clover, was converted to equol, and led to reproductive disorders and infertility (Bennetts and 
others 1946). Although about 1/3 of adult humans can metabolize daidzein to equol in the 
gut (Murphy and Hendrich 2002). Badger and others (2002) reason in their review of the 
subject that equol is nearly undetectable in infants fed soy based-infant formula and that the 
physiological differences between adult sheep and infant humans makes comparison 
difficult. They also point out that soy products containing isoflavones have been consumed 
for centuries in countries with high population growth and that sexual development and 
fertility problems have not been observed in those populations. 
Concerns about isoflavone consumption by infants will likely continue to be a topic for 
considerable debate until definitive studies are done to gauge the impact of the isoflavones on 
infants. The impact of isoflavones on breast cancer patients will also require further 
consideration. Conflicting data prevent a confident recommendation for this segment of the 
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population. Messina and Loprinzi (2001) present a lengthy review of this topic that is far 
beyond the scope of the current literature review. They cite studies that show isoflavones, 
particularly genistein, have been shown to both stimulate and inhibit cell or tumor growth 
depending on the animal model. Since many women who have had breast cancer are now 
taking tamoxifen, which binds to estrogen receptor sites competitively against estrogen, 
consideration was given to what interaction or impact isoflavones might have on this drug. 
Results were conflicting for in vitro studies, but in vivo studies suggested that there was no 
harm and potentially a benefit to consuming soy isoflavones. Gotoh and others (1998) 
evaluated control, 10% miso, tamoxifen, and miso plus tamoxifen diets to rats with N-
nitroso-N-methylurea-induced mammary cancer. Tumor incidence was 91, 77, 68, and 10% 
and tumor multiplicity was 4.5,2.4,1.4, and 0.2%, respectively, for the different diets. 
Constantinou and others (2001) evaluated tamoxifen, soy protein isolate, and the 
combination on DMBA-induced mammary carcinogenesis. Tamoxifen reduced the number 
of tumors per rat by 29%, while soy protein isolate and the combination reduced the number 
of tumors by 37 and 62%, respectively. Messina and Loprinzi concluded that the data does 
not clearly show whether soy is harmful or beneficial to breast cancer patients, but suggested 
that if women enjoy consuming soy foods that they should continue to do so in moderation. 
The health benefits of isoflavones may include diminished menopausal symptoms, 
improved cardiovascular health, decreased osteoporosis, and cancer inhibition. It should 
again be noted that it is difficult to say with certainty that some other component of soy is not 
responsible for some of the benefits. It is possible that two or more components of soy act 
synergistically. 
Isoflavones, Soy, and Menopausal Symptoms 
Hot flushes are one side effect of menopause. Hormone replacement therapy (HRT) has 
been used to diminish flushes and protect against CHD and osteoporosis. However, recent 
reviews question the efficacy of HRT for preventing the latter conditions (van der Schouw 
and Grobbee 2001, Grady and Cummings 2001). HRT is also questionable for women with a 
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family history of breast cancer. Isoflavones are being promoted as estrogen replacements 
and many food items and supplements are marketed toward these consumers. Setchell and 
Cassidy (1999) reviewed recent literature and suggested that phytoestrogens were able to act 
as weak estrogens, especially in postmenopausal women. Evaluating the effect of soy foods 
on hot flushes has led to conflicting results and a high placebo effect (Albertazzi and others 
1998, Baird and others 1995, Brzezinski and others 1997, Murkies and others 1995). 
Isoflavones, Soy, and Cardiovascular Health 
In 1999, the US FDA made it clear that they believed there is a relationship between soy 
consumption and cardiovascular health. A cardiovascular health claim for a soy food can be 
applied when each serving has 6.25 grams of soy protein, contains less than 3 grams of fat 
(limit does not apply if all fat is from soy), contains less than 1 gram of saturated fat (total 
amount of saturated fat must not exceed 15% of total calories), contains no more than 20 
milligrams of cholesterol, and contains less than 480 mg of sodium (main dish and meal 
products must contain <720 or <960 mg sodium, respectively). Studies have shown that soy 
consumption and/or isoflavone consumption leads to lower serum cholesterol and lower LDL 
to HDL ratios in humans (Anderson and others 1995), decreased atherosclerosis in monkeys 
(Anthony and Clarkson 1998), and increased arterial elasticity in women (Nestel and others 
1997). 
As mentioned when discussing saponins and hypocholesterolemia above, researchers do 
not agree on the active components in soy for these cardiovascular health benefits. A review 
by Sirtori and Lovati (2001) presents evidence that suggests that soy proteins, particularly the 
7S fraction, are responsible for the hypocholesterolemic effects and point out studies in 
which ethanol-extracted soy devoid of soy isoflavones had no effect. Cassidy and others 
(1995) showed that isoflavones reduced total and LDL cholesterol in young women when 
they received a dose of 45 mg/day. Nestel and others (1997) showed that a 45 mg/d dose of 
genistein over several weeks did not change lipid profiles in women. Hendrich and Murphy 
(2001) suggested that soy isoflavones are not the only components of soy responsible for the 
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hypocholesterolemic effects and point out that the FDA did not include a statement about soy 
isoflavones in the soy health claim statement. 
Murphy and Hendrich (2002) propose mechanisms for the cardiovascular protecting 
effects of soy and soy components as: plasma lipid and profile improvement, mediated 
effects on blood pressure, effects on vascular and endothelial cell functions, platelet 
aggregation, activation and serotonin storage, LDL oxidation state, smooth muscle 
proliferation, estrogen receptor mediated-effects, and LDL receptor interactions. Research 
will continue in the attempt to elucidate the soy components and their roles in minimizing 
cardiovascular disease. 
Isoflavones, Soy, and Osteoporosis 
Soy seems to play a role in diminishing or preventing osteoporosis. Again, whether the 
active component is isoflavones or some other component of soy is unclear. Some evidence 
suggests that isoflavones likely play a role. A synthetic isoflavone, ipriflavone, lacks 
estrogenic activity but is structurally similar to daidzein and genistein, and one of its 
metabolites is daidzein. Ipriflavone is approved as an alternative to hormone replacement 
therapy for bone loss prevention. Aijmandi and others (1996) fed ovarectomized rats 
isoflavone-containing soy or casein. Bone retention was observed for the rats containing the 
soy diet. Messina and others (2002) pointed out in their review that three human studies with 
women indicated that isoflavone-containing or isoflavone-spiked soy diets favored bone 
density retention while another study did not. 
Murphy and Hendrich (2002) concluded that there is not enough evidence for a 
osteoporosis health claim for soy or isoflavones, but suggested that 60-90 mg of isoflavones 
per day, approximately 2-3 servings of traditional soy foods, may be useful for women 
concerned about osteoporosis to consume if they choose not to undergo hormone 
replacement therapy. 
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Isoflavones, Soy, and Cancer 
Barnes and others (1990) proposed that isoflavones in soybeans were responsible for 
tumor inhibition in chemically induced mammary cancer in rats. They fed both raw and 
autoclaved soy. Theoretically, 90% of the protease inhibitors should have been destroyed 
during autoclaving, with some Bowman-Birk inhibitor remaining. Yamashita and others 
(1990) showed that genistein inhibited tyrosine protein kinases, DNA topo-isomerases, and 
S6 kinases, at least in during in vitro experiments. Lamartimiere and others (1998) presented 
data that suggested genistein, when given in pharmacological doses to pregnant rats, caused 
mammary gland differentiation or maturation in their pups that yielded tissue less susceptible 
to carcinogenic insult. Messina and others (2002) described a study in which 100 mg/d 
isoflavone supplement was consumed by premenopausal women. No change in tissue 
density was observed. Decreased breast tissue density, such as that usually seen with 
tamoxifen use, generally is related to reduced cancer risk. They related that another study in 
women consuming 40 mg/d isoflavones from red clover did experience significantly reduced 
tissue density. These are good signs that isoflavones do not promote breast cancer and may 
reduce cancer risks. Murphy and Hendrich (2002) indicate that many in vitro studies have 
shown that genistein or daidzein alter cancer cell proliferation, but these occurred when using 
concentrations greater than that would be experienced from dietary soy and isoflavone 
consumption, considered to be in the range of 0.01 to 5 |iM. 
Asian men have lower incidences of prostate cancer than Europeans (Morton and others 
1997) and exhibit a higher concentration of equol and daidzein in their plasma and prostatic 
fluid. Since prostatic cancer responds to estrogen therapy, the authors suggested that 
phytoestrogens may play a role in reduced risk in prostate cancer. Pollard and Luckert 
(1997) showed that a rat model consuming an isoflavone-rich diet had a reduced rate of 
prostate cancer and a prolonged disease-free period when fed a soy-rich diet. Peterson and 
Barnes (1991 and 1993) were able to show that genistein and biochanin A inhibit growth of 
prostatic cancer cells in vitro. These results are promising, but more and long-term studies 
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need to be done in humans to determine the true effect of soy and soy phytochemicals on 
prostate cancer. 
E. Quantification of Isoflavones and Saponins and Preparation of Enriched Fractions 
Isoflavone Quantification 
Isoflavones are extracted by aqueous organic solvent solutions. A comparison of 
effective solvents has been reported by Murphy and others (2002). High performance liquid 
chromatography (HPLC) analysis has been the workhorse for quantification of isoflavones in 
food samples, as detailed in the "Isoflavone" section of this literature review. To accurately 
quantify soybean isoflavones, all 12 of the major isoflavone forms (aglucons, p-glucosides, 
6"-0-acetylglucosides, and 6"-0-malonylglucosides) must be purified and standard curves 
must be prepared for each. Purified standards of the aglucons and P-glucosides are 
commercially available. LC Laboratories (Woburn, MA) and Indofine Chemical Company, 
Inc. (Somerville, NJ) claim to have all 12 soy isoflavones commercially available. However, 
difficulties have been encountered purchasing the malonylglucosides. These isoflavones are 
labile, making them difficult to purify and retain in purified form without conversion. All 12 
of the major soy isoflavone forms (aglucons, P-glucosides, 6"-0-acetylglucosides, and 6"-0-
malonylglucosides) have been purified and quantified in our laboratory and used to develop 
the necessary standard curves. Klump and others (2001) have developed a process for 
alkaline heat extraction of isoflavones in which malonyl- and acetylglucosides are converted 
to P-glucosides for analysis. This is now an AO AC method and presents the advantage that 
laboratories only need to prepare standard curves for the aglucon and P-glucosides. The 
disadvantage of this method is the inability to evaluate the true isoflavone profile of the 
sample material. 
Murphy and others (1999) have detailed a quantification procedure employing HPLC 
analysis and have used it to build a USD A database for isoflavones in food products, as well 
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as measure isoflavones in urine, fecal, and plasma samples. HPLC analysis is an excellent 
method for quantifying isoflavones, but some have felt that the approximately one hour per 
sample run time was too slow and that other methods were more sensitive. 
Wang and Sporns (2000) have described a matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry (MALDI-TOF MS) method for isoflavone quantification. 
The authors report that a MALDI-TOF MS analysis can provide an isoflavone profile in 2 
min. In their study, only daidzin and genistin were evaluated as standards. HPLC coupled 
with MALDI-TOF allowed them to evaluate peaks that they assumed were other isoflavones, 
basing this assumption on their HPLC retention times compared to those reported by other 
researchers. 
Fang and others (2002) characterized isoflavones in rat urine using liquid 
chromatography/mass spectrometiy/mass spectrometry. This method was not faster than 
regular HPLC analysis, actually taking 80 min per sample, but did offer the advantage of 
assisting in identifying isoflavones and their metabolites. Daidzein, genistein, biochanin A, 
glycitein, dihydrodaidzein, dihydrogenistein, and O-desmethylangolenstein were used as 
standards. The authors reported the method to be simple and sensitive. 
Holder and others (1999) reported the use of liquid chromatography/electrospray-mass 
spectrometric quantification of genistein and daidzein and conjugated isoflavones in rat 
blood. Their extraction efficiency, using acetonitrile followed by a lengthy sample 
preparation process, was approximately 85% for genistein and the detection limit was 
reported to be 15 nM. The authors reported that an advantage of the LC/ES-MS method over 
LC/MS was the ability to measure isotopically-labeled internal standards. 
Some reported isoflavone quantification methods do not use HPLC. Creeke and others 
(1998) and Bennetau-Pelissero and others (2000) have described the use of ELIZA to 
measure pg and pmol quantities of soy isoflavones extracted from plasma or soy samples, 
respectively. Gas chromatography has been used to measure isoflavones in foods and non­
food seeds (Mazur and others 1998, Liggins and others 1998). 
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A problem with most of these methods is the cost to purchase, maintain, and effectively 
operate the required equipment. HPLC analysis will likely continue to be the preferred 
method for isoflavone analysis. 
Saponin Quantification 
Hu and others (2002) describe a method for quantification of Group B saponins. 
Previously, there was not a method to quantify saponins V, I, and II and their DDMP-
conjugated forms (ag, (3g, and (3a) in the same analysis. Formononetin was used as an 
internal standard. Ireland and others (1985), Oleszek and others (1990), and Tsukamoto and 
others (1995) have reported methods for HPLC-mass detection or ultraviolet absorbance 
detection to measure different saponin forms, either modified or unmodified. 
Dalluge and others (2003) have developed a liquid chromatography/electrospray 
ionization-mass spectrometry method to simultaneously identify all 12 soy isoflavones and 
13 soyasaponins, as well as quantify soyasaponin By Glycyrrhizin was used as an internal 
standard. 
Gu and others (2002) used liquid chromatography-mass spectrometry to simultaneously 
quantify all group A and group B soyasaponins. The structural similarity of these 
compounds has made them difficult to resolve by other methods. Samples were treated 
under mild conditions with sodium hydroxide to deacetylate group A saponins and cleave the 
DDMP moiety from the group B saponins. According to the authors, "Soyasaponins 
originating from the same initial structures were unified into well-defined structures and then 
quantified individually using the selective ion recording of their [M-H]~ ions." Quantification 
limits of group A and group B saponins were 1.74 and 1.89 ng, respectively. Recovery rates 
were 94.1 and 96.9%, respectively. 
Hemolysis (Birk and others 1969), colorimetric (Hostettmann and Marston 1995), gas 
chromatography-flame ionization detector (Meyer and others 1990), and gas 
chromatography-mass spectrometry (Price and others 1984) have been used for saponin 
quantification. Thin layer chromatography, a relatively simple, inexpensive method for 
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qualitative and quantitative analysis, has been an important tool for evaluating samples. 
Various capacities of this technique have been described by Shimoyamada and others (1990), 
Shiraiwa and others (1991), Price and others (1986), Curl and others (1988), Karikura and 
others (1991), and Hasegawa and others (1996). 
Most laboratories may find that equipment costs and technical expertise may limit them 
to using HPLC for the qualitative and quantitative analysis of soyasaponins. 
Preparation of Enriched Fractions 
Soy isoflavones are currently a desired ingredient for the supplement market and 
soyasaponins may be the next ingredient of interest. This is a brief review concerning 
methods to prepare enriched fractions. 
Kelly and others (2000) have described a pilot-scale method to extract aglucon 
isoflavones from defatted soy flour. A 7,000-kg quantity of soy flour was placed in a 
10,000-L vessel containing 5,000 L of water and 10 kg of (3-glucanase. A 1,000-L volume of 
ethyl acetate was layered on top. Glucoside isoflavones leached from the soy flour during 
agitation were hydrolyzed to the aglucon form and removed into the ethyl acetate phase. 
After about 18 h the agitation was stopped, separation of the phases occurred, and the ethyl 
acetate layer was removed. The ethyl acetate was evaporated until about 20 L remained. To 
this slurry 200 L of hexane were added and mixed for five min and then allowed to stand 
overnight. This produced a sludge, which was collected and dried at 85 °C. This material 
contained about 60% isoflavones. A more enriched fraction can be produced if the starting 
material is soy hypocotyls. A genistein-rich fraction can be recovered from the isoflavone-
rich dried sludge produced from soy flour or soy hypocotyl material. Approximately 3 kg of 
material was mixed with 1,000 L of acetone for about 2 h. After settling, the solvent was 
removed and evaporated leaving a genistein fraction that was about 92% pure, with the 
residual being daidzein and glycitein. Genistein purity was further increased to about 98.5% 
by employing an additional extraction step using ethanol at 80 °C, an ethanol volume 
reduction of approximately 70%, followed by crystallization of genistein upon cooling. 
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Gugger and others (2001) disclose a process by which soy solubles were heated to 80 °C, 
then passed through an ultrafiltration system with a 10,000 MW cutoff. From 15.26 kg of 
starting materials 9.4 kg of permeate were recovered. The permeate contained 6.6 g of 
isoflavones. Diafiltration of the retentate yielded another 2.14 g of isoflavones. Also 
described is the further purification of the permeate using a resin-packed glass liquid-
chromatography column. 
Waggle and others (2002) have described a method to recover isoflavones from soy 
molasses, the liquid material produced during aqueous acid or aqueous ethanol leaching of 
defatted soy flakes to produce soy protein concentrate. Enzymes were added to the molasses 
to convert almost all glucoside isoflavones to aglucons. Aglucons were precipitated by 
lowering the pH to about 4.5 and chilling to about 4 °C. The precipitate was formed into a 
cake by centrifuging, and the cake contained about 2-5% isoflavones by weight. 
Because isoflavones and soyasaponins are amphiphilic compounds that are extractable 
with weak organic solvent in water mixtures, soyasaponins are a likely contaminant of the 
enriched isoflavone fractions described above. Indeed, Dobbins (2002) described a method 
to recover an enriched saponin fraction starting from commercial soy isoflavone 
concentrates. Isoflavone concentrate was added to a 4:1 acetone and water solution, and then 
refluxed at 56 °C for 90 minutes. This material was filtered while maintaining temperatures 
above 50 °C. The filtrate was cooled to 5 °C and the precipitate that was formed was 
recovered by filtration. The recovered precipitate was 86% saponins and contained 0.2% 
isoflavones by weight. Isoflavones could be recovered from the stripped filtrate by 
extracting with hexane at 60 °C, mixing, settling, and dividing the two layers. Lecithin and 
fats remained in the hexane layer, while isoflavones were precipitated out of the aqueous 
layer at <10 °C. This filtered precipitate was found to be 72% isoflavones. 
Dobbins' process demonstrates the difficulty in separating isoflavones from saponins. 
Preparation of very pure fractions can only be accomplished with extensive chromatography. 
This separation problem will plague or add expense to projects designed to elucidate the 
biological properties of these two phytochemicals. 
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F. Soy Protein Structure 
On a dry weight basis, average soybeans contain 40% protein, and the protein is stored in 
protein bodies, which usually have a diameter of 5-8 jxm but can range in size from 2-20 |im. 
There has been some disagreement whether protein bodies are bound by membranes. 
Pemollet (1978) indicated that crystalloid protein bodies did not have membranes. Recent 
work, however, suggests that they are bound by Golgi- or endoplasmic reticulum-derived 
membranes (Herman and Larkins 1999, Kinney and others 2001). Boatright and Kim (2000) 
were able to show that membrane-bound crystalloid structures were visible with transmission 
electron micrography when samples were fixed at pH 6.4 and 5.6, but were not observed well 
when fixed at pH 7.2, a pH in the range of 7.0-7.4 commonly used for biological tissues. 
Ultracentrifugation of water-soluble protein extracts shows four major fractions with 
sedimentation values of 2S, 7S, 1 IS, and 15S. Wolf (1969) provided a sedimentation profile 
of these fractions. The 2S fraction contains, among other components, Kunitz and Bowman-
Birk protease inhibitors and cytochrome c. The 7S fraction contains the a-, (3-, and y-
conglycinin proteins, with p-conglycinin being the predominant form at about 50% of the 
three proteins. The 7S fraction may also include lectin, lipoxygenase, and p-amylase. The 
11S fraction contains the glycinin protein fraction. The 15S fraction is thought to be an 
aggregation of glycinin. At low ionic strength (e.g. 0.1 vs. 0.5 M) a 9S fraction exists. The 
9S fraction is thought to be a dimer of the 7S fraction. Nielsen (1985a) suggested that the 
proportions of these fractions are about 20,33,33, and 10% for 2S, 7S, 1 IS, and 15S, 
respectively. Lehnhardt and others (1983) reported that a commercial extraction of soy will 
contain these protein fractions at 22,37, 31, and 11%, respectively. 
Because the 7S and 11S globulin fractions comprise the majority of the extractable 
proteins, they have received the most attention. P-Conglycinin, the predominant 7S protein, 
is a trimer with a molecular mass of 150-200 kDa. It is a glycoprotein with a carbohydrate 
content of about 5%. Three major and one minor subunits have been identified: a, a', p, and 
y (minor). Thanh and Shibasaki (1976a) determined that the molecular mass in kDa of a, a', 
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(5 to be 57, 57, and 42 by electrophoretic 'mobility in SDS-polyacrylamide gels, respectively, 
while Medeiros (1982) reported these values to be 72, 68, and 52 kDa. These subunits have 
been found to combine in several different combinations within P-conglycinin trimers: a'pz, 
«Pz, aa'P, a%P, a%a% «3, and P3 (Thanh and Shibasaki 1978, Yamauchi and others 1981). 
The 11S glycinin is a hexamer with a molecular mass of300-380 kDa. Each of the 
subunits comprising the hexamer has an acidic polypeptide (acidic pi, -35 kDa) and a basic 
polypeptide (basic pi, -20 kDa), and these polypetides are linked by a disulfide bond. Six 
acidic and five basic subunit types have been identified and have been observed to naturally 
assemble as: AiaBn>, A2Bia, AibB2, A5A4B3, and A3B4 (Nielsen 1985b). 
Utsumi and others (1997) and Liu (1997) provide more complete reviews about 1 IS and 
7S structure and amino acid sequence. The 1 IS and 7S, or glycinin and P-conglycinin 
fractions, are primarily responsible for the functional properties of soy proteins. 
Fractionation of these proteins is of interest to better understand their separate contribution to 
functionality, to evaluate their impact on nutrition and potential health benefits, and to 
identify opportunities for new product development. 
G. Fractionation of Soy Proteins 
Differing physicochemical characteristics of the 1 IS and 7S protein fractions, such as 
isoelectric point, thermally-induced precipitation behavior, chemical interaction with 
reducing agents, and sensitivity to ionic strength, are among those used to aid in the 
fractionation of these proteins. Early research evaluated these parameters at the bench scale, 
but more recently these have been explored at pilot and industrial scales. 
Osborne and Campbell (1898) used a 10% sodium chloride solution to extract soy 
protein. The protein remaining after dialysis against water was termed glycinin. They also 
reported preparing three other fractions. Other researchers reported preparing soy extract 
fractions that had different isoelectric points and displayed different nitrogen concentrations. 
Consequently this "glycinin" fraction was recognized as being very heterogeneous. Nielsen 
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(1985a) credits Roberts and Briggs (1965) as one of the early researchers isolating and 
characterizing conglycinins and Catsimpoolas and Ekenstam (1969) for coining the three 
immunologically distinct fractions of conglycinin as a, (3, and y. 
Wolf and Sly (1967) used ultracentrifugation to explore whether meal to extraction ratio, 
extraction temperature, rate of cryoprecipitation, pH, and addition of reducing agents, 
sucrose, or salts improved cryoprecipitation of 1 IS proteins from 15S (soy protein polymers), 
7S, and 2S (containing trypsin inhibitors) proteins. They observed a direct relationship 
between an increase in protein extraction temperature and contamination of the 1 IS fraction 
by 15S, 7S, and 2S proteins, but 1 IS concentration from extract produced at 40 °C was twice 
that produced at 25 °C. Cryoprecipitation of 1 IS in 10 mL of extract at 0-2 °C was generally 
complete in less than one hour. Concentrations of sodium chloride and sucrose 
greater than 0.3 and 0.6 M, respectively, inhibited cryoprecipitation, but calcium chloride 
enhanced quantitative isolation of the 1 IS fraction. Reducing agents did not affect 
cryoprecipitation. These data were generated from bench-scale experimentation. Eldridge 
and Wolf (1967) and Wolf and Briggs (1959) also describe bench-scale purification and 
characterization of 11S protein. 
Roberts and Briggs (1965) described a bench-scale isolation and characterization of 7S 
protein accomplished by sequential salting out with ammonium sulfate coupled with cold 
treatments. A 2% globulin extraction in 0.5 ionic strength buffer at pH 7.6 was treated with 
ammonium sulfate or cold treatment to produce precipitate fractions. Precipitates were 
removed at: 1) 0.40 saturation, 2) 0.50-0.55 saturation, 3) cold treatment, 4) 0.60 saturation, 
5) cold treatment, and 6) 0.80-0.90 saturation. Fraction 1 contained primarily 2S proteins. 
Fraction 2 contained most of the 15S proteins and primarily 1 IS proteins with contaminating 
amounts of 2S and 7S. Fractions 4 and 5 were both comprised of 70% 7S and 30% 11S 
proteins. Fraction 6 contained 85% 7S, 5% 2S, and 10% 1 IS. This may have been suitable 
for producing small quantities of enriched 7S, or P-conglycinin fraction, but it is not practical 
for large-scale production of that fraction. 
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Thanh and Shibasaki (1976b) described a straightforward means to sequentially 
fractionate the 11S and 7S fractions. They used a meal to 0.03 M Tris-HCl buffer ratio of 
1:20 at pH 8.0 containing 0.01 M 2-mercaptoethanol to extract the soluble soy protein. The 
insolubles were removed by centrifugation, then the supernatant was acidified to pH 6.4 with 
2N HC1. The 1 IS (glycinin) precipitate was removed by centrifugation. The supernatant 
was acidified to pH 4.8. The resulting 7S (P-conglycinin) precipitate was suspended in 0.03 
M Tris-HCl and dissolved by increasing the pH to 7.6 with 2 N NaOH. Then the pH was 
adjusted to 6.2. After centrifugation the supernatant fraction contained the 7S globulin 
fraction and the precipitate fraction contained the 9S, or dimerized 7S fraction. Thanh and 
Shibasaki claimed that there was veiy little cross contamination between the two fractions. 
However, Iwabuchi and Yamauchi (1987), using immunological methods, determined that 
the method of Thanh and Shibasaki produced a glycinin fraction that was 79% glycinin, 6% 
P-conglycinin, and 15% other, whereas the P-conglycinin fraction contained 52% p-
conglycinin, 3% glycinin, and 45% other. 
O'Keefe and others (1991) modified Thanh and Shibasaki's method. Instead of using 
precipitation at 6.4 and 4.8 to recover the glycinin and P-conglycinin fractions, they 
incorporated an additional precipitation step at pH 5.3. This method produced a crude p-
conglycinin fraction that had less contamination by glycinin, verified by SDS-PAGE, but the 
authors reported a decrease in yield of P-conglycinin fraction. Some of the loss undoubtedly 
occurred in the intermediate fraction precipitated at pH 5.3. Immunoelectrophoresis 
indicated no immunoreactive glycinin in the P-conglycinin fraction and only 0.06% P-
conglycinin in the glycinin fraction. It should be noted, however, that denatured forms of 
contaminating glycinin and P-conglycinin would not have been quantified by the 
Immunoelectrophoresis, possibly suggesting less contamination than was actually present. 
Nagano and others (1992) also developed their own modified version of Thanh and 
Shibasaki's method. They used a meal to solvent ratio of 1:15 rather than 1:20, an extraction 
pH of 7.5 rather than 8.0, and water as the extracting solution rather than 0.03 M Tris buffer. 
After insolubles were separated from the solubilized protein, sodium bisulfite at (0.98 g/L) 
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was added, rather than 2-mercaptoethanol. The supernatant was acidified to pH 6.4 and the 
mixture was chilled overnight on ice. The glycinin precipitate was removed by 
centrifugation, and then the ionic strength of the supernatant was increased by adding sodium 
chloride until the concentration was 0.25 M. This solution was then acidified to pH 5.0. 
This produced an intermediate fraction than Thanh and Shibasaki's method did not produce, 
but similar to the intermediate fraction prepared by O'Keefe and others. After the 
intermediate fraction was removed by centrifugation, a two-fold dilution of distilled water 
followed by acidification to pH 4.8 was used to precipitate the P-conglycinin fraction. 
Nagano and others indicated that their glycinin and P-conglycinin fraction purities were both 
greater than 90% according to SDS-PAGE densitometry results. 
Several U.S. patents have been awarded for protein fractionation processes. Davidson 
and others (1979) disclosed a pilot-scale process by which four different protein fractions 
with different functional properties could be produced from a soy protein extract. Defatted 
soy flakes with a minimum nitrogen solubility index of 60 were agitated with water at a 1:5 
ratio. Extraction was carried out at 55 to 70 °C for 15 to 50 minutes at pH 6.2 to 6.8, the pH 
of an aqueous extraction of the flakes without additional pH adjustment. Insolubles were 
removed by centrifuge or by screening. The authors stated that to improve protein recovery 
from the insoluble fraction two extraction passes could be employed using a 8:1 solvent-to-
flake ratio. A counter-current process was described by which the extract from a previous 
extraction was used to extract proteins from unextracted flakes. Flakes that have been 
extracted once were exposed to fresh water for the second extraction. The extraction was 
carried out at about 65 °C with 15 minutes of extraction time for each step. The resulting 
extract was about 10 to 11% solids and 6 to 7% protein. The recovered extract was cooled to 
5 to 10 °C over one to three hours, then held at that temperature for about one hour. This 
first precipitate fraction (Fraction 1) was then removed by centrifugation, yielding a yellow, 
stringy curd. The precipitate, or curd, was then either freeze-dried, spray-dried, or received 
additional washing. Before washing the curd, the pH was lowered to 5.3, then washed at 
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27 °C, and then the pH was adjusted to 6.3 to 6.8 before drying. The supernatant was further 
processed in one of two ways. 
The first process method included decreasing the pH of the supernatant to 4.5, near the 
isoelectric point. The resulting curd (Fraction 2) was removed by centrifugation and dried. 
The second process began by heating the extract back to 32 to 38 °C, then acidifying to 5.3. 
The resulting precipitate (Fraction 3) was removed by centrifugation, washed, neutralized to 
pH 6.5, and then dried. The whey from the previous step was brought to 10 to 16 °C and 
acidified to pH 4.5. The resulting curd (Fraction 4) was rubbery and was freeze-dried rather 
than spray-dried due to the difficulty encountered in preparing a suspension. It could be re-
dissolved by adding water and adjusting the pH to 6.8, after which it could be spray dried. 
The patented process of Davidson and others was essentially a two-stage process yielding 
glycinin and P-conglycinin fractions or a three stage process yielding a glycinin, 
intermediate, and P-conglycinin fraction. The low extraction pH likely led to a poor recovery 
of soluble proteins as it was at or near the pH of 6.4 used to precipitate glycinin in other 
fractionation processes. Additionally, freeze drying would not be practical for pilot- or 
industrial-scale processes. 
A patent by Howard and others (1983) disclosed a method to make 7S and 11S fractions. 
They referenced early patents concerning soy protein isolate production and isolation of 
glycinin. Their invention suggested the use of defatted soybean meal, soy flour, soy grits, 
soy protein concentrates, and/or soy isolates as starting materials. Solvent-to-flake ratios of 
5:1 to 20:1 were specified, with a ratio of 10:1 reported as optimal for 7S and 1 IS extraction. 
While extractions could be carried out at 6.0 to 10.0, they indicted that 7.0 to 8.5 was best to 
preserve the native characteristics of the 1 IS and 7S proteins. A 20 to 40 °C temperature 
range was cited as best for extraction, but it was indicated that temperatures of up to 50 °C 
could be used for short periods, i.e. two minutes or less. 
The first example of the process of Howard and others (1983) produced three protein 
fractions. Fraction 1 was 95% 1 IS as determined by SDS-PAGE, while the second fraction 
contained 30% 7S and 70% 1 IS. The third fraction reportedly was 95% 7S. These products 
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were produced from defatted soy grit. The grits were extracted with a 10:1 solvent-to-flake 
ratio at pH 8.0 for 30 minutes at 22 °C. The extracting solution also contained 0.03 M 
sodium chloride and 0.77 mM sodium bisulfite. The extract was acidified to pH 6.0 to 
recover the 11S fraction. The resulting supernatant was acidified to pH 5.5 to recover the 
mixed 1 IS and 7S fractions. Acidification of the resulting supernatant to pH 4.5 precipitated 
the 7S fraction. 
Also disclosed in the patent by Howard and others (1983) was the effect of varying the 
ionic strength and reducing strength of the extraction solution. At pH 6.0 the percent curd 
yield increased dramatically from 3.2 to 19.7% as sodium chloride concentration was 
increased from 0 to 0.02 M. Contamination of 11S curd by 7S generally decreased as sodium 
chloride concentration was increased. It was shown that when sodium bisulfite was omitted 
or was present at concentrations greater than 2.5 mM a significant portion of the 7S fraction 
was insoluble and contaminated the 11S curd. A range of 0.48 to 1.92 mM was determined 
to be acceptable to keep the 7S fraction soluble during acid precipitation of the 11S and 
mixed 11S/7S fractions. Solubility of the 7S fraction was less than 80% in this bisulfite 
range at pH 5.5. 
Lehnhardt and others (1983) disclosed a dramatically different approach in the patent for 
pilot-scale 1 IS and 7S protein fractionation. In their first example they used a 14:1 solvent-
to-defatted soy grit ratio stirred slowly for one hour at 40 °C and pH 8.0. The extract was 
acidified to pH 4.3. The isoelectrically precipitated curd was isolated by centrifugation. The 
curd was dispersed in water at a ratio of 15 (dry solids basis) to 85. Sodium bisulfite and 
sodium chloride were added to prepare concentrations of 7.5 mM and 0.1 M, respectively, 
and this solution was stirred at 21.5 °C for 30 minutes at pH 4.5. The pH was then adjusted 
to pH 5.3 and stirring was continued for one hour. The resulting suspension was 
centrifuged. The resulting 11S curd reportedly was comprised of 70.5% 11S and 29.6% 7S 
as determined by SDS-PAGE. The 7S-containing extract was again acidified to precipitate 
the 7S fraction, which was removed by centrifugation. The 7S fraction reportedly had only 
11% contamination. 
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Lehnhardt and others (1983) also evaluated the effect of the 7S extracting medium pH on 
the composition of the 7S soluble and 1 IS insoluble fractions. As the pH was increased from 
5.1 to 5.6, the percentage of 7S in the 7S fraction decreased from 94.9 to 46.6%. The 7S 
composition of the insoluble 11S fraction decreased from 40.0 to 23.1 % over the same pH 
range. The composition of the pH 4.3 curd was 37.4 % 7S and 51.0% 1 IS. The authors 
indicated that it was desirable to allow some contamination of the 7S fraction by 11S to 
provide ease of manipulation of the 7S fraction, which otherwise would be a highly visco-
elastic gum. 
Wu and others (1999) described a pilot-scale fractionation process yielding kilogram 
quantities of fractionated soy storage proteins. The process parameters were quite similar to 
that of Nagano and others (1992). Fifteen to twenty kg of defatted soy flakes were 
suspended in water at a solvent-to-flake ratio of 10:1 to 15:1. The pH was adjusted to 8.5 
and the suspension was stirred for one hour at 20 °C. The insolubles were removed by 
centrifugation, and then mixed with water at a 1:10 or 1:5 ratio. The second extraction, also 
at 20 °C, lasted for 30 minutes. Insolubles were again removed by centrifugation. The 
extracts from the first and second extraction steps were combined, sodium bisulfite added at 
0.98 g/L, the solution was acidified to pH 6.4, and the suspension was chilled overnight at 
4 °C. The glycinin, or 1 IS, precipitate was removed by centrifugation. Sodium chloride was 
added to the supernatant to prepare a 0.25 M concentration and the solution was acidified to 
pH 5.0. After stirring for one hour, the suspension was centrifuged to remove an 
intermediate fraction comprised primarily of glycinin and p-conglycinin proteins. Water was 
added 2:1 to the supernatant, the pH was lowered to 4.8, and the suspension was chilled at 
4 °C overnight. The P-conglycinin fraction was recovered by centrifugation. 
Wu's process was sequential in nature and utilized continuous centrifuges. Continuous 
centrifuges may not return yields as high as those produced at the bench scale using high­
speed, batch centrifuges, because the de-watering capabilities are not as good. However, the 
process clearly demonstrated scale-up potential. The percent yield on a dry basis for Wu's 
bench-scale glycinin, P-conglycinin, and intermediate fractions were 12.9, 9.8, and 10.1, 
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respectively, while those for the pilot-scale process were 11.2, 10.9, and 9.1. SDS-PAGE 
densitometry indicated that purities of the bench-scale and pilot scale glycinin fractions were 
95.7 and 84.2%, respectively, while those for P-conglycinin were 77.6 and 71.8%. 
Other fractionation methods have been published. Wu and others (2000) used pH 
adjustment and ultrafiltration as a simplified method to fractionate glycinin and p-
conglycinin. Production of the solubilized protein extract was the same as that for Wu and 
others (1999). Sodium bisulfite was added to the extract to bring the concentration to 
0.03 M, the pH was lowered to 6.0, and the suspension was chilled overnight at 7 °C. 
Centrifugation recovered the glycinin fraction. The supernatant was adjusted to pH 7.0 and 
concentrated with an RC-100 membrane feed and bleed system. The retentate was the p-
conglycinin fraction. An intermediate fraction was not produced. 
Wu's simplified method had dry basis yields of glycinin and P-conglycinin at 9.7 and 
19.6%, whereas the sequential fractionation method had yields of 9.4,10.3, and 4.8% for 
glycinin, p-conglycinin, and intermediate, respectively. Protein content and purity of the 
glycinin fractions was reportedly similar between the two methods. The P-conglycinin purity 
of the simplified method was 9% lower than that of the sequential fractionation method. 
Saito and others (2001) developed a novel bench-scale method for fractionating glycinin 
and P-conglycinin employing phytase. Soymilk was produced from defatted soy flakes, and 
the pH of the soymilk was adjusted to 6.0. Phytase was added to this soymilk, and the 
mixture was held 1 hour at 40 °C. The precipitated protein fraction was removed by 
centrifugation, yielding the glycinin fraction. The supernatant was acidified to pH 5.0, and 
the resulting precipitate, the P-conglycinin fraction, was removed by centrifugation. The 
authors reported that the purity of both fractions was greater than 80%. The potential 
advantage of this method is that the treated extract does not need to be chilled to precipitate 
glycinin. It also has the added benefit of reducing the phytate content of soy. 
Currently, glycinin (1 IS) and P-conglycinin (7S) fractions are not commercially 
available. The additional processing steps to prepare the fractions are time-consuming and 
involve much more extensive use of processing equipment compared to production of soy 
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concentrates and soy protein isolates. The functional properties or nutritional aspects of the 
glycinin and P-conglycinin fractions may not offer cost-effective advantages compared to 
existing soy ingredient products. Since only very small amounts of these products have been 
available for applications evaluation, little information concerning this experimentation exists 
in the literature. Bringe's (2001) patent disclosed a soybean line that had a high P-
conglycinin content and described application of the high P-conglycinin isolate in regard to 
very successful beverage and cheese production, as well as its functionality as an emulsifier 
and gelling agent. If plant breeding efforts to shift glycinin and p-conglycinin ratios are 
successful, the need to fractionate soy proteins through processing techniques may become 
moot. 
H. Soy Protein Functionality 
Kinsella (1979) defined protein functionality as the physicochemical properties of the 
proteins and their interactions with other food components. Examples of functional 
properties are solubility, emulsification, foaming capacity and stability, gelation, water- and 
fat-binding capacity, hydrophobicity, viscosity, and flavor-binding. Many frustrating factors 
confound comparisons of results among published data. First, preparation of the protein is 
critical. Processing steps that differ in heat treatment and duration, pH, contaminating ions 
and ionic strength, and type of isolation and purification buffers and conditions are a few of 
the considerations that must be taken into account. Each condition will play a role in the 
configuration of the protein relative to its native state and how that configuration reacts in a 
particular environment. Even the ratio of the types of proteins comprising the protein 
sample, such as the 7S and 11S fractions in soy, and the type and prevalence of subunits 
comprising each particular protein, such as the a, a' and P subunits of P-conglycinin, affect 
protein functionality. These subunit differences could occur between the same plant genetic 
source grown in different environmental conditions or be due to varietal differences. Finally, 
the functionality tests themselves can be maddening. There are many published methods to 
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measure a particular functionality, most being empirical rather than intrinsic, but ensuring 
uniform testing between laboratories can be difficult. Regenstein and Regenstein (1984) 
pointed out several considerations for performing solubility testing including dissolving time, 
concentration of material, dissolving conditions, stirring, appropriateness of the solvent, and 
relationship of the measurement to the final use in the product. 
Functionality of proteins can be purposely altered by physical methods, such as heating, 
acidification, or alkali treatments that change the secondary and tertiary structures of a 
protein; by chemical methods, such as acylation, phosphorylation, and deamidation; and by 
enzymatic methods leading to proteolysis with enzymes, such as trypsin, pepsin, and 
bromelin. Liu (1997) presents a short review of each of these topics. Boye and others (1997) 
and Schwenke (1997) present more extensive reviews. 
Volumes could easily be written reviewing functionality testing for soy products alone. 
This review will cover the functionality tests most relevant to my research. 
Solubility 
Different protein solubilities are necessary to produce a wide variety of food systems. To 
produce a protein drink in which the protein stays in solution, a highly soluble protein is 
desired. Processed meats, for which water and fat binding is desired, utilize proteins with 
low solubility so that the proteins are not lost during heat processing. 
Protein solubility is influenced by, among a host of other factors, the relative proportion 
of hydrophilic and hydrophobic areas on the exterior of a protein, the charge density of the 
protein, pH and ionic strength of the solution, and temperature (Vojdani 1997). Terms to 
express protein solubility are protein dispersibility index, water dispersibility protein, 
nitrogen solubility index, solubility index, water soluble protein, percent protein or nitrogen 
solubility, degree of turbidity, percent insolubility, dispersibility and maximum protein 
solubility. Protein solubility is usually determined in salt-free water or buffered water at a 
specified ionic strength, although the buffer can influence solubility. Methods used to 
measure liquid or solid protein samples are Kjeldahl, Dumas, spectrophotometry at 280 nm 
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or 191-194 nm, Lowry, bicinchoninic acid, Biuret, and dye-binding. Each of these methods 
has advantages and disadvantages. 
Solubility is measured by adding a known amount of sample or protein to water or buffer. 
If water is used, acid or base can be used to adjust pH as desired. After a suitable 
solubilization and stabilization period (e.g. 1 h with stirring that does not produce foaming), 
the solution is clarified, usually by centrifugation. Protein content of the extract, and 
sometimes the precipitate, is measured. 
Shen (1976,1981) showed the effects of pH and ionic strength on soy protein isolate and 
described the effects of various salts on soy protein solubility. The data show evaluation of 
protein solubility at one pH is not sufficient to compare different proteins, although a one 
point evaluation is not uncommon. For instance, Khatib and others (2002) evaluated the 
solubility of glycinin and p-conglycinin fractions from four different soybean varieties. The 
solubility of P-conglycinin fractions at pH 7 ranged from 55 to 67%, while glycinin solubility 
ranged from 65 to 84%. This gives a limited picture of two very different soy proteins. 
Others have attempted to give a more complete description of solubility. Lakemond and 
others (2000) reported that at an ionic strength of 0.2 their purified glycinin exhibited nearly 
100% solubility at pH<4 and >6.5 and about 10% at pH 4.6 to 5.8. Wu and others (1998) 
evaluated the effects of papain modification of soy protein isolate. The solubility of the 
isolate was approximately 38,4, 55, 85, and 92% at pH 3, 5,7,9,11, respectively. 
Enzymatic treatment increased solubility. Exhaustive analysis at over a range of pH values 
and ionic strengths generated by different cationic and anionic salts provides the best 
understanding of solubility for a particular protein, but what is practical must also be 
considered. 
Gelation 
A gel network is necessary in many food systems to hold moisture, fat, flavors, and 
water-soluble components. Gels also provide the characteristic and customary textures of 
many foods. 
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According to Matsumura and Mori (1996), gelation is a two-step process involving 
conformational change or partial denaturation of protein followed by gradual association or 
aggregation of the protein molecules. Tombs (1974) describes gelation of globular proteins 
as a highly oriented 'string of beads', generally yielding a transparent or translucent 
appearance, or a random aggregation, generally yielding a turbid appearance. Chemical 
forces involved in gel formation are hydrophobic interactions, hydrogen bonding, 
electrostatic interaction, and disulfide bonding. Some of the research reviewed below 
evaluates how these types of interactions can be enhanced or disrupted with regard to gel 
formation. 
Yamauchi and others (1991) published an extensive review covering the heat-induced 
gelation of the soy proteins, glycinin, and p-conglycinin, as related to structure of the 
proteins. Effects of protein concentration, reducing agents, ionic strength, protein subunit 
contribution, and temperature of denaturation were also considered. 
Choice of gelation temperature is aided by differential scanning calorimetry (DSC) data. 
Onset (To), peak (Ta), and final (Tf) protein denaturation temperatures can be obtained from 
DSC data. When a protein solution is heated in the range of To to Tj a weak gel forms. Gel 
strength increases from Td to Tf, due to the increased number of denatured protein molecules 
available to aggregate and form a network. Above Tf the gel hardness decreases due to 
excessive heat damage. Puppo and Anon (1999) showed that 20% (w/w) solutions of 7S and 
11S fractions at pH 8.0 had peak denaturation temperatures of 79 and 90 °C, respectively. 
Yamauchi and others (1991) cited peak denaturation temperatures of 75 and 90 °C, 
respectively. Sorgentini and others (1995) reported the temperatures as 74 and 83 °C, 
respectively. Denaturation temperatures are affected by pH and salt concentration (Kinsella 
and others 1985), so heating conditions must be chosen carefully to ensure that the proteins 
denature during the heating process. 
Gel properties can be measured by two different methods (Matsumura and Mori 1996). 
The first involves small deformation using oscillatory rheology, which provides fundamental 
information. A complex shear modulus G* is defined by: 
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G* = G' + /G" 
where G' is the storage (elastic) modulus, G" is the loss (viscosity) modulus, and i is a 
complex number. The second method uses large deformation force and provides empirical 
information, such as firmness or hardness measured in units such as Newtons. Usually the 
sample is pierced or deformed with a plunger causing rupture of the gel structure. 
Hatta and others (1986) explored the effects of pH (2-9) and sodium chloride 
concentration (10-80 mM) on gel strength of a 5% ovalbumin system heated at 80 °C. Peak 
gel strengths occurred at pH 3 and 7 for all NaCl concentrations, with these strengths being 
highest at 30 and 40 mM sodium chloride concentration. For all ionic strengths, gels were 
generally weak between pH 4-5 and were very weak or nonexistent at pH 2 and 8. 
Nakamura and others (1986) indicated that minimum glycinin and P-conglycinin 
concentrations for gel formation at 100 °C and 0.5 jn were 2.5 and 7.5%, respectively. Khatib 
and others (2002) reported that the storage modulus (G') of glycinin and P-conglycinin gels 
from four soybean varieties ranged from 4.43 to 5.39 and 4.11 to 4.64, respectively, 
indicating that the elastic characteristics were not very different for the two major storage 
proteins. 
Nagano and others (1996) evaluated gelation of preheated soy protein isolates prepared 
from a control, a glycinin-rich, and a P-conglycinin-rich soybean variety. A 12% (w/w) 
solution of each was heated from 30 to 80 °C, and then cooled to 20 °C at 2 °C/min. The 
G'/Pa, an expression elasticity or strength, for the glycinin-rich and control samples were still 
zero at 80 °C, but the p-conglycinin-rich line was about 60. Final G'/Pa were about 250, 60, 
and 2 for the P-conglycinin-rich, control, and glycinin-rich varieties, respectively. The data 
may have been more useful had the temperatures been taken to 90 or 100 °C for a longer 
time, permitting denaturation of the glycinin in samples. These data do indicate, however, 
that a P-conglycinin isolate might be more useful than soy protein isolate for gelling in meat 
systems that are cooked to 160 °F (71.1 °C). 
Wang and Damodaran (1991) used a puncture method to evaluate gel structure or 
hardness of soy isolate, 1 IS (glycinin), and 7S (p-conglycinin) gels of varying protein 
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concentrations and ionic strengths, contributed by 0.5 M NaCl and NaC104 (a structure 
destabilizer). Concentrations of soy protein ranging from 8-12% in 20 mM sodium 
phosphate buffer were heated at 90 °C for 30 min then cooled to 4 °C for 20 h. Gel hardness 
increased with increasing protein concentration for samples in buffer, with hardness (gm x 
10"2 ) at 12% protein being about 10, 5, and 10 for 1 IS, 7S, and soy isolate gels, respectively. 
At 0.5 M NaCl, the 1 IS sample did not form gels at any protein concentration. The 0.5 M 
NaClÛ4 diminished gel strength somewhat. In contrast, the salt treatments did not 
dramatically affect 7S gel strength. 
Whereas each laboratory is able to make comparisons between controls and treatments 
for their experiments, comparison of data among research projects is extremely difficult due 
to the difference in assay technique and sample preparation. 
Emulsification Capacity 
Many foods are protein-stabilized emulsions or foams. Examples are milk, butter, 
margarine, salad dressings, hot dogs, and ice cream. It is important to understand why 
different food proteins act differently and to predict how they will perform in food 
applications relative to other potential protein ingredients. 
An emulsion can be defined as a dispersion of two immiscible liquids. There are two 
types of emulsions: water in oil, such as butter, or oil in water, such as milk. Over time, the 
dispersed phase of an emulsion will generally move within the continuous phase, causing 
creaming, coalescence, or flocculation. Creaming occurs if the dispersed phase is of lower 
density than the continuous phase, resulting in a change in distribution of the disperse phase. 
Coalescence occurs when dispersed droplets approach and merge into larger droplets. 
Flocculation occurs when dispersed droplets become associated with other droplets, but do 
not merge. 
The stability of an emulsion depends on a balance of the forces associated at the interface 
of the oil and water. The van der Waals forces are attractive forces, but these tend to be 
balanced by electrostatic repulsive forces. Proteins, containing hydrophobic and hydrophilic 
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regions, may align themselves between the aqueous and disperse phases and provide steric 
forces that usually inhibit coalescence. Polymers in a system, such as starches, can prevent 
movement and association of the dispersed phase, but may enhance attraction in voids or 
regions where the polymer is lacking. 
Proteins function as emulsifiers by decreasing the interfacial tension between the oil-
water interface and by forming a barrier, comprised of electrostatic, structural, and 
mechanical components, that diminishes destabilization of the interface. Effectiveness of a 
protein in performing as a surfactant or emulsifier depends on its size, conformation (e.g. 
available hydrophobic and hydrophilic regions), viscosity relative to the system, the pH and 
ionic strength of the system, oil type, temperature, phase volumes, protein concentration, and 
the amount of mechanical energy applied to provide a homogeneous distribution of the 
protein. Kinsella (1979) describes soy globulins as slow to diffuse, but reduce interfacial 
tension between phases as protein concentration is increased. Salt addition may enhance 
diffusion rate, reduce charge repulsion between proteins, and improve interface hydrophilic 
associations. 
Emulsification capacity is commonly defined as the mL of oil per g of protein added to a 
solution to cause an inversion from oil-in-water to water-in-oil emulsion. Oil is added at a 
uniform rate to a low-concentration protein solution that is being rapidly stirred in a mixing 
or blending action. Inversion from oil in water to water in oil is usually determined visually 
(change in appearance or sudden drop in viscosity) or by conductimetry (sudden increase in 
electrical resistance at inversion point). Mixing rate, container shape, mixing blade shape 
and size, and protein sample volume and concentration are some of the physical factors that 
will influence the result. 
Liu's review (1997) summarizes that soy protein solubility is positively correlated with 
emulsification capacity. Emulsification capacity is decreased above 50 °C, but increases 
when ionic strength is increased from 0.03 to 0.05 at pH 7. Emulsion properties tend to be 
better at alkaline pH and poor at pH 5 to 6. 
63 
Ochiai and others (1981) showed that solubility of tryptic digested crude glycinin did not 
necessarily correlate with emulsification capacity. Heat-denatured and native state glycinin 
were enzymatically digested, and then the extract of the heat-denatured, enzymatically 
treated glycinin was separated into two fractions of differing molecular weight. The digested 
native-state glycinin, the high-molecular weight fraction, and the unhydrolyzed glycinin had 
solubility profiles that were near zero at about pH 5 and nearly 100 % within +/- one pH unit 
from pH 5. The emulsification capacity profiles followed that trend as well, but 
emulsification capacities at pH 5 were only half that of capacities below pH 4 and above pH 
7. The low molecular weight fraction no longer displayed the typical solubility curve and 
displayed solubility near 80% for the entire pH profile. The emulsification capacity profile 
for the low molecular weight fraction across different pH values was fairly flat as well, but 
was generally lower than that for other treatments. Consequently, it is difficult to say that 
solubility is always positively correlated with emulsification capacity. 
Bernard! Don and others (1991) also demonstrated that solubility of enzymatically-
treated soy does not translate into improved emulsification capacity. A bacterial and a fungal 
protease were used to digest the soy protein. Solubility was improved by proteolysis, but 
emulsification capacity was not. 
De Kanterewicz and others (1987) developed an index that described the relative 
hydrophobic-lipophilic nature of several proteins using water and oil uptake to characterize 
these attributes. The water-oil absorption index for a given protein was the mL water/g 
sample divided by the mL oil/g sample absorbed. They found that emulsification capacity 
was highest when the index value was near two and poor at extremes of the index value. 
They concluded that proteins need to have a suitable balance between lipophilic and 
hydrophilic characteristics. It was shown that this prediction method was less useful when 
applied to several different soy proteins at different concentrations. As concentration was 
increased from 0.5 to 4.0% there was a lower dependence of emulsification capacity on the 
index value. 
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Dagom-Scaviner and others (1987) showed that emulsification capacities of pea legumin 
and vicilin, bovine serum albumin (BSA), and casein were 58, 61, 112, and 90 g of oil/100 
mg protein, respectively. Bovine serum albumin has a molecular weight of about 66 kDa, is 
nearly 100% soluble from at least pH 3-9, and exhibits high surface hydrophobicity as 
measured by probe spectrofluorometry using 1 -anilinonaphthalene-8-sulfonate (ANS). Still, 
Dagom-Scaviner and others have shown, as we have in our laboratory, that BSA has a very 
high emulsification capacity. 
Clearly, there are many confounding factors to consider when trying to find a predictor of 
emulsification capacity. Comparison of published results among laboratories is also 
extremely difficult given the assay variability mentioned above. 
The emulsifying ability of soy proteins has been studied at the subunit level. Maruyama 
and others (1999) presented data concerning the structure-physicochemical function 
relationships of soybean P-conglycinin subunits. The a and a' subunits contain extension 
regions that are glycosylated. They suggested that solubility (at p, = 0.08), heat-induced 
association, and emulsifying activity were affected substantially by the carbohydrate 
moieties, as well as the core regions of the subunits. This was determined using recombinant 
nonglycosylated subunits and deletion mutants. Maruyama (2002) evaluated the emulsifying 
ability of all possible p-conglycinin heterotrimers. Emulsion particle size distribution 
revealed that the jump from one P unit per molecule to two led to particle-size distributions 
skewed toward larger emulsion particles as determined by using a laser light scattering 
instrument. Additional studies such as these may help direct plant breeding to produce 
soybeans with preferred functionality traits. 
Emulsification Activity and Stability 
The ability of a protein to aid in formation and to stabilize a freshly prepared emulsion is 
termed its emulsifying activity (EA) or emulsifying activity index (EAI). Several methods to 
understand this functional property have been invented, unfortunately comparison of results 
among the methods is difficult if not impossible. Generally, a pre-determined volume of oil 
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and protein solution are combined and then blended aggressively to form an emulsion. Hill 
(1996) briefly reviews several of the methods. Determination of particle-size distribution of 
the dispersed phase, using microscopy, Coulter counting, spectroturbidity, and laser 
scattering techniques, is one way to determine EA and EAI (one definition being area of 
interface stabilized per unit weight of protein). Emulsifying activity has also been defined in 
terms of conductivity differences between a protein solution and a fresh emulsion of that 
solution (Kato and others 1985). 
Emulsification stability is generally a temporal extension of the emulsification activity 
assay. It is a measure of the separation of the dispersed oil phase from the aqueous phase at 
prescribed temperature, gravitational field, and duration. Stability is measured in regard to 
creaming, flocculation, and coalescence as measured by visual, light-scattering techniques, 
ultrasound, and microscopy (Hill 1996). Destructive sampling of layers has also been 
utilized. 
Dagom-Scavinger and others (1987) evaluated the EAI of pea legumin and vicilin, BSA, 
and casein. Ten mL of oil were dispersed into 30 mL of 1.3 mg/mL protein solution at 
20,000 rpm for 30 sec. One-mL aliquots of emulsion were diluted 250 fold with 0.1 M 
sodium chloride solution plus 0.1% sodium dodecyl sulfate at pH 7. Absorbance was 
immediately measured at 500 nm. Their reported EAI was in units of m2/g, relating 
interfacial area stabilized to weight of protein. The EAI for pea legumin and vicilin, BSA, 
and casein were 60, 111, 133, and 110, respectively, differing somewhat in relation to their 
rankings for their emulsification capacities of 58, 61,112, and 90 g oil/100 mg protein, 
respectively. The authors noted that their results were somewhat different from those of 
Pearce and Kinsella (1978) for BSA and casein, reporting values of 197 and 166, 
respectively. Experimental conditions were reportedly similar except for the type of blender. 
Although the EAI values for the two proteins were different between research groups, the 
B S A/casein ratios were the same. 
Wu and others (1998) evaluated the emulsifying properties of soy protein isolate (SPI) 
with and without proteolytic enzyme modification by papain. Hydrolysates of 10, 30, and 60 
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min were produced, with a portion of the 60 min hydrolysate being separated by 
ultrafiltration into 20, 50 and 100 kDa fractions. Corn oil (2 mL) and 0.1% protein solution 
(6 mL) at pH 7 were combined and mechanically homogenized at high speed for 1 min. At 0 
and 10 min 50 pL were pipetted from the bottom of the emulsion and diluted with 5 mL of 
1% sodium dodecyl sulfate solution. Absorbance was measured at 500 nm. EAI was 
calculated as: 
EAI (m2/g) = 27(Ao x dilution factor/C xOx 10,000) 
where T = 2.303; A@ = absorbance measured immediately after emulsion formation; dilution 
factor = 100, C = weight of protein/unit volume (g/mL) of aqueous phase before emulsion 
formation; and <E> = oil volume fraction of the emulsion. ESI was calculated as : 
ESI (min) = Aq x At/AA 
where At = 10 min and AA = Aq — Ai». 
Wu and others (1998) found that the SPI had an EAI of 100, while the EAI for the digests 
and ultra-filtered fractions were 200-230 and 280-315, respectively. The ESI for SPI was 
about 37, whereas the ESI for digests and most ultra-filtered fractions were 42-48. The ESI 
for the lowest molecular weight fraction was about 22. The data suggest that proteolysis and 
fractions with diminished molecular weights increased EAI, but did little to improve ESI. 
ESI was greatly reduced when molecular weights were as low as 20 kDa. Surface 
hydrophobicity increased from about 12 to 27 with digestion, but the ultra-filtered fractions 
had surface hydrophobicities of only about 2. The cleaved fractions were not terribly 
hydrophilic, but enzyme modification probably had a molecular unfolding effect, opening the 
molecule to expose previously-hidden hydrophobic areas. From this data it seems difficult to 
generalize or predict ESI and EAI based on hydrophobicity alone. 
Chove and others (2001), using the methodology of Wu and others (1998), evaluated ESI 
and EAI of soy protein isolate fractions produced by sequential isoelectric precipitation at pH 
5.6, 5.1, and 4.5 and non-sequential precipitation at these values. The authors concluded that 
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fractions high in 7S globulin protein fractions had better functionality in terms of ESI and 
EAI. 
Khatib and others (2002) compared four soybean varieties for EAI and ESI of their 
respective glycinin and p-conglycinin fractions. EAI of the glycinin and P-conglycinin 
fractions ranged from 300 to 381 and 400 to 434 m2/g, respectively, while ESI ranged from 
160 to 191 h and 161 to 200 h, respectively. Emulsion was prepared by blending 10 mL of 
peanut oil with 30 mL of protein solution. Absorbance was read at 540 nm and initial and 
final ESI turbidity readings were taken at 0 and 24 h. 
Liu and others ( 1999) evaluated the emulsifying properties of 11S and acidic 11S 
proteins at various protein concentrations (0.1 to 1.0%) and ionic strengths (0.05 to 0.50). 
Emulsifying properties of acidic subunits of 11S (AS11S) were found to be better than those 
of 11S and heat-denatured 1 IS. The EAI of the AS 11S decreased from 1988 to 349 cm2/mg, 
as protein concentration was increased. At pH 7 and 0.5% (w/v) emulsion the droplet size of 
the ASUS increased only slightly from 0 to 140 h at 0.05-0.15 ionic strength, but increased 
dramatically at ionic strengths of 0.2 to 0.5. 
Additional research in this area is needed to better understand what factors influence 
emulsion stability and how to apply this information when developing food systems, since 
food systems are vastly different from well-defined laboratory conditions. 
Foaming 
Meringues, mousses, and beer are examples of air-protein food foams. Two thin 
air/water interfaces need to be created and maintained to prepare foams. Proteins adsorb at 
this interface, reduce surface tension, and interact via electrostatic, hydrophobic, hydrogen 
and co valent bonds that permit some stretching and deformation of the films. Mechanically-
induced foams are prepared in at least four ways: sparging of gas through a column of protein 
solution, whipping, shaking, and pouring. Evaluations of protein foams usually include one 
or more of the following measurements: foam volume, drained liquid volume, time to foam 
to a given volume, stability of foam based on time required for a specific volume of the foam 
68 
to collapse. As with the other functionality tests described above, experimental conditions 
such as protein solution concentration, volume of solution, sparger pressure and frit size, 
blending speed, and container characteristics are among the variables that can greatly 
influence the foaming results. 
Wilde and Clark (1996) reviewed foam formation and stability. They suggested that the 
amphipathic character of the amino acid side chains was responsible for the adsorption of 
proteins at interfaces. To effectively form interface films, proteins must move from the bulk 
solution to the interface, penetrate and incorporate into the surface layer, and undergo some 
degree of surface denaturation in the adsorbed layer. Protein size, surface hydrophobicity, 
and structural flexibility impact efficient protein film formation. Foams tend to be more 
stable around their isoelectric point since the charges are balanced and repulsion is 
minimized. Foams that maintain more liquid between the opposing interfacial films are more 
stable, preventing the films from contacting and rupturing. Liquid drainage from films is 
affected by bulk and surface viscosity and electrostatic repulsion of the two interfaces. 
Glycoproteins that contain large oligosaccharides that protrude into the lamellar liquid 
between the two interfaces have a stabilizing effect by reducing drainage. 
Attempts have been made to improve foaming properties by modifying the proteins, e.g. 
enzymatic digestion, enzymatic modification, and chemical derivatization, or by modifying 
the solution conditions, e.g. pH, ionic strength, or viscosity. Reducing molecular weight will 
improve rate of diffusion to the interface. Some modifications have increased 
hydrophobicity, changed surface charge, and improved flexibility, thus improving foaming 
functionality. 
Bernard! Don and others (1991) evaluated enzymatic modification of soy protein 
concentrates to improve functionality. Foaming capacity, the relative ability to produce 
foam, was evaluated by placing 30 mL of 3% (w/w) dispersion in a graduated cylinder and 
stirring it at 6000 rpm for 3 min. The percent volume increase of the system was calculated 
as a measure of foaming capacity. Foaming stability was determined by measuring the liquid 
drained from 10 mL of foam as a function of time. As degree of protein hydrolysis increased 
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from 0 to 10% the percent volume increased from 100 to 400%. There was little change in 
foaming capacity from 10 to 30% hydrolysis. However, foam stability was maximal at a 
10% degree of hydrolysis, being about twice as stable as at 0 and 20% hydrolysis. 
Wagner and Gueguen (1999) explored the effects of acid treatment and deamidation, as 
well as reducing treatment, on the foaming properties of glycinin. Foaming properties were 
measured by conductimetry. Foam was produced by sparging air into a column of protein 
solution at a rate of 10 mL/min until foam volume reached 75 mL. Maximum volume of 
liquid incorporated into the foam, rate of liquid incorporation, foam conductivity, and rate of 
liquid drainage, a measure of foam stability, were measured. The authors suggested that 
treatments, such as dissociation, deamidation, and reduction, that increased surface 
hydrophobicity, increased net charge, and decreased molecular size enhanced foam forming 
and stabilizing capacities. 
Lipids can destabilize foams from the soy proteins in flour and concentrates. Table 13 
displays foaming characteristics of some soy protein products. Isolate is at least 90% protein, 
whereas concentrate is only 60-70% protein with protein dilute by ash and fiber. Flour has 
the ash and fiber plus soluble carbohydrates. As components other than protein are removed, 
foaming capacity and foam stability are improved. 
Detail of the methods used by the authors in this section was included to reveal the 
variety of assays and conditions used to evaluate foaming. There is need for standardization 
of methods and publication of additional research to promote the understanding of the factors 
at work in foam production and stability and how this information relates to actual food 
systems. 
Surface Hydrophobicity in Relation to Protein Functionality 
Surface hydrophobicity has been used to try to better understand and predict functionality 
properties. Hydrophobic characteristics are important in the amphipathic nature of proteins 
that stabilize interfaces, as well as how they affect solubility. 
70 
The surface characteristics of proteins, and especially those modified by heat, enzymatic, 
or chemical treatment, is not always known. Thus, we cannot always know or predict the 
Table 13. Foaming capacity and stability of soy protein products 
Foam Stability -
Volume after time (min) 
Product Foaming Capacity 
(% volume increase) 
1 10 30 60 
Flow- 70 160 131 108 61 
Concentrate A 170 400 28 13 8 
Concentrate B 135 370 265 142 30 
Isolate A 235 670 620 572 545 
Isolate B 230 660 603 564 535 
Source: Lin and others (1974) 
surface hydrophobicity. There are empirical methods to assess this characteristic. Among 
those are partitioning of proteins into aqueous two-phase systems (e.g. dextran and 
polyethylene glycol); HPLC; binding and measurement of associated non-polar or polar 
ligands; contact angle measurement; intrinsic fluorescence of tryptophan, tyrosine, and 
phenylalanine; and probe spectrofluorometiy, which includes using amphiphilic 1-
anilinonaphthaIene-8-sulfonate (ANS) or cis-parinaric acid (Nakai and others 1996). Each of 
these methods has advantages and disadvantages, but detailing these is beyond the scope of 
this review. 
The ANS method is quite popular because it is fast and, beyond the possession of a 
fluorometer, is relatively inexpensive. ANS binds to membranes or hydrophobic cavities, 
and bound ANS fluoresces in organic solvents. Nakai and others (1996) warn that some 
solvents that are non-polar may still favor the rigid, planar configuration of the ANS 
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molecule responsible for fluorescence. Also, electrostatic and hydrophobic interactions may 
alter interaction of the protein and probes. 
Nakai (1983) reviewed the impact of protein hydrophobicity on structure-function 
relationships. It was suggested that hydrophobic and solubility information, when used in 
tandem, were better predictors of protein functionality than solubility alone. Kato and Nakai 
(1980) used fluorometry to evaluate several types of protein and determined there was a 
significant correlation (PO.Ol) between hydrophobicity and emulsifying capacity. 
Emulsifying activity increased with respect to hydrophobicity, while interfacial tension 
declined. 
Ovalbumin and lysozyme were heat treated without coagulation by Kato and others 
(1981). This caused an increase in surface hydrophobicity, a decrease in surface tension, and 
an increase in emulsifying and foaming capacities and stabilities. 
Commercial and laboratory-prepared soy protein isolates were evaluated for solubility 
and surface hydrophobicity by the ANS method by Wagner and others (2000). After creating 
a scatter plot of these data, the authors grouped the results into three zones: A, B, and C. 
Group A isolates were shown by DSC to be high in native state glycinin and (3-conglycinin 
and were prepared in the laboratory under mild conditions. Group A varied little by surface 
hydrophobicity, 170-200, but solubility ranged between 80 to nearly 100%. The isolates that 
had the highest solubility had been washed extensively with water, resulting in a decrease in 
salts, whey proteins and sugars, then re-dissolved to pH 8 and freeze dried with a low protein 
concentration. It was noted that all of these treatments tended to have a positive effect on 
solubility. Group B isolates had hydrophobicity values of 210 to 640 while having 
solubilities of about 65 to 98%. No obvious trend could be observed for solubility with 
regard to hydrophobicity. These isolates were prepared under conditions differing in time, 
temperature, and treatment with denaturing chemical agents. The authors tried to rationalize 
differences in solubility and hydrophobicity based on these differences, as well as differences 
in protein concentration during freeze drying. Group C isolates were dispersions of 8-13% 
protein that received substantial thermal treatment or 3% dispersions thermally treated in the 
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presence of calcium. For this group as surface hydrophobicity decreased solubility 
decreased. The authors hypothesized that "(a) the protein species undergoing aggregation are 
the more hydrophobic, so that only the hydrophilic ones remain soluble; and (b) as the 
proteins aggregate, they hide or occlude the hydrophobic zones, leaving part of the proteins 
as soluble aggregates of low surface hydrophobicity." 
Maruyama and others (1999) evaluated the surface hydrophobicity of normal P-
conglycinin subunits (a, a' and (3) and deletion mutants of a and a' lacking the N-
glycosylated extension regions. The hydrophobicity under all conditions, varied by ionic 
strength and pH, was a >a'>(3, with the deletion mutants having nearly identical 
hydrophobicity compared to their a and a' counterparts. This indicates that the extension 
regions do not significantly affect hydrophobicity. The authors provided data suggesting that 
interactions between the subunits do not affect native state P-conglycinin hydrophobicity. 
Wu and others (1999) used the ANS method to evaluate surface hydrophobicity of 
glycinin, P-conglycinin, and an intermediate fraction, containing both glycinin and p-
conglycinin, prepared in during pilot-plant fractionation of the proteins. These fractions were 
evaluated against soy protein isolate, also prepared at pilot scale, and casein. Isolate, P-
conglycinin, glycinin, intermediate, and casein had surface hydrophobicity values of 
approximately 600, 350, 275, 260, and 320. Wu hypothesized that the high value of the 
isolate was due to high salt content, which can increase protein-ANS interactions. The value 
for P-conglycinin with respect to glycinin was thought to be due to the amino acid 
composition and partial denaturation of the P-conglycinin. A significant portion of the 
glycinin and P-conglycinin fractions in the intermediate fraction was denatured, which one 
might expect to expose hydrophobic portions from the interior of the proteins. The 
somewhat lower hydrophobicity value of the intermediate fraction was thought to be due to 
lower protein content of the fraction. 
Surface hydrophobicity may be useful for understanding protein functionality for certain 
protein products or under certain well-defined conditions. It should not be used to make 
generalizations about solubility or emulsifying ability. 
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Viscosity 
Viscosity is a measure of the resistance of a medium to flow. It is important in food 
systems as it affects the ability of a protein to disperse and stabilize foams and emulsions, 
and it is also responsible for texture and mouth feel attributes. Protein concentration, 
dispersion conditions, pH, and ionic strength can all affect the viscosity of a solution or 
dispersion. Viscosity (r() is expressed in terms of shear stress (a, force/unit area) and shear 
rate (y, velocity/sample thickness). Newtonian fluids (e.g. water) have constant shear stress 
as shear rate is increased. Dispersions, emulsions, polymer solutions and colloids tend to 
display shear-thinning behavior. As shear rate is increased, shear stress increases somewhat 
rapidly, but as shear rate increases further shear stress increases more slowly. This is 
generally due to breakdown of structure within the liquid. A model often used to describe a 
simple shear-thinning liquid is the power law model: 
t| = Kf1 
where r| = apparent viscosity, K is a viscosity constant, y = shear rate, and n = the power law 
index, which is less than 1 for shear-thinning liquids. 
Measuring shear viscosity is often done with rotational viscometers, rate-controlled 
viscometers, or stress-controlled viscometers. Each of these techniques has advantages and 
disadvantages. These are outlined by Schenz and Morr (1996). Capillary viscometry is very 
accurate and provides intrinsic viscosity, but it is very time consuming. Surface viscometry 
is important in evaluating proteins used in emulsions and foams and measures the 
deformation and flow of film at a fluid interface with respect to adsorption or spreading. 
Circle and others (1964) published a detailed evaluation of rheology of heated and 
unhealed protein dispersions. Viscosity measurements were made on a Brookfield LVT 
viscometer using a Brookfield Helipath stand and appropriate spindles. The apparent 
viscosity of unhealed proteinate increased from about 0.06 to 4 poises as proteinate 
concentration was increased from 2 to 10% by weight at 60 rpm. Proteinate dispersions of 8 
to 12% were evaluated for unhealed and heated (100 °C, 30 min) samples. Unhealed 
samples increased from about 8 to 500 poises as concentration was increased, and heated 
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samples increased from about 75 to 1600 poises. As shear rate was increased from 3 to 60 
spindle revolutions per minute, a 6% (w/w) dispersion experienced a drop in apparent 
viscosity from about 2 to 0.75 poises. When dispersions of 8 and 10% were measured at 0.2 
to 60 rpm, apparent viscosity decreased from 50 to 4 poises and 400 to 9 poises, respectively. 
In another experiment, as pH of a 10% unhealed dispersion was increased from 6 to 9 
apparent viscosity increased from 9 to about 125 poises, with 99 poises at pH 7. Effects of 
various additives at different concentrations at pH 7 are shown below in Table 14. 
The data in the table generally show that as salt concentration was increased, viscosity 
decreased. For food additives that are emulsifiers or thickeners, as concentration was 
increased viscosity increased. This is a useful table when trying to understand how additives 
might affect a food system using protein to provide viscosity. 
Anon and others (2001) measured the apparent viscosity of commercial and laboratory 
soybean isolates at different water imbibing capacities (WIC). A Haake Rotavisco RV2 
viscometer was used at 20 °C and rotor speed was varied from 0 to 128 rpm in 2 min and 
then held for 1 min at 128 rpm Dispersions of 1.6 to 16% w/w were used. As WIC 
increased, the apparent viscosity increased, although laboratory isolates had values 10 times 
less than those of commercial isolates. Differences in particle density and shape of 
commercial isolates (spray-dried, small, spherical particles of ~1 g cm3) and laboratory 
isolates (lyophilized, irregular, flat, and compact plaques of >1.2 g/cm3) may have impacted 
apparent viscosity differences. Particles that align easily and do not resist flow exhibit a 
lower viscosity than particles that do not align well and physically interact more easily. 
The body of literature for viscosity of unhealed soy protein isolates and other products is 
relatively small compared that for solubility and emulsification. Available rheology 
information tends to be from gelled proteins. Building literature regarding viscosity, 
especially for modified or novel preparations, should be useful since viscosity is such an 
important aspect in emulsion and film formation. This information would be useful for both 
food and industrial applications. 
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Table 14. Efifect of various additives on apparent viscosity of a 10% soy proteinate 
dispersion 
Additive Additive concentration (%) Poises 
Control 43 
NaCl 0.1 32 
NaCl 1 18 
NaN03 0.05 53 
NaN03 0.5 37 
NaH2P04» H20 0.05 45 
NaH2P04* H20 0.5 28 
(NaP03)„ 0.05 47 
(NaP03)n 0.5 25 
Degummed soy oil 5 800 
Degummed soy oil 20 3270 
Soy lecithin 5 1330 
Soy lecithin 10 3130 
Wheat starch 5 48 
Wheat starch 10 117 
Carboxymethylcellulose 0.1 300 
Carboxymethylcellulose 1 2600 
Carrageenan 0.1 467 
Carrageenan 1 2130 
Na2S03 0.01 14.7 
Na2S03 0.1 0.4 
Na2S03 0.5 0.2 
NaN02 0.01 18.8 
NaN02 0.1 28.7 
NaN02 0.5 20 
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Table 14. (cont'd) 
NaH2P02«H20 0.05 52 
NaH2P02»H20 0.5 33 
Cysteine»HCl 0.05 0.4 
Cysteine«HCl 0.5 27 
Ascorbic Acid 0.05 49 
Ascorbic Acid 0.5 467 
Source: Circle and others (1964) 
Conclusions 
It is evident that there are difficulties in trying to predict performance relative to other 
proteins or preparations based on a single functionality test, such as solubility or 
hydrophobicity. Functionality testing on purified proteins, such as glycinin or P-conglycinin, 
or soy protein products, such as flours, concentrates, or isolates, provides basic research data 
that may assist in understanding what molecular aspects drive certain functionality 
characteristics. However, foods are complex systems. It may be useful to develop an 
understanding concerning how a protein's functionality in a well-defined, controlled system 
compares with the functionality of the protein in a real food system. This information may 
be extremely useful to small companies that don't have R&D resources to do extensive 
product development or functionality testing. 
I. Conclusions 
The soybean has probably received more scrutiny and attention than any other oil seed or 
cereal grain other than wheat. Given the rising world population and the soybean's position 
as a source of relatively low-cost and high-quality protein, worldwide soy consumption will 
continue to rise. The health benefits of its components will continue to be explored for years 
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to come. Developing the functional aspects of soy protein will continue to fuel its use in new 
and traditional food applications. 
References 
Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forinin E, DeAloysio D. 1998. The effects 
of dietary soy supplementation on hot flushes. Obstet Gynecol 91:6-11. 
American Academy of Pediatrics Committee on Nutrition. 1998. Soy protein-based formulas: 
recommendations for use in infant feeding. Pediatrics 101:148-153. 
American Soybean Association. 2003a.Defatted soy flour reference guide. 
http://soyasa.Org/documents/0/DSF_RefGuide.htm 
American Soybean Association. 2003b. Soy protein concentration reference guide. 
http://soyasa.org/documents/OZSPC_RefGuide.htm. 
American Soybean Association. 2003c. Soy protein isolate reference guide. 
http://soyasa.Org/documents/0/SPI_RefGuide.htm. 
American Soybean Association. 2003d. Textured soy protein reference guide. 
http://soyasa.Org/documents/0/TSP_RefGuide.htm. 
Anderson JW, Johnsstone BM, Cook-Newell ME. 1995. Meta-analysis of the effects of soy 
protein intake on serum lipids. N Engl J Med 333:276-282. 
Anderson RL, Wolf WJ. 1995. Compositional changes in trypsin inhibitors, phytic acid, 
saponins, and isoflavones related to soybean processing. J Nutr 125: 581S-588S. 
Anon CM, Sorgentini DA, Wagner JR. 2001. Relationships between different hydration 
properties of commercial and laboratory soybean isolates. J Agric Food Chem. 49:4852-
4858. 
Anthony MS, Clarkson TB. 1998. Comparison of soy phytoestrogens and conjugated equine 
estrogens on atherosclerosis progression in post-menopausal monkeys. Circulation 97:829. 
Arjmandi BH, Alekel L, Mollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC. 
1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of 
osteoporosis. J Nutr 126:161-167. 
Badger TM, Ronis MJJ, Hakkak R, Rowlands JC, Korourian S. 2002. The health 
consequences of early soy consumption. J Nutr 132:559S-565S. 
Baird DD, Umbach DM, Lansell L, Hughes CL, Setchell KDR, Weinberg CR, Haney AF, 
Wilcox AJ, McLachlan JA. 1995. Dietary intervention study to assess estrogenicity of 
dietary soy among post-menopausal women. J Clin Endocrinol Metab 80:1685-1690. 
Barnes S, Grubbs C Setchell S, Carlson J. 1990. Soybeans inhibit mammary tumors in 
models of breast cancer. In: Pariza MW, Aeschbacher HU, Eton JS, Sato S, editors. 
Mutagens and carcinogens in the diet. New York, Wiley. 
Beecher GR, Holden J, Bhagwat S, Haytowitz D, Murphy PA. 1999. 
http://www.nal.usda.gov/fiiic/foodcomp/Data/isoflav/isoflav/html 
Begbie R, Pusztai A. 1989. The resistance to proteolytic breakdown of some plant (seed) 
proteins and their effects on nutrient utilization and gut metabolism In: Friedman M, 
editor. Absorption and utilization of amino acids, CRC: Boca Raton, FL p 231-242. 
78 
Bennetau-Pelissero C, Le Houerou C, Lamothe V, Le Menn F, Babin R, Bennetau B. 2000. 
Synthesis of haptans and conjugates for ELISAs of phytoestrogens. Development of the 
immunological tests. J Agric Food Chem 48:305-311. 
Bennetts HW, Underwood EJ, Shier FL. 1946. A specific breeding problem of sheep on 
subterranean clover pastures in Western Australia. Aus Vet J 22:2-12. 
Berhow MA, Wagner ED, Vaughn SF, Plewa MJ. 2000. Characterization and antimutagenic 
activity of soybean saponin. Mutat Res 448:11-22. 
Berk Z. 1992. Isolated soybean protein. In: Berk Z. editor. Technology of production of 
edible flours and protein products from soybeans. Haifa, IsraekTechnion, Israel Institute of 
Technology. 
Bernard! Don LS, Pilosaf AMR, Bartholomai GB. 1991. Enzymatic modification of soy 
protein concentrates by fungal and bacterial proteases. J Am Oil Chem Soc 68:102-105. 
Birk Y. Saponins. 1969. Toxic constituents of plant food stuffs. In: Liener IE, editor. 
Academic Press, New York, p 161-182. 
Boatright WL, Kim KS. 2000. Effect of electron microscopy fixation pH on the 
ultrastructure of soybean protein bodies. J Agric Food Chem 48:302-304. 
Boye JI, Ma CY, Harwalkar VR. 1997. Thermal denaturation and coagulation of proteins. In: 
Damodaran S, Paraf A, editors. Food proteins and their applications. New York, Marcel 
Dekker. p 25-56. 
Briggs DR, Mann RL. 1950. An electrophoretic analysis of soybean protein. Cereal Chem 
27:243-257. 
Bringe, NA, inventor; Monsanto Company, assignee. 2001 Jan 9. High beta-conglcyinin 
products and their use. U.S. Patent 6,171,640. 
Brown JP. 1988. Hydrolysis of glycosides and esters. In: Roland JR, editor. Role of the gut 
flora in toxicity and cancer. San Diego: Academic Press, p 109-144. 
Brzezinski A, Aldercreutz H, Shaoul R, Rosier A, Shmueli A, Tanos V, Schenker JG. 1997. 
Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 4:89-
94. 
Business Communications Co. Inc. 2001. Soyfoods: trends and developments. Norwalk, 
Connecticut. 
Cantani A, Lucenti P. 1997. Natural history of soy allergy and/or intolerance in children, and 
clinical use of soy protein formulas. Pediatr Allergy Immunol 8:59-74. 
Cassidy A, Bingham S, Setchell K. 1995. Biological effects ofisoflavones in young women: 
importance of the chemical composition of soyabean products. Br J Nutr 74:587-601. 
Catsimpoolas N, Ekenstam C. 1969. Isolation of alpha, beta, and gamma conglycinins. Arch 
Biochem Biophys 129:490-497. 
Cheeke PR. 1996. Biological effects of feed and forage saponins and their impacts on animal 
production. In: Waller GR, Yamasaki K, editors. Saponins used in food and agriculture. 
New York, Plenum Press, p 377-380. 
Chove BE, Grandison AS, Lewis MJ. 2001. Emulsifying properties of soy protein isolate 
fractions obtained by isoelectric precipitation. J Sci Food Agric. 81:759-763. 
Circle S J, Meyer EW, Whitney RW. 1964. Rheology of soy protein dispersions. Effect of 
heat and other factors on gelation. Cereal Chem 41:157-172. 
Cook HJ. 1986. Neurobiology of the intestinal mucosa. Gastroenterol 90:1057-1081. 
79 
Constantinou A, Lantvit D, Lim E. Xu H, Pezzuto JM. 2001. Consumption of soy products 
may enhance tamoxifen's breast cancer preventative effects. Proc Am Assoc Cancer Res 
42:826. 
Coward L, Kirk M, Albin N, Barnes S. 1996. Analysis of plasma isolfavones by reverse-
phase HPLC-reaction ion monitoring-mass spectrometry. Clin Chem 247:121. 
Coward L, Smith M, Kirk M, Barnes S. 1998. Chemical modification of isoflavones in 
soyfoods during cooking and processing. Am J Clin Nutr 68:1486-1491 S. 
Creeke RI, Wilkinson AP, Lee HA, Morgan MRA, Price KR, Rhodes MJC. 1998. 
Development of ELISAs for the measurement of the dietary phytoestrogens daidzein 
and equol in human plasma. Food Agric Immunol 10:325-327. 
Curl CL, Price KR, Fenwick GR. 1988. Isolation and structural elucidation of a new saponin 
('soyasaponin v') from haricot bean. J Sci Food Agric 43:101-107. 
Dagom-Scaviner C, Gueguen J, Lefebvre J. 1987. Emulsifying properties of pea globulins as 
related to their adsorption behaviors. J Food Sci 52:335-341. 
Dalluge JJ, Eliason E, Frazer S. 2003. Simultaneous identification of soyasaponins and 
isoflavones and quantification of soyasaponin By in soy products, using liquid 
chromatography/electrospray ionization-mass spectrometry. J Agric Food Chem 
51:3520-3524. 
Davidson RM, Sand RE, Johnson RE, inventors; Anderson, Clayton & Co., assignee. 1979 
Oct 30. Method for processing soy protein and composition of matter. U.S. patent 
4,172,828. 
De Kanterewicz RJ, Elizalde BE, Pilosof AMR, Bartholomai GB. 1987. Water-oil absorption 
index (WOAI): A simple method for predicting the emulsifying capacity of food proteins. J 
Food Sci 52:1381-1383. 
De Kleijn MJJ, van der Schouw YT, Wilson PWF, Grobbee DE, Jacques PF. 1999. Intake of 
dietary phytoestrogens in postmenopausal women: the Framingham heart study. Abstract 
Third international symposium on the role of soy in preventing and treating chronic disease. 
De Weck-Gaudard D, Liardon R, Finot PA. 1988. Steriomeric composition of urinary 
lysinoalanine after ingestion of free or protein-bound lysinoalanine in rats. J Agric Food 
Chem 36:717-721. 
deOliviera JE, de Souza N, Jordao, Jr AA, Marchin JS. 1998. Methionine supplementation of 
soy products: effects on nitrogen balance parameters. Arch Latinoam Nutr 48:35-40. 
Dewick PM.1994. Isoflavanoids. In: Harborne JB, editor. The flavanoids: advances in 
research since 1986. New York; Chapman & Hall, p 117-232. 
Dobbins T, inventor; Wiley Organics, Inc., assignee. 2002 March 12. Process for isolating 
saponins from soybean-derived materials. U.S. patent 6,355,816. 
Eldridge AC, Wolf WJ. 1967. Purification of the 1 IS component of soybean proteins. 
Cereal Chem 44:645-652. 
Fang N, Yu S, Badger TM. 2002. Characterization of isoflavones and their conjugates in 
female rat urine using LC/MS/MS. J Agric Food Chem 50:2700-2707. 
Finot PA. 1997. Effects of processing and storage on the nutritional value of food proteins. 
In: Damodaran S, Paraf A, editors. Food proteins and their applications. New York:Marcel 
Dekker, Inc. 
Franke AA, Hankin JH, Yu MC, Maskarinec G, Low SH, Custer LJ. 1999. Isoflavone levels 
in soy foods consumed by multiethnic populations in Singapore and Hawaii. J Agric Food 
80 
Chem 47:977-986. 
Friedman M. 1982. Chemically reactive and unreactive lysine as an index of browning. 
Diabetes 31:5-14. 
Friedman M. 1999. Chemistry, biochemistry, nutrition, and microbiology of lysinoalanine, 
lanthionine, and histadinoalanine in food and other proteins. J Agric Food Chem 47:1307-
1318. 
Friedman M, Brandon DL. 2001. Nutritional and health benefits of soy proteins. J Agric 
Food Chem 49:1069-1086. 
Gestetner B, Assa Y, Henis Y, Tencer Y, Royman M, Birk Y, Bondi A. 1972. Interaction of 
Lucerne saponins with sterols. Biochim Biophys Acta 270:181-187. 
Gibson GR. 2002. Human gut microbiology: the end of the food chain or the start of good 
health? Microbiology Today 29:4-6. 
Gibson GR, Macfarlane GT. 1995. Human colonic bacteria: role in nutrition, physiology, and 
pathology. Boca Ration: CRC Press. 
Gotoh T, Yamada K, Ito A, Yin H, Kataoka T, Dohi K. 1998. Chemoprevention of N 
-nitroso-N-methylurea-induced rat mammary cancer by miso and tamoxifen, alone and in 
combination. Jpn J Cancer Res 89:487-495. 
Grady D, Cummings SR. 2001. Postmenopausal hormone therapy for prevention of fractures. 
How good is the evidence? J Am Med Assoc 285:2909-2910. 
Graf E, Eaton JW. 1993. Suppression of colonic cancer by dietary phytic acid. Nutr Cancer 
19:11-19. 
Grun IU, Adhikari K, Li C, Li Y, Lin B, Zhang J, Fernando LN. 2001. Changes in the profile 
of genistein, daidzein, and their conjugates during thermal processing of tofu. J Agric Food 
Chem 49:2839-2843. 
Gu L, Tao G, Gu W, Prior RL. 2002. Determination of soyasaponins in soy with LC-MS 
following structural unification by partial alkaline degradation. J Agric Food Chem 
50:6951-6959. 
Gugger E, Grabiel D, inventors; Archer Daniels Midland Company, assignee. 2001 Jan 9. 
Production of isoflavone enriched fractions from soy protein extracts. U.S. Patent 
6,171,638. 
Harbome JB. 1994. The flavanoids: advances in research since 1986. New York: Chapman 
Hall. 676 p. 
Hasegawa H, Sung J, Matsumiya S, Uchiyama M. 1996. Main ginseng saponin metabolites 
formed by intestinal bacteria. Planta Med 62:453-457. 
Hatta H, Kitabatake N, Doi E. 1986. Turbidity and hardness of a heat-induced gel of hen egg 
ovalbumin. Agric Biol Chem 50:2083-2089. 
Hayakawa K, Mizutani J, Wada K, Masa T, Yoshihara I, Mitsuoka T. 1990. Effects of 
soybean oligosaccharides on human faecal flora. Microbiol Ecol Health Dis 3:293. 
Hayashi K, Hayashi H, Hiraoka N, Ikeshiro Y. 1997. Inhibitory activity of soyasaponin II on 
virus replication in vitro. Plant Med 63:102-105. 
Hendrich S, Murphy PA. 2001. In: Wildman REC, editor. Handbook of nutraceuticals and 
functional foods. Boca Raton, FL: CRC Press, p 55-75. 
Henkel J. 2000. Soy: Health claims for soy protein, questions about other components. FDA 
Consumer May-June http://www.cfean.fda.gov/~dms/fdsoypr.html. 
81 
Herman EM, Larkins BA. 1999. Protein storage bodies and vacuoles. The Plant Cell. 11:601 
-613. 
Hettiarrachachy N, Kalapathy K. 1997. Soybean protein products. In; Liu K., editor. 
Soybeans: chemistry, utilization, and technology. New York: Chapman and Hall. 
Hill SE. 1996. Solubility. In: Hall GM, editor. Methods of testing protein functionality. New 
York:Blackie Academics & Professional, p 152-185. 
Hirose M, Ozaki K, Tabaka K, Fukushima S, Shiarai T, Ito N. 1991. Modifying effects of the 
naturally occurring antioxidants y-oryzanol, phytic acid, tannic acid and T]-tririacontane-
16,18-dione in a rat wide-spectrum organ carcinogenesis model. Carcinogenesis 12:1917 
-1921. 
Holder CL, Churchwell MI, Doerge DR. 1999. Quantification of soy isoflavones, genistein 
and daidzein, and conjugates in rat blood using LC/ES-MS. J Agric Food Chem 47:3764-
3770. 
Hostettmann K, Marston A. 1995. Saponins. In: Phillipson JD, Ayres DC, Baxter H, editors. 
Chemistry and pharmacology of natural products. Cambridge University Press:New York. 
Howard PA, Lehnhardt WF, Orthoefer FT, inventors; A. E. Staley Manufacturing Company, 
assignee. 1983 Jan 11. 7S and 1 IS vegetable protein fractionation and isolation. U.S patent 
4,368,151. 
Hu J. 2000. Isolation and quantitative analysis of soybean saponins by high performance 
liquid chromatography. [MS Thesis] Ames, IA: Iowa State University. 96 p. 
Hu J, Lee SO, Hendrich S, Murphy PA. 2002. Quantification of the Group B saponins by 
high performance liquid chromatography. J Agri Food Chem 50:2587-2594. 
Illinois Specialty Farm Products. 2003. High sucrose soybeans - updated for 2003. 
http://web.aces.uiuc.edu/value/factsheets/soy/fact-sucrose-soy.htm 
Iowa State University Extension. 2000. What you need to know about new food words -
phytochemicals, functional foods, nutraceuticals. PM 1846. 
Ireland PA, Dziedzic SZ. 1985. Analysis of soybean saponins by high-performance liquid 
chromatography. J Chromatogr 325:275-281. 
Ireland PA, Dziedzic SZ, Kearsley MW. 1986. Saponin content of soya and some 
commercial soya products by means of high-performance liquid chromatography of the 
sapogenins. J Sci Food Agric 37:694-698. 
Irvine C, Fitzpatrcik M, Robertson I, Woodhams D. 1995. The potential adverse effects of 
soybean phytoestrogens in infant feeding. N. Z. Med J. 108:208-209. 
Ishaaya I, Birk Y, Bondi A, Tencer Y. 1969. Soybean saponins IX. Studies of their effect on 
birds, mammals and cold-blooded organisms. J Sci Food Agric 20:433-436. 
Iwabuchi S, Yamauchi F. 1987. Determination of glycinin and P-conglycinin in soybean 
proteins by immunological methods. J Agric Food Chem. 35:200-205. 
Jariwalla RJ, Sabin R, Lawson S, Herman ZS. 1990. Lowering of serum cholesterol and 
triglycerides and modulation of divalent cations by dietary phytate. J Appl Nutr 42:18-28. 
Jun HS, Kim SE, Sung MK. 2002. Protective effect of soybean saponins and major 
antioxidants against aflatoxin B1-induced mutagenicity and DNA-adduct formation. J Med 
Food 5:235-240. 
Karikura M, Miyase T, Tanizawa H, Taniyama T, Takino Y. 1991. Studies on absorption, 
distribution, excretion and metabolism of ginseng saponins. VI. the decomposition products 
of ginsenoside Rb% in the stomach of rats. Chem Pharm Bull 39:400-404. 
82 
Kato A, Fujishige T, Matsudomi N, Kobayashi K. 1985. Determination of emulsifying 
properties of some proteins by conductivity measurements. J Food Sci. 50:56-58, 62. 
Kato A, Nakai S. 1980. S Biochim Biophys Acta. 624:13-20. 
Kato A, Tsutsumi N, Matsudomi N, Kobayashi K, Nakai S. 1981. Agric Biol Chem 45:2755 
-2760. 
Kelly GE, Huang JL, Deacon-Shaw MG, Waring MA, inventors; Novogen, Inc., assignee. 
2000 Nov 14. Preparation of isoflavones from legumes. U.S. Patent 6,146,668. 
Kennedy AR. 1995. The evidence for soybean products as cancer preventative agents. J Nutr 
125:733S-743S. 
Khalil AH, El-Adaway TA. 1994. Isolation, identification and toxicity of saponin from 
different legumes. Food Chem 50:197-201. 
Khatib KA, Herald TJ, Aramouni FM, MacRitchie F, Schapaugh WT. 2002. Characterization 
and functional properties of soy P-conglycinin and glycinin of selected genotypes. J Food 
Sci 67:2923-2929. 
Kim HJ, Chun YJ, Park JD, Kim SI, Roh JK, Jeong TC. 1997. Protection of rat liver 
microsomes against carbon tetrachloride-induced lipid peroxidation by red ginseng saponin 
through cytochrome P450 inhibition. Planta Med 63:415-418. 
Kim JS, Kwon CS. 2001. Estimated dietary isoflavone intake of Korean population based on 
National Nutrition Survey. Nutr Res 21:947-953. 
Kinjo J, Imagire M, Udayama M, Arao T, Nohara T. 1998. Structure-hepatoprotective 
relationships study of soyasaponins IIV having soyasapogenol B as aglycone. Planta Med 
64:233-236. 
Kinney AJ, Jung R, Herman EM. 2001. Cosuppression of the a subunits of P-conglycinin in 
transgenic soybean seeds induces the formation of endoplasmic reticulum-derived protein 
bodies. The Plant Cell. 13:1165-1178. 
Kinsella JE. 1976. Functional properties of proteins in foods: a survey. CRC Crit Rev Food 
Sci Nutri 7:219. 
Kinsella JE. 1979. Functional properties of soy proteins. J Am Chem Soc 56:242-258. 
Kinsella JE, Damodaran S, German B. 1985. Physicochemical and functional properties of 
oilseed proteins with emphasis on soy proteins. In: Altschul AM, Wilke HL, editors. New 
Protein Foods. New York, Academic Press, p 108-180. 
Kirk P, Patterson RE, Lampe JL. 1999. Development of a soy food frequency questionnaire 
to estimate isoflavone consumption in US adults. Am J Diet Assoc 99:558-563. 
Kitagawa I, Yoshikawa M, Hayashi T, Taniyama T. 1984. Quantitative determination of 
soyasaponins in soybeans of various origins and soybean products by means of high 
perfomance liquid chromatography. Yakugaku Zasshi 104:275-279. 
Klita PT, Mathison GW, Fenton TW, Hardin RT. 1996. Effects of alfalfa root saponins on 
digestive function in sheep. J Anim Sci 74:1144-1156. 
Klump S, Alfred MC, MacDonald JL, Ballam JM. 2001. Determination of isoflavones in soy 
and foods containing soy by extraction, saponification and LC: Collaborative study. J 
AOAC Int. 84:1865-1883. 
Koo M, Rao AV. 1991. Long-term effect of Bifidobacteria and neosugar on precursor lesions 
of colonic cancer in CF1 mice. Nutr Cancer 16:249. 
Koratkar R, Rao AV. 1997. Effect of soya bean saponins on azoxymethane-induced 
preneoplastic lesions on the colon of mice. Nutr Cancer 27:206-209. 
83 
Kulling SE, Rosenberg B, Jacobs E, Metzler M. 1999. The phytoestrogens coumesterol and 
genistein induce structural chromosomal aberrations in cultured human peripheral blood 
lymphocytes. Arch Toxicol 73:50-54. 
Kuo TM, VanMiddlesworth JF, Wolf WJ. 1988. Content of raffinose oligosaccharides and 
sucrose in various plant seeds. J Agric Food Chem 36:32. 
Lacaille-Dubois MA. 2000. Biologically and pharmacologically active saponins from plants: 
recent advances. In: Oleszek W, Marston A, editors. Saponins in food, feedstuff's and 
medicinal plants, p 205-218. 
Lakemond CMM, de Jongh HHJ, Hessing M, Gruppen H, Voragen AGJ. 2000. Soy glycinin. 
influence of pH and ionic strength on solubility and molecular structure at ambient 
temperatures. J Agric Food Chem. 48:1985-1990. 
Lamartiniere CA, Zhang JX, Cotroneo MS. 1998. Genistein studies in rats: potential for 
breast cancer prevention and reproductive and developmental toxicity. Am J Clin Nutr 
68:1400S-1405S. 
Langhendries JP, Hurrell RF, Fumiss DE, Hirschenhuber C, Finot PA, Bernard A, Battisti O, 
Bertrand JM, Senterre J. 1992. Maillard reaction products and lysinoalanine: urinary 
excretion and the effects on kidney function of preterm infants fed heat-processed milk 
formula. J Pediatr Gastroenterol Nutri 14:62-70. 
Lehnhardt WF, Gibson PW, Orthoefer FT, inventors; A. E. Staley Manufacturing Company, 
assignee. 1983 Jan 25. Fractionation and isolation of 7S and 1 IS protein from 
isoelectrically precipitated vegetable protein mixtures. U.S. patent 4,370,267. 
Liener IE. 1986. Trypsin inhibitors: concern for human nutrition or not? J Nutr 116:920-923. 
Liggins J, Bluck LJC, Coward WA, Bingham SA. 1998. Extraction and quantification of 
daidzein and genistein in food. Anal Biochem 264:1-7. 
Liggins J, Bluck LJC, Runsweick S, Atkinson C, Coward WA, Bingham SA. 2000. Daidzein 
and genistein contents of fruits and nuts. J Nutri Biochem 11:326-331. 
Lin MJ, Humbert ES, Sosulski FW. 1974. Certain functional properties of sunflower meal 
products. J Food Sci. 39:368-370. 
Liu K. 1997. Soybeans: chemistry, technology, and utilization. Florence, KY: International 
Thomson Publishing. 532 p. 
Liu M, Lee DS, Damodaran S. 1999. Emulsifying properties of acidic subunits of soy 1 IS 
globulin. J Agric Food Chem 47:4970-4975. 
LMC International. 1999. Soy protein market analysis. NY: LMC International. 
Lovati MR, Manzoni C, Gianazza E, Sirtori CR. 1998a. Soybean protein products as 
regulators of liver low-density lipoprotein receptors. I. Identification of active 
P-conglycinin subunits. J Agric Food Chem 46:2474-2480. 
Lovati C, Lovati MR, Gianazza E, Sirtori CR. 1998b. Soybean protein products as regulators 
of liver low-density lipoprotein receptors, n. a-a' rich commercial soy concentrate and a' 
deficient mutant differently affect low-density lipoprotein receptor activation. J Agric Food 
Chem 46:2481-2484. 
Lovati MR, Manzoni C, Gianazza E, Arnoldi A, Kurowska E, Carroll KK, Sirtori CR 2000. 
Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. J Nutr 130:2543 
-2549. 
Mahungu S, Diaz-Mercado S, Li J, Schwenk M, Singletary K, Faller J. 1999. Stability of 
isoflavones during extrusion processing of com/soy mixtures. J Agric Food Chem 47:279 
84 
-284. 
Malinow MR, McNuIty WP, McLaughlin P, Stafford C, Burns AK, Livingston AL, Kohler 
GO. 1981. The toxicity of alfalfa saponins in rats. Food & Cosmet Toxicol 19:443-445. 
Malinow MR, McNulty WP, Houghton DC, Kessler S, Stenzel P, Goodnight SH, Bardana 
EJ, Polatay JL, McLaughlin P, Livingston AL. 1982. Lack of toxicity of alfalfa saponins in 
monkeys. J Med Primatol 11:106-118. 
Manzoni C, Lovati MR, Gianazza E, Morita P, Sirtori CR. 1998. Soybean protein products as 
regulators of liver low-density lipoprotein receptors. II. Alpha-alpha' rich commercial soy 
concentrate and alpha' deficient mutant differently affect low-density lipoprotein receptor 
activation. J Agric Food Chem 46:2481-2484. 
Mao LC, Lee KH, Erbersdobler HF. 1993. Effects of heat treatment on lysine in soya protein. 
J Sci Food Agric 62:307-309. 
Maruyama N, Sato R, Wada Y, Matsumura Y, Goto H, Okuda E, Nakagawa S, Utsumi S. 
1999. Structure-physicochemical function relationships of soybean P-conglycinin 
constituent subunits. J Agric Food Chem 47:5278-5284. 
Maruyama N, Salleh MRM, Takahashi K, Yagasaki K, Goto H, Hontani N, Nakagawa S, 
Utsumi S. 2002. Structure-physicochemical function relationships of soybean P-conglycinin 
heterotrimers. J Agric Food Chem 50:4323-4326. 
Matsumura Y, Mori T. 1996. Gelation. In: Hall GM, editor. Methods of testing protein 
functionality. New YorkzBlackie Academics & Professional, p 77-109. 
Mazur WM, Duke J A, Wahala K, Rasku S, Adlercreutz H. 1998. Isofiavonoids and lignans 
in legumes: nutritional and health aspect in humans. J Nutri Biochem 9:192-200. 
Medeiros JS. 1982. Characterization of the subunits of p-conglycinin and the application of 
ELI SA to the determination of p-conglycinin and glycinin in soybeans. Ph.D. Thesis, 
Purdue University, West Lafayette, Indiana. 
Messina MJ. 1997. Soyfoods: Their role in disease prevention and treatment. In: Liu K, 
editor. Soybeans: chemistry, technology, and utilization. New York: Chapman Hall, p 442-
477. 
Messina MJ, Loprinzi CL. 2001. Soy for breast cancer survivors: a critical review of the 
literature. J Nutr 131:3095S-3108S. 
Messina M, Gardner C, Barnes S. 2002. Gaining insight into the health effects of soy but a 
long way still to go: commentary on the Fourth International Symposium on the Role of 
Soy in Preventing and Treating Chronic Disease. J Nutr 132:547S-551S. 
Meyer BN, Heinstein PF, Burnouf-Radosevich M, Delfel NE, McLaughlin JL. 1990. 
Bioactivity-directed isolation and characterization of quinoside A: one of the toxic/bitter 
principles of quinoa seeds (Chenopodium quinoa wild). J Agric Food Chem 38:205-208. 
Morton MS, Chan PSF, Cheng C, Blacklock N, MatosFerreira A, AbranchesMontiero L, 
Correia R, Lloyd S, Griffiths K. 1997. Lignans and isofiavonoids in plasma and prostatic 
fluid in men: samples from Portugal, Hong Kong, and the UK. Prostate 32:122-128. 
Murkies AL, Lombard C, Strauss BJG, Wilcox G, Burger HG, Morton MS. 1995. Dietary 
flour supplementation decreases postmenopausal hot flushes — effect of soy and wheat. 
Maturitas 21:189-195. 
Murphy PA, Wang H. 1994. Isoflavone content in commercial soybean foods. J Agric Food 
Chem 42:1666-1673. 
85 
Murphy PA, Song T, Buseman G, Barua K. 1997. Isoflavones in soy-based infant formulas. J 
Agric Food Chem 45:4635-4638. 
Murphy PA, Song TT, Buseman G, Barua K, Beecher GR, Trainer D, Holden J. 1999. 
Isoflavones in retail and institutional soy foods. J Agric Food Chem 47:2697-2704. 
Murphy PA, Hendrich S. 2002. Phytoestrogens in foods. Advances in food and nutrition 
research. 44:195-246. 
Murphy PA, Barua K, Hauck CC. 2002. Solvent extraction selection in the determination of 
isoflavones in soy foods. Journal of Chromatography B 777:129-138. 
Nagano T, Hirotsuka M, Mori H, Kohyama K, Nishinari K. 1992. Dynamic 
viscoelastic study on the gelation of 7S globulins from soybeans. J Agric Food Chem 
40:941-944. 
Nagano T, Fukuda Y, Akasaka T. 1996. Dynamic viscoelastic study on the gelation 
properties of (3-conglycinin-rich and glycinin-rich soybean protein isolates. J Agric Food 
Chem 44:3484-3488. 
Nakai S. 1983. Structure-function relationships of food proteins with an emphasis on the 
importance of protein hydrophobicity. J Agric Food Chem 31:676-683. 
Nakai S, Li-Chan E, Arteaga GE. 1996. Measurement of surface hydrophobicity. In: Hall 
GM, editor. Methods of testing protein functionality. New York: Blackie Academics & 
Professional, p 152-185. 
Nakamura T, Utsumi S, Mori T. 1986. Interactions during heat-induced gelation in a mixed 
system of soybean 7S and 11S globulins. Agric Biol Chem 50:2429 
Nestel PJ, Yamashita T, Sasahara T. 1997. Soy isoflavones improve systemic arterial 
compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler 
Thromb Vase Bio 17:3392-3398. 
Nielsen NC. 1985a. Structure of soy proteins. In: Altschul AM, Wilcke HL, editors. New 
protein foods. Volume 5: Seed Storage Proteins. New York: Academic Press, Inc. 
Nielsen NC. 1985b. Structure and complexity of the 1 IS polypeptides in soybeans. J Am Oil 
Chem Soc 62:1680-1685. 
Oakenfull DG, Topping DL, Illman RJ, Fenwick DE. 1984. Prevention of dietary 
hypercholestrolaemia in the rat by soya bean and quillaja saponins. Nutr Rep Inter 29:1039-
1041. 
Oakenfull D. 1986. Aggregation of saponins and bile acids in aqueous solution. Aust J Chem 
39:1671-1673. 
Oakenfull D, Sidhu GS. 1990. Could saponins be a useful treatment for 
hypercholesteremia? Eur J Clin Nutr 44:79-88. 
Ochiai K, Kamata Y, Shibasaki K. 1982. Effect of tryptic digestion on emulsifying properties 
of soy protein. Agric Biol Chem 46:91-96. 
Oh YJ, Sung MK. 2001. Soybean saponins inhibit cell proliferation by suppressing PKC 
activation and induce differentiation of HT-29 human colon adenocarcinoma cells. Nutr 
Cancer 39:132-138. 
O'Keefe SF, Wilson LA, Resurreccion AP, Murphy PA. 1991. Determination of the binding 
of hexanal to soy glycinin and P-conglycinin in an aqueous model system 
using a headspace technique. J Agric Food Chem 39:1022-1027. 
Oleszek W, Jurzystra M. 1990. High-performance liquid chromatography of alfalfa root 
saponins. J Chromatogr 519:109-116. 
86 
Osborne TB, Campbell GF. 1898. Proteids of the soy bean. J Am Chem Soc 20:419-428. 
Oste RE. 1991. Digestibility of processed food proteins. Adv Exp Med Biol 289:371-388. 
Pearce KN, Kinsella JE. 1978. Emulsifying properties of proteins: Evaluation of a 
turbidometric technique. J Agric Food Chem 26:716-723. 
Perkin JE. 1990. Appendix B. General guidelines for management of soy allergy. In: Perkin 
JE, editor. Food allergies and adverse reactions. Gaithersberg, Maryland: Aspen 
Publishers, Inc. p 249-252. 
Perkins EG. 1995. Composition of soybeans and soybean products. In: Erikson DR, editor. 
Practical handbook of soybean processing and utilization. Champaign, IL: AOCS Press 
and St. Louis, MO: United Soybean Board, p 9-28. 
Pemollet JC. 1978. Protein bodies of seeds: Ultrastructure, biochemistry, biosynthesis and 
degradation. 17:1473-1480. 
Peterson G, Barnes S. 1991. Genistein inhibition on the growth of human breast cancer cells: 
independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys 
Res Comm 179:661. 
Petereson G, Barnes S. 1993. Isoflavones inhibit the growth of human prostate cancer cell 
lines without inhibiting epidermal growth factor receptor phosphorylation. Prostate 22:335 
-345. 
Pollard M, Luckert PH. 1997. Influence of isoflavones in soy protein isolates on development 
of induced prostate-related cancers in L-W rats. Nutr Cancer 28:41-45. 
Potter JD, Topping DL, Oakenfull D. 1979. Soya saponins and plasma cholesterol. Lancet 
i:223. 
Potter SM, Jimenez-Flores R, Pollack J, Lone TA, Berber-Jimenez. 1993. Protein-saponin 
interaction and its influence on blood lipids. J Agric Food Chem 41:1287-1291. 
Potter SM. 1995. Overview proposed for the hypercholesterolemic effect of soy. J Nutr 
125:6068-61 IS. 
Price KR, Fenwick GR. 1984. Soyasaponin I, a compound possessing undesirable taste 
characteristics isolated from the dried pea (Pisum sativum L.). J Sci Food Agric 
35:887-892. 
Price KR, Curl CL, Fenwick GR. 1986. The saponin content and sapogenol composition of 
the seed of 13 varieties of legume. J Sci Food Agric 37:1185-1191. 
Price KR, Johnson IT, Fenwich GR. 1987. The chemistry and biological significance of 
saponins in feeds and feedingstuffs. CRC Crit Rev Food Sci Nutri 26:27-135. 
Puppo MC, Anon MC. 1999. Soybean protein dispersions at acid pH. Thermal and 
rheological properties. J Food Sci. 64:50-56. 
Rackis JJ, Gumbmann MR. 1982. Protease inhibitors: physiological properties and 
nutritional significance. In: Ory RL, editor. Antinutrients and natural toxicants in foods. 
Westport, CT: Food and nutrition press, p 203. 
Rao AV, Sung MK. 1995. Saponins as anticarcinogens. J Nutr 125:717S-724S. 
Regenstein JM, Regenstein CE. 1984. Protein functionality for food scientists. In: Regenstein 
JM, Regenstein CE, editors. Food protein chemistry. OrlandozAcademic Press. 
Rhee KC, Choi YR. 1981. Annual progress report of Food Protein Research and 
Development Center. College Station, TX: Texas A&M University, p 203-233. 
Ridout CL, Wharf SG, Price KR, Johnson IT, Fenwick GR. 1988. United Kingdom mean 
daily intakes of saponins — intestine-permeabilizing factors in legumes. Food Sci Nutr 
87 
42:111-116. 
Rimbach G, Pallauf J. 1999. Effect of dietaiy phytate on magnesium bioavailability and liver 
antioxidant status in growing rats. Food Chem Toxicol 37:37-45. 
Roberts RC, Briggs DR. 1965. Isolation and characterization of the 7S component of soybean 
globulins. Cereal Chem 42:71-85. 
Saito T, Kohno M, Tsumura K, Kugimiya W, Kito M. 2001. Novel method using phytase for 
separating soybean P-conglycinin and glycinin. Biosci Biotechnol Biochem. 65:884-887. 
Schenz TW, Morr CV. 1996. Solubility. In: Hall GM, editor. Methods of testing protein 
functionality. New York: Blackie Academics & Professional, p 61-75. 
Schneeman B, Gallaher D. 1986. Pancreatic response to dietary trypsin inhibitor: variation 
among species. Adv Exp Med Biol 199:185-187. 
Schwenke KD. 1997. Enzyme and chemical modification of proteins. In: Damodaran S, Paraf 
A, editors. Food proteins and their applications. New York, Marcel Dekker. p 393-424. 
Setchell KDR, Nechemias-Zimmer L, Cai J, Heubi JE. 1997. Exposure of infants to 
phytoestrogens from infant soy formulas. Lancet 350:23-27. 
Setchell KDR, Nechemias-Zimmer L, Cai J, Heubi JE. 1998. The isoflavone content of infant 
formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr 
68:1453S-1461S. 
Setchell KDR, Cassidy A. 1999. Dietary isoflavones: biological effects and relevance to 
human health. J Nutr 129:758S-767S. 
Shamsuddin AM, Baten A, Lahwani ND. 1992. Effect of inositol hexaphophate on growth 
and differentiation of human mammary cancer cell lines in vivo. Cancer Lett 64:195-202. 
Shamsuddin AM, Yang GY, Vucenik 1.1996. Novel anti-cancer functions of IP6:growth 
inhibition and differentiation of human mammary cancer cell lines in vitro. Anticancer 
Res 16:3287-3302. 
Sheehan D. 1997. Isoflavone content of breast milk and soy formulas: benefits and risks. Clin 
Chem 43:850-852. 
Shen JL. 1976. Solubility profile, intrinsic viscosity, and optical rotation studies of acid 
precipitated soy protein and of commercial soy isolate. J Agric Food Chem 24:784-788. 
Shen JL. 1981. Solubility and viscosity. In: Cherry JP, editor. Protein functionality in foods. 
Washington D C., American Chemical Society, p.89-109. 
Shimoyamada M, Kudo S, Okubo K, Yamauchi F, Harada K. 1990. Distributions of saponin 
constituents in some varieties of soybean plant. Agric Biol Chem 54:77-81. 
Shimoyamada M, Kudou S, Harada K. 1991. Variation in saponin contents in germinating 
soybean seeds and effects of light irradiation. Agric Biol Chem 55:577-579. 
Shiraiwa M, Harada K, Okubo K. 1991. Composition and content of saponins in soybean 
seed according to variety, cultivation year and maturity. Agric Biol Chem 55:323-331. 
Simonne AH, Smith M, Weaver DB, Vail T, Barnes S, Wei CI. 2000. Retention and changes 
of soy isoflavones and carotenoids in immature seeds (edemame) during processing. J Agric 
Food Chem 48:6061-6069. 
Singletaiy K, Faller J, Li JY, Mahungu S. 2000. Effect of extrusion on isoflavone content and 
antiproliferative bioactivity of soy/com mixtures. J Agric Food Chem 48:3566-3571. 
Sirtori CR, Lovati MR. 2001. Soy proteins and cardiovascular disease. Curr Atheroscler Rep 
3:47-53. 
88 
Smith AK, Cirek SJ. 1972. Soybeans: chemistry and technology. In: Smith AK, Cirek SJ, 
editors. Vol. 1 Proteins. Westport, CT: AVI Publishing Co. 
Song TT, Barua K, Buseman G, Murphy PA. 1998. Soy isoflavone analysis: quality control 
and new internal standard. Am J Clin Nutr. 68:1474S-1479S. 
Sorgentini DA, Wagner JR, Anon MC. 1995. Effects of thermal treatment of soy protein 
isolate on the characteristics and structure-function relationship of soluble and insoluble 
fractions. J Agric Food Chem 43:2471-2479. 
Soya & oilseed bluebook. 2003. World soybean: production & area harvested. P 352. 
Soyfoods.com. 2003. New foods, new uses: How soy protein can expand your business. 
http ://www. soyfoods.com/manufacture/market.html. 
SPINS/Soyatech Study. 2002. Soyfoods: The U.S. market 2002. SPINS, Inc. & Soyatech 
Inc. 
Strom BL, Schinnar R, Ziegler EE, Bamhart KT, Sammuel MD, Macones G A, S tailings VA, 
Drulis JM, Nelson SE, Hanson SA. 2001. Exposure to soy-based formula in infancy and 
endocrinological and reproductive outcomes in young adulthood. JAMA 286:807-814. 
Taniyama T, Yoshikawa M, Kitagawa I. 1988. Saponin and sapogenol. XLIV. Soyasaponin 
composition in soybeans of various origins and soyasaponin content in carious organs of 
soybean. Structure of soyasaponin V from soybean hypocotyls. Yakugaku Zasshi 108: 562-
571. 
Tava A, Odoardi M. 1996. Saponins from Medicago spp.: chemical characterization and 
biological activity against insects. In: Waller GR, Yamasaki K; editors. Saponins used in 
food and agriculture. New York, Plenum Press, p. 97-109. 
Thanh VH, Okubo K, Shibasaki K. 1975. Isolation and characterization of the 
multiple 7S globulins of soybean. Plant Physiol 56:19-22. 
Thanh VH, Shibasaki K. 1976a. Heterogeneity of P-conglycinin. Biochem Biophys Acta 
439:326-338. 
Thanh VH, Shibasaki K. 1976b. Major proteins of soybean seeds. A straightforward 
fractionation and their characterization. J Agric Food Chem 24:1117-1121. 
Thanh VH, Shibasaki K. 1978. Major proteins of soybean seeds. Subunit structure of P 
-conglycinin. J Agric Food Chem 26:692. 
Thompson LU, Zhang L. 1991. Phytic acid and minerals effect on early markers of risk for 
mammary and colon carcinogenesis. Carcinogenesis 12:2041-2045. 
Timbekova AE, Isaev ME, Abubakirov NK. 1996. Chemistry and biological activity of 
triterpenoid glycosides from Medicago sativa. In: Timbekova AE, editor. Saponins used in 
food and agriculture. New York: Plenum Press p. 171-182. 
Tombs MP. 1974. Gelation of globular proteins. Faraday Discuss Chem Soc 57:158-164. 
Topping DL, Storer GB, Calvert GD, Illman RJ, Oakenfull DG, Weller RA. 1980. Effects of 
dietary saponins on fecal bile acids and neutral sterols, plasma lipids, and lipoprotein 
turnover in the pig. Am J Clin Nutr 33:783-786. 
Tsukamoto C, Kikuchi A, Harada K, Kitamura K, Okubo K. 1993. Genetic and chemical 
polymorphisms of saponins in soybean seeds. Phytochem 34:1351-1356. 
Tsukamoto, C, Shimada S, Igita K, Kudou S, Kokubun M, Okubo K, Kitamura K. 1995. 
Factors affecting isoflavone content in soybean seeds: changes in isoflavones, saponins, and 
composition of fatty acids at different temperatures during seed development. J Agric Food 
Chem 43:1184-1192. 
89 
United Soybean Board. 2000. World soybean production 2000. www.united 
soybean.org/soystats2001/page_34.htm. 
Utsumi S, Matsumura Y, Mori T. 1997. Structure-function relationships of soy proteins. 
Food proteins and their applications. In: Damodaran S, Paraf A, editors. New York: Marcel 
Dekker, Inc. 
van der Schouw YT, Grobbee DE. 2001. HRT and heart disease: Dr. Jekyl or Mrs. Hyde? 
Maturitas 38:213-217. 
Vojdani F. 1996. Solubility. In, Hall GM. Methods of testing protein functionality. New 
York: Blackie Academics & Professional, p 11-60. 
Waggle DH, Bryan BA, inventors; Protein Technologies International, Inc, assignee. 2002 
Dec 17. Recovery of isoflavones from soy molasses. U.S. patent 6,495,141. 
Wagner JR, Gueguen J. 1999. Surface functional properties of native, acid-treated, and 
reduced soy glycinin. 1. Foaming properties. J Agric Food Chem 47: 2173-2180. 
Wagner JR, Sorgentini DA, Anon MC. 2000. Relation between solubility and surface 
hydrophobicity as an indicator of modifications during preparation processes of commercial 
and laboratory-prepared soy protein isolates. J Agric Food Chem 48:3159-3165. 
Wakai K, Egami I, Kato K, Katamura T, Tamakoshi A, Lin Y, Nakayama T, Wada M, Ohno 
Y. 1999. Dietary intake and sources of isoflavones among Japanese. Nutr Cancer 33:139 
-145. 
Wang C, Ma Q, Pagadala S, Sherrard MS, Krishnan PG. 1998. Changes of isoflavones 
during processing of soy protein isolates. J Am Oil Chem Soc 75:337-341. 
Wang CH, Damodaran S. 1991. Thermal gelation of globular proteins: Influence of protein 
conformation on gel strength. J Agric Food Chem 39:433-438. 
Wang H, Murphy PA. 1994a. Isoflavone content in commercial soybean foods. J Agric Food 
Chem 42:1666-1673. 
Wang H, Murphy PA. 1994b. Isoflavone composition of American and Japanese soybeans in 
Iowa: effects of variety, crop year, and location. J Agric Food Chem 42:1674-1677. 
Wang H, Murphy PA. 1996. Mass balance study of isoflavones during soybean processing. J 
Agric Food Chem 44:2377-2383. 
Wang J, Sporns P. 2000. MALDI-TOF MS analysis of isoflavones in soy products. J Agric 
Food Chem 2000 48:5887-5892. 
Wilde PJ, Clark DC. 1996. Foam formation and stability. In: Hall GM, editor. Methods of 
testing protein functionality. New York: Blackie Academics & Professional, p 110-152. 
Wolf WJ, Briggs DR. 1959. Purification and characterization of the 1 IS component of 
soybean proteins. Arch Biochem Biophys 85:186-199. 
Wolf WJ, Sly DA. 1967. Cryoprecipitation of soybean 1 IS protein. Cereal Chem 44:653-
668. 
Wolf WJ. 1969. Soybean protein nomenclature: a progress report. Cereal Sci Today 14:75, 
76, 78, 129. 
Wrick K. 2003. The U.S. soy market: an update & outlook. http://www.nutraceuticals 
world.com/JanFeb031 .htm. 
Wu S, Murphy PA, Johnson LA, Fratzke AR, Reuber MA. 1999. Pilot-plant fractionation of 
soybean glycinin and p-conglycinin. J Am Oil Chem Soc 76:286-293. 
Wu S, Murphy PA, Johnson LA, Reuber MA, Fratzke AR. 2000. Simplified process for 
soybean glycinin and P-conglycinin fractionation. J Agric Food Chem 48:2702-2708. 
90 
Wu WU, Hettiarchchy NS, Qi M. 1998. Hydrophobicity, solubility, and emulsifying 
properties of soy protein peptides prepared by papain modification and ultrafiltration. 
J Am Oil Chem Soc 75:845-849. 
Yamashita U, Kawada S, Nakano H. 1990. Induction of mammalian topoisomerase II 
dependent DNA cleavage by noninteractive fiavonoids, genistein and equol. Biochem 
Pharm 39:737-744. 
Yamauchi F, Sato M, Sato W, Kamata Y, Shibasaki K. 1981. Isolation and purification of a 
new type of P-conglycinin in soybean globulins. Agric Biol Chem 45:2863. 
Yamauchi F, Yamagishi T, Iwabuchi S. 1991. Molecular understanding of heat-induced 
phenomena of soybean protein. Food Reviews International 7:283-322. 
Yoshiki Y, Okubo K. 1995. Active oxygen scavenging activity of DDMP saponins in 
soybean seeds. Biosci Biotech Biochem 59:156-1557. 
Yoshiki Y, Kudou S, Okubo K. 1998. Relationship between chemical structures and 
biological activities of triterpenoid saponins from soybean. Biosci Biotechnol Biochem 
62:2291-2299. 
Young VR. 1991. Soy protein in relation to human protein and amino acid nutrition. J Am 
Diet Assoc 91:828-835. 
Zhang YL, Song TT, Cunnick JE, Murphy PA, Hendrich S. 1999. Daidzein and genistein 
glucuronides in vitro are weakly estrogenic and activate human natural killer cells in 
nutritionally relevant concentrations. J Nutr 129:399-405. 
91 
CHAPTER 2. SOY PROTEIN, ISOFLAVONE, AND SAPONIN 
PARTITIONING DURING PILOT-SCALE FRACTIONATION OF 
GLYCININ AND P-CONGLYCININ 
A paper to be submitted to the Journal of the American Oil Chemists ' Society 
David A. Rickert, Vanessa Smith, Lawrence A. Johnson, Patricia A. Murphy 
Abstract 
A pilot-scale process for fractionation of the major soy storage proteins, glycinin and P-
conglycinin, was scaled up from 15 kg of defatted soy flakes to 50 kg and evaluated for 
protein yield. The partitioning of isoflavones and saponins, protein-associated soy 
phytochemicals, was assessed. The glycinin and P-conglycinin fractions, and an intermediate 
fraction containing a mixture of the two proteins, contained 9, 17, and 3% of the total starting 
protein, respectively. The insoluble fraction, a waste stream, retained 59, 67, and 75% of the 
protein, isoflavones, and saponins, respectively. The whey, another waste stream, contained 
6% of the protein, 12% of the isoflavones, and less than 0.2% of the saponins. The three 
product fractions, when combined, contained 18 and 22% of the isoflavones and saponins, 
respectively. The saponin to isoflavone ratio was more than 2:1 for the P-conglycinin, but 
only about 1:1 for the glycinin. Distribution of the various isoflavone and saponin forms 
among process streams was altered during processing. The scaled-up process was less 
efficient for protein recovery. Additional processing of the insoluble and whey fractions may 
improve protein and phytochemical recovery. 
Introduction 
The efforts to elucidate the effects of soy protein and associated phytochemicals on 
human health, to understand how physicochemical characteristics of the soy storage proteins 
influence functional properties, and to develop new soy protein ingredients with unique or 
enhanced functional properties continue. These efforts are driven by consumer demand for 
dietary soy products and food industry desire to meet that demand with relatively 
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inexpensive soy ingredients that provide necessary protein functionality characteristics. 
Pilot-scale fractionation of glycinin and P-conglycinin is capable of producing kilogram 
quantities of these proteins, therefore facilitating their use in clinical human feeding studies, 
functionality testing, and ingredient application in food systems. 
In addition to the role of soy as a highly digestible protein with an excellent amino acid 
profile, consumption of soy foods and ingredients may provide several health benefits, such 
as improved cardiovascular health as part of a low-fat diet, anti-osteoporotic effects, and anti-
carcinogenic activity. The component or components of soy imparting these benefits, such 
as protease inhibitors, isoflavones, saponins, and soy protein itself, have been the subject of 
considerable debate (1-6), especially concerning cardiovascular health. Additional research 
in the form of clinical trials is needed. One such recent study endeavored to elucidate the 
respective roles of isoflavones and P-conglycinin on serum cholesterol and lipid profiles in 
humans. Pilot-scale production of P-conglycinin was necessary to produce adequate 
quantities of for the study. Understanding the partitioning of these co-products during pilot-
scale fractionation may suggest means for future modification of the system to direct 
partitioning or improve recovery of the co-products. 
The considerable effort to understand the functionalities of the major soy storage proteins 
in regard to protein structure has been reviewed (7). The process to understand structure-
function relationship continues with regard to genotype effect on functional properties and 
product applications (8-10). Limited evaluations of functionalities of pilot-scale produced 
glycinin and P-conglycinin fractions have been published (11-13). Additional information 
concerning functionalities of process fractions will be of interest as process improvement or 
modification occurs. Pilot-scale production will yield protein fractions in sufficient quantity 
to conduct food system evaluations. 
Development of an efficient, sequential method to prepare glycinin and P-conglycinin 
fractions for characterization and functionality studies and to produce kilogram quantities of 
the proteins on a pilot-scale has evolved over several decades. In 1976, Thanh and Shibasaki 
(14) described one of the first sequential bench-scale methods for separating glycinin and P-
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conglycinin fractions. This method was later modified by others after 1990 (15,16). Patents 
for pilot-scale processes producing enriched glycinin, p-conglycinin fractions, as well as 
mixtures of these proteins, have been disclosed (17-19). Wu et al. (11,20) employed two 
methods for pilot-scale fractionation of glycinin and P-conglycinin. The first method was a 
modification of a bench-scale process. Three fractions, glycinin, an intermediate mixture, and 
P-conglycinin, were separated by sequential precipitation controlled by pH and ionic 
strength. The second method was a simplified method resulting in only glycinin and P-
conglycinin fractions, yielding a larger p-conglycinin fraction at the expense of purity. 
The objective of this research was to evaluate the effect on protein yield as scale up from 
15 to 50 kg of defatted soy flake material was implemented for Wu's three-product 
fractionation process. The partitioning of protein and protein-associated phytochemicals, the 
isofiavones and saponins, was evaluated to gain understanding of their partitioning and 
insight concerning process improvement for recovery of these co-products. 
Materials and Methods 
Materials. Defatted, soybean white flakes were purchased from Cargill (Minneapolis, 
MN). Flakes were stored in sealed containers at 4 °C. HPLC-grade acetonitrile, methanol, 
trifluoroacetic acid, and glacial acetic acid for HPLC mobile phase and sample preparation 
were purchased from Fisher Scientific (Fair Lawn, NJ). HPLC-grade water for mobile phase 
and sample preparation was produced using a Milli-Q water system (Millipore Co., Bedford 
MA). 
Protein fractionation process. The pilot-scale fractionation process was a modification 
of that used by Wu et al. (11). Figure 1 displays a flow chart of the process. Fifty kg of 
defatted soy flakes were suspended in 400 kg of 20 °C tap water in a jacketed 800-L tank 
(Walker Stainless Equipment Company, New Lisbon, WI) stirred at 13 rpm. The pH of the 
suspension was adjusted to 8.5 with 2N NaOH and stirred at 22 rpm for 60 min. A Moyno-
type transfer pump (Electric Pump, Model IFFCA SSE SAA, Des Moines, IA) at 250 rpm 
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Defatted Soy Flakes (50 kg) 
Water (400 kg) 
>. 1st Sharpies Supernatant^ . 
1st Sharpies Insoluble 
Water (250 kg). 
2nd Sharpies Insoluble  ^  ^ 2nd Sharpies Supernatant^  
NaHS03 (0.98 g/L) 
neutralized to pH 7.0 
spray dried 1st Alfa Laval Supernatant 
Spray-Dried Glycinin NaCl addition (to 0.25 M) 
I Intermediate Precipitate  ^
neutralized to pH 7.0 
spray dried 
2nd Alfa Laval Supernatant 
Spray-Dried Intermediate Water added (2x supernatant weight) 
I p-Conglycinin Precipitate 
neutralized to pH 7.0 
desalted with 30-kd membrane 
spray dried 
•\r Whey 
adjusted to pH 5.0, stirred 1 hr at 7 °C 
fed to Alfa Laval centrifuge as above 
adjusted pH to 4.8, chilled at 7 °C overnight 
fed to Alfa Laval centrifuge as above 
adjusted to pH 6.4, chilled at 7 °C overnight 
420 rpm pump speed to feed Alfa Laval centrifuge with 9800 rpm bowl speed 
adjusted to pH 8.5, stirred 1 hr at 20 °C 
250 rpm Moyno pump speed to Sharpies centrifuge with 5700 
rpm bowl speed and 4000 rpm backdrive pinion speed 
stirred 30 min at 20 'C 
250 rpm Moyno pump speed to Sharpies centrifuge with 5700 
rpm bowl speed and 4000 rpm backdrive pinion speed 
Spray-Dried p-Conglycinin 
FIG. 1. Soy storage protein fractionation process. 
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pump speed (approximately 1.7 L/min) was used to feed the slurry to a Sharpies P660 
horizontal decanting centrifuge (Alfa Laval Separation Inc., Warminster, PA) set at 5700 rpm 
bowl speed and 4000 rpm backdrive pinion speed, separating the slurry into extract and 
residue fractions. To improve total recovery of solubilized proteins, the residue fraction was 
returned to the 800-L tank, suspended in 250 kg water (1:5 ratio based on 50 kg starting 
material), and stirred at 13 rpm for 30 min. The slurry was then centrifuged as above. The 
residue fraction from the second centrifuge pass was a waste stream and received no further 
processing. The extract fractions from the first and second centrifuge passes were combined 
in the 800-L tank, continuously stirred at 13 rpm, treated with solid sodium bisulfite to 
produce 10 mM SO2 (about 0.98g/L NaHS03)> adjusted to pH 6.4 using 2N HC1, chilled to 
approximately 7 °C, and maintained at this temperature overnight. 
A 420 rpm pump speed was used to feed the chilled, treated extract to an Alfa Laval 
BTPX 205 disc stack centrifuge with a 9800 rpm bowl speed, producing a glycinin 
precipitate fraction and a supernatant fraction. The glycinin precipitate was neutralized to pH 
7.0 with 2N NaOH and dried with an Anhydro Compact Spray Dryer (APV Crepaco Inc., 
Attleboro Falls, MA) with an air inlet temperature of 160 °C and outlet temperature of 85 °C. 
The supernatant fraction was returned to the 800-L tank, treated with solid NaCl to produce a 
0.25 M concentration, and then adjusted to pH 5.0. This treated supernatant was stirred for 
60 min at 13 rpm, and then fed to the Alfa Laval centrifuge as above. The resulting 
precipitate, termed the intermediate precipitate, was neutralized to pH 7.0 with 2N NaOH and 
spray dried as above. The supernatant was returned to the tank, combined with an amount of 
water equal to two times the supernatant weight, and adjusted to pH 4.8. The treated 
supernatant was stirred at 13 rpm and maintained at approximately 7 °C overnight. 
The chilled, treated supernatant was passed through the Alfa Laval centrifuge as above, 
producing P-conglycinin precipitate and whey. The whey waste stream received no further 
processing. The P-conglycinin precipitate was neutralized to pH 7.0 with 2N NaOH, 
measured for volume, and then desalted with a Feed and Bleed Membrane Filtration System 
(Model SRT-50; North Carolina SRT Inc., Cary, NC) and a 30-KD regenerated cellulose 
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membrane (North Carolina SRT Inc.). Diafiltration was performed until an amount of 
permeate equal to five times the volume of the pH-adjusted p-conglycinin precipitate had 
been collected. The retentate was then spray dried as above. 
Modifications to Wu's method (11) were as follows. A water-to-flake ratio of 8:1 was 
used instead of 15:1 or 10:1, producing an insoluble fraction with a higher solids content. 
Chill steps were at 7 °C instead of 4 °C because that was as low as the chilling system could 
provide for the configuration used. Neutralization pH of the glycinin, intermediate, and P-
conglycinin precipitate fractions was 7.0 instead of 7.5. The glycinin and intermediate 
fractions were not desalted for this study because no functionality or clinical trial uses were 
planned for these products. 
Sampling. For a given process stream, samples of uniform weight were collected at pre­
determined intervals and then combined into a composite sample. Composites of random 
grab samples were prepared for each spray-dried fraction. 
Proximate analyses. Moisture contents of high-moisture and spray-dried samples were 
determined by difference after freeze drying and oven drying (21), respectively. Ash (22) 
and nitrogen (23) analyses were performed in triplicate. To compensate for different 
nitrogen contents of the different protein fractions, conversion factors of 6.37 and 6.08 were 
used to calculate protein contents for the p-conglycinin and intermediate fractions, 
respectively. Protein contents of all other samples were calculated using 5.71 as the 
conversion factor. 
Isoflavone and group B saponin extraction and analyses. Extractions and HPLC 
analyses were conducted as reported by Hu et al. (24) for saponins and as reported by 
Murphy et al. (25) for isoflavones with minor modifications. Approximately 4 g of freeze-
dried or spray-dried material were accurately weighed into a 125-ml Erlenmeyer flask. 
Fourteen mL of distilled water and 20 mL of acetonitrile were added to the flask, as well as a 
stir bar. The flask was capped, and then mixed on a rotary shaker (Innova Model 2050, New 
Brunswick Sci., Edison, NJ) at 300 rpm for 2 hat ambient temperature. 
97 
The modified extraction method differed as follows from the methods described by 
Murphy (24) and Hu (25). For optimal isoflavone extraction from a particular food matrix, 
Murphy used 10 mL of acetonitrile, 2 mL of 0.1 N HC1, and water as needed (approximately 
7 mL). Hu used 100 mL of 70% ethanol and 2.5 h of extraction time for saponin extraction. 
The modified method did not give significantly different (f<0.05) phytochemical 
concentrations compared to the referenced methods when ground, defatted soy flakes were 
analyzed. 
The extract was vacuum filtered (No. 42 filter paper, Whatman, Hillsboro, OR), and the 
filtered extract was quantitatively transferred to a 500-mL round-bottomed flask, using 
acetonitrile to facilitate the transfer, and evaporated to dryness using a rotary evaporator 
(Brinkmann, Westbury, NY) at <30 °C. Isoflavones and saponins were recovered from the 
round-bottomed flask with 80% HPLC-grade methanol in water to a final volume of 10.0 
mL. The sample was passed through a 0.45 pjtn polytetrafluoroethylene filter (Alltech 
Associates, Deerfield, IL) prior to HPLC analysis. 
Quantification of the isoflavones and group B saponins was performed on different 
HPLC systems, but using the same type of reverse-phase column, an RP-18, 5 gm, 
4.6 i.d. x 250 mm YMC-ODS-AM-303 column (YMC, Inc., Wilmington, NC). Isoflavones 
were separated using a gradient system comprised of 0.1% glacial acetic acid in water (A) 
and 0.1% glacial acetic acid in acetonitrile (B). After a 20 pL injection, the system was 
maintained at 15% B for 5 min, increased to 29% B over 31 min, and then increased to 35% 
B in 8 min. The system was returned to 15% B and maintained at that concentration for 15 
min before the next injection. The flow rate was 1.0 mL/min for the first 5 min, increased to 
1.5 mL/min for the next 40 min, and then returned to 1.0 mL/min. The UV absorbance was 
recorded from 200-350 nm. Peak areas at 254 nm were used for analysis. 
Saponins were separated using a gradient system consisting of 0.05% trifluoroacetic acid 
in water (A) and acetonitrile (B). The programmed gradient did not differ substantially from 
that used by Hu et al. (24). Solvent B was increased from 37 to 40% in 15 min, and then 
solvent B was further increased to 48% over 20 min. Finally, solvent B was increased to 
98 
100% in 2 min, held at 100% for 3 min, then returned to 37% over 2 min. The system was 
maintained at 37% B for 8 min before the next injection. The flow rate was maintained at 1 
mL/min throughout. The UV absorbance was monitored from 190 to 350 nm. Peak areas at 
205 and 292 nm were used for analysis of non-DDMP and DDMP saponins, respectively. 
For quality control purposes, an isoflavone standard solution (genistin, genistein, and 
daidzein) and a saponin standard solution (saponin I) were injected on the respective systems 
prior to analyzing samples. Preparation of isoflavone and saponin standards and calibration 
curves is described elsewhere (24,25). Isoflavone recovery from ground soy flake and 
freeze-dried soy protein isolate material similar to the fractionated proteins was evaluated 
using a concentrated isoflavone extract produced from soy flakes and containing 7.5 
pmol/mL isoflavones in 80% methanol. Saponin recovery from these matrices employed a 
mixture of saponin I and II at concentrations of 4.8 and 3.9 pmol/mL, respectively, in 80% 
methanol. Samples were spiked, mixed thoroughly, and then allowed to air dry overnight. 
Extraction was performed as above. 
Statistical analysis. Means, least significant differences, and ANOVA results were 
calculated using the SAS system (version 6, SAS Institute Inc., Cary, NC). 
Results and Discussion 
Effects of scale up. Wu et al. (11) developed a pilot-scale soy protein fractionation 
process to prepare glycinin- and (3-conglycinin-rich fractions, as well as an intermediate 
fraction that contained both glycinin and P-conglycinin. These protein fractions were 
separated sequentially, employing acid precipitation, chilling, and ionic strength 
manipulation of the protein extract and supernatant fractions. The intermediate fraction was 
precipitated between the glycinin and P-conglycinin fractions to improve the purity of the P~ 
conglycinin fraction, removing substantial quantities of glycinin remaining in the supernatant 
after the glycinin precipitation step. Wu reported that most of the glycinin and P-conglycinin 
proteins comprising the intermediate fraction were no longer in their native state. Scale-up 
ofWu's process was required to meet demands for p-conglycinin, which was needed for a 
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clinical study to evaluate the impact of isoflavones and P-conglycinin on serum cholesterol 
and lipid profiles in humans. Scale up from Wu's 15-kg process to the 50-kg level enabled 
an evaluation of the effects of scale up. 
In addition to the desired products, glycinin, intermediate, and P-conglycinin, the 
fractionation process produced two waste stream fractions, the insoluble residue and the 
whey. One impact of scale up was the decrease in protein extraction rate from the starting 
material, demonstrated by the dry mass and protein remaining in the insoluble fraction. The 
percentage fraction yield for the insoluble fraction, i.e. dry basis insoluble fraction weight 
divided by the dry basis weight of the starting material and expressed as a percentage, for the 
15-kg process reported by Wu et al. (11) was 49.1%, whereas that of the 50-kg process was 
73.1% (Table 1). The percentage protein recovery in the insoluble fraction, i.e. dry-basis 
protein weight divided by total dry-basis protein and expressed as a percentage, was 38.8% 
for the 15-kg process compared to 58.6 % for the 50-kg process, demonstrating a significant 
portion of the high fraction weight observed for the 50-kg process was due to decreased 
protein recovery from the starting material. The protein content of the insoluble fraction was 
similar for the two processes. 
The protein concentrations of the 50-kg process product fractions were lower than 
reported by Wu et al. (11) for the 15-kg process. One reason for this difference was that Wu 
et al. used diafiltration with a 30-KD regenerated cellulose membrane to desalt the protein 
fractions prior to spray drying, whereas only the P-conglycinin fraction of the 50-kg process 
was desalted. The effect of not desalting the intermediate fraction was dramatic, with protein 
concentrations for the 15- and 50-kg processes being 85.8 and 54.4%, respectively. To 
precipitate the intermediate fraction, the supernatant recovered after glycinin precipitation 
was adjusted to 0.25 M NaCl and pH 5.0 with 2 N HC1. Consequently, the ash content of the 
intermediate fraction was higher than that of the other product fractions. This difference in 
ash concentrations between product fractions is demonstrated in Table 2. Data are means of 
two process runs. The ash concentrations for the glycinin and p-conglycinin precipitate 
fractions were 3.5 and 5.1%, respectively, compared to 19.6% for the intermediate 
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TABLE 1 
Effects of Process Scale Up on Yield, Content, and Recovery 
Fractionation Process 
Process Fractions 
Glycinin Intermediate p-Conglycinin Insolubles 
Fraction Yield (%, db") 
Wu pilot-plant process" 9.4 ± 0.2 4.9 + 0.2 9.4 ± 1.6 49.1 +4.4 
Scaled-up processc 5.8 ±2.1 3.0 ± 0.2 10.3 ±0.2 73.1 ±0.5 
Protein Content (%, db) 
Wu pilot-plant process 92.8 ± 0.6 85.8 + 0.6 97.6 ±0.1 42.4 ± 1.0 
Scaled-up process 81.2 + 0.9 54.4 ±0.1 91.3 ±0.7 43.3 ±0.2 
Protein Recovery (%) 
Wu pilot-plant process 16.2 ± 0.3 7.9 ±0.4 17.2 ±2.8 38.8 ±2.7 
Scaled-up process 8.7 + 3.2 3.0 ±0.2 17.4 ±0.2 58.6 ± 0.2 
°db, dry basis. 
*n=3, 15 kg of defatted soy flake starting material, data from Wu et al. (11). 
cn=2, 50 kg of defatted soy flake starting material. 
TABLE 2 
Mass Balance Data for the Scaled-Up Fractionation Process 
Weight 
(kg, as is)" 
Weight 
(k&db*) 
Ash 
(%, db) 
Ash 
(kg, db) 
Protein 
(%, db) 
Protein 
(kg, db) 
Isoflavones 
(umol/g, db) 
Isoflavones 
(mmol, db) 
Saponins 
(|imol/g, db) 
Saponins 
(mmol, db) 
Flakes 50.00cf 47.29. 6.3fa 3.0b 53.9d. 25.5, 8.25Cd 390. 5.39a, 255. 
1SEC 125.43d, 11.44. 7.9ef 0.9d 57.4cd 6.6d 10.18. 117d 5.90bc 68d 
ISR 305.63, 38.50b 6.9.$ 2.7b 45.2f 17.4b 7.78d. 300b 5.8 lbc 224b 
2SE 81.00ef 4.64f 8.6de 0.4de 57.5cd 2.7f 10.14. 47f 6.47ab 30, 
2SR 435.00b 34.54c 6.8efe 2.4b 43.3, 15.0c 7.59de 262. 5.57bcd 193c 
1ALS 223.95a 14.86d 10.8d 1.6C 50.9. 7.6d 9.08,be 135d 4.74d 71d 
GLYP 16.00ef 2.83ft 3.5^ 0.1. 83.0b 2.4& 9.73.b 28» 4.78d 14. 
GLYSD 2.85f 2.T2& 5.5ah 0.2. 81.1b 2.2& 9.56ab 26& 4.60d 13. 
2ALS 253.38c 16.92d 29.6b 5.0. 389. 6.6d 5.29d, 90. 1.36. 23„ 
INT P 16.10ef 153, 19.6c 0.3de 58.5c 0.9„ 8.50bcd 13, 5.88bc 9, 
INT SD 1.48f 1.42. 21.1c 0.3j. 54.2de 0.8k 7.39def 11= 4.58d \ 
Whey 735.25, 10.01 e 43.5. 4.4. 14.8h 1 • 5ah 4.80h 48f 0.05f 0.5. 
BCONP 26.30ef 4.91f 5-1 aJi 0.3d. 89.1a 4.4. 6.72.f 33a, 7.23. 36. 
BCON SD 5.08f 4.86f 5.1^i 0.3d. 91.2. 4.4. 6.28g, 31fe 7.41. 36. 
LSD 114.62 2.37 2.1 0.7 3.9 1.2 1.20 25 2.14 13 
"Subscript, lowercase letters within a co umn indicate significant difference at PO.05. 
*db, dry basis. 
"Abbreviations: ISE, first Sharpies centrifuge pass extract; ISR, first Sharpies pass residue (insoluble fraction); 2SE, second Sharpies pass extract; 2SR, 
second Sharpies pass residue; 1ALS, first Alfa Laval supernatant; P, precipitate; SD, spray dried; 2ALS, second Alfa Laval supernatant; INT, 
intermediate; BCON, p-conglycinin; LSD, least significant difference. 
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precipitate fraction. The ash content of the P-conglycinin precipitate samples did not reflect 
the effects of desalting because the samples were collected prior to the desalting step. The 
dry-basis ash concentration of the whey solids was about 44%, demonstrating that most of 
the ash was carried through the process in the aqueous fraction and expelled in the whey 
waste stream. 
An interesting difference between the 15- and 50-kg processes was the distribution of 
proteins among the three product fractions. Table 1 shows that, on a percentage basis, the 
intermediate fraction of the 15-kg process was larger relative to the glycinin and P-
conglycinin fractions compared to the 50-kg process. The percentage recoveries of protein in 
the P-conglycinin fractions were essentially the same for both processes, while recovery in 
the glycinin fraction of the 50-kg process was about one-half that of the 15-kg process. 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) data was not 
available for both processes, so the effect of this distribution difference on product fraction 
purity cannot be discussed. It is possible that the p-conglycinin purity for the 50-kg process 
was lower than that of the 15-kg process. A larger percentage of total protein was lost into 
the whey fraction for the 15-kg process, 19.9%, than for the 50-kg process, 12.3%. 
The 50-kg process was not as efficient as the 15-kg process with regard to protein 
extraction and recovery. When the three product fractions were summed, the data indicate 
that the percentage protein recovery was about 12% less for the 50-kg process. However, the 
50-kg process recovered about 13.4 kg of total protein, compared to 5.7 kg for the 15-kg 
process. Additionally, 4.7 kg of P-conglycinin fraction were produced per process run for the 
50-kg process, about 3.6 times more than for the 15-kg process. Thus, scale-up greatly 
decreased the number of process runs needed to supply the desired amount of P-conglycinin. 
Several factors may have led to the yield differences between the two processes. The 
defatted soy flake starting material was from different crop years and probably from different 
varieties and growing locations. Flake storage time may have been different, and defatted 
soy flake preparation was certainly different. Any of these factors may have impacted 
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protein solubilization. Finally, the processing equipment, which was the same for both 
processes, may have operated at different efficiencies due to wear and other factors. 
It should be noted that both protein fractionation processes had lower fraction mass yields 
than was observed for soy protein isolate, a protein product of a least 90% dry-basis protein 
recovered by isoelectric precipitation of extracted soy proteins. The soy protein isolate 
process used at the Iowa State University Center for Crops Utilization Research pilot plant, 
employing the equipment to produce the fractionated proteins described here, generally 
produces a protein isolate yield of 33%. This compares to a combined glycinin, intermediate, 
and p-conglycinin fraction yield of 19 and 24% for the 50- and 15-kg fractionation processes, 
respectively. Industry may experience soy protein fraction yields as high as 44%. One 
reason for the superior fraction yield received during soy protein isolate production is the 
higher protein extraction temperature, reported to be as high as 80 °C (26). The 20 °C 
extraction temperature used for the fractionation processes minimizes loss of native state 
protein, promoting the efficient fractionation of the proteins (11). 
Mass balance and partitioning. The fractionation process employed a two-pass system to 
increase protein recovery. The flake slurry was centrifuged to produce an extract, the first 
Sharpies extract, and a residue fraction, the first Sharpies residue. The first Sharpies residue 
was extracted with more water and then centrifuged, producing the second Sharpies extract 
and the second Sharpies residue, which was a waste stream. The first and second Sharpies 
extracts were combined, treated with sodium bisulfite and acid, precipitating the glycinin. 
The glycinin was recovered by the Alfa Laval centrifuge, also producing the first Alfa Laval 
supernatant. Further treatment of supematants and two subsequent passes through the Alfa 
Laval centrifuge yielded the intermediate and P-conglycinin fractions. 
As described above, Table 2 shows that most of the ash from the salt, sodium bisulfite, 
acid, and base treatments was deposited in the intermediate fraction (0.3 kg, dry basis) or 
carried through with the whey (4.4 kg, dry basis). The ash content of the intermediate 
fraction, compared to the other product fractions, may need to be considered when evaluating 
protein functionality, as functionality is affected by ionic strength. The protein 
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concentrations of the product fractions were different, about 83, 59, and 89% for the glycinin, 
intermediate, and P-conglycinin precipitate fractions, respectively. The p-conglycinin was 
very close to the 90% dry basis protein concentration required of soy protein isolates. The 
glycinin produced would have met this 90% requirement if a nitrogen conversion factor of 
6.25, used by industry for soy, had been employed instead of 5.71, as suggested by Wu et al. 
(11), to calculate protein concentration. 
The total protein content of the starting flake material was about 25.5 kg. The total 
protein in the Sharpies extracts was 6.6 and 2.7 kg for the first and second Sharpies extracts, 
respectively, while total protein content of the first Sharpies residue was 17.38 kg. The first 
protein extraction pass recovered 26% of the total protein in the starting material, whereas 
the second pass recovered about 15% of the total protein in the first Sharpies residue or 10% 
of original total protein in the starting material. Diminishing returns suggest that it might not 
economically feasible to add additional extraction passes to improve protein recovery. 
The isoflavone concentration in the extracts was about 35-40% higher than the saponin 
concentrations, but there were also about 50% more total isoflavones in the starting material. 
Although isoflavones are less hydrophobic than the saponins, both of these phytochemicals 
have very low solubility in water, largely being pulled into the extract through mass action 
and possibly by association with the proteins. Table 2 data show that about 30 and 26% of 
the isoflavones and saponins, respectively, were recovered from the starting material during 
the first extraction. The second extraction pass recovered an additional 12% for each, based 
on total isoflavones and saponins in the starting material. This recovery relationship was 
very similar to that observed for the protein. 
The data in Table 3 show that the mass balance recoveries for protein, isoflavones, and 
saponins were 94, 97, and 97%, respectively. Mass balance recoveries for the daidzein, 
glycitein, and genistein families, each family being comprised of an aglucon, P-glucoside, 
acetylglucoside, and malonylglucoside form, were 105, 107, and 102%, respectively. For the 
non-DDMP and DDMP saponin families, V and ag, I and Pg, and II and pa, mass balance 
recoveries were 52,116, and 88%, respectively. The low recovery for the V and ag saponin 
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TABLE 3 
Scaled-Up Process Co-Product Recovery and Disi tribution 
Insoluble Glycinin Intermediate P-Conglycinin Whey 
Total 
Recovery 
Protein 
(weight %, db") 59 9 3 17 6 94 
Isoflavones 
(mole %, db) 67 7 3 8 12 97 
Saponins 
(mole %, db) 75 5 3 14 0.2 97 
"db, dry basis. 
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family was likely due to small peak areas leading to quantification inaccuracies. Table 3 also 
shows that 59, 67, and 75% of the protein, isoflavones, and saponins were not recovered 
from the second Sharpies residue fraction, a waste stream. The low recovery of saponins 
from the insoluble fraction, which still contained the majority of the protein, supports a 
limited body of literature suggesting that saponins associate with glycinin and P-conglycinin 
through hydrophobic interaction, hydrogen bonding, or ionic bonding (27). It may be 
possible that the isoflavones also associate with the proteins, though to a lesser extent. The 
whey fraction contained 12% of the total isoflavones, while a negligible quantity of saponins 
were found in the whey. This again demonstrates a difference in hydrophobicity or suggests 
a difference in affinity for protein or other components remaining in the whey. About 6% of 
the total protein was recovered in the whey fraction. 
The high protein and phytochemical contents of the insoluble fraction suggest that the 
fraction might be economically exploited with further processing, other than additional 
aqueous extraction steps. Organic solvent extraction might be utilized to recover the 
phytochemicals. Enzymatic treatment of the fraction with cellulases and/or proteinases may 
enhance solubilization of the remaining proteins, making it then feasible to attempt additional 
aqueous extraction passes. The whey is another potential stream for protein and 
phytochemical recovery. It may be possible to precipitate and recover whey proteins through 
heating, acid precipitation, or a combination of these. Recovery of isoflavones from the 
whey by column chromatography or membrane filtration may be possible, although probably 
not economical. 
Migration of isoflavones into the aqueous phase and their persistence in that fraction is 
not unusual and has been demonstrated previously by Wang and Murphy (28), who 
conducted mass balance studies for tempeh, tofu, and soy protein isolate production. By 
difference, about 12% of the total isoflavones were lost from raw whole soybeans to the soak 
water during soybean processing for tempeh production. During soymilk production for tofu 
manufacture, the isoflavone content of the soaking water was found to contain 1% of the total 
isoflavones. About 44% of total isoflavones were present in the whey after tofu processing. 
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Mass balance of the bench-scale soy protein isolate process showed that about 60% of the 
total isoflavones were removed from the starting material into the extract, approximately 
twice as much as removed during the first extraction in our 50-kg fractionation process. 
They recovered 48% of the isoflavones in the isolate and 11% in the whey. The total 
isoflavone recovery from all product and waste fractions of the soy isolate process was about 
114% compared to the starting material. Achieving accurate mass balance accounting can be 
problematic. For the 50-kg fractionation process evaluated here, total recovery of 
isoflavones and saponins from product and waste stream fractions was about 97% for each. 
Some mass balance accounting issues can be attributed to the sample matrix and the 
efficiency of phytochemical recovery by the solvent extraction process prior to analysis. A 
small quality control recovery study with ground, defatted soy flakes and freeze-dried soy 
protein isolate revealed considerable recovery differences between these matrices. Recovery 
of saponin I and II was about 99% for the flake material, but only 60-70% for the isolate. 
Isoflavone recoveries were 75-92% for the flake material, with the aglucons exhibiting the 
lowest recoveries. Isoflavone aglucon recovery from the isolate material was 65-75%, while 
recoveries for the glucosides and malonylglucosides were 78-93%. 
Isoflavone and saponin partitioning during protein fractionation affected the relative 
proportion of their concentrations in the glycinin and P-conglycinin fractions compared to the 
soy flake starting material. The isoflavone-to-saponin ratio for the flakes was about 1.5:1, as 
it was for the intermediate fraction. The ratios for the glycinin and P-conglycinin fractions 
were about 0.8:1 and 2.1:1, respectively. Using the 8-anilino-1 -naphthalene sulfonic acid 
(ANS) fluorescence method, Wu et al. (11) demonstrated that P-conglycinin had more 
surface hydrophobicity than did glycinin, about 370 compared to 260, though much lower 
than that demonstrated by a soy protein isolate, 640. Based on the isoflavone and saponin 
partitioning differences observed for glycinin and P-conglycinin, in addition to Wu's 
hydrophobicity data, it may be suggested that physicochemical characteristics of proteins 
affect partitioning of the phytochemicals. Limited data are available concerning soy 
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isoflavone and saponin proportions in soy products. Hu (29) reported isoflavone:saponin 
concentration ratios in soy protein isolates ranging from about 0.4:1 to 0.7:1. 
Effect of processing on phytochemical profile. All 12 common soybean isoflavones and 6 
forms of group B soyasaponins were quantified. The isoflavones are comprised of three 
aglucon forms, daidzein, genistein, and glycitein, and their respective malonylglucoside, 
acetylglucoside, and p-glucoside forms (Fig. 2). The malonylglucosides are the predominant 
form in raw soy flour, comprising about 80% of the mole isoflavone mass (30). The (3-
glucosides comprise another 15%, with negligible amounts of aglucons and virtually no 
acetylglucosides. High temperature processing, such as toasting or frying in oil causes 
decarboxylation of the malonylglucosides to acetylglucosides and (3-glucosides. Toasted soy 
germ has a mole mass distribution of 50% P-glucoside, 38% acetylglucoside, and 5% 
malonylglucoside (30). Milder processing conditions, such as the heating of soy milk during 
tofu manufacturing, converts at least a portion of the malonylglucosides to aglucons and p-
glucosides. The isoflavone mole distribution in tofu is about 37% malonylglucoside, 25% p~ 
glucoside, and 37% aglucon (30). Presence of glucosidase enzymes, e.g. during soaking 
steps, converts the three glucoside forms to their respective aglucon forms (30). During 
tempeh production, fermentation organisms produce p-glucosidases that alter the isoflavone 
mole distribution to 50% aglucon, 35% malonylglucoside, and 17% P-glucoside (30). 
Table 4 shows the concentration of each type of isoflavone for each process fraction. 
There were no significant differences for the individual isoflavones before and after spray 
drying. The temperature treatment was probably too mild and brief to cause conversions. 
The data suggest that there was P-glucosidase activity occurring in the soy slurry prior to the 
first Sharpies centrifuge pass. The genistein concentration of the flakes was 0.15 nmol/g, but 
the concentration in the first Sharpies extract was 0.31 jimol/g. This trend was obvious, 
approximately doubling the genistein concentration while the total isoflavone concentration 
in the first Sharpies extract was only about 25% greater than for the flakes. These types of 
comparisons and conclusions are more difficult when the total isoflavone concentrations vary 
greatly between fractions. For instance, the total isoflavone concentration of the first 
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FIG. 2. Isoflavone structures. 
TABLE 4 
Distribution of Isoflavones in Process Fractions (umol/g, dry basis) 
MOtN06 DIN AcDIN DEIN MGLY GLY AcGLY GLYEIN MGIN GIN AcGIN GEIN Total 
Flakes 2.31b 0.9 ld 0.09. 0.14b 0.47bcd 0.39. 0.06 0.04h 2.46Cd 1.13d, 0.09abc 0.15h 8.25cd 
1SEC 2.75. 1.27b 0.03b 0.32a 0.57. 0.49ab nd 0.08^ 2.74abc 1.57* 0.06def 0.31h 10.18, 
ISR 1.92, 1.05cd 0.02b 0.27,* 0.39ef 0.40. nd 0.07a 2.0 lef 1.32cd 0.06dcf 0.28b 7.78de 
2SE 2.45b 1.43. 0.01b 0.38fl! 0.50b 0.53. nd O.lOf, 2.51bcd 178. 0.05def 0.39a 10.14a 
2SR 1.68d 1.14b. 0.01b 0.31^ 0.34f« 0.42k nd 0.08a 1.78& 1.44bc 0.05def 0.33a 7.59de 
1ALS 2.35b 0.93d 0.03b 0.62, 0.48bc 0.38cd nd 0.16de 2.3 Id, 1.10c 0.05def 0.67cf 9.08ab. 
GLYP 1.97c 0.64ef 0.04b 0.85cd 0.44cde 0.29, 0.02 0.22, 2.87. l.lSae 0.11, 1.0 led 9.73* 
GLY SD 1.97c 0.71, 0.04b 0.75de 0.43a, 0.3 ld. 0.07 0.18cd 2.81ab 1.27cde 0.10* 0.87de 9.56* 
2ALS 1.01c 0.55f 0.02b 0.55ef 0.21h 0.25ef 0.01 0.14def 1.26,; 0.67f 0.04ef 0.58f, 5.29a 
INT P 1.01c 0.70c 0.02b 1.20ab 0.21h 0.31. 0.02 0.28ab 1 -67fa 1.27cde 0.05def 1.46b 8.50b.d 
INT SD 0.92ef 0.66ef 0.02b 1.01b. 0.19h 0.29, 0.06 0.24k 1-51 ahij 1.13d, 0.06cde I.23k 7.39def 
Whey 1.66d 0.27. 0.02b 0.40f, 0.33, 0.20f 0.02 0.12efa 1.21 j 0.25, 0.03f 0.24h 4.74b 
BCON P 0.84ef 0.12b 0.02b 129. 0.19b 0.09, 0.06 0.30. 1.56ai 0.32. 0.07bcd 1.94. 6.72ef 
BCON SD 0.75f 0.13a 0.03b 1.20ab 0.17b 0.09, 0.06 0.28* 1.40M 0.36, 0.07.de 1-81. 6.28% 
LSD 0.23 0.14 0.04 0.22 0.05 0.07 NDIFF 0.06 0.34 0.22 0.03 0.26 1.20 
"Isoflavone abbreviations: MDIN, malonyldaidzin; DIN, daidzin; AcDIN, acetyldaidzin; DEIN, daidzein; MGLY, malonylglycitin; GLY, glycitin; 
AcGLY, acetylglycitin; GLYEIN, glycitein; MGIN, malonygenistin; GIN, genistin; AcGIN, acetylgenistin; GEIN, genistein. 
^Subscript, lowercase letters with a column indicate significant difference at f<0.05. 
"Abbreviations: ISE, first Sharpies centrifuge pass extract; ISR, first Sharpies pass residue (insoluble fraction); 2SE, second Sharpies pass extract; 2SR, 
second Sharpies pass residue; 1ALS, first Alfa Laval supernatant; P, precipitate; SD, spray dried; 2ALS, second Alfa Laval supernatant; INT, 
intermediate; BCON, p-conglycinin; LSD, least significant difference; NDIFF, not different. 
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Sharpies extract was 10.18 pmol/g, while that of the whey was only 4.74 (jmol/g. For this 
type of comparison it was difficult to readily determine whether the distribution of the 
individual isoflavones changed or whether the concentration of the individual isoflavone was 
low or different just because the total isoflavone concentration was so different. 
Consequently, all total isoflavone values were normalized to the total isoflavone 
concentration of the first Sharpies extract, the highest concentration. Each individual 
isoflavone for a given process fraction was then adjusted using the same correction factor 
used for the total of that fraction (Table 5). 
When data are presented in a normalized fashion, it is not difficult to observe a decline in 
malonyldaidzin as the process progressed from flakes to spray-dried P-conglycinin, 2.90 to 
1.21 (jmol/g. A similar trend was observed for daidzin, 1.14 to 0.22 fimol/g. These 
differences were significant. There was also a significant decrease in acetyldaidzin 
concentration, but only for the flakes compared to the rest of the fractions. The daidzein 
concentrations correspondingly increased from 0.17 to 1.95 {imol/g for these two fractions. 
The isoflavone conversion that occurred seemed to be related to the action of p-glucosidases, 
as daidzein was accumulating at the expense of both malonyldaidzin and daidzin. Since 
there was not even a mild heating step, the conversion of malonyldaidzin to daidzin did not 
seem to occur in a substantial fashion. There may have been a small amount of |3-
glucosidase action on the acetyldaidzin, as these concentrations decreased. The process was 
clearly not converting malonyldaidzin to acetyldaidzin. These trends observed for the 
daidzein family occurred for the genistein family as well, but the concentrations of the 
malonylgenistin did not decrease to the same extent as was observed for malonyldaidzin. 
The isoflavone distributions of the whey and p-conglycinin fractions were very different. 
The malonyldaidzin concentration of the whey was about three times that of the P-
conglycinin, whereas the daidzein concentration of the P-conglycinin was about 2.3 times 
that of the whey. This suggests a different affinity of the isoflavones for an aqueous 
environment. The malonylglucosides are more hydrophilic than the aglucons, so it stands to 
reason that a higher proportion of the malonyl forms might be in the whey fraction. 
TABLE 5 
Normalized" Distribution of Isoflavones in Process Fractions (nmol/g, dry basis) 
MDIN'" DIN AcDIN DEIN MGLY GLY AcGLY GLYEIN MGIN GIN AcGIN GEIN 
Flakes 2.90b 1.14d 0.11a 0.17, 0.59b 0.49k 0.07 0.05, 3.09. 1.41de 0.12. 0.19. 
ISE" 2.79k 1.29c 0.03b 0.32h 0.58k 0.49k nd 0.08f 2.78b 1.59c 0.06c 0.32f, 
ISR 2.55de 1.39k 0.03b 0.36* 0.52de 0.53* nd 0.09f 2.67k 176k 0.07. 0.37cr, 
2SE 2.50, 146* 0.01b 0.39* 0.51, 0.54* nd 0.10f 2.57bcd 1.81* 0.05c 0.39ef, 
2SR 2.29f 1.55, 0.01b 0.43. 0.46f 0.57a nd 0.1 lf 2.43cde 1.96, 0.06c 0.46ef 
1ALS 2.68cd 1.06de 0.03b 0.71f 0.55cd 0.44cd nd 0.18c 2.63bc 1.25c 0.06c 0.76d 
GLYP 2.11* 0.69hi 0.04b 0.91d 0.47f 0.3 lf 0.03 0.24d 3.09, 1.24e 0.12* 1.08c 
GLY SD 2.14. 0.77* 0.05b 0.81e 0.47f 0.34ef 0.08 0.20. 3.04. 1.38c 0.11 *c 0.94cd 
2ALS 1.98h 1.07d 0.03b 1.07c 0.41, 0.49k 0.03 0.28, 2.46cdc 1.31e 0.07cde 1.13c 
INT P 1.27, 0.89f, 0.02b 1.51b 0.27h 0.39de 0.03 0.35b 2.10. 1.60c 0.07de 
OO 
INT SD 1.30, 0.93ef 0.02b 1.43b 0.27h 0.40* 0.09 0.33b 2.13f, 1.60, 0.09,bcde 1.73b 
Whey 3.63, 0.58, 0.05b 0.86dc 0.72, 0.43cd 0.05 0.25cd 2.64bc 0.53f 0.06c 0.53c 
BCON P 1.28, 0.18, 0.03b 1.96, 0.28h 0.14, 0.09 0.46, 2.36def 0.49f 0.1 l*c 2.95. 
BCON SD 1.21, 0.22, 0.04b 1.95, 0.27h 0.14, 0.10 0.46a 2.26ef, 0.59f 0.1 l*cd 2.97. 
LSD 0.15 0.11 0.05 0.10 0.03 0.07 NDIFF 0.30 0.25 0.18 0.04 0.21 
"Total isoflavone concentrations from Table 4 were normalized to the highest concentration, and then each isoflavone for a given total concentration was 
multiplied by that respective normalization factor. 
^Isoflavone abbreviations: MDIN, malonyldaidzin; DIN, daidzin; AcDIN, acetyldaidzin; DEIN, daidzein; MGLY, malonylglycitin; GLY, glycitin; 
AcGLY, acetylglycitin; GLYEIN, glycitein; MGIN, malonylgenistin; GIN, genistin; AcGIN, acetylgenistin; GEIN, genistein. 
"Subscript, lowercase letters with a column indicate significant difference at P<0.05. 
^Abbreviations: ISE, first Sharpies centrifuge pass extract; ISR, first Sharpies pass residue (insoluble fraction); 2SE, second Sharpies pass extract; 2SR, 
second Sharpies pass residue; 1ALS, first Alfa Laval supernatant; P, precipitate; SD, spray dried; 2ALS, second Alfa Laval supernatant; INT, 
intermediate; BCON, p-conglycinin; LSD, least significant difference; NDIFF, not different. 
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The group B saponins quantified were V, I, II, ag, |3g, and (3a. The latter three possess a 
2,3-dihydro-2,5-dihydroxy-6-methyl-4H-pyran-4-one (DDMP) moiety that is quite labile. 
When the moiety is liberated from ag, pg, and Pa, the resulting non-DDMP forms are V, I, 
and II, respectively (Fig. 3). 
Table 6 shows saponin distribution of the process fractions. The flakes have relatively 
high ag, Pg, and Pa concentrations, about 85% of the measured saponins, compared to their 
saponin V, I, and II counterparts. This is in agreement with Hu (29), reporting that the 
DDMP-conjugated saponins comprised about 85% of the group B saponins in raw soybean 
seeds. Saponin Pg was present in the highest concentration, 3.36 jimol/g in our flakes, with 
an ag to Pg ratio of 1:13. As expected, this was much different than the 1:2 ratio calculated 
by Hu for soy hypocotyls. Hypocotyls, compared to cotyledons, are high in saponin ag or V 
but very low in Pa or II. The soy flakes used for the 50-kg process were not processed to 
remove the hypocotyls, but the cotyledon material had a dilution effect on the ag or V 
concentration. The saponin concentration of soy hypocotyls, as measured by Hu, was about 
8 times that of soybean flour, 27.46 vs. 3.31 pmol/g on an as is basis. 
The as is saponin concentration of the fractionated proteins, 4.82,4.97, and 7.73 jimol/g 
for glycinin, intermediate, and P-conglycinin, respectively, were generally lower than Hu 
(29) observed for commercial soy isolate and concentrates on an as is basis. Two isolates 
had concentrations of 10.60 and 9.51 (imol/g. An acid washed soy concentrate and an 
ethanol-washed concentrate had concentrations of 9.41 and 0.20 gmol/g, respectively, 
demonstrating the extensive saponin extraction caused by the ethanol-wash concentrate 
process. 
During the 50-kg soy protein fractionation process, a conversion from DDMP to non-
DDMP saponins was observed. By the time the soy slurry, which had a Pg concentration of 
3.36 nmol/g, was separated into the first Sharpies extract and first Sharpie residue, spanning 
only a few hours, roughly 50% of the labile DDMP forms had lost their DDMP moiety. This 
rapid conversion seemed to diminish, with pg concentrations leveling off at about 1.5 
gmol/g. Even by the time the P-conglycinin precipitate was recovered, about three days after 
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FIG. 3. Structures of group B soyasaponins. 
Rha: rhamnosyl; Glc: glucosyl; Y: yes; N: no 
DDMP: 2,3-dihydro-2,5-dihydroxy-6-methyl-
4//-pyran-4-one 
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TABLE 6 
Distribution of Saponins in Process Fractions (iimol/g, dry basis) 
V° I II ag Pg pa Total 
Flakes nd 0.65, 0.17c 0.26 3.36. 0.96. 5.39bCef 
ISE" 0.4(L 2.50c 1.02kd 0.12 1.43kd 0.44b 5.90k 
ISR 0.40k 2.16d 0.87d 0.16 1.74b 0.48b 5.8 lbCe 
2SE 0.47* 3.08ak 1.29ak 0.10 1-lOdcf 0.33c 6.37* 
2SR 0.42k 2.51bcd 1.04bcd 0.11 1.17c(ie 0.34c 5-57bCef 
1ALS 0.37k 1.98d 0.82d 0.10 L13cdcf 0.34c 4.78cef 
GLYP 0.39k 2.05a 0.83d 0.31 0.79f 0.28d 4.60ef 
GLY SD 0.3 L 1.90d 0.82d 0.09 1.12def 0.34c 4.60f 
2ALS 0.18d 0.50e 0.25e 0.02 0.30, 0.13e 1.36e 
INT P 0.41k 2.62bcd 1.23ak 0.09 1.16cc 0.40k 5.88bc 
INT SD 0.38k 2.04d 0.99=4 0.08 0.9 lef 0.32c 4.70def 
BCON P 0.56. 3.26* 1.36* 0.14 l-44bcd 0.47b 723. 
BCON SD 0.55. 3J8. 1.42. 0.13 1.50k 0.46b 7.41. 
LSD 0.11 0.76 0.36 NDIFF 0.37 0.09 1.22 
Normalized6 Distribution of Sa ponins in Process Fractions (pmol/g, dry basis) 
V I II ag Pg Pa 
Flakes nd 0.93d 0.25c 0.37 4.83. 1.39, 
ISE 0.53^ 328* 1.34c 0.16 1.88k O.SSbc 
ISR 0.53b 2.88c 1.16d 0.22 2.33b 0.64k 
2SE 0.57b 3.75. 1-57*0 0.12 1.35c 0.40e 
2SR 0.58b 3.49* 1-44*0 0.15 1.63c 0.47dc 
1ALS 0.60b 323k 1.35c 0.16 1.85bc 0.56ce 
GLYP 0.65b 3.42* 1.38kd 0.52 1.32d 0.47de 
GLY SD 0.53b 3.21k l-39bcd 0.16 1.90k 0.58kd 
2ALS 1.03, 2.81c 1-42*0 0.11 1.65c 0.73b 
INT P 0.55b 3.38* 1.60*c 0.12 1.56c 0.55ce 
INT SD 0.62b 3.37* 1.63*c 0.13 1.50c 0.53cc 
BCON P 0.61b 3.50* l-46*c 0.15 1.54c 0.50ce 
BCON SD 0.57b 3.53* 1.48*c 0.13 1.57c 0.48ce 
LSD 0.14 0.47 0.24 NDIFF 0.55 0.17 
"Subscript, lowercase letters within a co umn indicate significant difference at P<0.05. 
^Abbreviations: ISE, first Sharpies centrifuge pass extract; ISR, first Sharpies pass residue (insoluble 
fraction);2SE, second Sharpies pass extract; 2SR, second Sharpies pass residue; 1ALS, first Alfa Laval 
supernatant; P, precipitate; SD, spray dried; 2ALS, second Alfe Laval supernatant; INT, intermediate; 
BCON, p-conglycinin; LSD, least significant difference; NDIFF, not différait. 
Total saponin concentrations were normalized to the highest concentration, and then each saponin for a 
given total concentration was multiplied by that respective normalization factor. 
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the fractionation process was initiated, the concentration of the Pg was not significantly 
different than it had been for the first Sharpies extract and residue fractions. This was not 
expected. Hu (29) showed that there was not a significant conversion of Pg to saponin I 
within 3 hat room temperature. However, this fractionation process took about three days to 
complete. It seemed as if there were a protective effect or an equilibrium was reached. 
As was done for the isoflavones, Table 6 was normalized to the fraction that had the 
highest saponin concentration. The total saponin concentrations were similar for most of the 
fractions, so the impact of normalization was not as dramatic as observed for the isoflavones. 
The normalization made it very clear that the individual saponin concentrations did not 
change dramatically, and in most cases not significantly, from the first Sharpies extract to the 
spray-dried P-conglycinin. An exception to this was the second Alfa Laval supernatant 
(2ALS) for saponin V. The saponin V concentrations also seemed high compared to the ag 
saponin in the starting material and the process fractions. Spray drying did not seem to affect 
the conversion of DDMP to non-DDMP saponins. As for the isoflavones, the heat treatment 
and duration of spray drying were probably too short to have a significant affect. 
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CHAPTER 3. ISOFLAVONE AND SAPONIN PARTITIONING DURING 
BENCH-SCALE SOY ISOLATE PRODUCTION: EFFECTS OF 
TEMPERATURE AND pH 
A paper to be submitted to the Journal of Food Science 
David A. Rickert, Melissa A. Meyer, Jiang Hu, Patricia A. Murphy 
Abstract 
Temperature and pH affect protein solubilization from soy flakes. Varying these 
parameters during the solubilization step of bench-scale soy protein isolate production 
affected isoflavone and saponin recovery, partitioning, and profile. Discrepancies in the 
phytochemical mass balance led to investigation of soy slurry prepared at 25 or 60 °C and pH 
8.5, 9.5, or 10.5. The total saponin concentration in the slurry was not affected by these 
conditions, but increasing temperature and pH decreased total isoflavone concentrations. 
This observation led to modification of phytochemical extraction conditions. Sample 
neutralization prior to extraction increased quantified isoflavone concentration of the soy 
slurry material, while neutralizing the isolate fraction dramatically increased quantified 
saponin concentrations. Phytochemical extraction pH should receive careful consideration 
when analyzing soy samples for isoflavones and saponins. 
introduction 
Soy isoflavones have received considerable attention as plant phytoestrogens that may 
favorably impact human health. The potential effects of soy isoflavones on bone integrity 
(Murphy and Hendrich 2002), colon and breast cancer (Messina and Bennick 1998, Messina 
1999), and cardiovascular health (Setchell and Cassidy 1999) have been reviewed. Although 
they have received less scrutiny, soy saponins may also provide health benefits. Oakenfull 
and Sidhu (1990) have reviewed the ability of saponins to treat hypercholesterolemia. Soy 
saponins seem to have an anticarcinogenic effect against colon cancer (Koratkar and others 
1997, Sung and others 1995). Due to their potential health impact, the contents of these soy 
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phytochemicals in foods and their fate during soy food and soy ingredient processing are of 
considerable interest. 
The isoflavone contents of soybean varieties (Wang and Murphy 1994a), commercial 
soybean foods (Wang and Murphy 1994b), ethnic soy foods (Franke and others 1999), retail 
and institutional soy foods (Murphy and others 1999) and infant formulas (Murphy and 
others 1997) have been published. Wang and Murphy (1996) have detailed the partitioning 
of isoflavones and the mass distribution or profile of isoflavone isomers during soy protein 
isolate, soymilk, tofu, and tempeh processing. Isoflavone profile is important since the 
glucoside forms require enzymatic modification to the aglycone forms for gut absorption in 
humans (Xu and others 1995). Profile changes have been described for isoflavones during 
soy protein isolate processing (Wang and others 1998), com/soy mixture extrusion (Mahungu 
and others 1999), p-glucosidase treatment (Matsuura and Obata 1993), thermal processing of 
tofu (Grim and others 2001), and edamame processing (Simonne and others 2000). 
Absence of good analytical methodology and limited interest have hindered 
quantification and reporting of soy saponin data. An efficient HPLC method to measure 
group B saponins, comprising approximately 83% of total soyasaponins in defatted soy meal 
(Gu and others 2002), was recently developed by Hu and others (2002). This method was 
used to quantify saponin concentrations in nearly 50 soybean varieties (Hu and others 2002), 
as well as soymilk, tempeh, textured vegetable protein, tofu, soy protein isolate, and soy 
concentrates. Tsukamoto and others (1995), Ireland and others (1986), and Kitagawa and 
others (1984) have measured soy saponin concentrations in soybeans, soy ingredients, and 
soy foods, respectively. 
Another group of soy saponins, group A saponins, have also been quantified by HPLC 
analysis. Group A and group B saponins exhibit structural similarities, and each group has 
labile forms that undergo structural changes under certain processing conditions. These 
numerous, structurally similar saponins have complicated quantification of each specific soy 
saponin. Shimoyamada and others (1990) and Shiraiwa and others (1991) have described 
HPLC methods to quantify group A and group B saponins. Evidence suggests that when soy 
121 
is heated in an aqueous environment above 80 °C and at least pH 9, the structure of several 
group A forms becomes so similar to several group B forms that they share the same HPLC 
retention time and cannot be resolved (Meredith 2002). These processing conditions may be 
encountered during the manufacture of some soy protein isolates, influencing the 
quantification of group B saponins in these isolates. 
Soy protein isolate is a popular soy ingredient with useful protein functionality and may 
be the most significant source of soy protein, and thus soy phytochemicals, for those not 
consuming more traditional soy foods, such as tofu or soy milk. Soy protein isolate is the 
isoelectric precipitate of the alkaline protein extract from defatted soy flakes. The protein is 
generally extracted at temperatures of up to 80 °C and pH 7.5 to 9.0 (Berk 1992), although 
60 °C and pH 8.5 are more typical of conditions employed commercially. Conditions of 
approximately 25 °C and pH 8.5 have been used to extract soy proteins in their native state 
for efficient fractionation of the soybean storage proteins, glycinin and p-conglycinin (Wu 
and others 1999). 
The objective of the current research was to determine whether isoflavone and saponin 
partitioning, recovery, and profile during soy protein isolate production are affected by 
extraction temperature (25 and 60 °C) and pH (8.5-10.5). An additional interest was whether 
group A saponins could be observed to influence group B concentrations under one or more 
of the treatment conditions. 
Materials and Methods 
Materials 
The starting material for soy slurry and soy protein isolate production was defatted soy 
white flakes from Cargill (Minneapolis, MN). Flakes were stored in sealed containers at 
4 °C. HPLC-grade acetonitrile, methanol, trifluoroacetic acid, and glacial acetic acid for 
HPLC mobile phase and sample preparation were purchased from Fisher Scientific (Fair 
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Lawn, NJ). HPLC-grade water for mobile phase and sample preparation was produced using 
a Milli-Q water system (Millipore Co., Bedford, MA). 
Soy Slurry and Soy isolate Production 
Soy slurries were prepared by combining defatted soy flakes with de-ionized water (6 g 
flakes and 60 g water) at 25 or 60 °C with continuous stirring in 125-mL Erlenmeyer flasks. 
The pH of each slurry was then adjusted to 8.5, 9.5, or 10.5, as measured with an automatic 
temperature control (ATC) pH meter and probe, using 2 N NaOH. The pH was readjusted as 
needed at 15 and 30 min, and the processing was ended at 30 min. Slurries were then freeze-
dried. Each treatment was performed in duplicate. 
Soy protein isolates were prepared as follows. Defatted soy flakes were combined with 
de-ionized water (80.0 g flakes to 800 g water) at 25 or 60 °C and stirred continuously. The 
pH of each slurry was adjusted to 8.5, 9.5, or 10.5, as measured with an ATC pH meter and 
probe, using 10N NaOH. The pH was readjusted as needed at 15 and 30 min, and the 
protein solubilization was ended at 30 min. Slurries were passed through a 60-mesh screen. 
The recovered liquid fractions were centrifuged at 14,000 x g for 30 min at 15 °C. The 
resulting precipitates and the screenings from the previous step were combined to comprise 
the respective insoluble fractions, weighed, frozen, and freeze dried. Supernatants at 20 °C 
were adjusted to pH 4.5 with 2 N HC1, refrigerated at 4 °C for 1 h, and then centrifuged at 
14,000 x g for 30 min at 4 °C. Resulting supernatant (whey) and precipitate (isolate) 
fractions were weighed and freeze-dried. Each treatment was performed in duplicate. 
Isoflavone and Group B Saponin Extraction and Analysis 
Extractions and HPLC analyses were conducted as reported by Hu and others (2002) for 
saponins and Murphy and others (1999) for isoflavones with modifications. Approximately 
2.5 g of freeze-dried slurry, insoluble fraction, or protein isolate, or 4.0 g of freeze-dried 
whey fraction, was accurately weighed into a 125-mL screw-capped Erlenmeyer flask, and 
14 mL of water and 20 mL of acetonitrile were added to the flask to extract the isoflavones 
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and saponins. Extractions were performed with and without neutralization to pH 7, adjusted 
using 2N HC1 or 2N NaOH, and flasks were shaken at 300 rpm for 2 h at room temperature. 
This modified extraction method differed as follows from the methods described by 
Murphy and others (1999) and Hu and others (2002). For optimal isoflavone extraction from 
a particular food matrix, Murphy and others ( 1999) used 10 mL of acetonitrile, 2 mL of 0.1 N 
HC1, and water as needed (approximately 7 mL). Hu and others (2002) used 100 mL of 70% 
ethanol and 2.5 h of extraction time for saponin extraction. The modified method did not give 
significantly different (P<0.05) phytochemical concentrations compared to the referenced 
methods when ground, defatted soy flakes were analyzed. 
The extract was vacuum filtered (Whatman 42 paper, Hillsboro, OR), and the extract was 
rotary evaporated to dryness at <30 °C. The residue was dissolved and recovered in 80:20 
methanolrwater to a volume of 10.0 mL. Samples for isoflavone analysis were filtered 
through a 0.45-jim polytetrafluoroethylene filter (Alltech Associates Inc., Deerfield, IL) prior 
to HPLC analysis. Samples for saponin analysis were further purified using a disposable 
CI8 cartridge (Waters Corporation, Milford, MA.). Cartridges were preconditioned by 
sequentially passing 3 mL of de-ionized water, 2 mL of 100% methanol, and 4 mL of de-
ionized water through the cartridges. Exactly 2.0 mL of the sample was combined with 7 mL 
of de-ionized water, mixed vigorously, and then passed through the cartridge. The cartridge 
was then washed with 5 mL of 5% methanol. The saponins were finally eluted from the 
cartridge with 2.0 mL of 100% methanol. This purified extract was filtered with a 0.45-pm 
filter as above prior to HPLC analysis. Quantification of the isoflavones and group B 
saponins was performed on different HPLC systems, but using the same type of column, an 
RP-18, 5 (j.m, 4.6 i.d. x 250 mm YMC-ODS-AM-303 column (YMC, Inc., Wilmington, NC). 
For quality control purposes, an isoflavone standard solution (genistin, genistein, and 
daidzein) and a saponin standard solution (saponin I) were injected on the respective systems 
prior to analyzing samples. Preparation of isoflavone and saponin standards and calibration 
curves is described by Murphy and others (1999) and Hu and others (2002). Isoflavone 
recovery from ground soy flake and freeze-dried soy protein isolate material was evaluated 
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using a concentrated isoflavone extract produced from soy flakes and containing 7.5 
(imol/mL isoflavones in 80% methanol. Saponin recovery from these matrices employed a 
mixture of saponin I and II at concentrations of 4.8 and 3.9 fimol/mL, respectively, in 80% 
methanol. Samples were spiked, mixed thoroughly, and then allowed to air dry overnight. 
Extraction and analysis were performed as above. 
Protein Quantification 
Nitrogen content of the defatted soy flakes and process fractions was measured using the 
combustion or Dumas method (AOAC 990.03) with a Rapid NIII analyzer (Elementar 
Americas, Inc., Mt Laurel, NJ). These values were converted to Kjeldahl nitrogen 
concentrations using a conversion formula (Jung and others 2003). A conversion factor of 
6.25 was used to convert nitrogen to protein content. 
Statistical Analysis 
The data was analyzed using ANOVA. Both Dunnetts and Tukeys adjustments were 
made in comparing the LS Means for different response variables depending on the situation 
for which they were compared. Means were also compared using least squares differences. 
These results were calculated using SAS (version 8.2, SAS Institute Inc., Cary, NC). 
Results and Discussion 
Protein Partitioning during Isolate Production 
Traditional extraction conditions employed in soy protein isolate production are pH 7.5 -
9 and temperatures up to 80 °C (Berk 1992), although U.S. patents have disclosed a much 
broader range of extraction conditions with regard to pH and temperature. Proprietary 
concerns limit specific information about commercial extraction conditions, but pH 8.5 and 
60 °C are commonly accepted extraction conditions for isolate production and are used at the 
Iowa State University Center for Crops Utilization Research (CCUR) pilot plant. CCUR 
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reports their dry weight basis isolate yields are typically 33%, but industry yields may be as 
high as 44%. Conditions of pH 8.5 and 25 °C have been used in the CCUR pilot plant when 
extracting protein for soy protein fractionation to prepare glycinin- and (i-conglycinin 
enriched fractions (Wu and others 1999, Wu and others 2000). This relatively low extraction 
temperature was employed for the fractionation process to maximize the amount of native 
state storage proteins, which have been hypothesized to fractionate more efficiently (Wu and 
others 2000). Compared to soy protein isolate production, fraction weight yields have been 
low for the pilot-scale fractionation process, typically less than 30%. This probably was due 
primarily to the low protein extraction temperature. 
Protein solubilization conditions of 25 °C at pH 8.5 and 60 °C at pH 8.5-10.5 were 
chosen for bench-scale isolate production. These selections were made to simulate extraction 
conditions employed in the CCUR pilot plant for the soy protein isolate production and soy 
protein fractionation, and to evaluate the effects of increasing the extraction pH above 8.5. 
Increased extraction temperature and increasing extraction pH significantly increased 
fraction weight and total protein recovery in the isolate fraction (Table 1). The dry weights 
of the insoluble fractions were inversely related to those for the isolate. The protein 
concentration of the isolates was not significantly different among treatments. 
Phytochemical Partitioning and Distribution During Isolate Production 
Soy isoflavones are comprised of three aglycone forms, daidzein, genistein, and glycitein, 
and their respective glucoside forms. There are three glucoside forms for each aglycone: 6"-
O-malonylglucoside, 6"-0-acetylglucoside, and the simple p-glucoside (Figure 1). The 
malonylglucoside of each aglycone family is the predominant form in raw soybeans (Wang 
and Murphy 1994a), with prevalence of combined forms generally being genistein-daidzein 
»glycitein on a mole basis. When processed under mild conditions, malonylglucosides will 
gradually convert to the p-glucoside forms (Murphy and others 1999, Wang and Murphy 
1996). Conversion of malonylglucosides to acetylglucosides occurs during more abusive 
conditions, such as toasting and extrusion (Farmakalidis and Murphy 1985, Mahungu and 
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Table 1 - Effect of protein solubilization temperature and pH on fraction weight 
and protein partitioning during bench-scale soy protein isolate production 
Insoluble0, *'c Isolate Whey 
Fraction weight (g, dbrf) 
25 °C pH 8.5 35.19. 22.70c 18.0 lab 
60 °C pH 8.5 32.34b 26.21b 17.32k 
60 °C pH 9.5 33.62b 25.41b 16.66c 
60 °CpH 10.5 30.73c 28.34a 18.56a 
LSD' 1.47 1.25 0.89 
Protein concentration (%, db) 
25 °C pH 8.5 43.0a 90.0 18.8a 
60 °C pH 8.5 40.5b 89.4 
00 
60 °C pH 9.5 39.4b 89.6 16.3b 
60 °C pH 10.5 35.5c 87.1 15.3c 
LSD 1.6 Not Different 0.8 
Total protein (g, db) 
25 °C pH 8.5 15.1a 20.4c 3.39. 
60 °C pH 8.5 13.1b 23.4b 2.56c 
60 °C pH 9.5 13.2b 22.8b 2.72k 
60 °CpH 10.5 10.9c 24.7a 2.83b 
LSD 0.8 1.1 0.18 
"Dry basis weight, protein concentration, and total protein of the starting material were 73.88 g, 
50.09 %, and 41.23 g, respectively. 
*n=2. 
"Values within a column with different subscript letters were significantly different at P< 0.05. 
ddb, dry basis. 
"LSD, least significant difference. 
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R, 
Ri 
Isoflavone R; Rz 
Daidzein H H 
Genistein H OH 
Glycitein OCH3 H 
Isoflavone ri r2 rj 
Genistin H OH H 
Glycitin OCH3 H H 
Daidzin H H H 
Malonyigenistin H OH COCH2COOH 
Malonylglycitin OCH3 H COCH2COOH 
Malonyldaidzin H H COCH2COOH 
Acetylgenistin H OH COCH3 
Acetylglycitin OCH3 H COCH3 
Acetyldaidzin H H COCH3 
Figure 1 - Isoflavone structures 
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others 1999). In the presence of |3-glucosidases, glucoside isoflavones will be converted to 
aglycones (Wang and Murphy 1996). 
Soyasaponin composition of whole soybeans has been reported to be about 75% group B 
saponins and 25% group A saponins (Ireland and others 1986). The group B saponins that 
could be measured by the method used for our research (Hu and others 2002) were V, I, II, 
ag, Pg, and pa. The latter three group B saponins have a 2,3-dihyro-2,5-dihydroxy-6-methyl-
4fl-pyran-4-one (DDMP) moiety with a labile bond, and these forms readily convert to V, I, 
and II, respectively (Figure 2). Group B saponins III, IV, yg, and ya are also present in 
soybeans, but only in very small quantities. It is difficult to isolate adequate quantities of 
these saponins to prepare standard curves. Group A saponins (Figure 3) have a sugar group 
at normal environmental temperatures that is labile at pH 9 and temperatures above 80 °C 
(Meredith 2002). When these sugar groups are removed, group A saponins A* and A%, A5 
and A%, and Ag and A3, are structurally very similar to group B saponins V, III, and IV, 
respectively. Unpublished data (Meredith 2002) suggest these altered, group A saponin pairs 
elute simultaneously with their group B counterparts, causing overestimation of group B 
saponins and an overall increase in measured saponins, provided only group B saponins are 
being quantified. Our method did not permit quantification of group B saponins III and IV. 
Consequently, co-elution of modified A5 and A% with III and A& and A3 with IV could not be 
effectively evaluated. Dramatic increases would need to be observed in saponin V 
concentrations to demonstrate that a conversion of A4 and Ai and co-elution with saponin V 
had occurred under various treatment conditions. 
Soy protein isolate, recovered by precipitating protein from the protein extract by 
adjusting the pH to the isoelectric point (pH 4.5), may be neutralized from pH 4.5 to pH 6.8-
7.5 prior to spray drying to help disperse the isolate curd and to enhance dispersion of the 
spray-dried product in aqueous applications, if that is desired. For this study, the isolate was 
not neutralized prior to freeze drying. Our typical phytochemical extraction method 
demonstrated discrepancies in the phytochemical mass balance data. In an attempt to correct 
this situation, neutralization of sample slurry just prior to phytochemical extraction was 
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OH 
CH 
CH CH3 CH 
CH HOOC 
HO 
HO 
HO 
HO 
saponin ri r2 DDMP 
Pg CH2OH a-L-Rha Y 
I CH2OH a-L-Rha N 
Pa H a-L-Rha Y 
II H a-L-Rha N 
yg CH2OH H Y 
HI CH2OH H N 
ya H H Y 
IV H H N 
ag CH2OH p-D-Glc Y 
V CH2OH p-D-Glc N 
Figure 2 - Structures of group B soyasaponins 
Rha: rhamnosyl; Glc: glucosyl; Y: yes; N: no 
DDMP: 2r3-dihydro-2,5-dihydroxy-6-methyI-4//-
pyran-4-one 
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OH 
CH; CH; 
[OOH CH. 
HO 
HO 
HO 
OH 
OH 
kOAc HO 
OAc 
OAc 
Soyasaponin Ri Ra R3 
Aa = acetyl A4 CH2OH P-D-Glc H 
Ab = acetyl Ai CH2OH P-D-Glc CH2OAc 
Ac CH2OH a-L-Rha CH2OAC 
Ad H P-D-Glc CH2OAc 
Ae = acetyl A5 CH2OH H H 
Af= acetyl A2 CH2OH H CH2OAc 
Ag = acetyl Aa H H H 
Ah = acetyl A3 H H CH2OAc 
Figure 3 - Group A acetylated soyasaponin structures 
Glc: glucosyl; Rha: rhamnosyl; Ac: acetyl 
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explored. Neutralization did have a favorable effect on phytochemical recovery in certain 
cases. Consequently, freeze-dried soy protein isolates, as well as the insoluble and whey 
fractions, were extracted for isoflavones and saponins both with and without neutralization of 
the sample slurry prior to extraction. Table 2 shows the mass balance data from soy isolate 
production for the isoflavones and saponins. For the insoluble fraction there was a clear, and 
in most cases significant, trend in total isoflavone and saponin recovery from the starting 
material as temperature and pH was increased, similar to that observed for the fraction 
weight and protein. Even though the phytochemical concentration for each insoluble fraction 
was multiplied by the fraction weight, which declined with increasing temperature and pH, 
the decrease in fraction weight did not account for all of the decrease in total phytochemical 
recovered in the insoluble fraction for the high temperature, high pH treatments. The 
treatment conditions affected total phytochemical recovery. 
Saponins were not detected in the whey fraction, and total isoflavones recovered in the 
whey fraction were not significantly different among treatments. For both neutralized and 
not neutralized protein isolate samples, there were clear, significant, positive trends in 
quantified saponins as temperature and pH increased. Interestingly, neutralization of the 
sample slurry prior to phytochemical extraction significantly increased measured saponins. It 
is possible that as the sample slurry was neutralized, the physicochemical relationship 
between the saponins and proteins was altered. There is a carboxyl group on the glucuronic 
acid of the group B saponins that may have a pK@ of approximately 4. This could account for 
ionic interaction with the proteins near the isoelectric point of the proteins. 
Unexpectedly, summed isoflavone and saponin fraction totals (insoluble + isolate + 
whey) were both low compared to the total isoflavones and saponins measured in the starting 
material. Soy flake and process fraction matrices were probably responsible for at least a 
portion of this discrepancy. A recovery study with ground, defatted soy flakes and the 
freeze-dried soy protein isolate revealed considerable recovery differences between these 
matrices. Recovery of saponin I and II was about 99% for the flake material, but only 60-
70% for the isolate. Isoflavone recoveries were 75-92% for the flake material, with the more 
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Table 2 - Effect of protein solubilization temperature and pH on isoflavone and 
Isoflavones (p.mol, dry basis) Saponins (j-imol, dry basis) 
Treatment Insoluble" Isolate Whey Totals Insoluble Isolate Totals 
Ground Flakes 648 515 
25 °C pH 8.5* 196a 227d 135 558* 276. 118f 394* 
25 °C pH 8.5NC 198a 267k 115 580* 26 lab 200cd 461 
60 °C pH 8.5 157b 272k 106 535* 237k 128ef 365* 
60 °C pH 8.5N 0
0 VO 
296. 101 565* 238k 206cd 444 
60 °C pH 9.5 160b 263c 118 541* 235k 178de 413* 
60 °C pH 9.5N 169b 265bc 126 560* 223cd 278b 501 
60 °C pH 10.5 100d 277b 108 485* 204cd 244k 448 
60 °C pH 10.5N 130c 263c 123 516* 194d 344. 538 
LSD* 14 12 NDe 33 57 
"Values within a column with different subscript letters were significantly different at P< 0.05. 
*n=2. 
TM, neutralized at time of phytochemical extraction. 
^LSD, least significant difference. 
*ND, not different. 
* Indicates that the sum of the insoluble, isolate, and whey fractions is different (f<0.05, Dunnetts test) from 
the amount of isoflavone or saponin in the ground, defatted soy flakes. 
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hydrophobic aglycones exhibiting the lowest recoveries. Isoflavone aglycone recovery from 
the isolate material was 65-75%, while recoveries for the (3-glucosides and 
malonylglucosides were 78-93%. Neutralization of the phytochemical extraction solution 
increased saponin I and II recovery from the isolate samples by about 15% for saponin I and 
25-45% for saponin II. Recovery of the aglycone isoflavones from the isolate samples 
increased by 10-15% with neutralization. 
Isoflavone and saponin concentrations in the process fractions were evaluated, as well as 
the effect of process conditions on isoflavone and saponin profiles (Tables 3 and 4). The 
isoflavone content of the starting material was 8.8 jimol/g. Partitioning of the isoflavones led 
to concentrations of3.26-5.63 (imol/g in the isoflavone-depleted insoluble fraction, 9.29-
11.78 |nmol/g in the isolate product, and 5.95-7.47 pmol/g in the whey fraction. The ranges 
reflect the effect of treatment and neutralization. Modest isoflavone enrichment in the isolate 
compared to the starting material was demonstrated. The isoflavone profile was altered by 
treatment conditions for the insoluble, isolate, and whey fractions. For both neutralized and 
non-neutralized samples, as temperature and pH were increased, malonylglucosides and 
acetylglucosides were converted to (3-glucosides. Apparently, there was very little 
glucosidase activity, as conversion of glucosides to aglycones was not substantial. However, 
the protein solubilization time was relatively short, limiting the amount of time a glucosidase 
would have for isoflavone modification. The trend toward lower aglycone concentrations in 
the insoluble, isolate, and whey fractions as temperature and pH were increased may have 
been caused by reduced aglycone recovery from the sample matrices during analytical 
extraction. Temperature and pH affect protein native state, and as proteins unfold, additional 
hydrophobic areas are exposed. The aglycones are more hydrophobic than the glucosides 
and may have an affinity for exposed hydrophobic regions on proteins. Acetylglucoside 
concentrations did not increase, probably because process conditions were aqueous and still 
relatively mild, compared to toasting or roasting at low moisture concentrations. 
Processing effects on isoflavone profile have received considerable investigation, due in 
part to a study by Izumi and others (2000) that demonstrated that aglycone isoflavones are 
Table 3 - Effect of protein solubilization temperature and pH on isoflavone distribution in process fractions from 
bench-scale soy protein isolate production 
Concentration (^imol/g, dry basis) 
Treatment" Din c MDin AcDin Dein Glyin MGly* Glyein Gin MGin AcGin Gein Total 
Insoluble Fraction 
25 °C pH 8.5 0.79c 1.17a 0.06 0.19. 0.29a 0.24. 0.05 1.12d 1.37a 0.06b 0.23 5.56ab 
25 °C pH 8.5N® 0.81a 1.18a 0.04 0.20a 0.29d 0.24. 0.06 1.13d 1.36a 0.08ab 0.25 5.63a 
60 °C pH 8.5 0.92c 0.77b 0.04 0.14b 0.28d 0.16b 0.05 1.28cd 0.92b O.O8ab 0.22 4.86cd 
60 °C pH 8.5N 0.96c 0.85b 0.06 0.15b 0.30d 0.17b 0.05 1.32c 0.99b 0.10a 0.26 5.20k 
60 °C pH 9.5 1.50a 0.08c nd 0.13bc 0.44a nd 0.04 2.27. 0.08c 0.02de 0.20 4.76d 
60 °C pH 9.5N 1.52a 0.11c nd 0.14b 0.44a 0.03d 0.05 2.34. 0.15c 0.04c 0.22 5.04cd 
60 °CpH 10.5 0.97c 0.03c nd 0.11c 0.36c 0.09c 0.05 1.50b nd nd 0.15 3.26f 
60 °C pH 10.5N 1.11b 0.07c nd 0.13bc 0.41b nd 0.05 2.25. nd 0.03cd 0.18 4.23, 
LSE/ 0.11 0.09 NDIFF 0.03 0.03 0.02 NDIFF 0.17 0.13 0.02 NDIFF 0.38 
Isolate Fracti on 
25 °C pH 8.5 0.84c 2.40b 0.07 0.46 0.31d 0.49b 0.10 1.52a 3.19b 0.12c 0.52 10.02k 
25 °C pH 8.5N 0.94d 2.98. 0.10 0.48 0.36d 0.57a 0.10 1.68d 3.85. 0.18ab 0.55 11.78a 
60 °C pH 8.5 1.44c 1.94c 0.08 0.38 0.45c 0.41c 0.10 2.31c 2.56d 0.14bc 0.58 10.38b 
60 °C pH 8.5N 1.52c 2.23b 0.11 0.39 0.47c 0.45bc 0.11 2.40c 2.86c 0.19a 0.58 11.30a 
60 °C pH 9.5 2.97. 0.25d nd 0.42 0.85b 0.07d 0.11 4.6 lab 0.40c 0.04d 0.65 10.37b 
60 °C pH 9.5N 2.97, 0.32d nd 0.42 0.86b 0.09d 0.11 4.51b 0.46e 0.05d 0.64 10.44b 
60 °C pH 10.5 2.68b 0.26d nd 0.37 0.90a nd 0.12 4.82a 0.03f 0.02d 0.56 9.77cd 
60 °C pH 10.5N 2.67b nd nd 0.37 0.90a nd 0.13 4.64ab nd 0.03d 0.54 9.29d 
LSD 0.09 0.17 NDIFF NDIFF 0.03 0.06 NDIFF 0.30 0.25 0.04 NDIFF 0.56 
°n=2. 
^Values within a column with different subscript letters were significantly different at p< 0.05. 
"Abbreviations: Din, daidzin; MDin, malonyldaidzin; AcDin, acetyldaidzin; Dein, daidzein; Glyin, glycitin; MGly, malonylglycitin; 
Glyein, glycitein; Gin, genistin; MGin, malonyigenistin; AcGin, acetylgenistin; Gein, genistein; nd, none detected; NDIFF, not different. 
rfAcetylglycitin was not detected for any samples and was not included in the table. 
*N, neutralized at time of phytochemical extraction. 
^LSD, least significant difference. 
Table 3 (continued) 
Concentration (jamol/g, dry basis) 
Treatment" Din0,c MDin AcDin Dein Glyin MGly" Glyein Gin MGin AcGin Gein Total 
Whey Fraction 
25 °C pH 8.5 1.15f 2.46g 0.03 0.20a 0.45c 0.44a 0.06, 0.93d 2.46a 0.05a 0.15a 7.47 
25 °C pH 8.5N* 1.37ef 1.41b 0.07 0.23a 0.46c 0.26ab 0.06a 1.1 led 1.41b 0.05a 0.17a 6.41 
60 °C pH 8.5 1.67de 1.52b nd 0.06b 0.56c 0.29ab 0.02b l.lBcd 1.52b 0.04a 0.04b 6.12 
60 °C pH 8.5N 1.89d 0.88c 0.06 0.07b 0.56c 0.18bc 0.02b 1.38c 0.88c 0.05, 0.04b 5.82 
60 °C pH 9.5 3.12ab 0.20d nd 0.07b 0.96a 0.03c 0.02b 2.51ab 0.20d nd 0.06b 7.09 
60 °C pH 9.5N 3.47, 0.04d nd 0.07b 1.03a nd 0.02b 2.80a 0.04d nd 0.06b 7.58 
60 °C pH 10.5 2.46c 0.12d nd 0.05b 0.79b 0.15bc nd 2.35b 0.12d nd 0.04b 5.95 
60 °C pH 10.5N 2.87b 0.01d 0.01 0.06b 0.91a 0.01c 0.01b 2.69. O.Old 0.02b 0.04b 6.65 
LSD7 0.37 0.51 NDIFF 0.04 0.12 0.21 0.03 0.30 0.44 0.01 0.03 NDIFF 
°n=2. 
''Values within a column with different subscript letters were significantly different at P< 0.05. 
^Abbreviations: Din, daidzin; MDin, malonyldaidzin; AcDin, acetyldaidzin; Dein, daidzein; Glyin, glycitin; MGly, malonylglycitin; 
Glyein, glycitein; Gin, genistin; MGin, malonyigenistin; AcGin, acetylgenistin; Gein, genistein; nd, none detected; NDIFF, not different. 
dAcetylglycitin was not detected for any samples and was not included in the table. 
*N, neutralized at time of phytochemical extraction. 
ZLSD, least significant difference. 
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Table 4 - Effect of protein solubilization temperature and pH on saponin 
distribution in process fractions from bench-scale soy protein isolate production 
Concentration (pmol/g, dry basis) 
Treatment" Ve I II «g 1 Pg Pa Total 
Insoluble Fraction 
25 °C pH 8.5 0.66 2.74d 1.13 0.24 2.40a 0.68a 7.84a 
25 °C pH 8.5NC 0.46 2.68d 1.16 0.24 2.24. 0.66a 7.43ab 
60 °C pH 8.5 0.91 3.17c 1.37 0.15 1.39b 0.38b 7.36* 
60 °C pH 8.5N 0.63 3.18c 1.27 0.20 1.64b 0.45b 7.37* 
60 °C pH 9.5 0.91 4.23a 1.85 nd" nd nd 7.00,^ 
60 °C pH 9.5N 0.76 3.93d, 1.82 nd 0.10c nd 6.62bc 
60 °C pH 10.5 0.93 3.94» 1.77 nd nd nd 6-65bc 
60 °C pH 10.5N 0.80 3.68b 1.84 nd nd nd 6.32k 
LSD" NDIFF 0.42 NDIFF NDIFF 0.54 0.17 0.87 
Isolate Fraction 
25 °C pH 8.5 0.45de 1.41f 0.66e 0.16b 1.91b 0.59b 5.18d 
25 °C pH 8.5N O.SÔcde 2.43ef 1.05de 0.30. 3.39. 1.08a 8.81bc 
60 °C pH 8.5 0.39e 2.14ef 0.94, 0.10b 0.98d 0.35d 4.90d 
60 °C pH 8.5N 0.63^ 3.47de 1.47c 0.13 1.62c 0.54c 7.87c 
60 °C pH 9.5 0-78bcd 4.21c 193k 0.07b nd nd 6.99c 
60 °C pH 9.5N 1.13* 6.93* 2.89a nd nd nd 10.96* 
60 °C pH 10.5 0.92k 5.43k 2.26b nd nd nd 8.61k 
60 °C pH 10.5N 1.44. 7.56, 3.15. nd nd nd 12.15. 
LSD 0.37 1.60 0.47 0.12 0.19 0.04 2.37 
"n=2. 
*Values within a column with different subscript letters were significantly different at f<0.05. 
IN, neutralized at time of phytochemical extraction. 
4nd, none detected. 
'"LSD, least significant difference. 
^NDIFF, not different. 
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absorbed faster and in greater quantities than are the glucoside forms in the gut. However, a 
study by Xu and others (2000) suggested that isoflavone bioavailability was not affected by 
isoflavone source or profile. Wang and Murphy (1996) published the first mass balance data 
for isoflavone partitioning and distribution during tempeh, soymilk and tofu, and soy protein 
isolate processing. Bean soaking prior to processing led to a 10% loss of isoflavones into the 
soak water. Aglycone concentration increased during soaking, probably due to the action of 
p-glucosidases. Cooking processes increased concentrations of acetylgenistin and 
acetyldaidzin. During soy protein isolate production, malonylglucosides were primarily 
converted to aglycones (Wang 1994). Isoflavone retention in the insoluble fraction during 
isolate production was about 50%, substantially higher than the 20-35% observed here. 
Wang and others (1998) also evaluated the changes in isoflavones during soy protein 
isolate production. The primary profile change was increased aglycone content of the isolate 
compared to soy flakes. Singletaiy and others (2000) reported that the major isoflavone 
profile effect of extruding a mixture of com and soy was the conversion of 
malonylglucosides to acetylglucosides. Grim and others (2001) reported the predominant 
isoflavone profile change during thermal processing of previously manufactured tofu was 
due to de-esterification of the malonylglucosides and acetylglucosides to the ^-glucosides. 
All three of the preceding research groups did not prepare standard curves for malonyl- and 
acetylglucosides, but rather calculated these values from the corresponding glucoside forms 
by correcting for molecular weight differences. An additional observation by Griin and 
others (2001) was the decrease of aglycone isoflavones in the tofu during processing. They 
suggested that this was due to leaching or degradation of the aglycones. Degradation is 
unlikely under the relatively mild conditions described. Griin and others (2001) provided 
recovery data for genistein and genistin, but no recovery data was provided by Wang and 
others (1998) or Singletaiy and others (2000). 
In addition to phytochemical partitioning and profile distribution, there was interest in 
treatment effects and interactions on phytochemical concentrations for the process fractions. 
Analysis of variance (ANOVA) results revealed that isoflavone concentration of insoluble 
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fractions were significantly affected by treatment pH and by neutralization of the samples 
prior to phytochemical extraction. ANOVA tables have been included in Appendix A. 
There was also significant interaction between pH and neutralization. Least square means 
are shown for both treatment temperatures (Table 5), but since the experiment was not 
balanced, the significance of the pH by neutralization interaction is shown only for the 60 °C 
treatments. The interaction was significant because neutralized and non-neutralized samples 
tested significantly different at pH 10.5, but not when the pH was 8.5 or 9.5. When 
neutralizing the insoluble fraction, the pH was decreased from 8.5, 9.5, or 10.5 to 7.0. 
Apparent pKa values for the aglycone isoflavone 4' hydoxyls are 9.50,9.55, and 9.73 for 
genistein, daidzein, and glycitein, respectively (McLeod and Shepherd 2000). Krol (2000) 
reported that the pKa of the 4' hydroxyl for soy isoflavones was 9.9, but 9.2 for the 5 
hydroxyl. Krol also reported that the pKa of the 7 hydroxyl of the aglycones was 7.6, the pKa 
of the P-glucoside was about 11, and the pK& of the malonyl carboxyl was about 5.7. It is 
possible that the ionization of the isoflavones at high pH caused an increased ionic 
interaction between the isoflavones and the protein matrix. This interaction may have 
diminished as the charges on the isoflavones were altered at neutral pH. 
None of the least square means (LSM) analyses for isoflavone concentrations of the whey 
fractions was significant, but pH, neutralization, the temperature by neutralization 
interaction, and the pH by neutralization interaction were all significant for the isolate. The 
pH by neutralization interaction tested significant because when the pH was 8.5 the LSM 
isoflavone concentration value was 0.92 pmol/g higher than not neutralized, but when the pH 
was 10.5 the neutralized value was 0.48 pmol/g less than the not neutralized (Table 6). For 
the soy protein isolate, the sample slurry pH was adjusted from pH 4.5, the pH at which the 
isolate was precipitated during processing, to 7.0 for phytochemical extraction. For the pH 
8.5 treatments at 25 and 60 °C, there was still a relatively high concentration of 
malonylglucosides in the isolate. At pH 10.5 and 60 °C, however, the concentration of 
malonylglucosides in the isolate was low. The malonyl carboxyl group of the 
malonylglucosides has a pK* of 5.7. These facts may explain why neutralizing the isolate 
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Table 5 - Least square means for isoflavone concentrations of the insoluble fractions 
from bench-scale soy protein isolate production 
pH 8.5*' pH 8.5 Nc pH 9.5 pH 9.5 N pH 10.5 pH 10.5 N 
25 °C 5.56 5.63 
60 °C 4.86ac 5.20c 4.76*; 5.04c 3.26b 4.23, 
"Values are dry basis concentrations in gmol/g. 
^Subscript, lowercase letters that are different within a row indicate significant differences (/>«).05) between 
least square means for pH by neutralization interaction. Because 60 °C was the only temperature at which 
every level of pH and neutralization were tested, significance was shown only for the 60 °C treatments. 
TST, neutralized at time of phytochemical extraction. 
Table 6 - Least square means for isoflavone concentrations of soy protein isolates 
produced by a bench-scale process 
pH 8.5** pH 8.5 Nc pH 9.5 pH 9.5 N pH 10.5 pH 10.5 N 
25 °C 10.03bd 11.78, 
60 °C 10.38* 11.30* 10.37* 10.44* 9.77cd 9.29k 
"Values are dry basis concentrations in gmol/g. 
^Subscript, lowercase letters that are different within the table indicate significant differences (P0.05) 
between least square means for pH by neutralization and temperature by neutralization interactions. 
CN, neutralized at time of phytochemical extraction. 
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slurry prior to phytochemical extraction improved isoflavone recovery for the pH 8.5 
treatments. 
For the total isoflavone concentrations of the soy protein isolates, the temperature by 
neutralization interaction tested significant. This was because at 25 °C the LSM for the 
neutralized sample was 1.75 gmol/g larger than the not neutralized sample and they were 
significantly different, but when the temperature was 60 °C, the difference between 
neutralized and not neutralized treatments was only 0.92 grnol/g and they were no longer 
significantly different. This may again have been influenced by the concentration of 
malonylglucosides in the soy protein isolate. Temperature had an effect on malonylglucoside 
conversions, but temperature did not influence conversion as aggressively as did the pH at 
which the protein solubilization occurred. 
The effect of processing on soy saponins has received much less attention than has the 
isoflavones, due in part to the difficulty to purify standards and efficiently quantify the 
saponins. Hu and others (2002) described methods to address these difficulties for several 
group B saponins: V, I, II, ag, Pg, and Pa. The concentration of these six saponins in the 
starting material was 7.0 gmol/g, similar to the 6.32-7.84 gmol/g concentrations of the 
insoluble fraction. The saponin concentration of the isolate, as discussed for the mass 
balance above, was dramatically affected by neutralization. The saponin profiles in the 
insoluble and isolate fractions were quite different across treatments and from the starting 
material. Table 7 shows the saponin profile of the starting material. For both the insolubles 
and soy protein isolate, the conversion of the group B DDMP forms ag, Pg, and Pa to V, I, 
and II, respectively, was dramatic and eventually complete as temperature and pH increased, 
demonstrating how labile the DDMP saponins were (Table 4). 
As described above, group A saponins Ai-A^ lose a labile sugar group at temperatures 
above 80 °C and a pH of at least 9. These modified group A saponins have been reported to 
elute at the same retention time as group B saponins V, III, or IV, with modified A; and A4 
eluting with saponin V. For the insoluble fraction, there was no significant difference in 
saponin V concentrations among treatments (Table 4). Soy protein isolates that were 
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Table 7 - Saponin distribution in material from soy slurry production 
Concentration (|xmol/g, dry basis) 
Treatment" Ve I II ag Pg pa Total 
Ground Flakes 0.44 1.34; 0.58h 0.27, 3.35. 0.99. 6.97 
25 °C pH 8.5 0.31 2.05* 0.82A 0.24. 2.81* 0.80* 7.04 
25 °C pH 8.5NC 0.35 1.78M 0.66* 0.23* 2.51k 0.75k 6.29 
25 °C pH 9.5 0.46 2.42efeh 0.95feh 0.17k 2.05cd 0.57c 6.62 
25 °C pH 9.5N 0.47 2.24s* 0.99,6* 0.15c 1.71de 0.53de 6.10 
25 °C pH 10.5 0.71 3.57c 1.52M 0.04c 0.35, 0.14f 6.34 
25 *C pH 10.5N 0.65 2.78cf 1 -48cde 0.09de 1.00f 0.34, 6.35 
60 °C pH 8.5 0.68 2.97dc 1.40cdef 0.13c 1.25ef 0.37, 6.80 
60 °C pH 8.5N 0.70 2.58* 1.13defe 0.13c 1.43ef 0.44de 6.43 
60 °C pH 9.5 0.99 4.34gh 199* nd" nd nd 7.33 
60 °C pH 9.5N 0.85 4.14k 1.78abc nd 0.04e nd 6.81 
60 °C pH 10.5 0.91 4.91, 2.07. nd nd nd 7.89 
60 °C pH 10.5N 0.54 4.20bc 1.68abc nd nd nd 6.42 
LSD' NDIFF' 0.69 0.50 0.06 0.58 0.20 NDIFF 
"n=2. 
^Values within a column with different subscript letters were significantly different at P<0.05. 
'N, neutralized at time of phytochemical extraction. 
dnd, none detected. 
*LSD, least significant difference. 
^NDIFF, not different. 
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neutralized prior to phytochemical extraction showed that saponin V concentrations for the 
pH 9.5, 60 °C and pH 10.5, 60 °C treatments were significantly higher than pH 8.5 
treatments at either 25 or 60 °C. Saponin ag converts to saponin V upon loss of the DDMP 
moiety. If saponin V and saponin ag concentrations are summed for the neutralized soy 
protein isolate samples, the range in combined concentrations was 0.61 to 1.44 pmol/g from 
the pH 8.5,25 °C to the pH 10.5, 60 °C treatment. However, the total saponin concentrations 
corresponding to these two treatments were 8.81 and 12.15 gmol/g, respectively. When the 
combined saponin V and ag concentrations, 0.61 and 1.44 pmol/g from above, were 
expressed on a percentage basis relative to the total saponin concentrations for those samples, 
the results were 9.8 and 11.9%. Consequently, if saponins A4 and Ai eluted at exactly the 
same retention time as saponin V, their influence on the total saponin concentration was 
small. It is possible that our extraction conditions were too mild, 60 °C as opposed to >80 °C, 
for this conversion to be realized and measured. 
Modified group A saponins A5 and A%, and A* and A3 may elute at the same retention 
time as group B saponins III and IV. Our method does not quantify these group B saponins. 
A very small peak, however, was observed for neutralized samples from the insoluble and 
isolate fractions of 60 °C, pH 8.5,9.5, and 10.5 treatments during a retention time region in 
which saponins III or IV may elute. Whether this peak was group A saponins or just 
conversion of group B DDMP saponins yg or ya to group B non-DDMP saponins III and IV, 
respectively, was difficult to determine. 
The LSM for total saponin concentrations of the insoluble and isolate fractions were 
statistically analyzed for the effect of treatments and interactions. For the insoluble fraction, 
only pH tested significant. These least square means are shown in Table 8. For the isolate, 
pH and neutralization both tested significant. LSM are shown in Tables 9a and 9b. The 
protein matrix seemed to have a considerable effect on saponin extraction. A small body of 
evidence suggests that there is a definite interaction of saponins with glycinin and P-
conglycinin proteins, the major storage proteins in soybeans, through hydrophobic 
interaction, hydrogen bonding, or ionic bonding (Shimoyamada and others 1998). 
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Table 8 - Least square means of saponin concentrations of the insoluble 
fractions from soy protein isolate production for various levels of pH and 
temperature 
pH 8.5*» pH 9.5 pH 10.5 
25 °C 7.63 
60 °C 7.37, 6.80ab 6.49b 
"Values are dry basis concentrations in (imol/g. 
^Subscript lowercase letters that are different within a row indicate significant differences 
(P<0.05) between least square means for pH. Because 60 °C was the only temperature at 
which each pH was evaluated, significance was shown only for the 60 °C means. 
Table 9a - Least square means for saponin concentrations of the soy protein 
isolate fractions for various levels of pH and temperature 
pH 8.5*'» pH 9.5 pH 10.5 
25 °C 7.00 
60 °C 6.38b 8.98, 10.38a 
"Values are dry basis concentrations in (imol/g. 
^Subscript, lowercase letters that are different within a row indicate significant differences 
(P<0.05) between least square means for pH. Because 60 °C was the only temperature at which 
each pH was evaluated, significance was shown only for the 60 °C means. 
Table 9b - Least square means for saponin concentrations of the soy protein 
isolate fractions for neuf tralization and temperature 
Not Neutralized0,6 Neutralized 
25 °C 
60 °C 6.83b 10.33, 
"Values are dry basis concentrations in (imol/g. 
^Subscript, lowercase letters that are different within a row indicate significant difference 
(P<0.05) between least square means for neutralization treatments. Means for the 25 °C 
treatments were not calculated. 
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Effect of Protein Solubilization Conditions and Sample Neutralization on Soy Slurry 
The soy slurry or soy protein solubilization experiment was designed to eliminate mass 
balance discrepancies caused by fractionating soy flakes into insoluble, isolate, and whey 
fractions, each with potentially different protein matrix characteristics. The soy slurry study 
utilized a similar set of protein solubilization treatment conditions, but there was no 
subsequent separation of the soluble and insoluble components. This provided a uniform 
matrix to evaluate for each treatment condition. The soy slurry experiment was also 
balanced for pH (8.5, 9.5, and 10.5) and temperature treatments (25 and 60 °C), whereas the 
soy protein isolate experiment did not include all pH treatments at 25 °C. As done for the 
soy protein isolate experiment, phytochemical extraction of samples from each treatment was 
performed with and without neutralization. 
Table 7 shows that at 25 °C the extent of conversion ofDDMP saponins (ag, (3g, and Pa) 
to non-DDMP saponins (V, I, and II) increased with increasing pH. However, increasing the 
protein solubilization temperature from 25 to 60 °C at pH 8.5 had as much effect on this 
DDMP conversion as increasing pH from 8.5 to 10.5 at 25 °C, suggesting that temperature 
had a more profound effect on the extent of conversion. The saponin V concentrations were 
not significantly different across treatments (Table 7). When saponin V and ag were 
summed, differences among these sums were even smaller than differences among saponin V 
concentrations. This suggests that if any group A saponins were eluting at the saponin V 
retention time, the concentrations were extremely low. 
Statistical analysis using least square means for treatment effects and treatment 
interactions on saponin concentrations showed that only neutralization produced a significant 
difference (P<0.05) across treatment conditions. LSM were 6.40 and 7.00 for neutralized 
and not neutralized treatments, respectively. 
For the soy slurry experiment, extraction of isofiavones from the dried slurry material 
declined as the protein solubilization pH increased (Table 10). As seen for the insoluble 
fraction of the soy protein isolate experiment (Table 3), isoflavone extraction was enhanced 
by neutralizing the samples prior to extraction. Again, the pKa and ionization of the 
Table 10 - Isoflavone distribution in material from soy slurry production 
Concentration (gmol/g, dry basis) 
Treatment" Din*" MDin AcDin Dein Glyin MGly* Glyein Gin MGin AcGin Gein Total 
Ground Flakes 1.04e 2.40a 0.09 0.16 0.41. 0.48a 0.05 1.27e 2.57. 0.13a 0.17 8.77a 
25 °C pH 8.5 1.09e 2.17k nd 0.16 0.37, 0.40be 0.05 1.37, 2.27b 0.09d 0.18 8.15abc 
25 °C pH 8.5Ne 1.09, 2.21,b 0.07 0.18 0.39, 0.42b 0.05 1.37, 2.35ab 0.10c 0.20 8.43ab 
25 °C pH 9.5 1.34%, 1.78c nd 0.15 0.42de 0.32d 0.04 1.74d 1.91c 0.07, 0.17 7.95bcd 
25 °C pH 9.5N 1 • 16cde 1.99c 0.06 0.17 0.38, 0.36Cd 0.05 1.48e 2.18b 0.09d 0.20 8.14abc 
25 °C pH 10.5 1.97b 0.85f nd 0.15 0.56bc 0.18f 0.04 2.56c 0.92, 0.04f 0.17 7.45cde 
25 °C pH 10.5N 1.76b 1.22, 0.03 0.16 0.52cd 0.24, 0.05 2.34, 1.42d 0.07, 0.18 8.01bcd 
60 °C pH 8.5 1.41c 1.67d nd 0.24 0.43de 0.32d 0.07 1.75d 
OO 
0.09d 0.36 8.12abc 
60 °C pH 8.5N 1.27cde 1.73a 0.07 0.24 0.40, 0.33d 0.07 1.53d* 1.91c 0.11b 0.37 8.06abcd 
60 °C pH 9.5 132. •
s r
-o
 nd 0.24 0.69a 0.05, 0.07 3.04b 0.22fg 0.04f 0.35 7.18, 
60 °C pH 9.5N 2.40a 0.26, nd 0.25 0.68a 0.07K 0.07 3.29b 0.34f 0.03, 0.38 7.80bcde 
60 °C pH 10.5 1.92b 0.04h nd 0.18 0.62ab nd 0.06 2.52, 0.02, 0.03, 0.26 5.64f 
60 °C pH 10.5N 2.25, 0.10eh nd 0.20 0.70a 0.10 0.06 3.66a 0.02, 0.03, 0.29 7.36de 
lsly 0.25 0.21 NDIFF NDIFF 0.10 0.05 NDIFF 0.37 0.24 0.01 NDIFF 0.73 
°n=2. 
^Values within a column with different subscript letters were significantly different at P<0.05. 
cAbbreviations: Din, daidzin; MDin, malonyldaidzin; AcDin, acetyldaidzin; Dein, daidzein; Glyin, glycitin; MGly, malonylglycitin; Glyein, 
glycitein; Gin, genistin; MGin, malonylgenistin; AcGin, acetylgenistin; Gein, genistein; nd, none detected; NDIFF, not different, 
^cetylglycitin was not detected in any of the samples. 
"N, neutralized at time of phytochemical extraction. 
fLSD, least significant difference 
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isoflavones may affect their extraction at high pH. The isoflavone profile suggests that one 
or more of the glucoside forms were being hydrolyzed to the aglycone forms, but this 
conversion was small compared to conversion of malonylglucosides to their respective (3-
glucosides. The conversion to (3-glucosides seemed to be affected primarily by increased pH 
rather than increased temperature. For instance, the concentration of genistin for the 25 °C, 
pH 8.5 treatment was 1.37 gmol/g, whereas that of the 25 °C, pH 10.5 and 60 °C, pH 8.5 
treatments were 2.56 and 1.75 pmol/g , respectively. Analysis of least square means for total 
isoflavones indicated that temperature, pH, and neutralization, as well as temperature by pH 
and neutralization by pH were all significant. Tables 1 la and 1 lb display least square means 
comparisons for the pH by temperature interaction and pH by neutralization interaction, 
respectively. The pH by neutralization interaction was significant because the difference 
between means for neutralized samples with respect to not neutralized samples were 
significantly different at pH 10.5. The temperature by pH interaction was significant because 
the least square means for treatments at 25 °C were significantly different than the means at 
60 °C when the pH was 10.5, but were not different when the pH was 8.5 or 9.5. 
Conclusions 
Increased temperature and pH increased protein solubilization from the starting material 
and increased fraction weight and protein recovery in the isolate fraction during soy protein 
isolate processing. This relationship was also observed for isoflavones and saponins. The 
soy slurry experiment showed that changes with respect to saponin profile occurred by 
conversion of malonylglucosides to (3-glucosides as temperature and pH were increased, 
although the effect of pH was more dramatic on this conversion. Conversely, the conversion 
of DDMP saponins to non-DDMP saponins was affected more by increased temperature than 
increased pH. The pH of the solvent system used to extract soy isoflavones and saponins 
should be taken into consideration when trying to optimize extraction of isoflavones and 
saponins from analytical samples. This was especially true for saponin recovery from soy 
protein isolate that had been precipitated at pH 4.5 but not neutralized prior to drying and for 
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Table lia - Least square means of isoflavone concentrations of soy slurry 
materials for various levels of pH and temperature for evaluation of 
pH by temperature interaction 
pH 8.5"'» pH 9.5 pH 10.5 
25 °C 8.29. 8.05a 7.73a 
60 °C 8.08a 7.49a 6.50b 
"Values are dry basis concentrations in gmol/g. 
''Subscript, lowercase letters that are different within the table indicate significant differences 
between least square means at P<0.05. 
Table lib - Least square means of isoflavone concentrations of soy slurry 
materials for various levels of pH and neutralization for evaluation of pH 
by neutralization interaction 
pH 8.5"'» pH 9.5 pH 10.5 
Neutralized 8.24* 7.97a 7.68a 
Not Neutralized 8.13, 7.57. 6.55b 
"Values are dry basis concentrations in gmol/g. 
^Subscript, lowercase letters that are different within the table indicate significant differences 
between least square means at P<0.05. 
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isoflavones in soy samples with a pH near 10.5, where isoflavones are ionized and can 
interact more aggressively with the sample matrix. If group A saponins were modified 
during the higher temperature and pH treatments and did elute with saponin V, their effect on 
total group B saponin concentrations was negligible. 
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CHAPTER 4. PILOT-SCALE FRACTIONATION OF GLYCININ AND 
P-CONGLYCININ: PROCESS IMPROVEMENT 
A paper to be submitted to the Journal of Agricultural and Food Chemistry 
David A. Rickert, Lawrence A. Johnson, Patricia A. Murphy 
Abstract 
Extraction pH from 7.5 to 9.0, ethanol concentration of 0 to 10% (v/v), water-to-flake 
ratio of 6:1 to 15:1, and temperature from 25 to 65 °C were investigated for their abilities to 
improve protein yield and phytochemical recovery from 80.0 g of defatted soy white flakes 
during bench-scale soybean glycinin and P-conglycinin fractionation, with improved process 
conditions to be employed for pilot-scale fractionation. Extraction parameters of 45 °C and 
10:1 water-to-flake ratio were considered optimum conditions. A pilot-scale comparison 
using 20 kg of starting material was conducted for the optimized method and the modified 
Nagano method, used previously by our research group for protein fractionation and wherein 
extraction conditions of 20 °C and 15:1 water-to-flake ratio were employed. The optimized 
method yielded significantly more P-conglycinin (2.10 vs. 1.29 kg), lower (3-conglycinin 
purity (67.8 vs. 79.1%), higher glycinin purity (89.9 vs. 85.3%), more isoflavones in the 
protein extract (63.3 vs. 48.6 mmol), higher isoflavone concentration (0.67 vs. 0.31 (imol/g) 
and saponin concentration (3.66 vs. 1.13 pmol/g) in the (3-conglycinin, lower saponin 
concentration in the glycinin precipitate (0.57 vs. 1.17 pmol/g), and lower total saponin (13.5 
vs. 17.0 mmol) in an intermediate protein fraction containing both glycinin and 
P-conglycinin. 
Introduction 
Glycinin and P-conglycinin are the two major storage proteins in soybean seeds. There 
have been substantial efforts to understand the amino acid profile, subunit composition of the 
native-state proteins, and especially the physicochemical characteristics of these proteins as 
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they affect protein functionality (1,2). Consumption of soy proteins and associated 
phytochemicals, such as isoflavones and saponins, may provide health benefits, such as 
improved cardiovascular health as part of a low-fat diet, anti-osteoporotic effects, and anti-
carcinogenic activity (3). Research efforts to define the health impact of each of these soy 
components continue. 
Bench-scale soy protein fractionation has been utilized to produce enriched glycinin and 
P-conglycinin fractions for protein characterization purposes (4-6). Pilot-scale fractionation 
processes for producing glycinin and p-conglycinin fractions, as well as mixtures of these 
proteins, have been patented (7-9). Wu et al. (10-11) developed two pilot-scale methods for 
soy protein fractionation using defatted soy white flakes as the starting material. One method 
was the scale-up of a modified bench-scale process, termed the modified Nagano method, 
yielding an intermediate fraction comprised of a mixture of glycinin and p-conglycinin, a 
glycinin-rich fraction, and a P-conglycinin-rich fraction. Sequential protein fractionation was 
controlled by pH and ionic strength adjustment of solubilized protein extracted from defatted 
soy white flakes. The other method, referred to as a simplified method, yielded only glycinin 
and P-conglycinin fractions. This method produced a larger p-conglycinin fraction, but at the 
expense of purity. 
The protein solubilization temperature utilized for both of the methods of Wu et al. (10, 
11) was 20 °C, much lower than temperatures of up to 80 °C that are employed for soy 
protein isolate production (12). The 20 °C was used to maximize the amount of native state 
storage proteins, which have been hypothesized to fractionate more efficiently (11). Soy 
protein isolate production, similar to Wu's modified-Nagano fractionation process, is 
accomplished by extraction of protein from defatted soy flakes under alkaline conditions, 
followed by isoelectric precipitation. Dry-basis mass recovery has typically been about 33% 
for isolate produced at the Center for Crops Utilization Research (CCUR) pilot plant at Iowa 
State University. Wu reported mass recoveries of only 24 and 29% for the three-fraction 
process and simplified process, respectively. 
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Isoflavone content and profile of several soy foods (13, 14) and information about the 
fate of isoflavones during soy protein isolate processing (15, 16) have been reported. Effect 
of processing on isoflavone profile may be important because glucoside forms require 
enzymatic modification in the gut to the aglucon forms for absorption in humans (17). 
Saponin contents of soybeans, soy foods, and soy ingredients have also been reported (18-
21). However, partitioning of saponins during soy protein fractionation and soy protein 
isolate production, as well as mass balance and profile data, has not been reported. 
Extraction and partitioning differences between isoflavones and saponins have not been 
described for these processes. 
The primary objective of the current research was to improve pilot-scale protein 
solubilization from the defatted soy flake starting material without decreasing mass and 
protein recovery in the glycinin and p-conglycinin fractions or substantially decreasing purity 
of these fractions. A second objective was to enhance isoflavone and saponin recovery from 
the starting material in order to potentially increase their recovery in product fractions. An 
inspection of phytochemical partitioning among the process fractions was also desired. 
These objectives were first addressed through bench-scale experimentation. A range of pH 
values (7.5-9.0), ethanol concentrations (0-10%), temperatures (25-65 °C), and water-to-flake 
ratios (6:1 to 15:1) were each evaluated for their effect on protein solubilization, and for 
some conditions, protein and phytochemical partitioning. Conditions that offered process 
improvement were combined to develop an optimized process. Pilot-scale fractionation was 
then conducted to compare the optimized process with the Wu modified Nagano process 
(10). Protein and phytochemical partitioning observed for the two protein fractionation 
processes were also compared to protein and phytochemical partitioning observed for the 
pilot-scale soy protein isolate process. 
Materials and Methods 
Materials. Defatted soy white flakes for bench-scale and pilot-scale work were from 
Cargill (Minneapolis, MN) and the Research Oil Mill at Texas A&M University, 
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respectively. Texas A&M flakes were year 2000 harvest, IA 2042 variety, and had an 84% 
protein dispersibility index. Flakes were stored in sealed containers at 4 °C until use. HPLC-
grade acetonitrile, methanol, trifluoroacetic acid, and glacial acetic acid for HPLC mobile 
phase and sample preparation were purchased from Fisher Scientific (Fair Lawn, NJ). 
HPLC-grade water for mobile phase and sample preparation was produced using a Milli-Q 
water system (Millipore Co., Bedford, MA). 
Effect of pH on Bench-Scale Protein Solubilization. Soy slurry was prepared at 
ambient temperature by combining water and 80.0 g defatted soy white flakes (15:1 ratio) 
and stirring as rapidly as possible with a magnetic stir bar. Slurry was adjusted to pH 7.5, 
8.0, 8.5, or 9.0 using 2N NaOH, maintained at that pH, and stirred for 1 h. Large particulate 
insolubles were removed using a 60-mesh screen, whereas smaller insolubles were removed 
by centrifugation at 14,000 x g for 30 min at 20 °C. Supernatant protein concentration was 
determined by the biuret method (22) with bovine serum albumen as the standard (Fraction 
V, Sigma Chemical Co., St. Louis, MO). The product of the protein concentration and 
supernatant volume was considered the mass of protein solubilized and recovered. 
Effect of Ethanol on Bench-Scale Protein Solubilization and Fractionation. Bench-
scale fractionation for this study (Figure 1), as well as for the water-to-flake and temperature 
studies below, was a modification from Wu et al. (10), where 50 g of flakes, a 120-mesh 
stainless-steel screen for removal of large insolubles, and a 30-min protein solubilization 
period were used. 
Soy slurry was prepared at ambient temperature by combining water, containing ethanol 
concentrations of 0, 0.1,1.0, or 10%, and 80.0 g defatted soy flakes (15:1 ratio) and stirring 
as rapidly as possible with a magnetic stir bar. Slurry was adjusted to pH 8.5 using 2N 
NaOH, maintained at that pH, and stirred for 1 h. Insolubles were removed by screening and 
centrifugation as for the pH study. Sodium bisulfite was added to the supernatant to produce 
a 10 mM SO2 concentration, and the pH was adjusted to 6.4 using 2N HC1. The protein 
dispersion was chilled overnight at 4 °C. The glycinin-rich precipitate was recovered by 
centrifugation at 7500 x g for 20 min at 4 °C. The supernatant was adjusted to 0.25 M NaCl 
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Figure 1. Soy protein fractionation process. 
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and pH 5.0, stirred for 1 h, and then centrifuged at 14300 x g for 30 min at 4 °C to recover 
the intermediate protein fraction, which contained glycinin, P-conglycinin, and other 
proteins. Water was added 2:1 to the resulting supernatant and the pH was adjusted to 4.8. 
The P-conglycinin-rich precipitate was removed from the whey fraction by centrifugation at 
7500 x g for 20 min at 4 °C. The insoluble fraction and fractionated proteins were weighed, 
and then freeze dried. Freeze-dried weight was regarded as the dry weight and used in 
calculating solids content. 
Effect of Water-to-Flake Ratio on Bench-Scale Protein Extraction and 
Fractionation. Soy slurry was prepared at ambient temperature by combining water with 
80.0 g of defatted soy white flakes at 6:1, 8:1,10:1, or 15:1 ratio and stirring as rapidly as 
possible with a magnetic stir bar. Slurry was adjusted to pH 8.5 using 2N NaOH, maintained 
at that pH, and stirred for 1 h. The storage proteins were then fractionated as described 
above. The insoluble fraction, whey, and fractionated proteins were weighed, and then 
freeze dried. 
Effect of Temperature on Bench-Scale Protein Extraction and Fractionation. Soy 
slurry was prepared by combining 80.0 g of defatted white flakes at 10:1 water-to-flake ratio, 
stirring as rapidly as possible with a magnetic stir bar, and heating to 25, 35,45, 55, or 65 °C. 
Slurry was adjusted to pH 8.5, maintained at that pH, and stirred for 1 h. The storage 
proteins were then fractionated as described above. The insoluble fraction, whey, and 
fractionated proteins were weighed, and then freeze dried. 
Pilot-Scale Protein Fractionation. Extraction conditions for the defatted soy white 
flakes (20.0 kg) were 15:1 water-to-flake ratio at 20 °C, used by Wu et al. (10) for previous 
pilot-scale fractionation, or 10:1 water-to-flake ratio at 45 °C (optimized conditions). Flakes 
and temperature-adjusted tap water were combined by stirring at 22 rpm in a jacketed 800-L 
tank (Walker Stainless Equipment Company, New Lisbon, WI), adjusted to pH 8.5 with 2 N 
NaOH, maintained at that pH, and stirred at 13 rpm for 1 h. Slurry was fed to an Alfa Laval 
BTPX disc stack centrifuge (Alfa Laval Separation Inc., Warminster, PA) at 9800 rpm bowl 
speed (approximately 12,000 x g) at a feed rate of ~2 L/min with a Moyno transfer pump 
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(Electric Pump, Model IFFCA SSE SAA, Des Moines, IA) at 300 rpm. The insoluble 
fraction was sampled and then discarded. 
The protein extract was treated with NaHSOs to provide 10 mM SO2, adjusted to pH 6.4 
with 2N HC1, and cooled overnight at ~7 °C. Glycinin-rich precipitate was recovered using 
the Alfa Laval centrifuge at 9800 rpm bowl speed and 420 rpm transfer pump speed (~4 
L/min). The resulting supernatant was adjusted to 0.25 M NaCl and pH 5.0, stirred at 13 rpm 
for 1 h, and then centrifuged at 9800 rpm bowl speed with a 420 rpm transfer pump speed. 
The resulting intermediate fraction precipitate was comprised of a mixture of glycinin, (3-
conglycinin, and other proteins. The supernatant was diluted 2:1 with water, adjusted to pH 
4.8, and chilled overnight at ~7 °C. The P-conglycinin-rich precipitate was removed by 
centrifugation at 9800 rpm bowl speed with a 420 rpm transfer pump speed. The whey 
fraction was sampled and discarded. Recovered protein fractions were adjusted to pH 7.5 
with 2N NaOH and then desalted with a Feed and Bleed Membrane Filtration System (Model 
SRT-50; North Carolina SRT Inc., Cary, NC) and a 30-KD regenerated cellulose membrane 
(North Carolina SRT Inc.). Diafiltration was continued until permeate equaling 5X the 
original volume of protein dispersion was collected. The protein retentate was dried in an 
Anhydro Compact Spray-Dryer (APV Crepaco Inc., Attleboro Falls, MA) with an air inlet 
temperature of 160 °C and air outlet temperature of 85 °C. Samples of in-process 
supematants, the whey, the insoluble fraction, and protein products after neutralization and 
after diafiltration were collected and freeze dried. 
Deviations from the pilot-scale process described by Wu et al. (10) were as follow. Wu's 
protein extract was separated from the insoluble fraction using a two-pass system through a 
Sharpies P660 decanting centrifuge (Alfa Laval Separation Inc., Warminster, PA) instead of 
a single pass through the Alfa Laval BTPX 204 disc stack centrifuge. Wu chilled overnight 
at 4 °C, while we chilled at ~7 °C. 
Soy Protein Isolate Production. Flakes were extracted (Figure 2) with a 10:1 water-to-
flake ratio at 60 °C. Flakes and temperature-adjusted water were combined with mixing as 
above and adjusted to pH 8.5 with 2 N NaOH. The slurry was stirred for 30 min at 13 rpm, 
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Figure 2. Soy protein isolate process. 
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and then the insolubles were removed by centrifugation as above. The supernatant was 
adjusted to pH 4.5 using 2N HC1 and then chilled overnight at ~7 °C. The soy protein isolate 
was recovered by centrifugation, adjusted to pH 6.8, and then spray dried. Samples of in-
process supernatant, the insoluble fraction, the whey, and neutralized soy isolate samples 
were collected and freeze-dried. 
Proximate Analysis. Nitrogen contents of bench-scale samples were determined by 
micro-Kjeldahl (23), whereas nitrogen contents from pilot-scale samples were determined 
using the combustion or Dumas method (24) with a Rapid NIII analyzer (Elementar 
Americas, Inc., Mt Laurel, NJ). Dumas method values were converted to Kjeldahl nitrogen 
values using a conversion formula (25). A correction factor of 6.25 was used to convert from 
percent nitrogen to protein content. Moisture and ash were determined (26, 27). 
Urea-SDS-PAGE. Sodium dodecylsulfate-polyacrylamide gel electrophoresis was 
performed using the method described by Wu et al. (10). Sample containing 25-mg of 
protein was dissolved in 10 mL of protein extraction buffer (50 mM THAM, pH 8.0, 5.0 M 
urea, 0.2% SDS, and 2% 2-mercaptoethanol). This protein solution was diluted 1:1 with 2x 
sample buffer (125 mM THAM, pH 6.8, 5.0 M urea, 0.2% SDS, 20% glycerol, and 0.01% 
bromophenol blue). Protein was loaded at 45 pg per well. An 8-18% polyacrylamide 
gradient was used. Electrophoresis was performed at 130 V for 6 h. Gels were stained with 
a methanol/acetic acid/water (50:10:40) solution containing 0.22% Coomassie Blue and then 
destained in the same solution without the Coomassie Blue. Densitometry was determined 
using Kodak ID Image Analysis version 3.5 (Kodak, Rochester, NY) on scanned images 
produced by a Biotech Image Scanner (Amersham Pharmacia, Piscataway, NJ). 
SDS-PAGE results were calculated as follows. Densitometry values for lipoxygenase, 
(3-conglycinin subunit, and glycinin subunit bands were summed. This sum was then used as 
the denominator for a corresponding numerator comprised of a sum of subunit bands for a 
given protein. When multiplied by 100, this provided percentage composition for that 
protein with respect to the protein bands measured by densitometry analysis. 
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Surface hydrophobicity. Surface hydrophobicity was measured by a modification of 
that used by Wu et al. (10), using 1 -anilino-8-naphthalene sulfonic acid magnesium salt 
monohydrate (ANS, ICN Biomedicals, Inc., Aurora, OH). A 1% (w/w) dry-basis sample 
dispersion was prepared in de-ioinized water and the pH was adjusted to 7 using 2N HC1 or 
NaOH. The dispersions were stirred for 1 h, with pH adjusted at 15, 30, and 60 min. 
Undissolved material was removed by centrifugation at 10000 x g for 10 min at 20 °C. The 
protein content of the supernatant was determined by using the biuret method (22) with 
bovine serum albumen as the standard. Soluble protein was diluted with 0.1 M phosphate 
buffer (pH 7.0) to obtain concentrations ranging from 6.25 to 1000 pg/mL. ANS (40 pL, 
8.0mM in 0.01 M phosphate buffer) was dispersed in 3-mL aliquots of each dilution. 
Fluorescence intensity units (FIU) were measured with a Turner Quantech® 
spectrophotometer (Barnstead Thermolyne, Dubuque, IA) using 440 nm (excitation) and 535 
nm (emission) filters. FIU were standardized using a solution of 40 |j.L ANS in 3 mL 
phosphate buffer as the zero point and 15 JJ.L ANS in 3 mL of methanol assigned a value of 
80 FIU. The FIU were plotted versus percent protein concentration. The slope of the 
regression line was considered as the surface hydrophobicity. Samples were run in triplicate. 
The conditions and parameters used by Wu et al. (10) that were different from those 
stated above were as follow. Protein was serially diluted in the range of 1-100 pg/mL. 
Excitation and emission wavelengths were 350 and 525 nm, respectively. A 100 |iL aliquot 
of ANS was added to 5 mL of diluted dispersion. 
Differential Scanning Calorimetry. Samples (15-20 mg) of 10% (w/w) dry basis 
protein dispersion were hermetically sealed in aluminum pans. A sealed, empty pan was 
used as reference. The samples were analyzed at 10 °C/min in a range of25-120 °C using an 
SU Exstar 6000 (Seiko Instrument, Inc., Japan). All samples were repeated at least four 
times. 
Isoflavone and Group B Saponin Extraction and Analysis. Extractions and HPLC 
analyses were conducted as reported by Hu et al. (18) for saponins and Murphy et al. (13) for 
isoflavones, with a few modifications. About 2.5 g of freeze-dried slurry, insoluble fraction, 
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or isolate, or 4.0 g freeze-dried whey fraction was accurately weighed into 125-mL screw-
capped Erlenmeyer flasks, and 14 mL of water and 20 mL of acetonitrile were added to the 
flasks. For pilot-scale samples, this mixture was neutralized to pH 7.0 with 2N HC1 or 2N 
NaOH prior to extraction, but bench-scale samples were not neutralized prior to extraction. 
Flasks were shaken at 300 rpm for 2 hat room temperature. 
This extraction method differed as follows from the methods described by Murphy et al. 
(13) and Hu et al. (18). For optimal isoflavone extraction from a particular food matrix, 
Murphy et al. (13) used 10 mL of acetonitrile, 2 mL of 0.1 N HC1, and water as needed 
(approximately 7 mL). Hu et al. (18) used 100 mL of 70% ethanol and 2.5 h of extraction 
time for saponin extraction. The modified method did not give significantly different 
(P<0.05) phytochemical concentrations compared to the referenced methods when ground, 
defatted soy flakes were analyzed. 
The sample was filtered, and the extract was rotary evaporated to dryness at < 30 °C. 
The residue was dissolved in 80% methanol to a volume of 10.0 mL. Sample for isoflavone 
and saponin quantification was filtered through a 0.45-gm polytetrafluoroethylene filter 
(Alltech Associates Inc., Deerfield, IL) prior to HPLC analysis. Quantifications of the 
isoflavones and group B saponins were performed on different HPLC systems, but using the 
same type of column, an RP-18, 5 pm, 4.6 i.d. x 250 mm YMC-ODS-AM-303 column 
(YMC, Inc., Wilmington, NC). 
Saponins were separated using a gradient system consisting of 0.05% trichloroacetic acid 
in water (A) and acetonitrile (B). The programmed gradient did not differ substantially from 
that used by Hu et al. (18). Solvent B was increased from 37 to 40% in 12 min, and then B 
was further increased to 48% over 25 min. Finally, B was increased to 100% in 1 min, held 
at 100% for 2 min, then returned to 37% over 5 min. The flow rate was maintained at 1 
mL/min throughout. The UV absorbance was monitored from 190 to 350 nm. Peak areas at 
205 nm (saponins V, I, and II) and 292 nm (saponins ag, Pg, and Pa) were used for analysis. 
For quality control purposes, an isoflavone standard solution (genistin, genistein, and 
daidzein) and a saponin standard solution (saponin I) were injected on the respective systems 
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prior to analyzing samples. Preparation of saponin and isoflavone standards and calibration 
curves are described elsewhere (13, 18). Isoflavone recovery from ground soy flake and 
freeze-dried soy protein isolate material were evaluated using a concentrated isoflavone 
extract produced from soy flakes and containing 7.5 pmol/mL isoflavones in 80% methanol. 
Saponin recovery from these matrices employed a mixture of saponin I and II at 
concentrations of 4.8 and 3.9 pmol/mL, respectively, in 80% methanol. Samples were 
spiked, mixed thoroughly, and then allowed to air dry overnight. Extraction and analysis 
were performed as above. 
Statistical Analysis. Least square means, least significant differences, and ANOVA 
results were calculated using the SAS system (version 6, SAS Institute Inc., Cary, NC). 
Results and Discussion 
Primary objectives were to improve pilot-scale protein solubilization from the defatted 
soy flake starting material without decreasing mass and protein recovery in the glycinin and 
P-conglycinin fractions or substantially decreasing purity of these fractions and to enhance 
isoflavone and saponin recovery from the starting material to potentially increase their 
recovery in product fractions. Because of the substantial cost involved with pilot-scale 
fractionation, process improvements were first investigated at bench scale. Protein and 
phytochemical solubilization parameters evaluated were pH, ethanol concentration in the 
solubilization medium, water-to-flake ratio, and temperature. Optimized process conditions 
were then evaluated at pilot-scale. 
Bench Scale - Effect of pH. The effect of pH on protein solubilization is shown in 
Table 1. Protein in the extract increased from pH 7.5 to 9.0, although protein content was not 
significantly different between pH 8.5 and 9.0. Solubility profiles of fractionated glycinin 
and p-conglycinin have revealed that the solubilities of these two fractions are very similar 
from pH 8.0 to 10.0 (28). However, below pH 8.0, glycinin solubility began to decrease, 
diminishing steeply below pH 7.0. Decline in p-conglycinin solubility lagged by about 1 pH 
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Table 1. Effect of pH on Bench-Scale Protein Extraction from Defatted Soy 
White Flakes0 
PH Protein (g)6,c 
7.5 27.4C 
8.0 29.8k 
8.5 32.0d, 
9.0 33.3. 
LSD" 3.1 
"80.0 g flakes at 6.6% moisture. 
^Subscript, lowercase letters indicate significant differences at PO.OS. 
cn=2. 
^LSD, least significant difference. 
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unit. It is possible that at pH 7.5, solubilization of glycinin was more limited, accounting for 
the lower protein recovery at pH 7.5 observed here. Increasing solubilization pH above 9.0 
increases the risk of lysinoalanine formation, although lysinoalanine formation is more 
extensive as temperatures are increased (29). Lysinoalanine has been shown to induce 
changes in kidney cells of rats, but based on non-human primate data low doses are probably 
safe for humans (30). Additionally, isoflavones ionize above pH 9.0 (31, 32), possibly 
altering their hydrophobicity, polarity, and partitioning from the soy matrix. Consequently, 
we decided to retain the solubilization pH of 8.5 used by Wu et al. (10). 
Bench Scale - Effect of Ethanol. Improved solubilization of isoflavones and saponins 
from the starting material was desired, with the hypothesis that higher concentrations of these 
phytochemicals in the extract would translate into higher concentrations in the protein 
product fractions. Solvents, such as acetonitrile, ethanol, and methanol, have been used to 
extract soy phytochemicals from food and soy samples. The hypothesis was that if a small 
amount of solvent was included in the solubilization medium the phytochemical content of 
the protein extract might be improved. Although ethanol is not as efficient as acetonitrile in 
extracting isoflavones (33), it was a logical solvent choice for this potential food application. 
The isoflavone and saponin concentrations in the defatted soy flakes were 8.68 and 6.51 
jimol/g, respectively. Table 2 shows that increasing ethanol concentration in the 
solubilization medium from 0 to 10.0% significantly decreased dry-basis isoflavone 
concentration in the insoluble fraction, a process waste stream, from 4.53 to 4.08 pxnol/g. 
Dry-basis saponin concentration did not change significantly, ranging from 6.19 to 6.36 
p.mol/g. These small differences in phytochemical concentrations in the insoluble fractions 
among treatments indicated that increased ethanol concentration in the solubilization medium 
had little impact on improving phytochemical recovery from the starting material. This 
limited effect on extraction was not surprising, because 70% ethanol and 59% acetonitrile 
solutions (18,13) are commonly used for soy saponin and isoflavone extraction, respectively. 
These phytochemicals are poorly soluble or insoluble in water. Their transfer into the extract 
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Table 2. Ethanol Effect on Phytochemical Mass and Concentration in Insoluble 
Fractions Produced during Bench-Scale Soy Protein Fractionation" 
Ethanol in Isoflavone Saponin 
extraction concentration6 Total isoflavones concentration Total saponins 
solution (nmol/g, db") (Mmol, db) (nmol/g, db) (nmol, db) 
None" 4.53. 135 6.28 187 
0.1% 4.49a 135 6.27 188 
1.0% 4.42b 131 6.19 184 
10.0% 4.08, 138 6.36 215 
LSD'' 0.11 Not Different Not Different Not Different 
"80.0 g defatted soy white flakes, 6.6% moisture. 
^Subscript, lowercase letters within a column indicate significant difference at P<0.05. 
'db, dry basis. 
dn=2. 
"LSD, least significant difference. 
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fraction from the starting material was likely either from a mass action effect or due to then-
associations with solubilized proteins. 
While there apparently was a modest improvement in solubilizing isoflavones as ethanol 
concentration of the extraction medium increased, increasing the ethanol concentration had a 
detrimental effect on the weight of the insoluble fraction and on the fractionation process 
(Table 3). The dry-basis weight of the insoluble fraction increased significantly from 29.77 
to 33.81 g as the ethanol concentration of the medium was increased to 10%, indicating 
reduced solubilization of some soluble soy components. The glycinin fraction weight 
increased with increasing ethanol concentration, but not significantly, while the intermediate 
fraction weight did increase significantly between 1 and 10% ethanol. These increases 
apparently occurred at the expense of the p-conglycinin fraction. It is possible that P-
conglycinin was more readily denatured than glycinin, causing the differences in solubilizing 
and partitioning. However, SDS-PAGE analysis of the extract did not provide supporting 
evidence for the hypothesis that p-conglycinin was solubilized less efficiently by the 10% 
ethanol solution. Lipoxygenase, P-conglycinin, and glycinin distributions in the extract 
showed no obvious trends and were not significantly different, ranging from 6.8 to 8.0%, 
37.9 to 40.3%, and 52.1 to 54.9%, respectively. Based on minimally improved isoflavone 
recovery at the expense of protein solubilization and fractionation, ethanol in the 
solubilization medium was rejected as a means of process improvement. 
Bench Scale - Effect of Water-to-Flake Ratio. The amount of water used in the 
solubilization of protein and phytochemicals from defatted soy flakes is important for 
maximizing solubility. However, the volume of water used is also very important from a 
processing standpoint. The more water used, the more time required for each centrifuge 
pass. Wu et al. (10) used water-to-flake ratios of 15:1 and 20:1. Lehnhardt et al. (9) 
disclosed in their patent that a 10:1 water-to-flake ratio was optimal for glycinin and p-
conglycinin recovery. With the flake material used here, a 6:1 ratio was the lowest that could 
be employed and still maintain the ability to effectively stir the suspension. Consequently, 
water-to-flake ratios of 6:1, 8:1,10:1, and 15:1 were selected for evaluation. 
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Table 3. Ethanol Effect on Product Recovery during Bench-Scale Fractionation 
of Soy Storage Proteins" 
Ethanol in 
extraction solution 
Insoluble* 
(g, dry basis) 
Glycinin 
(g, dry basis) 
Intermediate 
(g, dry basis) 
p-Conglycinin 
(g, dry basis) 
None" 29.77b 7.89 7.22b 6.91. 
0.1% 30.03b 8.00 7.12b 6.92. 
1.0% 29.75b 8.51 7.44b 6.81. 
10.0% 33.81. 9.04 8.92. 2.01b 
LSD" 2.76 Not Different 1.12 1.02 
"Starting material was 80.0 g ("as is" basis, 6.6% moisture) defatted soy white flakes. 
^Subscript, lowercase letters within a column indicate significant difference at P<0.05. 
cn=2. 
rfLSD, least significant difference. 
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The effect of water-to-flake ratio on process fraction weights, protein concentration, and 
total protein for each product or waste stream fraction is shown in Table 4. The dry basis 
weight of the insoluble fraction decreased significantly from 41.28 to 30.99 g for the 6:1 to 
15:1 water-to-flake ratios, respectively. Higher water-to-flake ratios were clearly more 
efficient at extracting solubles from the starting materials. The glycinin and intermediate 
fraction weights increased significantly as water-to-flake ratio increased from 6:1 to 15:1, but 
differences between 10:1 and 15:1 water-to-flake ratios were not significant. There was no 
significant difference among p-conglycinin fraction weights. When the three product 
fraction weights were summed for each ratio, combined weights ranged from 17.73 to 21.84 
g for 6:1 and 15:1, respectively. This represents only about a 4 g difference, compared to 
about a 10 g difference observed between the insoluble fractions for the 6:1 and 15:1 
treatments. This demonstrates that while there is improved extraction of solubles from the 
starting material at higher water-to-flake ratios, less than 50% of that material is being 
recovered in the protein product fractions. The weight of the whey fraction, a process waste 
stream, increased significantly across treatments. This increase was due to two factors: the 
increased quantity of solubles liberated from the starting material but not recovered in the 
product fractions; and the increased addition ofNaHSOg and NaCl to maintain the proper 
concentrations during fractionation. Total fraction weights also reflected this increased salt 
addition. 
The protein content of the insoluble fraction decreased significantly as water-to-flake 
ratio increased, indicating increased extraction efficiency at higher water-to-flake ratios. 
The protein contents of the glycinin and intermediate fractions increased significantly as 
water-to-flake ratio was increased, possibly due to a higher proportion of the salts staying in 
solution during these protein precipitation steps. The protein content of the whey fraction 
decreased significantly as water-to-flake ratio increased, reflecting the increase in salt 
concentration of the fractions. 
When the total protein from all process fractions was summed for each treatment, there 
was no significant difference among treatments. This indicates an excellent accounting of 
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Table 4. Water-to-Flake Extraction Ratio Effect on Fraction Weight and Protein 
Recovery during Bench-Scale Fractionation of Soy Storage Proteins" 
Insoluble Glycinin | Intermediate | P-Conglycinin Whey Total 
Process Fraction Weights (g, dry basis)" 
6:lc 41.28, 5.45b 5.47b 6.81 15.04d 74.05c 
8:1 38.18. 7.06. 5.85b 7.12 21.09c 79.29b 
10:1 33.76b 7.87. 7.00, 6.61 25.24b 80.48b 
15:1 30.9% 7.97. 7.35. 6.52 32.37. 85.21, 
LSD" 3.19 1.22 0.76 Not different 1.82 4.39 
Protein Concentration (%) 
6:1 44.4. 92.9c 69.6c 95.7 22.1, 
8:1 41.6b 96.9b 73.0b 96.2 20.8b 
10:1 40.1c 99.2* 78.3, 96.2 18.3c 
15:1 40.2, 100.3, 80.8, 97.1 15.9d 
LSD 0.8 2.4 2.8 Not different 1.8 
Total Protein (g, dry basis) 
6:1 18.3. 5.06c 3.79b 6.51 3.33c 37.1 
8:1 15.9b 6.84b 4.27b 6.85 4.38b 38.2 
10:1 13.6, 7.80,b 5.48, 6.36 4.62b 37.8 
15:1 12.5, 7.99. 5.94, 6.34 5.15, 37.9 
LSD 1.4 1.08 0.68 Not different 0.40 Not different 
"Starting material was 80.0 g ("as is" basis, 6.6% moisture) defatted soy white flakes. 
"Subscript, lowercase letters indicate significant differences at P<0.05. 
en=2. 
''LSD, least significant difference. 
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protein mass balance. Total protein for the glycinin and intermediate fractions increased as 
water-to-flake ratio increased, but differences were not significant between 10:1 and 15:1 
ratios. Total proteins for the P-conglycinin fractions were not significantly different. 
Another criterion for process improvement was maintenance or improvement of fraction 
purity. SDS-PAGE data regarding fraction purity is shown in Table 5. There were no 
significant differences across treatments for glycinin fraction purity. However, purity of the 
(3-conglycinin fraction increased from 59.4 to 66.1% as water-to-flake ratio increased, with 
differences being insignificant between the 10:1 and 15:1 ratios. 
Improved extraction of phytochemicals from the starting material with increased 
deposition in the product fractions was desired. Table 6 shows the effects of water-to-flake 
ratio on isoflavone extraction and partitioning. The dry-basis isoflavone concentration of the 
insoluble, glycinin, intermediate, and p-conglycinin fractions decreased with increasing 
water-to-flake ratio. Differences in isoflavone concentration in the whey fraction were not 
significant, but total isoflavones in the whey fraction increased as water-to-flake ratio 
increased. Recall that the dry weight of the whey fraction increased with increasing water-
to-flake ratio. These data indicated that improved isoflavone extraction from the starting 
material did not translate into increased isoflavone concentration in the product fractions, 
rather an increase in isoflavones in the whey. Shen and Bryan (34) also describe concerns 
about the ability of isoflavones to be lost from protein fractions through supernatant or wash 
fractions. Their patent discloses a method to enzymatically convert glucoside isoflavones in 
protein extract to aglucons prior to isoelectric precipitation of the protein. They indicate that 
the precipitated protein should not be washed or that washing should be quite limited to 
avoid loss of the aglucons from the protein. 
Isoflavones were preferentially partitioned among the product fractions, with distribution 
being about 3.2:2.4:1 on a jjmol/g basis for the intermediate, glycinin, and P-conglycinin 
precipitate fractions, respectively. Wu et al. (10) indicated that most of the glycinin and 
P-conglycinin proteins comprising the intermediate fraction were no longer in native state. 
One hypothesis is that as native state of the proteins is lost and protein unfolding is increased, 
Table 5. Water-to-Flake Extraction Ratio Effeci s on Protein Distribution during Bench-Scale Soy Protein Fractionation 
Water-to-
flake ratio G ycinin Fraction" Intermediate Fraction P-Conglycinin Fraction 
LOX " (%) p-Con (%) Gly (%) LOX (%) P-Con (%) Gly (%) LOX (%) p-Con (%) Gly (%) 
6:1e nd" 12.9 87.1 23.0^, 40.2 36.8, nd 59.4b 40.6, 
8:1 nd 13.4 86.6 26.2, 36.1 37.7k nd 61.9b 38.1* 
10:1 nd 13.0 87.0 22.6,b 36.2 41.2,b nd 65.7, 34.3k 
15:1 nd 12.4 87.6 19.4b 37.0 43.6, nd 66.1, 33.9, 
LSD' Not different Not different 4.0 Not Different 3.7 3.7 3.7 
Insoluble Fraction Protein Extract from Flakes Whey 
LOX (%) P-Con (%) Gly (%) LOX (%) P-Con (%) Gly (%) LOX (%) P-Con (%) Gly (%) 
6:1 9.4 52.2% 38.4 7.1 36.1 56.8 16.1 37.8 46.1 
8:1 10.0 52.1b 37.9 7.2 35,6 57.2 16.6 34.8 48.6 
10:1 9.9 54.7, 35.4 7.6 36.4 56.0 19.2 33.1 47.7 
15:1 10.0 55.1, 34.9 7.4 36.1 56.5 18.3 33.5 48.2 
LSD Not different 2.1 Not different Not different Not different Not different Not different Not different Not different 
"Subscript, lowercase letters within a column indicate significant differences at f<0.05. 
6Abbreviations: LOX, lipoxygenase; p-Con, P-conglycinin; Gly, glycinin. 
cn=2. 
rfnd, none detected. 
eLSD, least significant difference. 
Table 6. Water-to-Flake Extraction Ratio Effects on Isoflavone Concentrations and Mass in Process Fractions Produced 
Water-
to-flake Insol*" Gly Intermed P-Con Whey Insol Gly Intermed P-Con Whey Total 
ratio (nmol/g) (Htnol/g) (Hmol/g) (Hmol/g) (Hmol/g) (nmol) (nmol) (nmol) (nmol) (nmol) (nmol) 
6:1" 7.02. 10.17, 15.3b 4.79. 4.17 290. 55.4 84, 32.6. 63b 525 
8:1 6.29^ 9.74b 15.8. 3.81b 4.90 240b 68.7 93be 27.1b 103* 532 
10:1 5.49, 9.40, 15.1b 3.27b, 4.81 185, 74.0 105, 21.7b, 121. 507 
15:1 4.63d 8.34d 13.8, 2.85, 4.50 143d 66.4 101,b 18.6, 146. 476 
LSD' 0.39 0.15 0.5 0.61 ND* 30 ND 9 5.4 43 ND 
"Starting material was 80.0 g ("as is" basis, 6.6% moisture) defatted soy white flakes. 
"Abbreviations: Insol, insoluble; Gly, glycinin; Intermed, intermediate; P-Con, p-conglycinin. 
Subscript, lowercase letters within a column indicate significant differences at P<0.05. 
dn=2. 
"LSD, least significant difference. 
^ND, not different. 
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more hydrophobic areas are exposed to interact with the isoflavones. However, this does not 
explain the high isoflavone content of the glycinin fraction compared to the P-conglycinin 
fraction. The low isoflavone recoveries in the P-conglycinin fractions did not seem to be 
associated with depleted quantities of isoflavones, because the whey fractions still retained 
substantial quantities of isoflavones. 
Saponin partitioning into the intermediate fraction relative to the glycinin and P-
conglycinin fractions was even more substantial than for the isoflavones (Table 7). The 
saponins are more hydrophobic than the isoflavones. Consequently, they may have been 
even more attracted to the non-native state proteins in the intermediate fraction than were the 
isoflavones. No saponins were detected in the whey fraction. Concentration differences 
across treatments were significant only for glycinin, ranging from 2.67 pmol/g for the 6:1 
ratio to 1.27 p.mol/g for the 15:1 ratio. Saponin concentrations in the insoluble fractions were 
very uniform across treatments, but the total protein content of the insoluble fraction 
decreased by about one-third as water-to-flake ratio was increased. This may indicate that 
the saponins were intimately associated with another matrix component than protein in the 
insoluble fraction. For all process fractions, there were no significant differences in saponin 
concentrations between the 10:1 and 15:1 ratios. 
Unexpected for the isoflavones and saponins was the incomplete accounting of these 
phytochemicals. The starting material contained 648 fimol of isoflavones and 486 pmol of 
saponins. Mass balance data (Tables 6 and 7) show that total isoflavones ranged from 507 to 
531 |imol, while total saponins ranged from 340 to 406 pmol. These values translate to about 
80 and 70-84% of isoflavones and saponins in the starting material, respectively. Differences 
in soy flake and process fraction matrices were probably responsible for at least a portion of 
this discrepancy. 
A recovery study with ground, defatted soy flakes and freeze-dried soy protein isolate 
revealed considerable recovery differences between these matrices. Recovery of the saponin 
I and II spike was about 99% for the flake material, but only 60-70% for the isolate. 
Isoflavone recoveries were 75-92% for the flake material, with the more hydrophobic 
Table 7. Water-to-Flake Extraction Ratio Effects on Saponin Concentrations and Mass in Process Fractions Produced 
during Bench-Scale Soy Protein Fractionation" 
TvinnlnUl aP /"lli i**i Tntât<MA/4iofa R_PrtnnUf/>i«iM TmoaIiiUIa Tnfatwa/linla O Z-1 1- T/\4-Water-to- Insoluble* Glycinin Intermediate P-Conglycinin Insoluble Glycinin Intermediate P-Conglycinin Total 
flake ratio (nmol/g) (nmol/g) (limol/g) (nmol/g) (fimol) (nmol) ((irnol) (nmol) (nmol) 
6:1' 7.05 2.67. 16.5 1.51 291, 14.5 90 10.2 406, 
8:1 7.16 2.02b 18.2 1.73 273b 14.2 106 12.3 406. 
10:1 7.05 1.62c 15.8 1.97 238, 12.8 110 13.0 374b 
15:1 6.80 1.27, 14.7 1.74 211„ 10.1 108 11.3 340c 
LSD" NDe 0.39 ND ND 15 ND ND ND 12 
"Starting material was 80.0 g ("as is" basis, 6.6% moisture) defatted soy white flakes. 
'Subscript, lowercase letters within a column indicate significant differences at P<0.05. 
cn=2. 
rfLSD, least significant difference. 
"ND, not different. 
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aglucons exhibiting the lowest recoveries. Isoflavone aglucon recovery from the isolate 
material was 65-75%, while recoveries for the p-glucosides and malonylglucosides were 78-
93%. For the recovery study (Chapter 3), neutralizing the phytochemical extraction solution 
increased saponin I and II recoveries from the isolate samples by about 15% for saponin I 
and 25-45% for saponin II. Recovery of the aglucon isoflavones from the isolate increased 
by 10-15% by neutralizing the phytochemical extraction medium. 
Bench-scale process samples in the current study were not neutralized prior to freeze 
drying or phytochemical extraction. Consequently, the pH of the extraction medium used 
during phytochemical analysis was approximately 4.8 for p-conglycinin and 5.0 for the 
intermediate fractions. A glucuronic acid on the saponin aglucon has a pK* of approximately 
4, and this possibly led to ionic bonding of the saponins within the protein matrix of the 
product fractions and poor recovery during phytochemical extraction. 
The 10:1 water-to-flake ratio was selected for use in further process improvement for the 
following reasons. Process fraction weights and total protein for the 10:1 and 15:1 ratios 
were significantly higher than for the 6:1 and 8:1 ratios, or there was no significant 
difference. There was not a significant difference between fraction weights or total protein 
for the 10:1 and 15:1 ratios. The purity of the P-conglycinin fraction was significantly higher 
for the 10:1 and 15:1 ratios, although there was not a significant difference between the two 
ratios. Saponin concentrations in the intermediate and P-conglycinin fractions were not 
significantly different, although the concentrations in the glycinin fraction for the 10:1 and 
15:1 ratios were significantly lower. Unfortunately, isoflavone concentrations generally were 
significantly lower for the 10:1 ratio compared to the 6:1 or 8:1 ratios. However, the 10:1 
ratio was still selected because the differences in phytochemical concentrations, though in 
some cases statistically significant, were small. Phytochemical recovery in product fractions 
was a secondary selection criterion compared to protein recovery and purity. 
Bench Scale - Effect of Temperature. As process temperature was increased to as high 
as 80 °C during the solubilization of soy proteins, protein recovery was increased (12). Wu 
et al. (10) were concerned that by increasing protein solubilization temperature the native 
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state of the soy proteins would be affected and the fractionation process would be less 
efficient. Extraction temperatures of25-65 °C were selected to test this hypothesis. 
Insoluble fraction weight, protein concentration, and total protein decreased significantly 
with increasing temperature, indicating improved protein recovery (Table 8). Intermediate 
fraction weight increased significantly with increased solubilization temperature. The onset 
temperatures for (3-conglycinin and glycinin denaturation are approximately 68 and 82 °C, 
respectively (35). The fraction weight of the P-conglycinin fraction began to decrease 
significantly at 55 °C, but dropped drastically at 65 °C. Denaturation was likely the cause of 
this decline, with the protein being partitioned to the intermediate fraction. The weight of the 
glycinin fraction was also significantly lower at 65 °C. These data support the findings of 
Wu et al. (10) that the intermediate fraction is primarily composed of glycinin and P-
conglycinin proteins that are no longer in native state. The whey fraction weights were not 
significantly different, indicating that denatured protein was not being partitioned into that 
fraction. Protein concentrations of the product fractions were not significantly different 
across treatments, with the exception of glycinin at 65 °C, so total protein mirrored 
observations for fraction weights. On a fraction weight and protein basis, extraction at 45 °C 
provided the best process improvement, offering the best returns for the product fractions. 
The purities of the P-conglycinin fractions were not significantly different from 25 to 45 °C. 
The purity of the glycinin fraction was significantly better at 45 °C compared to 25 and 35 °C 
(Table 9). 
Isoflavone concentration decreased significantly with increased protein solubilization 
temperature for all process fractions, except the whey fraction (Table 10). Saponin 
concentrations behaved similarly to the isoflavones, except there were no saponins in the 
whey fraction and there were no significant differences across treatments for the P~ 
conglycinin fraction (Table 11). This decrease in phytochemical concentrations for all 
fractions was accounted for in the phytochemical totals of the intermediate fraction, into 
which increasingly more protein mass was partitioned. Isoflavone and saponin totals from all 
process fractions, as for the water-to-flake study, were low. 
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Table 8. Extraction Temperature Effects on Fraction Weight and Protein 
Recovery in Process Fractions Produced during Bench-Scale Fractionation of 
Soy Storage Proteins* 
Insoluble" Glycinin Intermediate p-Conglycinin Whey Total 
Process Fraction Weights (g, dry basis) 
25°Cc 32.17a 8.41b, 6.49d 6-7 lab 23.22 76.99 
35 °C 29.22b 9.31. 7.58d 7.39, 26.00 79.49 
45 °C 28.05k 8.96ab 9.53, 7.55. 25.29 79.36 
55 °C 28.62bc 8.26, 12.91b 6.29b 23.64 79.70 
65 °C 27.3 lc 6.02d 22.73, 1.68, 23.09 80.82 
LSD" 1.46 0.60 1.41 1.07 ND' ND 
Protein Concentration (%) 
25 °C 40.3, 98.8a 75.8 94.7 18.2a 
35 °C 37.0b 97.0. 72.7 94.7 18.0a 
45 °C 35.8, 96.8a 73.1 94.2 17.lab 
55 °C 34.7,d 97.5. 74.5 93.6 16.3bc 
65 °C 34.2d 92.9^ 76.8 93.7 15.0c 
LSD 1.2 3.1 ND ND 1.4 
Total Protein (g, dry basis) 
25 °C 13.0. 8.31b 4.91, 6.34ab 4.23ab 37.1 
35 °C 10.8b 9.03. 5.51d 6.99. 4.67. 36.9 
45 °C 10.0, 8.67ab 6.96, 7.10. 4.32ab 37.3 
55 °C 9.9., 8.05b 9.62b 5.88b 3.85b, 37.7 
65 °C 9.4d 5.59« 17.44a 1.57c 3.46, 37.4 
LSD 0.7 0.66 0.57 0.89 0.59 ND 
"Starting material was 80.0 g ("as is" basis, 6.6% moisture) defatted soy white flakes. 
"Subscript, lowercase letters indicate significant differences at PO.OS. 
cn=2. 
dLSD, least significant difference. 
"ND, not different. 
Table 9. Extraction Temperature Effects on Protein Distribution in Process Fractions Produced during Bench-Scale 
Extraction 
temperature Protein Extract" G1 Kcinin Fracti on P-Conglycinin Fraction 
LOX8 (%) P-Con (%) Gly (%) LOX (%) P-Con (%) Gly (%) LOX(%) P-Con (%) Gly (%) 
25 °CC 7.8 44.3 47.9 nd" 17.3 82.7 nd 73.5 26.5 
35 °C 8.2 47.3 44.5 nd 18.3 81.7 nd 74.3 25.7 
45 °C 7.3 44.2 48.5 nd 14.3 85.7 nd 73.0 27.0 
LSD" Not different Not different Not different 2.2 2.2 Not different Not different 
"Subscript, lowercase letters within a column indicate significant differences at f<0.05. 
'Abbreviations: LOX, lipoxygenase; P-Con, P-conglycinin; Gly, glycinin. 
cn=2. 
dnd, none detected. 
"LSD, least significant difference. 
Table 10. Extraction Temperature Effects on Isoflavone Concentrations and Mass in Process Fractions Produced during 
Bench-Sea e Soy Protein Frac donation" 
Extraction 
temperature 
Insol*' 
(|xmol/g) 
Gly 
(nmol/g) 
Intermed 
(nmol/g) 
P-Con 
(nmol/g) 
Whey 
(nmol/g) 
Insol 
(nmol) 
Gly 
(nmol) 
Intermed 
(nmol) 
P-Con 
(nmol) 
Whey 
(nmol) 
Total 
(nmol) 
25 °C 5.33. 9.48. 15.1a 3.04. 5.08 171. 79.6* 98, 20.5 118 487 
35 °C 5.26ab 9.10. 14.5ab 3.16. 5.44 153b 84.7. 109d 23.4 141 513 
45 °C 5.04cd 8.44b 13.9b 2.65ab 5.12 14 lcd 75.7b, 132, 20.0 129 498 
55 °C 5.07^ 8.35b 12.3, 2.31b 5.47 145bc 68.9, 159b 14.5 130 517 
65 °C 4.85d 7.86, 10.4d IS' 5.12 132d 47.3d 237. IS 118 535 
Lsrx 0.20 0.47 0.7 0.55 ND8 10 7.2 10 ND ND ND 
"Starting material was 80.0 g ("as is" basis, 6.6% moisture) defatted soy white flakes. 
'Abbreviations: Insol, Insoluble; Gly, Glycinin, Intermed, Intermediate; P-Con, P-Conglycinin. 
"Subscript, lowercase letters within a column indicate significant differences at f<0.05. 
dn=2. 
eIS, insufficient sample. 
^LSD, least significant difference. 
gND, not different. 
Table 11. Extraction Temperature Effect on Saponin Concentrations and Mass in Process Fractions Produced during 
Extraction 
temperature 
Insoluble" 
(nmol/g) 
Glycinin 
(nmol/g) 
Intermediate 
(nmol/g) 
B-Conglycinin 
(nmol/g) 
Insoluble 
(nmol) 
Glycinin 
(nmol) 
Intermediate 
(nmol) 
(3-Conglycinin 
(nmol) 
Total 
(nmol) 
25 °CC 6.51. 1.74a 18.6» 1.78 209, 14.60b 121c 11.9* 357 
35 °C 6.30. 1.83a 18.0» 1.84 184b 17.05, 136c 13.6» 351 
45 °C 6.05a 1.09c 17.0b 1.90 170bc 9.76, 162b 14.3. 356 
55 °C 5.55b 0.80d 13.9, 1.44 159, 6.61d 179b 9.0b 353 
65 °C 4.70, 1.44b 9.0d IS" 128d 8.68c 204. IS 341 
LSD" 0.48 0.28 0.8 ND/ 16 2.07 22 3.1 ND 
"Starting material was 80.0 g ("as is" basis, 6.6% moisture) defatted soy white flakes. 
'Subscript, lowercase letters within a column indicate significant differences at P<0.05. 
cn=2. 
rfIS, insufficient sample. 
"LSD, least significant difference. 
•'ND, not different. 
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Based on fraction and protein weights, as well as fraction purity, a protein solubilization 
temperature of 45 °C was selected for process improvement. Phytochemical concentrations 
tended to be lower for this treatment compared to the 25 and 35 °C treatments; however, 
differences were not substantial, and in some cases not significant. 
Pilot Scale - Wu Modified-Nagano Method vs. Optimized Fractionation Process. 
Because bench-scale results may change as a result of scale up, the process of Wu et al. (10) 
(with a major modification) and an optimized process based on the bench-scale process 
improvement were compared at the pilot scale. The Wu modified-Nagano process, which 
will be referred to as the Wu process from here onward, used a 20 °C protein solubilization 
temperature and 15:1 water-to-flake ratio, while the optimized process used 45 °C and a 10:1 
ratio. The major modification of the process as described by Wu et al. (10) was required due 
to equipment performance. Wu utilized a two-pass system through a Sharpies P660 
decanting centrifuge, but due to poor dewatering, this centrifuge was not used. A one-pass 
system employing an Alfa Laval BTPX 205 disc centrifuge was substituted and worked 
satisfactorily, producing a much drier insoluble fraction. Time savings were also realized 
using a one-pass system. However, a 10:1 water-to-flake ratio was the lowest ratio that could 
be used without plugging the centrifuge. 
Soy protein isolate was also produced at the pilot scale so that protein fraction weight, 
protein yield, and phytochemical recovery could be evaluated against the fractionation 
processes. The protein solubilization temperature and water-to-flake ratio employed for soy 
isolate production were 60 °C and 10:1, respectively. 
The wet weights of the Wu-method extract and supernatant fractions were significantly 
larger than the optimized method because the water-to-flake ratio was larger (Table 12). 
This difference also directly affected the ash content of the 2nd supernatant and whey 
fractions. Sodium chloride addition to alter the ionic strength of the 1st supernatant and 
precipitate the intermediate fraction was based on volume of the 1st supernatant. 
Consequently, the ash content of the 2nd supernatant and whey fractions were significantly 
higher. Diafiltration was used to reduce the ash concentration in product fractions to 
Table 12. Mass Balance Com] parisons for Pilot-Scale Frac donation Processes 
Fraction Method 
Wet Weight 
(kg)" 
Weight 
(kg, db)' 
Ash 
(%, db) 
Total Ash 
(kg, db) 
Protein 
(%, db) 
Total Protein 
(kg, db) 
Isoflavones 
(Hmol/g, db) 
Isoflavones 
(mmol, db) 
Saponins 
(Hmol/g, db) 
Saponins 
(mmol, db) 
Flakes 
Wu 20.00 18.06 6.6 1.19 59.1* 10.67 6.15 111.1 5.26 95.0 
Opt. 20.00 18.02 6.8 1.23 61.6 11.10 5.90 106.3 5.16 93.0 
Insoluble 
Wu 100.25 7.90 6.4 0.50 49.9 3.95 3.89 30.8 5.98 47.5 
Opt. 85.71 7.38 6.4 0.48 48.0 3.55 4.11 30.3 7.26 53.6 
Extract 
Wu 281.35** 10.04* 9.0 0.90 66.1 6.63 4.84** 48.6** 3.01 30.2 
Opt. 194.80 10.68 9.0 0.96 67.1 7.17 5.93 63.3 3.31 35.4 
GLY Pc 
Wu 19.05 2.55 3.6 0.09 98.5 2.52 6.25 15.9 1.17* 3.0* 
Opt. 13.23 J 2.34 3.0 0.07 99.8 2.34 6.37 14.9 0.57 1.3 
GLY DIA 
Wu 56.80 2.34 1.9 0.04 104.1 2.44 2.28 5.3 1.01* 2.3* 
Opt. 48.15 2.13 1.6 0.03 104.3 2.22 1.80 3.9 0.35 0.7 
GLY SD 
Wu 2.37 2.25 1.9 0.04 104.2 2.35 2.30 5.2 0.70 1.6 
Opt. 2.15 2.04 1.7 0.03 105.6 2.16 1.83 3.8 0.36 0.8 
1st 
Supernatant 
Wu 294.10** 7.65** 13.9 1.06 52.1** 3.98** 6.86 52.4 3.46 26.5 
Opt. 208.73 8.41 12.6 1.06 55.8 4.69 6.40 53.8 3.44 28.8 
INT P 
Wu 15.23 1.64 13.9 0.23 75.9 1.24 8.33 13.6 14.74 24.0 
Opt. 19.55 1.64 13.7 0.22 78.3 1.29 8.57 14.0 11.09 18.0 
INT DIA 
Wu 36.58 1.27 2.7 0.03 91.6* 1.16 3.28 4.1 16.38 20.6** 
Opt. 46.93 1.25 2.5 0.03 94.4 1.18 2.33 2.9 13.17 16.0 
INT SD 
Wu 1.27 1.21 2.6 0.03 91.5 1.11 3.09 3.7 14.09 17.0** 
Opt. 1.30 1.23 2.5 0.03 95.5 1.18 2.28 2.8 11.35 13.5 
2nd 
Supernatant 
Wu 311.45** 10.18 50.4** 5.14** 26.2* 2.67 2.19 22.3 0.12 1.2 
Opt. 220.73 9.81 40.1 3.93 33.8 3.31 2.29 22.4 0.15 1.4 
BCON P 
Wu 21.53 1.40 9.2 0.13 89.7 1.25 1.96* 2.8* 1.50 2.3 
Opt. 24.00 2.45 7.1 0.17 91.3 2.24 3.33 8.2 5.22 13.2 
BCON 
DIA 
Wu 39.51 1.16* 2.7 0.03** 100.0* 1.16* 0.30* 0.3* 1.16** 1.4* 
Opt. 48.25 2.18 2.6 0.06 98.2 2.14 0.70 1.5 4.57 10.2 
BCON SD 
Wu 1.37* 1.29* 2.6 0.03** 99.4 1.28* 0.31* 0.4* 1.13** 1.5* 
Opt. 2.21 2.10 2.6 0.05 98.9 2.07 0.67 1.4 3.66 7.8 
Whey 
Wu 932.25** 8.77* 59.4** 5.21** 13.7 1.20* 3.42 30.1 0.24 2.1 
Opt. 673.25 7.23 53.4 3.86 14.2 1.02 4.09 29.6 0.32 2.3 
"A single asterisk indicates significance at P<0.10, two indicate significance at P<0.05. n=2. 
*db, dry basis. 
cAbbreviations: GLY, glycinin; INT, intermediate; BCON, |3-conglycinin; P, precipitate; DIA, after dialysis; SD, spray dried; Opt., optimized. 
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minimize the effect of salts during functionality testing. Dry-basis ash concentration prior to 
and after diafiltration ranged from 3.0 to 13.9% and 1.6 to 2.7%, respectively. Diafiltration 
of the protein products caused about a 4-7% loss of protein, and phytochemical losses from 
these fractions were substantial as well. Estimating by difference, 70-90% of the isoflavones 
were lost to the permeate, but only 15-45% of the saponins were lost. This indicates that the 
saponins may be more intimately associated with the proteins than are the isoflavones. The 
molecular weight cutoff of the cellulose membrane was 30 KD and the molecular weights of 
the isoflavones and saponins are all less than 1.1 KD. 
One of the most interesting differences between the two processes was the significantly 
increased fraction weight of the optimized-method P-conglycinin fraction. The fraction 
weight of the optimized-process spray-dried P-conglycinin was 2.10 kg, while that of the Wu 
process was 1.29 kg. Table 13, which shows SDS-PAGE data for selected process fractions, 
indicates that the optimized-method P-conglycinin has a significantly lower purity, 67.8%, 
compared to 79.1% for the Wu process. This is lower than the 73-74% purity for p-
conglycinin observed for the 25-45 °C treatments for the bench-scale comparison (Table 9). 
The optimized process had a higher fraction weight for the extract (Table 12). This weight 
was evidently not partitioned into the optimized-process glycinin and intermediate fractions, 
as they were not significantly different than for the Wu process, but partitioned into the p-
conglycinin fraction. Total protein results for the two methods reflect what was observed for 
the fraction weights. 
The protein extract of the optimized method contained a significantly higher isoflavone 
concentration and higher total isoflavones. This was not expected. Bench-scale results from 
the water-to-flake ratio study showed that increasing the ratio increased the amount of 
isoflavones recovered from the insoluble fraction (Table 6). Because the Wu method used a 
15:1 ratio, compared to 10:1 for the optimized method, we predicted that the Wu-method 
extract would be higher in isoflavones. The bench-scale temperature study demonstrated that 
increased temperature significantly decreased isoflavone concentration in the insoluble 
fraction, but these differences were not substantial (Table 10). The isoflavone concentration 
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Table 13. Distribution of Proteins in the Starting Material and Selected Process 
Streams from Pilot-Scale Soy Protein Fractionation and Soy Protein Isolate 
Production 
Lipoxygenase"'" (%) P-Conglycinin (%) Glycinin (%) 
Soy flake starting material 7.3bcd 42.1ft 50.7, 
Soy protein isolate (SPI) 5.2cde 47.2a, 47.6«i 
Wu process glycinin ndc 14.7b 85.3b 
Optimized process glycinin nd 10.2j 89.9, 
Wu process intermediate 11.4a 41.0g 47.6a! 
Opt. process intermediate 10. lab 39.4, 50.5, 
Wu process 3-conglycinin 3.1e 79.1. 17.9; 
Opt. process P-conglycinin 4.2de 67.8b 28. lh 
SPI process extract 5.9ak 50.8cd 43.3cfe 
Wu process extract 8.2abc 51.8c 400, 
Opt. process extract 6. lcde 52.1, 41.8» 
SPI process insoluble fraction 10.2,„ 45.1ef 44.7d,f 
Wu process insoluble fraction 7-lbcd 46.4, 46.5(xic 
Opt. process insoluble fraction 9.7,y 42.4fe 47.9a, 
LSD" 3.5 3.6 4.2 
"Subscript, lowercase letters within a column indicate significant differences at P<0.05. 
6n=2. 
'None detected. 
dLSD, least significant difference. 
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of the insoluble fraction was not different for the Wu and optimized methods. This 
significant difference for isoflavones in the extract did not dramatically promote isoflavone 
differences in other fractions; however, the isoflavone concentrations and totals were 
significantly different at P<0.10 for the p-conglycinin fraction. 
Saponin concentrations and totals for the insoluble and extract fractions were not 
significantly different between the Wu and optimized processes. However, in most cases 
there were significant differences between the processes for the product fractions. The 
saponin concentrations and totals for the glycinin and intermediate fractions were greater for 
the Wu method, while saponins were higher in the P-conglycinin fraction for the optimized 
method. An observation during the bench-scale studies was that a high proportion of the 
isoflavones and saponins were partitioned into the intermediate fraction. This was observed 
for the pilot-scale processes as well. One hypothesis for this partitioning was that a large 
proportion of the glycinin and P-conglycinin in the intermediate fraction was no longer in 
native state and that the relatively hydrophobic phytochemicals were more attracted to these 
unfolded proteins that presented more hydrophobic patches. DSC data (Table 14) suggest 
that very little native-state protein remained in the intermediate fractions for both processes, 
while the optimized process contained less native state P-conglycinin than did the Wu 
process. The intermediate fraction of the optimized method demonstrated high surface 
hydrophobicity, 183, compared to 129 and 124 of the glycinin and p-conglycinin fractions, 
respectively, suggesting a reason for the high saponin content of the intermediate fraction 
(Table 14). However, hydrophobicity values for the optimized-process glycinin and 
p-conglycinin do not help to explain why the saponin concentration was so high in the P~ 
conglycinin fraction compared to the glycinin fraction. The surface hydrophobicity values 
for the Wu process were 114,105, and 80 for glycinin, intermediate, and P-conglycinin, 
respectively. Again, these values do little to explain saponin partitioning among the product 
fractions, as the values do not parallel the observed saponin partitioning. With caution, it 
might be suggested that saponins have an affinity for denatured p-conglycinin. This would 
explain the high saponin concentration in the intermediate fractions. Very little P~ 
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Table 14. Enthalpy and Surface Hydrophobicity of Pilot-Scale Soy Protein Isolate 
and Soy Storage Protein Fractionation Products 
Enthalpy (mJ/mg protein, dry basis) Surface 
Hydrophobicity p-Conglycinin" Glycinin 
Soy protein isolate" 0.08d 7.98b 227. 
Wu process glycinin ndc 21.78a 114c 
Optimized process glycinin nd 22.82a 129c 
Wu process intermediate LOS, 1.40c 105c 
Opt. process intermediate 0.58cd 1.98c 183b 
Wu process P-conglycinin 7.53a 0.52c 
<s
\ 
OO 
Opt. process 3-conglycinin 5.85b 0.89c 124c 
LSD" 0.87 3.05 25 
"Subscript, lowercase letters within a column indicate significant difference at P<0.05. 
6n=2. 
cnd, none detected. 
rfLSD, least significant difference. 
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conglycinin is in the native state in these fractions. In addition, the P-conglycinin fraction of 
the optimized method had less native-state P-conglycinin in the p-conglycinin fraction and a 
higher concentration of saponins in the p-conglycinin fraction compared to the Wu method. 
Fraction weights, total protein, and total isoflavones and saponins in the product fractions 
were compared to evaluate differences between the Wu, modified, and soy protein isolate 
processes (Table 15). Comparisons are for the precipitate fractions because the Wu and 
optimized processes employed diafiltration prior to spray drying. Fraction weight and total 
protein of the optimized process approached those for the soy protein isolate. Mass yields for 
the Wu, optimized, and isolate fractions (with glycinin, intermediate, and P-conglycinin 
fractions summed) were 31, 36, and 37%, respectively. Protein yields were 47, 53, and 54%, 
respectively. Total phytochemicals recovered in the soy protein isolate were significantly 
and substantially higher than for the other methods. Isolate used a solubilization temperature 
of 60 °C, which should have led to additional loss of native state of the proteins, possibly 
increasing phytochemical affinity for the proteins. 
There are several forms of soybean isoflavones and saponins. Processing conditions can 
cause conversion between these forms. It has not been determined whether the saponin 
profile is of dietary significance, but isoflavone profile is important because glucoside forms 
require enzymatic modification to the aglucon forms for gut absorption in humans (17). Soy 
isoflavones are comprised of three aglucon forms, daidzein, genistein, and glycitein, and their 
respective glucoside forms. There are three glucoside forms for each aglucon: 6"-0-
malonylglucoside, 6"-0-acetylglucoside, and the simple p-glucoside (Figure 3). The 
malonylglucoside of each aglucon family is the predominant form in soybeans (36), with 
prevalence of combined forms generally being genistein ~ daidzein »glycitein on a mole 
basis. When processed under mild conditions malonylglucosides will gradually convert to 
the P-glucoside forms (13,15). Conversion of malonylglucosides to acetylglucosides occurs 
during more abusive conditions, such as toasting and extrusion (37,38). In the presence of 
native soybean P-glucosidases, the glucoside isoflavones will be converted to their respective 
aglucon forms (15). 
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Table 15. Mass Balance Comparison of Products, Protein, and Phytochemicals of Pilot-
Scale Soy Protein Isolate and Combined Glycinin, Intermediate, and P-Conglycinin 
Precipitates" from the Wu and Optimized Soy Protein Fractionation Processes 
Product Weight" Total Protein Isoflavones in Saponins in 
(kg) (kg) Products (mmol) Products (mmol) 
Wuc 5.58 5.01 32.3b 29.3b 
Optimized 6.44 5.87 37.1b 32.4b 
Soy Protein Isolate 6.71 5.98 53.0. 46.0. 
LSD" Not different Not different 5.3 10.8 
"Precipitate fractions prior to diafiltration and spray drying. 
'Subscript, lowercase letters within a column indicate significant difference at P<0.05. 
cn=2. 
rfLSD, least significant difference. 
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Ri o 
-OH 
Ri 
Isoflavone Ri R% 
Daidzein H H 
Genistein H OH 
Glycitein OCH3 H 
Isoflavone ri r2 ra 
Genistin H OH H 
Glycitin OCH3 H H 
Daidzin H H H 
Malonylgenistin H OH COCH2COOH 
Malonylglycitin OCH3 H COCH2COOH 
Malonyldaidzin H H COCH2COOH 
Acetylgenistin H OH COCH3 
Acetylglycitin OCH3 H COCH3 
Acetyldaidzin H H COCH3 
Figure 3. Isoflavone structures. 
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The group B saponins that can be measured by the method of Hu and others (18) are V, I, 
II, ag, Pg, and Pa. The latter three have a 2,3-dihyro-2,5-dihydroxy-6-methyl-4//-pyran-4-
one (DDMP) moiety that is labile, and these forms readily convert to V, I, and II, 
respectively (Figure 4). Group B saponins III, IV, yg, and ya are also present in soybeans, 
but only in very small quantities. It is difficult to isolate adequate quantities of these 
saponins to prepare standard curves. 
For the Wu, optimized, and soy protein isolate processes a substantial portion, 30-35%, 
of the malonylglucoside isoflavones present in the defatted soy flakes were converted to the 
p-glucoside and aglucon forms, or for which could not be accounted (Table 16). 
Malonyldaidzin concentration in the soy flakes was 1.92 pmol/g compared to 1.24 and 1.36 
gmol/g for the isolate precipitate and glycinin precipitate, respectively. The glycinin fraction 
was chosen for this comparison because processing times were similar for glycinin and soy 
protein isolate, and these fractions all had similar total isoflavone concentrations. Data 
suggest that there were two competing conversions acting on the malonylglucosides. For the 
isolate precipitate, malonylglucosides were converted to the P-glucosides and aglucons. 
There was essentially no conversion to the acetylglucoside forms because the process 
conditions were too mild. The protein solubilization temperature, 60 °C, drove the 
conversion to the p-glucosides, and this temperature probably limited the glucosidase activity 
responsible for conversion to the aglucons. 
The conversion scheme was different between the Wu and optimized processes and also 
different than observed for the soy protein isolate. The data support the hypothesis that 
protein solubilization temperature affected the conversion process. For the glycinin 
precipitate of the Wu method, converted malonylglucosides were recovered as aglucons. In 
fact, the P-glucosides present in the starting material were also converted to aglucons. This 
suggests that there was considerable glucosidase activity, sufficient time for enzyme action, 
and insufficient effect by the process temperature to compete with this conversion and 
increase P-glucoside concentrations. For the optimized process, conversion of 
malonylglucosides to aglucons was not as substantial. Daidzin concentration decreased only 
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OH 
CH 
CH 
CH 
L - -
CH 
O 
CH2OH 
HOOC, 
HO 
HO 
HO 
HO 
saponin Ri Ri DDMP 
Pg CH2OH a-L-Rha Y 
I CH2OH a-L-Rha N 
Pa H a-L-Rha Y 
II H a-L-Rha N 
yg CH2OH H Y 
HI CH2OH H N 
ya H H Y 
IV H H N 
ag CH2OH p-D-Glc Y 
V CH2OH p-D-Glc N 
Figure 4. Structures of group B soyasaponins. 
Rha: rhamnosyl; Glc: glucosyl; Y: yes; N: no 
DDMP: 2,3-dihydro-2,5-dihydroxy-6-methyl-4//-
pyran-4-one 
Table 16. Isoflavone Profiles of Selected Pilot-Scale Soy Protein Fractionation and Soy Protein Isolate Process 
Fraction MDIN"' DIN AcDIN DEIN MGLY GLY AcGLY GLYEIN MGIN GIN AcGIN GEIN Total 
Wu" GLYP 1.36b 0.08d= 0.07„bcd 0.76bc 0.15ab, 0.04c nd" 0.13 2.42. 0.18.f6 0.09,& 0.97c 6.25b 
Opt. GLYP 1.28b 0.62c O.OSabc 0.39de 0.18,b 0.16b nd 0.05 2.06bC 1.04, 0.09,b 0.41fahii 6.37b 
Wu GLY AD 0.23d 0.01. 0.02cde 0.30de 0.03c O.Old nd 0.04 0.88, 0.05fK 0.07,bCef 0.63defah 2.27,de 
Opt. GLY AD 0.22d 0.09de 0.02de 0.13de 0.05c 0.04c nd 0.03 0.6 lef 0.30efe 0.08,be 0.24; 1.80efa 
Wu GLY SD 0.24c 0.02de nd 0.3 Id. 0.03c O.Old 0.01 0.08 0.86, 0.07f. 0.05bCefa 0.63def„ 2.30c 
Opt. GLY SD 0.21a 0.09de O.Olde 0.14de O.OScd 0.04c 0.04 0.02 0.59efe 0.3 lefft 0.08,bed 0.25ii 1.83,f 
Wu INT P 1.45b 0.14de 0.05abcde 1.49, 0.15abc 0.07c nd 0.21 2.30* 0.41 efc 0.05bCefa 2.01, 8.33, 
Opt. INT P 1.48b 0.87b 0.09. 0.92b 0.19ab 0.20b nd 0.14 2.03bc 1.49b 0.08,bed 1.07, 8.57, 
Wu INT AD 0.12d 0.02de nd 0.83b 0.02cd 0.02c nd 0.08 0.33fSh 0.13,6, 0.04def„ 1.67,b 3.28, 
Opt. INT AD 0.09d 0.1 la. 0.03c, 0.40cde 0.02c 0.04c nd 0.05 0.25ch 0.50d, 0.06,bCefc 0.77ce 2.32«d. 
Wu INT SD 0.12d 0.01c nd 0.79b 0.02c 0.02c nd 0.07 0.31» 0.08,fa 0.04defa 1.62b 3.08c 
Opt. INT SD 0.09d 0.1 Id. 0.01. 0.40de 0.03c 0.04c nd 0.05 0.24ch 0.48d, 0.06,bCeffl 0.76cef 2.28c, 
Wu BCON P 0.32cd 0.02de nd 0.43cd 0.03c 0.01c nd 0.04 0.45fO 0.06ftt O.O3.ft, 0.56.fabî 196d. 
Opt. BCON P 0.56, 0.25d 0.03cd. 0.43cd 0.08bcd 0.07c nd 0.06 0.82. 0.44d,f 0.05bCefc 0.54efahi 3.33, 
Wu BCON AD 0.03d nd nd 0.06. nd nd nd nd 0.05h 0.02. nd 0.14, 0.29h 
Opt. BCON AD 0.02d 0.03a. nd 0.12d. nd 0.02c nd 0.01 0.06h 0.12.fo 0.03,fc 0.28hii 0.70ftd, 
Wu BCON SD 0.03d O.Olde nd 0.06, O.Old nd nd nd 0.05h 0.02. nd 0.13; 0.3 lh 
Opt. BCON SD 0.02d 0.03d. nd 0.12d. nd 0.02c nd nd 0.06h 0.12.fo 0 02. 0.28hii 0.67gb 
Isol ISOLP 1.24b 1.59a 0.09,b 0.22d, 0.23, 0.40, nd 0.07 1.42d 2.26, 0.10, 0.29ohii 7.91» 
Isol ISOL SD 1.23b 1.55, 0.02de 0.22d, 0.21, 0.39, nd 0.07 1.40d 2.24, 0.08bCe 0.29ghii 7.73a 
SF FLAKES 1.92. 0.71k 0.08ab 0.09de 0.22, 0.17b 0.04 0.02 1.83, 0.81c 0.09,b 0.07, 6.01b 
LSiy 0.33 0.23 0.06 0.36 0.14 0.06 NDIFF* NDIFF 0.35 0.41 0.04 0.35 1.15 
Tactions 
"(imol/g, dry basis. 
''Subscript, lowercase letters within a column indicate significant difference at P<0.05. 
"Abbreviations: MDIN, malonyldaidzin; DIN, daidzin; AcDIN, acetyldaidzin; DEIN, daidzein; MGLY, malonylglycitin; GLY, glycitin; AcGLY, 
acetylglycitin; GLYEIN, glycitein; MGIN, malonylgenistin; GIN, genistin; AcGIN, acetylgenistin; GEIN, genistein; Wu, Wu process; Opt., optimized 
process; Isol, isolate; SF, soy flakes (ground); GLY, glycinin; INT, intermediate; BCON, (3-conglycinin; P, precipitate fraction; AD, after dialysis; 
SD, spray dried. 
dn=2. 
end, none detected. 
^LSD, least significant difference. 
gNDIFF, not different. 
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slightly compared to the starting material and genistin concentrations actually increased 
slightly. The solubilization temperature, 45 °C, must have limited the action of the 
glucosidases. The intermediate and P-conglycinin precipitates also display the conversion 
features described for the glycinin precipitate. Isoflavone accounting problems were 
probably due to poor recovery of the aglucons from the glycinin fraction matrix. As 
described above, isoflavone aglucon recovery may be as low as 65-75% from soy protein 
isolate. 
The effect of diafiltration on isoflavone loss into the permeate was demonstrated (Table 
16). Spray drying did not cause a significant conversion among the isoflavones. The 
intermediate fraction had the highest concentration of aglucons. Again, if surface 
hydrophobicity or lack of protein native state have a role in attracting the relatively 
hydrophobic phytochemicals, it is predictable that the most hydrophobic isoflavones, the 
aglucons, would be present in higher concentrations in this fraction. The p-conglycinin 
fraction had the highest percentage of aglucons, >40%. Time for enzymatic activity, surface 
hydrophobicity, and partitioning of more hydrophilic forms into previous fractions probably 
all contributed to this result. 
The DDMP forms of the saponins were in relatively high concentrations in the defatted 
soy flake starting material, similar to what was seen for the malonylglucosides of the 
isoflavones (Table 17). These DDMP forms, ag, pg, and Pa were rapidly converted to 
saponin V, I, and II, respectively. One of the most surprising effects of the process on the 
saponins was nearly total conversion of DDMP forms to non-DDMP forms during 
diafiltration. This was most easily observed for the intermediate fraction precipitate (Table 
16). The diafiltration process lasted only 3-4 h, yet conversion was nearly complete. 
Possibly the pressure of the diafiltration system was responsible for the conversion. 
In conclusion, process improvement did lead to an increased overall fraction weight and 
protein recovery compared to the Wu method, approaching those for the soy protein isolate 
process. The P-conglycinin fraction was increased significantly, but at the cost of purity. 
Functionality testing will indicate whether decreased P-conglycinin purity is a disadvantage. 
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Table 17. Saponin Profiles of Selected Pilot-Scale Soy Protein Fractionation and Soy 
Protein Isolate Process Fractions" 
Fraction V" I II ag Pg pa Total 
Wuc GLYP nd* 0.64fe 0.31m nd 0.12d 0.11d 1.17* 
Opt. GLYP nd 032. 0.17a nd 0.02d 0.06d 0.57h 
Wu GLY AD nd 0.63& 0.38efeh nd nd nd 1.01* 
Opt. GLY AD nd 0.20* 0.15h nd nd nd 0.35h 
Wu GLY SD nd 045, 025* nd nd nd 0.70h 
Opt. GLY SD nd 0.13, 0.23d, nd nd nd 0.35h 
Wu INT P 0.70 6.3 lcd 3.17k 0.19 3.10. 1.27. 14.74* 
Opt. INT P 0.74 5.35d 2.63, 0.11 1.60b 0.67b ll.Old 
Wu INT AD 0.98 10.10a 5.29. nd nd nd 16.38. 
Opt. INT AD 1.35 7.70k 3.76t nd 0.19d 0.16d 13.17bcd 
Wu INT SD 0.81 8.61* 4.67. nd nd nd 14.09*, 
Opt. INT SD 0.72 6.90= 3.43bc nd 0.14d 0.16d 11.35c 
Wu BCON P nd 0.72% 0.43efth nd 0.23d 0.11d 150* 
Opt. BCON P 0.34 2.40e 1.18de 0.07 0.87, 0.37, 5.22* 
Wu BCON AD nd 0.77& 0.39efeh nd nd nd 1.16* 
Opt. BCON AD 0.63 2.47. 1 • 15<ief nd 0.20d 0.12d 4.57* 
Wu BCON SD nd 0.74fc 0.38efeh nd nd nd 1.13* 
Opt. BCON SD 0.29 2.08* 1.01 jefg nd 0.15d 0.12d 3.66& 
Isol ISOLP 0.55 3.26, 1.43, 0.04 1.14^ 0.44c 6.86, 
Isol ISOL SD 0.57 3.33, 1.49d 0.09 1.09c 0.41, 6.98, 
SF FLAKES 0.01 0.62& 0.35esa, 0.19 2.98, 1.13, 5.28* 
LSD NDIFF 1.52 0.86 NDIFF 0.48 0.16 2.27 
"nmol/g, dry basis. 
^Subscript, lowercase letters within a column indicate significant difference at f<0.05. 
cn=2. 
^Abbreviations: V, I, and II are non-DDMP saponins; ag, Pg, and Pa are DDMP saponins; 
Wu, Wu process; Mod, modified process; Isol, isolate; SF, soy flakes (ground); GLY, glycinin; INT, 
intermediate; BCON, p-conglycinin; P, precipitate fraction; AD, after dialysis; SD, spray dried; Opt., 
Optimized; LSD, least significant difference; nd, none detected; NDIFF, not different. 
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The soy isolate contained significantly more phytochemicals than did either of the protein 
fractionation processes. It will be difficult to further modify the fractionation process to 
increase phytochemical yield in the product fractions while maintaining the ability to 
efficiently and effectively fractionate the proteins because different physicochemical protein 
properties are needed to achieve these two goals. 
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CHAPTER 5. PILOT-SCALE FRACTIONATION OF SOY STORAGE 
PROTEINS: FUNCTIONAL PROPERTIES 
A paper to be submitted to the Journal of Food Science 
David A. Rickert, Lawrence A. Johnson, Patricia A. Murphy 
Abstract 
Two pilot-scale soy protein fractionation processes, differing by protein solubilization 
conditions, were each employed to produce glycinin, P-conglycinin, and an intermediate 
fraction, a mixture of the two proteins. These protein products were compared for 
functionality by measuring apparent viscosity, solubility, gel strength, foaming 
characteristics, emulsification capacity, emulsification activity, and emulsification stability. 
Differential scanning calorimetry, sodium dodecylsulfate-polyacrylamide gel electrophoresis, 
and surface hydrophobicity analyses were performed to assist in interpreting functionality 
characteristics. There were significant differences among protein fractions, and in some 
cases between the same protein fraction from the different processes. This suggests that the 
fractionation process and modifications to that process are capable of filling a range of 
functionality needs. 
Introduction 
The functional properties of soy proteins have been exploited in a multitude of 
applications, e.g. solubility in beverages, viscosity in gravies, gelling properties in meats, 
foaming in whipped toppings, and emulsification in hot dogs and sausages. The current 
popularity of soy, due to its relatively inexpensive ingredient cost and potential health 
benefits (Messina 1997), continues to drive soy research and commercial development of 
new food products. 
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Understanding the physicochemical properties of soy protein that translate into desirable 
functional properties is much more difficult than understanding soy ingredient economics 
and demand. Glycinin and |3-conglycinin are the main storage proteins in soybean seeds, 
comprising nearly 70% of total seed protein (Nielsen 1985). Consequently, these proteins 
are largely responsible for the functional characteristics of soy ingredients, as well as those 
for traditional soy foods such as tofu. Glycinin and P-conglycinin are complex proteins. 
Under most conditions, glycinin is a hexamer of subunits, each of which contains an acidic 
and a basic polypeptide connected by a disulfide bond (Staswick and others 1984). There are 
at least five glycinin gene products leading to heterogeneity in mature glycinin 
macromolecules, providing multiple types of glycinin subunits. B-conglycinin is a trimer, 
comprised of different compositions of three possible subunits, a, a', and P (Nielsen 1985). 
Different forms of these subunits (a, 0.2, 013, p, P2, and p;) provide heterogeneity in the trimer. 
The glycinin and P-conglycinin contents in soybeans are different among varieties and are 
affected by the growing environment (Murphy and Resurreccion 1984, Fehr and others 
2003). All of these factors can affect soy protein functionality. 
Functionality is substantially affected by changes to the native state of the proteins during 
processing, because the proteins begin to unfold and hydrophobic regions of the interior are 
exposed. These changes in native state can be caused by heat processing during solvent 
removal after oil extraction, during protein solubilization for isolate production, or during the 
leaching process for soy protein concentrate production. For instance, ethanol extraction of 
oligosaccharides during soy protein concentrate production will denature soy proteins (Berk 
1992). Limited proteolysis of soy proteins with enzymes has been used to alter protein native 
state, alter the size to charge ratio, and improve functionality characteristics such as 
solubility, foaming, and emulsifying capacity (Schwenke 1997, Nielsen 1997). These 
processes have provided soy products with different functional properties appropriate for 
various ingredient applications. Ionic strength and pH of the food systems in which these 
ingredients are used further influence their functionalities. For instance, soy protein 
solubility is generally lowest at pH 4-5. Ionic strength (e.g. as altered by NaCl 
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concentration) will affect solubility as well, but the extent of change in solubility is related to 
the pH of the system. 
While industry has developed processes yielding a variety of soy products with useful 
functional properties, basic research has endeavored to elucidate how these two storage 
proteins influence soy protein functionality. Bench-scale fractionation procedures of Thanh 
and others (1976) and Nagano and others (1992), among others, have been used to produce 
glycinin- and (3-conglycinin-rich fractions, characterized directly or with further purification, 
to address physicochemical and functional properties of these proteins. For instance, Utsumi 
and others (1984) evaluated heat-induced interactions between the two soy proteins. Fisher 
and others (1990) studied the effects of gelation and heat and chemical denaturation on 
glycinin and p-conglycinin. Wagner and Guéguen (1999a, b) evaluated the foaming and 
emulsifying properties of native, acid-treated and reduced soy glycinin. Lakemond and others 
(2000) evaluated the effects of pH and ionic strength soy glycinin. Wagner and Guéguen 
(1995) compared unmodified glycinin to deamidated and reduced glycinin for surface active 
properties. Studies have even been conducted with regard to subunit composition or the 
subunits themselves. Liu and others (1999) evaluated the emulsifying properties of the acidic 
subunits of glycinin. Maruyama and others (1999) studied the structure-physicochemical 
function relationships of P-conglycinin subunits with respect to solubility, surface 
hydrophobicity, thermal stability, heat induced association, and emulsifying ability. 
Efforts to evaluate glycinin and P-conglycinin properties have influenced plant breeding. 
Nagano and others (1996) evaluated the gelation properties of soy protein isolates produced 
from low p-conglycinin and low glycinin soybean lines. Bringe (2001) disclosed that a high 
p-conglycinin soybean line had useful characteristics for certain food applications. Khatib 
and others (2002) and Riblett and others (2001) have fractionated glycinin and p-conglycinin 
from several soybean lines with different protein compositions and compared functional 
characteristics among the lines. 
A substantial body of research has been accomplished using bench-scale fractionation of 
glycinin and P-conglycinin. Information about products from pilot-scale applications is 
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much more limited. Fractionation processes have been patented (Davidson and others 1979, 
Lehnhardt and others 1983), but it is not clear whether these are pilot-scale or bench-scale 
processes. Wu and others (1999) describe a pilot-scale process to produce kg quantities of 
glycinin, p-conglycinin, and an intermediate fraction consisting of a combination of the two 
proteins. 
The objective of the current work was to compare protein produced by the method of Wu 
and others (1999), an optimization of Wu's fractionation method, and soy protein isolate, all 
produced at pilot scale. These data may suggest potential food system applications for the 
fractionated proteins. 
Materials and Methods 
Storage protein fractionation and soy protein isolate production 
The starting material for the soy protein fractionation and soy protein isolate processes 
was defatted soy white flakes (from IA 2042 variety, 2000 harvest, 84% protein dispersibility 
index) produced at the Research Oil Mill at Texas A&M University in August 2001. The 
flakes were stored in sealed containers at 4 °C until use. 
Extraction conditions for soy protein fractionation were 15:1 water-to-flake ratio at 
20 °C, used by Wu et al. (10) for previous pilot-scale fractionation, or 10:1 water-to-flake 
ratio at 45 °C (optimized conditions). Flakes (20.0 kg) and temperature-adjusted tap water 
were combined by stirring at 22 rpm in a jacketed 800-L tank (Walker Stainless Equipment 
Company, New Lisbon, WI), adjusted to pH 8.5 with 2 N NaOH, maintained at that pH, and 
stirred at 13 rpm for 1 h. Slurry was fed to an Alfa Laval BTPX disc stack centrifuge (Alfa 
Laval Separation Inc., Warminster, PA) at 9800 rpm bowl speed (approximately 12,000 x g) 
at a feed rate of ~2 L/min with a Moyno transfer pump (Electric Pump, Model IFFCA SSE 
SAA, Des Moines, IA) at 300 rpm to separate soluble and insoluble components. 
The protein extract was treated with NaHSOs to provide 10 mM SO2, adjusted to pH 6.4 
with 2N HC1, and cooled overnight at ~7 °C. Glycinin-rich precipitate was recovered using 
the Alfa Laval centrifuge at 9800 rpm bowl speed and 420 rpm transfer pump speed (~4 
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L/min). The resulting supernatant was adjusted to 0.25 M NaCl and pH 5.0, stirred at 13 rpm 
for 1 h, and then centrifuged at 9800 rpm bowl speed with a 420 rpm transfer pump speed. 
The resulting intermediate fraction precipitate was comprised of a mixture of glycinin, (3-
conglycinin, and other proteins. The supernatant was diluted 2:1 with water, adjusted to pH 
4.8, and chilled overnight at ~7 °C. The P-conglycinin-rich precipitate was removed by 
centrifugation at 9800 rpm bowl speed with a 420 rpm transfer pump speed. Recovered 
protein fractions were adjusted to pH 7.5 with 2N NaOH and then desalted with a Feed and 
Bleed Membrane Filtration System (Model SRT-50; North Carolina SRT Inc., Cary, NC) and 
a 30-KD regenerated cellulose membrane (North Carolina SRT Inc.). Diafiltration was 
continued until permeate equaling 5X the original volume of protein dispersion was 
collected. The protein retentate was dried in an Anhydro Compact Spray-Dryer (APV 
Crepaco Inc., Attleboro Falls, MA) with an air inlet temperature of 160 °C and air outlet 
temperature of 85 °C. 
Deviations from the pilot-scale process described by Wu et al. (10) were as follow. Wu's 
protein extract was separated from the insoluble fraction using a two-pass system through a 
Sharpies P660 decanting centrifuge (Alfa Laval Separation Inc., Warminster, PA) instead of 
a single pass through the Alfa Laval BTPX 204 disc stack centrifuge. Wu chilled overnight 
at 4 °C, while we chilled at ~7 °C. 
For soy protein isolate production, flakes (20.0 kg) were extracted with a 10:1 water-to-
flake ratio at 60 °C. Flakes and temperature-adjusted water were combined with mixing as 
above and adjusted to pH 8.5 with 2 N NaOH. The slurry was stirred for 30 min at 13 rpm, 
and then the insolubles were removed by centrifugation as above. The supernatant was 
adjusted to pH 4.5 using 2N HC1 and then chilled overnight at ~7 °C. The soy protein isolate 
was recovered by centrifugation, adjusted to pH 6.8, and then spray dried. 
Other protein samples 
Bovine serum albumin Fraction V (A-7906, Sigma, St. Louis, MO) and Supro 670 
(Protein Technologies International, St. Louis, MO) were evaluated by some assays. 
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Proximate analysis 
Nitrogen content of the defatted soy flakes and process fractions was measured using the 
combustion or Dumas method (AOAC 990.03) with a Rapid NIII Analyzer (Elementar 
Americas, Inc., Mt. Laurel, NJ). These values were converted to Kjeldahl nitrogen 
concentrations using a conversion formula (Jung and others 2003). A 6.25 conversion factor 
was used to convert percentage nitrogen to protein content. Moisture and ash were 
determined (AACC method 44-15A, AACC method 08-03). 
Urea-SDS-PAGE 
Sodium dodecylsulfate-polyacrylamide gel electrophoresis was performed using the 
method described by Wu and others (1999). A 25-mg protein sample was dissolved in 10 
mL of protein extraction buffer (50 mM THAM, pH 8.0, 5.0 M urea, 0.2% SDS, and 2% 2-
mercaptoethanol). This protein solution was diluted 1:1 with 2x sample buffer (125 mM 
THAM, pH 6.8, 5.0 M urea, 0.2% SDS, 20% glycerol, and 0.01% Bromophenol blue). Each 
lane was loaded with 45 gg protein. An 8-18% polyacrylamide gradient was used. 
Electrophoresis was performed at 130 V for 6 h. Gels were stained with a methanol/acetic 
acid/water (50:10:40) solution containing 0.22% Coomassie Blue and then destained in the 
same solution without Coomassie Blue. Densitometry was determined using Kodak ID 
Image Analysis version 3.5 (Kodak, Rochester, NY) on scanned images produced by a 
Biotech Image Scanner (Amersham Pharmacia, Piscataway, NJ). 
SDS-PAGE results were calculated as follows. Densitometry values for lipoxygenase, 
p-conglycinin subunits, and glycinin subunit bands were summed. This sum was then used 
as the denominator for a corresponding numerator comprised of a sum of subunit bands for a 
given protein. When multiplied by 100, this provided a percentage composition for that 
protein with respect to the protein bands measured by densitometry analysis. 
Differential scanning calorimetry 
Samples (15-20 mg) of 10% (w/w) dry basis protein dispersion were hermetically sealed 
in aluminum pans. A sealed, empty pan was used as reference. The samples were analyzed 
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at 10 °C/min in a range of25-120 °C using an SU Exstar 6000 (Seiko Instrument, Inc., 
Japan). All samples were repeated at least four times. 
Surface hydrophobicity 
Surface hydrophobicity was measured by using a modification of the method used by Wu 
and others (1999), using 1 -anilino-8-naphthalene sulfonic acid magnesium salt monohydrate 
(ANS, ICN Biomedicals, Inc., Aurora, OH). A 1% (w/w) dry-basis sample dispersion was 
prepared in de-ionized water and the pH was adjusted to 7 using 2N HC1 or NaOH. The 
dispersions were stirred for 1 h, with pH adjusted at 15, 30, and 60 min. Undissolved 
material was removed by centrifugation at 10000 x g for 10 min at 20 °C. The protein 
content of the supernatant was determined using the biuret method (AOAC 1970) with 
bovine serum albumen (Sigma, St. Louis, MO) as the standard. Soluble protein was diluted 
with 0.1 M phosphate buffer (pH 7.0) to obtain concentrations ranging from 6.25 to 1000 
Hg/mL. ANS (40 \iL, 8.0mM in 0.01 M phosphate buffer) was dispersed in 3-mL aliquots of 
each dilution. Fluorescence intensity units (FIU) were measured with a Turner Quantech® 
spectrophotometer (Barnstead Thermolyne, Dubuque, IA) using 440 nm (excitation) and 535 
nm (emission) filters. FIU were standardized using a solution of 40 pL ANS in 3 mL 
phosphate buffer as the zero point and 15 pL ANS in 3 mL of methanol assigned a value of 
80 FIU. The FIU were plotted versus percent protein concentration. The slope of the 
regression line was considered to be the surface hydrophobicity. Samples were run in 
triplicate. 
The conditions and parameters used by Wu and others (1999) that were different from 
those stated above were as follow. Protein was serially diluted in the range of 1-100 gg/mL. 
Excitation and emission wavelengths were 350 and 525 nm, respectively. A 100-pL aliquot 
of ANS was added to 5 mL of diluted protein. 
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Solubility 
A 1% (w/w) dry-basis sample dispersion was prepared in de-ionized water, and the pH 
was adjusted to 3, 4, 5, 6, 7, 9 or 11 using 2N HC1 or NaOH. The dispersions were stirred for 
1 h, with pH adjusted at 15, 30, and 60 min. Aliquots (30.0 g) of dispersions were portioned 
into 50-mL centrifuge tubes and centrifuged at 10000 x g for 10 min at 20 °C. Supernatant 
was measured for protein content using the biuret method with bovine serum albumen as the 
standard. Solubility was calculated as follows: 
% Solubility = (protein in supernatant/initial protein content) x 100. 
This method was a modification of Bian and others (2003). Bian used a 0.1% protein 
dispersion, 0.1 M HC1 and NaOH, and centrifugation at 32,500 x g. 
Emulsification capacity 
Emulsification capacity was measured using the method of Bian and others (2003). 
Twenty-five g of a 2% (w/w) dry-basis sample dispersion adjusted to pH 7, 5, or 3 with 2N 
HC1 or NaOH was transferred to a 400-mL plastic beaker. Soybean oil, dyed with Fat Red 
7B (Sigma, St. Louis, MO), was continuously blended into the dispersion at a rate of 37 
mL/min using a Bamix wand mixer (ESGE AG Model 120, Mettlen, Switzerland) at the low 
setting until phase inversion was observed. The emulsification capacity (gram oil/gram 
sample) was calculated as g of oil used to cause inversion multiplied by 2. Samples were run 
at least in triplicate. 
Emulsification activity and stability 
This is a modification of the method of Chove and others (2001). Twenty-one mL of a 
2% (w/w) dry basis sample dispersion at pH 7 was blended with 7 mL of fully refined 
soybean oil (Bakers and Chefs Vegetable Oil, North Arkansas Wholesale Company Inc., 
Bentonville, Arkansas) in a 250-mL beaker for 1 min using a Bamix wand mixer (ESGE AG 
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Model M133, Mettlen, Switzerland) at low speed. Immediately after mixing, the emulsion 
was diluted 1:1000 with 0.1% sodium dodecylsulfate. The absorbance at 500 nm was 
measured, and this absorbance was recorded as the emulsification activity. After 15 min the 
absorbance was measured again. These two absorbance readings were used to calculate the 
emulsification stability. 
ES (min) = (A0/A0-Aj5)t 
Where: Ao and A\s are absorbance at time zero and 15 min, respectively, and t is the time 
interval. Samples were run in triplicate. 
Modifications to the method of Chove and others (2001) were as follow. Chove and 
others (2001) used a 1:4000 dilution. They serially diluted samples at 0 and 10 min, rather 
than measuring the absorbance of the same dilution at 0 and 15 min. Chove and others 
(2001) measured time zero absorbance at 500 nm and used this value to calculate an 
emulsification activity index. 
Foaming 
A 0.5% (w/w) dry-basis sample dispersion was prepared at pH 7. A 95-mL aliquot was 
loaded into a custom-designed glass column (58.5 cm x 2 cm) with a coarse glass frit at the 
bottom, and N? was purged through the sample at 100 mL/min flow rate. Time for the foam 
to reach the 300-mL mark, time for one-half of the liquid incorporated into foam to coalesce 
to liquid, and volume of liquid incorporated into foam were measured. Three parameters 
were calculated: 
Foaming capacity (FC) = V/(fr x tf) 
K (specific rate constant of drainage) = l/(Vmax x Xia) 
Vj (rate of liquid conversion to foam) = Vmax/tf 
Where: Vf = a fixed volume of 300 mL, fr = the flow rate of gas in mL/min, tf = time in min 
to reach Vf, V^ax = the volume in mL of liquid incorporated into foam, and Xm = the time for 
draining half the liquid incorporated into foam. Samples were run in triplicate. 
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Viscosity 
A 10% (w/w) dry-basis sample dispersion was prepared at pH 7. The sample was applied 
to the plate of a RS-150 Rheo Stress (Haake, Karlsruhe, Germany) and shear was applied 
with a 60-mm 2° titanium cone (C60/2Ti) over the range of 10-500/s at 23 °C. Shear rate (y) 
and shear stress (T) over the course of the analysis, in combination with the power law 
formula application, were used to determine the consistency coefficient (K) and the flow 
behavior index (n), where x =Ky ". Using k, n, and y, apparent viscosity (r|) was estimated by 
the following formula: r] = Kyn'1. Samples were run in triplicate. 
Gelling 
A 10% (w/w) dry-basis sample dispersion was prepared and the pH was adjusted to 3, 5, 
or 7 using 2N HC1. Due to foaming problems, samples were stirred slowly to reduce bubbles 
and an aliquot from the bottom of the container was portioned into a 30-mL No. 14000 
KIMAX® beaker. Beakers were incubated in a water bath at 80 or 99 °C for 30 min, cooled 
in a water bath, and chilled overnight at 4°C. Gel strength was measured with a TA-XT2 
Analyzer (Texture Technologies Corp., Scarsdale, NY) using Texture Expert Version 1.22 
software (Stable MicroSystems Ltd., Surrey, England). The probe was a TA-111" diameter 
acrylic AOAC cylinder 35-mm tall. Test speeds were: pre-test, 2 mm/s; test, 0.9 mm/s; and 
post-test, 0.9 mm/s. The compression distance was 10 mm. The highest point on the 
analysis curve was regarded as the peak force and was expressed in N. The area under the 
analysis curve was regarded as the total force or work and was expressed in Nmm. Samples 
were run at least in triplicate. 
Statistical analysis 
Least square means, least significant differences, and ANOVA results were calculated 
using the SAS system (version 6, SAS Institute Inc., Cary, NC). 
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Results and Discussion 
The pilot-scale protein fractionation processes employed for this study produced three 
distinct protein fractions: glycinin, intermediate, and P-conglycinin. The intermediate 
fractionation was a mixture of glycinin and P-conglycinin. Precipitation of the intermediate 
fraction was employed to increase the purity of the p-conglycinin fraction. In previous work 
Wu and others (1999) determined by rocket Immunoelectrophoresis that most of the glycinin 
and P-conglycinin in the intermediate fraction was denatured. 
The material for the current characterization and functionality comparison study was 
produced during a previous study (Chapter 4). The current optimized process used a lower 
water-to-flake ratio (10:1) and higher temperature (45 °C) during protein solubilization 
compared to the control, or Wu, process (15:1 water-to-flake ratio and 25 °C). For soy 
proteins, the most significant effect of this process modification was increased P-conglycinin 
fraction at the expense of decreased purity of the P-conglycinin. 
Increasing protein solubilization temperature should increase protein denaturation, with 
extent of denaturation being directly related to the increase in temperature. This was 
observed in process improvement experiments with bench-scale evaluation of solubilization 
temperatures. A solubilization temperature of 55 °C, near the onset temperature of 
approximately 68 °C for P-conglycinin denaturation (Riblett and others 2001), increased the 
weight of the intermediate fraction at the expense of the P-conglycinin fraction, supporting 
Wu and others' (1999) observation of denatured proteins in the intermediate fraction. We 
hypothesized that if a protein solubilization temperature of 45 °C affected protein native 
state, there should be a difference in functionality between protein products from the two 
fractionation methods used here. Protein denaturation can significantly affect protein 
functionality by opening the protein and exposing hydrophobic regions sheltered in the 
interior. Exposed hydrophobic groups may decrease solubility through aggregation and 
increase foaming and emulsification by creating a more amphipathic molecule. 
209 
The glycinin, intermediate, and P-conglycinin fractions produced by the optimized and Wu 
fractionation process were desalted prior to spray drying, because protein functionality was 
to be evaluated. Salts and ionic strength can alter protein functionality (Kinsella 1979). Wu-
and optimized-method mean ash concentrations for the glycinin, intermediate, and P-
conglycinin precipitate fractions were about 3.3,13.8, and 8.2%, respectively, but were 
reduced to 1.8,2.6, and 2.7% after diafiltration. 
Soy protein isolate was prepared using a pilot-scale process for further comparison 
purposes. The isolate was not desalted so that it would more accurately reflect commercial 
isolates, which may contain a maximum of 4.5% ash (Anonymous 2003). The ash content of 
the isolate averaged 5.7%. 
Sodium dodecylsulfate-polyacrylamide gel electrophoresis 
SDS-PAGE was used to compare relative amounts of glycinin, P-conglycinin, and 
lipoxygenase in the process fractions (Table 1). Lipoxygenase is an enzyme capable of 
producing undesirable flavor profiles in soy products if not inactivated, but it is used for its 
bleaching properties in baked products. Compared to the a, a', and p bands of the 
P-conglycinin and acidic and basic bands of the glycinin fraction, it is the only other 
prominent band in protein extracts from soy. The soy protein isolate had approximately 
equal quantities of glycinin and p-conglycinin, but also a small amount of lipoxygenase. The 
protein distributions of the optimized- and Wu-method intermediate fractions were similar to 
that of the soy protein isolate, but the intermediate fractions had about twice as much 
lipoxygenase. The optimized process glycinin contained significantly less P-conglycinin 
(10.2%) than did the Wu-process glycinin fraction (14.7%), but glycinin purities were not 
significantly different. P-Conglycinin fraction purities for both processes were less than 80% 
and were significantly different. The optimized-process P-conglycinin contained 
significantly more glycinin compared to the Wu-process P-conglycinin. 
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Table 1 - Distribution of proteins in pilot-scale soy protein isolate and 
products of soy storage protein fractionation 
Lipoxygenase 
(%y 
p-Conglycinin 
(%) 
Glycinin 
(%) 
Soy protein isolate" 5.2bc 47.2c 47.6b 
Wu process glycinin ndc 14.7, 85.3, 
Optimized process glycinin nd 10.2f 89.9. 
Wu process intermediate 11.4. 41.0d 47.6b 
Optimized process intermediate 10.1* 39.4d 50.5b 
Wu process p-conglycinin 3.1c 79.1. 17.9, 
Optimized process P-conglycinin 4.2c 67.8b 28.1c 
LSD" 5.5 4.5 5.0 
"Subscript, lowercase letters within a column indicate significant differences at f<0.05. 
*n=2. 
cnd, none detected. 
rfLSD, least significant difference. 
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Differential scanning calorimetry (DSC) 
DSC analysis was used to evaluate how much native-state glycinin and P-conglycinin 
were present in the protein products (Table 2). Higher enthalpies indicate more native-state 
protein. The soy protein isolate had almost no native-state p-conglycinin, even though SDS-
PAGE revealed that about half of the protein in the fraction was p-conglycinin. The protein 
solubilization temperature used for the isolate process was 60 °C. Riblett and others (2001) 
revealed that the onset temperature for denaturation of p-conglycinin from four soybean lines 
was about 69 °C and the peak temperature was about 76 °C. The 60 °C solubilization 
temperature likely caused the loss of P-conglycinin native state. 
The glycinin-fraction DSC curves made it impossible to separate P-conglycinin 
enthalpies from the glycinin enthalpies. Consequently, the enthalpies for the glycinin 
fractions were overstated, and no p-conglycinin contaminant enthalpies were reported 
independently. Wu and others (1999) measured native state of their process fractions using 
rocket Immunoelectrophoresis and reported that no native-state P-conglycinin was present in 
the glycinin fraction. However, the enthalpy curves for our glycinin, from both the 
optimized- and Wu-process fractions, were quite large and started at the onset temperature 
for denaturation of p-conglycinin, observed during DSC analysis of the p-conglycinin 
fraction, suggesting some native-state P-conglycinin was present. There was no significant 
difference between glycinin enthalpies for the glycinin fractions of the Wu and optimized 
processes. 
The intermediate fractions contained relatively low amounts of native-state proteins. Wu 
and others (1999) determined that almost no native-state proteins remained in their 
intermediate fractions. In the current work, the Wu process had a higher enthalpy for 
p-conglycinin in the P-conglycinin fraction than did the optimized process. This may have 
been due to the difference in protein solubilization temperatures for the two different 
fractionation processes. The higher solubilization temperature of the optimized process may 
have led to increased denaturation of the p-conglycinin and therefore lower enthalpy. 
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Table 2 - Enthalpies of storage proteins in pilot-scale soy protein isolate and 
protein fractionation products determined by differential scanning calorimetry 
Enthalpy (mJ/mg protein, dry basis) 
3-Conglycinin0 Glycinin 
Soy protein isolate" 0.08d 7.98b 
Wu-process glycinin ndc 21.78a 
Optimized-process glycinin nd 22.82, 
Wu-process intermediate 1.08c 1.40c 
Optimized-process intermediate 0.58cd 1.98c 
Wu-process P-conglycinin 7.53. 0.52c 
Optimized-process P-conglycinin 5.85b 0.89c 
LSD* 0.87 3.05 
"Subscript, lowercase letters within a column indicate significant difference at P<0.05. 
*n=2. 
cnd, none detected. 
dLSD, least significant difference. 
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Surface hydrophobicity 
Surface hydrophobicity contributes to the functionality of proteins. Table 3 shows the 
surface hydrophobicities for the process fractions. The magnitude of the fluorescence 
intensity is correlated with surface hydrophobicity. Soy protein isolate had the highest 
surface hydrophobicity. The native-state data (Table 2) indicate that there was almost no 
native-state p-conglycinin in the isolate, and possibly a diminished amount of native-state 
glycinin. Because proteins unfold during denaturation, the hydrophobic regions of the 
protein interior become exposed. Subsequent re-arrangement of the protein may again 
shelter some of these regions, but the surface hydrophobicity may be increased if the re­
arrangement does not take the molecule back to native state. Wagner and others (1996) 
demonstrated that when soy protein isolate was acidified from pH 4.5 to pH 1.0 at RT, there 
was a substantial increase in denaturation of the protein as measured by DSC. The surface 
hydrophobicity increased as the pH was decreased, indicating a relationship between loss of 
native state and surface hydrophobicity. 
For the Wu process, the glycinin, intermediate, and P-conglycinin hydrophobicities were 
114, 105, and 80, respectively, but they were 129, 183, and 124, respectively, for the 
optimized process. The higher hydrophobicities for the optimized-process fractions were 
probably due to the extent of protein denaturation caused by the higher protein solubilization 
temperature. The DSC data supported this reasoning for the P-conglycinin fraction, but were 
not convincing for the glycinin and intermediate fractions. The hydrophobicity of the soy 
protein isolate was about twice that of the Wu process fractions. This is in agreement with 
the hydrophobicity data reported by Wu and others (1999). The hydrophobicity of their 
glycinin and intermediate fractions were not statistically different, in agreement with results 
from our Wu method, but their P-conglycinin fraction was more hydrophobic than were their 
glycinin and intermediate fractions. Hayakawa and Nakai (1985) also determined that 
P-conglycinin was more hydrophobic than glycinin. In contrast, our optimized- and Wu-
process p-conglycinins had lower hydrophobicity compared to the glycinin and intermediate 
fractions, at least within their respective process. 
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Table 3 - Surface hydrophobicity of pilot-scale soy protein isolate and soy 
storage protein fractionation products 
Hydrophobicity" 
Soy protein isolate" 227. 
Wu-process glycinin 114e 
Optimized-process glycinin 129c 
Wu-process intermediate 105c 
Optimized-process intermediate 183b 
Wu-process P-conglycinin 80d 
Optimized-process P-conglycinin 124c 
LSD' 25 
"Subscript, lowercase letters within a column indicate significant difference at /><().05. 
*n=2. 
TLSD, least significant difference. 
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Solubility 
The preferred solubility of soy protein depends on its application. For meat applications, 
relatively low solubility is desired so that the protein is not lost during processing, providing 
water-holding and fat-binding capabilities. Applications such as emulsification and foaming 
require a very soluble protein, which moves rapidly to interfaces and stabilizes them. The 
isoelectric region, the range where net charge is at a minimum, is between pH 4.2 to 4.6 for 
soy protein. This is the pH range where they generally display the lowest solubility. At pH 
extremes, especially under alkaline conditions, solubility is generally improved by 
dissociation and disaggregation of the proteins (Ishino and Ikamato 1975). It is important to 
report the nature of the solvent used to evaluate solubility since ionic strength can 
dramatically affect solubility (Shen 1976). 
The solubility profiles of the glycinin, intermediate, and p-conglycinin fractions, as well 
as soy protein isolate, are shown in Table 4. The point of lowest solubility differs among the 
products. The soy protein isolate had low solubility between pH 4 and 5, approximately the 
isoelectric range for soy proteins. The region of lowest solubility for glycinin was pH 5 to 
6. In protein fractionation schemes, pH values around 6.4 have been used to precipitate the 
glycinin fraction from P-conglycinin (Wu and others 1999). These data suggest why that is a 
prudent choice. The isoelectric regions of the intermediate fraction curves were similar to 
those for soy protein isolate. Sodium dodecylsulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) results for the isolate and the intermediate fractions were similar in peptide 
band array, showing approximately equal portions of glycinin and P-conglycinin (Table 2). 
However, the differential scanning calorimetry (DSC) data showed that there was much more 
native-state glycinin in the isolate than in the intermediate fraction. The isoelectric region for 
the P-conglycinin fractions was very sharp, occurring near pH 5. 
There were no significant differences between the Wu- and optimized-method solubility 
curves for the glycinin and P-conglycinin fractions. The intermediate-fraction solubility 
curves showed lower solubility across most of the pH range compared to the glycinin and 
P-conglycinin fractions, probably due to the amount of denatured proteins in the intermediate 
Table 4 - Solubility of soy protein isolate and fractionated soy proteins (%) 
pH 3° pH 4 pH 5 pH 6 pH 7 pH 9 pH 11 
Soy protein isolate" 91.6a 5.3a 4.70a 91.5a 91.8a 92.0. 92.8 
Wu-process glycinin 88.5a 72.6ab 0.00 1.6d 84.5a 88.0a 88.2 
Optimized-process glycinin 88.7a 87.8a 1.66bc 9.9d 87.9a 89.8a 90.7 
Wu-process intermediate 53.4b 22. Id 0.49c 40.3c 47.9b 53.8b 83.7 
Optimized-process intermediate 79.8a 44.0C 2.61b 64.0bc 74.4, 81.6a 93.9 
Wu-process P-conglycinin 87.5, 83. lab 0.00 84.7ab 86.8a 87.9a 88.9 
Optimized-process p-conglycinin 88.3. 66.5b 0.00 86.9ab 89.7, 89.2a 88.3 
LSDC 11.9 18.9 1.19 26.6 21.3 13.1 NDIFF" 
"Subscript, lowercase letters within a column indicate significant difference at P<0.05. 
'n=2. 
1,SD, least significant difference. 
dNDIFF, not different. 
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fraction. Supro 670, a commercial isolate that receives substantial high temperature 
treatment during processing, displayed no native-state glycinin or P-conglycinin and 
demonstrated somewhat lower solubility than the isolate across the pH range evaluated (data 
not shown). 
The hydrophobicity of the pilot plant soy protein isolate was much higher than most of 
the other protein fractions. High surface hydrophobicity can lead to lower solubility due to 
attraction of hydrophobic regions of the protein molecules, causing aggregation. However, 
surface hydrophobicity is not always a good indicator of solubility. Bovine serum albumen 
(BSA), as measured here, had a surface hydrophobicity of2001, compared to 227 for the soy 
protein isolate. However, the percentage solubility of the BSA was 99% at pH 5, while soy 
protein isolate solubility was less than 5% at pH 5. The difference between these proteins is 
that BSA has a high ratio of hydrophilic to hydrophobic groups on its surface, so its 
solubility is not as influenced by its isoelectric point (Damodaran 1997). BSA also has a 
molecular weight of about 68 kD, much less than the 180 and 320 kD molecular weights of 
P-conglycinin and glycinin, respectively. 
The optimized-process intermediate fraction displayed higher solubility across the 
measured pH range compared to the Wu-process intermediate fraction. The second 
replication of the optimized-process intermediate fraction demonstrated considerably higher 
solubility across the range of pH values, compared to the first replication, greatly influencing 
the average pH values of the replications. The second replication had three times as much 
native-state glycinin, measured by DSC, and had about 10% more glycinin and 50% less 
lipoxygenase, as measured by SDS-PAGE. These aspects may have altered the solubility 
profile. Compared to the first replication, more acid was required to adjust the pH to 5.0 to 
precipitate the intermediate fraction of the second replication of the optimized method. The 
dry-basis fraction weight of the second replication glycinin fraction was about 11% less 
compared to the first replication. This suggests that more glycinin was available for 
precipitation and was precipitated into the intermediate fraction of the second replication of 
the optimized method. 
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The intermediate fractions tend to have lower solubilities, but the solubilities of the 
glycinin, intermediate, and (3-conglycinin fractions were not so substantially different to be 
recommended for different applications. The largest solubility differences were due to the 
isoelectric points of the proteins, (e.g. glycinin compared to p-conglycinin) and exploiting 
these differences may lead to varied applications. 
Bian and others (2003) evaluated solubility of Wu-process (called Nagano process in 
their paper) glycinin, P-conglycinin, and intermediate fractions from material prepared by 
Wu and others (1999). Results at pH 2 to 10 were nearly identical to those reported here. 
Emulsification capacity 
Emulsification capacity is a critical functionality in food systems such as sausages, 
batters, and salad dressings. The role of proteins in emulsion formation and stability is to 
decrease the interfacial tension between water and oil fractions in the food system. Ability of 
the protein to move rapidly to the interface and remain at the interface, preventing 
coalescence, determines the effectiveness of an emulsifier. Other factors affecting 
emulsification are protein concentration, surface charge, and molecular flexibility capable of 
revealing hydrophobic regions that can better interact with the oil phase. 
The emulsification capacity assay employed here involved rapid mixing of oil into a 
protein dispersion. Mixing continued until phase inversion occurred. This method measured 
how much oil the protein can stabilize, but it did not provide a measure of the texture of the 
emulsion and the stability of the emulsion. As discovered through mixer calibration, energy 
input can easily have a more dramatic effect on the results than the nature of the protein. 
Effect of mixing and shearing on emulsification results has been documented (Tomberg 
1978, Waniksa and others 1981). Emulsification capacity was evaluated at pH: 7, 5, and 3. 
These values were selected because they fell within the range of most food systems and to 
determine whether pH might influence protein fraction choice for maximum emulsification 
capacity. 
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At pH 7, the P-conglycinin fractions of the Wu and optimized processes had the highest 
emulsification capacities (Table 5), each over 600 g oil/g protein. This suggests that the 
surface hydrophobicity of the p-conglycinin was rapidly altered under emulsification 
conditions or actually had higher surface hydrophobicity than reported above. The surface 
hydrophobicities of BSA, soy isolate, and Supro 670, a commercial isolate with no remaining 
native-state storage proteins, were 2002, 227, and 94, respectively, while their emulsification 
capacities were 1026,431, and 578 g oil/g sample, respectively. The low emulsification 
capacity of the Supro 670 soy protein isolate compared to our soy protein isolate was 
surprising, because the surface hydrophobicity of the Supro 670 was actually higher. High 
surface hydrophobicity should translate to high emulsification capacity. Perhaps the lower 
solubility of the Supro 670, about half that of soy protein isolate at pH 7, affected 
emulsification capacity by altering its ability to move to the emulsification interface and 
stabilize the interface. 
The emulsification capacities of the glycinin fractions were significantly lower than those 
observed for p-conglycinin. Aoki and others (1980) showed that a p-conglycinin-rich 
fraction generally had better emulsifying capacity than did a glycinin-rich 
fraction. It has been suggested that because |3-conglycinin is a smaller molecule than 
glycinin, |3-conglycinin can move to the interface more quickly (Utsumi and others 1997). In 
addition, the intra- and intersubunit disulfide bonds in glycinin cannot undergo rapid 
rearrangement at the interface and expose hydrophobic regions that interact with the oil 
phase, making it less effective than (3-conglycinin for emulsification. Bian and others (2003) 
demonstrated that at pH 7, the Wu-type glycinin, intermediate, and |3-conglycinin fractions 
had emulsification capacities of about 190,220, and 275 g oil/g sample, respectively. The 
emulsification capacities of our Wu-process fractions were 371,208, and 621 g oil/g sample 
for glycinin, intermediate, and P-conglycinin fractions, respectively. It was not surprising 
that the emulsification capacities reported by Bian were different from our Wu-process 
fractions even though the fractionation process was essentially the same. The soy flakes 
were from different crop years, probably from different soybean varieties, and prepared at 
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Table 5 - Emulsification capacity of soy protein isolate and fractionated soy 
proteins (g oil/g sample, dry basis) 
pH T" pH 5 pH 3 
Soy protein isolate" 43 U, 272k 477efrfl 
Wu-process glycinin 371a 583.k 530edef 
Optimized-process glycinin 173, 579*, 623* 
Wu -process intermediate 208h 591 abc 244u 
Optimized-process intermediate 424*;, 363j 484dCfe 
Wu-process P-conglycinin 62 lab 453fgy 554bcde 
Optimized-process p-conglycinin 65 la 394hij 571 abed 
"Subscript, lowercase letters within the table indicate significant differences at P0.05. 
*Least significant difference = 88. 
cn=2. 
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different facilities. Thus, the fractionated proteins may have had different protein 
characteristics. Another important difference was the mixing devices used during 
emulsification. Even though the mixing units were similar, we have observed that a 
relatively small difference in mixing speeds can cause a dramatic difference in emulsification 
capacity. Slower speeds and less power produce a higher emulsification capacity. 
Changing the protein dispersion pH prior to emulsification had a dramatic effect on some 
fractions. The emulsification capacities of the soy protein isolate and the p-conglycinin 
fraction were 40% less at pH 5 compared to emulsification capacities at pH 7, while the 
glycinin and intermediate fraction capacities increased by 14 to 70%. Emulsification 
capacities at pH 3 generally returned close to those at pH 7 for the isolate, intermediate, and 
p-conglycinin fractions. However, the emulsification capacities of the glycinin fractions 
remained near the pH 5 capacities. Bian and others (2003) showed that the glycinin fraction 
at pH 2 had an emulsification capacity of about 320 g oil/g protein compared to about 200 g 
oil/g protein at pH 7, while differences for the P-conglycinin were not significant between 
these treatments. Franzen and Kinsella (1976) showed that emulsifying capacity of soy 
protein isolate follows the pH solubility profile. That trend was not observed in the present 
work for the glycinin fractions and the Wu-intermediate fraction; however, the solubility 
profile of glycinin does begin to decrease around pH 7. 
Commercial soy isolate at pH 5.3 to 5.6 has been shown to provide poor emulsifying 
properties for frankfurter and sausage meats (Hutton and Campbell 1977). The 
emulsification capacities reported in the present work suggest that the glycinin or 
intermediate fractions are better suited for meat applications because at pH 5 they exhibited 
about twice the emulsification capacity of our soy protein isolate. 
Emulsification activity and stability 
Emulsification activity and stability are additional means of evaluating emulsifying 
properties of proteins. The emulsification capacity assay demonstrates the maximum amount 
of oil that can be emulsified per unit protein. Driving an emulsion to phase inversion, from 
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oil-in-water to water-in-oil, probably does not accurately reflect what occurs in a food 
system, but it is commonly used to evaluate emulsifying properties of proteins. Emulsions 
for the emulsification activity assay are prepared well below the inversion point. Dilution of 
the emulsion permits turbidimetric evaluation. The amount of turbidity immediately after 
emulsification is an indication of how much protein is adsorbed to the surface of the oil 
fraction, which is disrupted into fine particles during blending. 
Emulsification stability is a measure of how long the emulsion from the emulsification 
activity assay persists, resisting creaming, flocculation, and coalescence. Others have 
sampled and diluted the emulsion at one or more specific intervals after the initial emulsion 
was evaluated for turbidity. Decreased turbidity was taken to indicate a loss of stability of 
the emulsion. Here, only one dilution of the emulsion was made. The turbidity was 
measured immediately after dilution and then at 15 min. This change was implemented to 
eliminate problems with subsequent sampling of the emulsification. 
The soy protein isolate, optimized-process intermediate fraction, and optimized-process 
p-conglycinin exhibited significantly higher emulsification activities compared to the other 
process fractions (Table 6). The same was true for emulsification stability. Process fractions 
demonstrating high emulsification activity had low or diminished protein native state and had 
high surface hydrophobicity. An advantage of the optimized process was improved 
emulsifying properties, at least for the intermediate and P-conglycinin fractions. Bian and 
others (2003) used an emulsification activity index to express emulsification activity. Their 
method demonstrated roughly the same relationship for glycinin, intermediate, and 
p-conglycinin as observed here (absorbance values of 0.088, 0.150, and 0.158, respectively). 
Their method gave values of about 105, 530, and 430 m2/g, respectively. Both methods used 
similar emulsification and dilution steps, employing spectrophotometry measurement of 
turbidity to evaluate emulsification characteristics. As noted for the emulsification capacity 
assay, mixing speed and power characteristics of the blender used to create the emulsion, as 
well as blending time, will influence assay results. 
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Table 6 - Emulsification activity and stability of soy protein isolate and 
fractionated soy proteins 
Emulsification activity" 
(absorbance at 500 nm) 
Emulsification stability 
(min) 
Soy protein isolate6 0.242a 150b 
Wu-process glycinin 0.088c 49c 
Optimized-process glycinin 0.074c 60c 
Wu-process intermediate 0.150b 72c 
Optimized-process intermediate 0.273a 313. 
Wu-process p-conglycinin 0.158b 
<
0: OO 
Optimized-process P-conglycinin 0.228a 132b 
LSDC 0.053 40 
"Subscript, lowercase letters in the same column indicate significant difference at P<0.05. 
bn=2. 
"LSD, least significant difference. 
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Khatib and others (2002) evaluated the glycinin and p-conglycinin fractions from four 
soybean lines for emulsification activity index and emulsification stability. Averaged values 
across the four lines showed that the emulsification activity was higher (386 vs. 324 m2/g 
protein) for the glycinin fraction, but there was no statistical difference between the glycinin 
and P-conglycinin fractions. 
Foaming properties 
The same physicochemical properties necessary for emulsification are important for 
foaming. For foaming, protein stabilizes the interface between the water and air phases. The 
protein must move rapidly to the interface and provide sufficient viscosity and elasticity to 
prevent membrane rupture. To promote foam stability, the protein must reduce interfacial 
tension and form continuous films around the air bubbles. Proteins in the films are held 
together by electrostatic, van der Waals, and hydrophobic interactions (Kinsella and others 
1985). 
There were statistical differences in FC for the protein products, with FCs ranging from 
0.83 to 1.34 (Table 7). The foaming capacities of the optimized-process fractions were 
higher for all three fractionation products compared to those from the Wu process. Some 
evidence provided here suggests that there is less native-state protein in the optimized-
process fractions compared to the Wu-process fractions. Limited heat treatment of soy 
protein dispersions, with temperatures of 75-80 °C being optimal (Eldridge and others), 
reportedly increases foaming properties. Heating may cause dissociation of protein subunits 
and diminished P-conglycinin native state, producing proteins that more readily unfold at the 
air-water interface and stabilize the film. However, in the current work P-conglycinin gave 
the lowest FCs. The FC of the soy protein isolate was similar to the FCs of glycinin and 
intermediate fractions. 
Due to the considerable variability in time for one-half of the foam to coalesce into liquid 
(ti/2), there were no significant differences between K values. The P-conglycinin fractions 
for both processes were significantly slower for liquid-to-foam conversion. Bian and others 
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Table 7 - Foaming properties of soy protein isolate and fractionated soy 
proteins 
FC*" K (mL min)"1 V; (mL/min) 
Soy-protein isolate" 1.13b 0.0072 19.5. 
Wu-process glycinin 1.1% 0.0131 14.6ab 
Optimized-process glycinin 1.34. 0.0149 15.6, 
Wu-process intermediate 1.16b 0.0057 19.5, 
Optimized-process intermediate 1.24* 0.0158 16.6. 
Wu-process P-conglycinin 0.83a 0.0140 7.3C 
Optimized-process P-conglycinin 0.98c 0.0142 10.1% 
LSD* 0.14 Not different 5.4 
"Subscript, lowercase letters within a column indicated significant difference at /><().05. 
* Abbreviations: FC, foaming capacity; K, foam stability rate constant; Vj, rate of liquid 
incorporation into foam. 
en=2. 
rfLSD, least significant difference. 
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(2003) were not able to show a difference in FCs for the glycinin, intermediate, and p-
conglycinin fractions they evaluated. Their glycinin demonstrated a significantly higher K 
value than the intermediate and p-conglycinin fractions, indicating that the glycinin foams 
were less stable. However, in contrast to the liquid-to-foam conversion (v;) observed here, 
their P-conglycinin fraction demonstrated a significantly higher rate of liquid-to-foam 
conversion compared to the intermediate and glycinin fractions. Their fractionation process 
conditions were nearly identical to the Wu process used here. 
Apparent viscosity 
Viscosity, a measure of the resistance to flow, is an important aspect of protein 
dispersions for formation and stability of emulsions and foams. Dispersions of 10% (w/w) 
for the fractionated proteins and the soy protein isolate were evaluated across a range of 
shear rates (Table 8). For all fractions, as shear rate increased, apparent viscosity decreased. 
This trend was also observed by Circle and others (1964) for sodium soy proteinates. At low 
shear rates protein molecules are not all oriented with the direction of flow, causing higher 
apparent viscosity. At higher shear rates, the molecules become oriented with the direction 
of flow and apparent viscosity decreases. 
At low shear rates, there were no significant differences in apparent viscosity among the 
storage protein fractions and the soy protein isolate (Table 8). However, as shear rate 
increased apparent viscosities significantly increased for the intermediate fractions relative to 
the other fractions and the soy isolate. Particle size and shape are important factors affecting 
viscosity. Shen (1976) showed that soy protein in native state at pH 7 had lower intrinsic 
viscosity than soy protein denatured with guanidine hydrochloride or alkali treatment at pH 
12. Unfolded or non-native state proteins, such as those of the intermediate fractions, would 
have a larger particle size and may more readily participate in protein interactions, such as 
hydrogen bonding, electrostatic interactions, and hydrophobic interactions. Though not 
significant, there were differences in apparent viscosities between the Wu and optimized 
processes for the intermediate and p-conglycinin fractions, with the optimized-process 
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Table 8 - Apparent viscosities of soy protein isolate and fractionated soy 
proteins 
Apparent viscosity (Pa s i at stated shear rate (s"1) 
10 100 200" 500 
Soy protein isolate* 0.028 0.020 0.018k 0.016c 
Wu-process glycinin 0.011 0.007 0.006; 0.005c 
Optimized-process glycinin 0.013 0.006 0.005c 0.004c 
Wu-process intermediate 0.360 0.142 0.108a 0 075* 
Optimized-process intermediate 0.479 0.185 0.140, 0.096, 
Wu-process p-conglycinin 0.026 0.021 0.019bc 0.018bc 
Optimized-process P-conglycinin 0.051 0.034 0.030bc 0.026bc 
LSD" Not different Not different 0.090 0.058 
"Subscript, lowercase letters within a column indicate significant difference at P<0.05. 
*n=2. 
"LSD, least significant difference. 
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fractions having higher viscosities. If non-native state proteins have molecular size, shape, 
and interactions favoring increased viscosity, then these differences would be expected based 
on DSC results. There was no correlation between apparent viscosity and emulsification 
capacity, emulsification activity, or foaming capacity. Recall that viscosity affects the rate at 
which proteins can reach the interface and stabilize a foam or emulsion. 
Gelling 
Gelling is an extremely important food system functionality. Sausages, yogurt, tofu, 
cheese, and pudding are examples of food systems using protein gelation. For gelation to 
occur, a protein must be at least partially denatured, and then the protein molecules must 
associate or aggregate into a structure, either highly ordered or random. Gel formation is 
affected by protein concentration, pH, ionic strength, ionic species, and heating 
considerations, such as temperature and time (Circle and others 1964). 
Native-state analysis by DSC was used to determine appropriate gelation temperatures. 
The minimum temperature for protein gel production is the onset temperature for 
denaturation. The hardest gels are obtained between the peak denaturation temperature and 
the endpoint of denaturation (Matsumura and Mori 1996). The average peak and endpoint 
temperatures for the P-conglycinin and glycinin from the isolate and fractions evaluated in 
the current work were 73 and 79 °C for P-conglycinin and 90 and 96 °C for glycinin, 
respectively. To ensure that this temperature range was met for the interior of the samples, 
the 10% protein dispersions were heated in a water bath at 80 or 99 °C for 30 min. Gelling 
was evaluated at three pH values, 7, 5, and 3, to suggest what applications might be best 
suited for the different fractions. 
Although peak force (firmness) and total force (work) values for glycinin fractions are 
shown in Table 9, they did not gel at pH 7, 80 °C. The lack of gelling was likely due to 
insufficient change in native state or denaturation from the heat treatment and did not permit 
the second step in gel formation, the association of denatured proteins into a network. 
Glycinin heated at 99 °C did form opaque gels. Utsumi and others (1997) commented in 
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Table 9 - Gel strength characteristics of soy protein isolate and fractionated soy 
proteins 
Dispersion pH and gelling temperature 
pH 7 
80 °C* 
pH 7 
99 °C 
pH 5 
80 °C 
pH 5 
99 °C 
pH 3 
80 °C 
pH 3 
99 °C 
Peak force or firmness (N) 
Soy protein isolate O.Biki 5.3* NGF6 2-Ochiikl 3.5fchi GNP 
Wu-process glycinin 0.2H* 4.5cfg NGF 8.5cd GNP NGF 
Optimized-process glycinin 0.2m* 3.9fd, NGF 13.7, GNP NGF 
Wu-process intermediate 0.5k, 1-Ojiki NGF 3.2f2hii NGF l-3hiikl 
Opt.-process intermediate 3.5fghi 5.5rf NGF L9ghiikl 2.8fffhiik GNP 
Wu-process P-conglycinin 14.0. 12.3ab UTM" GNP" 14.4, GNP 
Opt.-process p-conglycinin 8.7cd lO.lfcc 7.Ode GNP 10.lt ,  GNP 
LSD" for peak force = 2.65 
Total force or work (Nmm) 
Soy protein isolate 4.8g 39.2d NGF 12.7fd,j 24.7defflh GNP 
Wu-process glycinin L7;* 36. la NGF 25.7defc GNP NGF 
Optimized-process glycinin 1-7,* 31.9d= NGF 40.4d GNP NGF 
Wu-process intermediate 3.1B 7.8b NGF 16.9efchi NGF 9.3hii 
Opt.-process intermediate 28.5dcf 35.5d NGF H.9ehii 18-lefghi GNP 
Wu Process P-Conglycinin 90.5  ^ 73.3c UTM GNP 142.8, GNP 
Opt.-process P-conglycinin 58.2c 63.3c 32.6de GNP 98.8b GNP 
LSD for total force = 15.95 
"Subscript, lowercase letters within a table indicate significant difference at ?<0.05. 
*NGF, no gel formed. 
"UTM, unable to measure. 
dGNP, gel not prepared. 
"LSD, least significant difference. 
* Although values were given, samples had not gelled. 
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their review of this topic that glycinin gels have been formed at 80 °C, but the forces 
maintaining the network structure were different than gels formed at 100 °C. Hydrogen 
bonding may have been more prevalent in the gel structure formed at 80 °C because there 
was less unfolding of the glycinin. At 100 °C, unfolding would have been more extensive, 
leading primarily to hydrophobic interactions. 
Like the glycinin fractions, soy protein isolate heated at 80 °C at pH 7 did not gel. This 
was probably due to the approximately equal portions of glycinin and P-conglycinin, as 
shown by SDS-PAGE analysis (Table 1), with the glycinin disrupting the gelling properties 
of the p-conglycinin at this temperature. The P-conglycinin fractions did produce firm gels at 
80 °C and pH 7. Again, this functionality was because the heat treatment was sufficient to 
cause the protein to denature, the first step in the gelling process. The firmness of the 
p-conglycinin gels was not significantly different for gelling treatments of 80 °C and 99 °C at 
pH 7, indicating that the increased temperature did not have a detrimental effect on the gel-
forming properties. 
The Wu-process intermediate fraction behaved very differently compared to that of the 
optimized process at both 80 and 99 °C at pH 7. The firmness of the optimized-process 
intermediate gels was 3.53 and 5.45 N, respectively, compared to 0.47 and 0.96 N for the 
Wu-process gels. There was no significant difference in glycinin content between these 
process fractions, and during the 99 °C treatment any differences in protein unfolding should 
have been eliminated. The DSC data also does not assist in explaining this difference. For 
the P-conglycinin fractions, firmness of the Wu-process material was higher at both 
temperatures than the optimized-process material. The smaller amount of native-state 
P-conglycinin in the optimized-process p-conglycinin fraction may have caused reduced 
firmness compared to the Wu-process P-conglycinin fraction gels, but this contradicts what 
was observed for the intermediate fractions. The Wu-process intermediate fraction had more 
native-state P-conglycinin, but had a lower firmness. These firmness values were difficult to 
explain with the available data. 
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The gel characteristics at pH 5 were quite different compared to gels formed at pH 7. 
Gels, if they formed, were white, opaque, and tofu-like. For the glycinin and intermediate 
dispersions heated at 80 °C, the protein precipitated, but did not form a network. The Wu-
process P-conglycinin sample heated at 80 °C did form a hard, tofu-like gel, but the height of 
the gel was so limiting that the texture could not be measured. The firmness of the 
optimized-process P-conglycinin gel at pH 5, 80 °C was not significantly different than the 
pH 7 gel heated at 80 °C, but the pH 5 optimized-process p-conglycinin gel looked tofu-like. 
Matsumura and Mori (1996) cited several studies suggesting that highly ordered "string of 
beads" type gels tend to be translucent or transparent, while randomly aggregated protein 
gels tend to be opaque. It is possible that because the proteins were near their isoelectric 
point, the protein structures could not associate in an ordered manner. Glycinin gels prepared 
at pH 5, 99 °C were significantly firmer than gels from the soy isolate or intermediate 
fractions formed under these conditions. p-Conglycinin gels were not prepared at pH 5 and 
99 °C because gels could be formed at 80 °C. 
Gels that formed at pH 3 were generally translucent, like the gels formed at pH 7. The 
glycinin fractions would not gel at either 80 or 99 °C at pH 3. However, p-conglycinin 
formed gels that were similar in firmness to gels formed at pH 7. Soy protein isolate gels 
formed at pH 3, 80 °C were not significantly different in firmness from those formed at pH 7, 
99 °C. Soy isolate gels were not prepared for analysis at pH 3, 99 °C, but gels were observed 
to form under these conditions. The Wu-process intermediate fraction would not form a gel 
at pH 3 unless it was heated at 99 °C. Even under those conditions it was still a very weak 
gel, as was the gel produced for the optimized-process intermediate fraction at pH 3, 80 °C. 
Probably the most interesting result of the gelling study was the strength of the 
P-conglycinin gels that could be formed at pH 3. This protein fraction may perform well in 
some high acid food systems or in jellied products containing acidic fruit juice or flavorings. 
The P-conglycinin fraction would be the preferred protein among those studied here for use 
at pH 7 if firm gelling properties were desired. 
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Conclusions 
There were functionality differences among the unique, fractionated products, and with 
respect to our soy protein isolate. This was especially true for emulsification and gelling. 
Functionality differences between the glycinin and P-conglycinin fractions may potentially 
be exploited and utilized. Further modification of these fractions may lead to additional 
products with unique functional properties. However, fractionated proteins may not be as 
economical as soy protein isolate, or even a modified isolate, due to increased processing 
requirements. Future work should include a more exhaustive evaluation of the functional 
properties of the process fractions, for example at additional pH values and for different ionic 
strengths. The performance of these fractions in actual food systems, when compared to 
commercial isolates, would be interesting as well. 
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CHAPTER 6. CONCLUSIONS 
This body of work sought to answer questions about the effects of soy protein 
fractionation process scale up, protein and phytochemical partitioning during processing, 
accurate accounting of the fate of phytochemicals during processing, and how different 
fractionation process conditions alter the functionality of glycinin, intermediate, and p-
conglycinin fractions. Explanation of the observations with respect to the physicochemical 
aspects of the proteins and phytochemicals was desired. 
Scale up of the fractionation process from 15 to 50 kg of starting material increased total 
protein recovery about 2.4-fold. However, about 12% less protein was recovered in the 
product fractions. This was primarily due to poor protein extraction from the defatted soy 
flakes. It is difficult to determine from available information whether this difference in 
extraction efficiency was due to functionality characteristics of the different soy flake starting 
material or equipment efficiency. It is possible that the flakes used in the scaled-up process 
had a lower protein dispersibility index compared to the white flakes used by Wu and others 
(1999) for the 15-kg process. Varietal, environmental, and storage differences may have also 
affected results. It would be interesting to perform a scale-up study using identical material 
in the same time frame to get a more accurate picture of this issue. The efficiency of both 
processes was poof with respect to protein recovery during soy protein isolate production. 
For research purposes, the current efficiency may be acceptable. However, the fractionated 
proteins would need to have very unique functional properties, or require minimal additional 
processing to yield unique properties, in order to be competitive in the marketplace. The 
fractionation process is long and capital intensive. 
The process improvement study provided interesting results. The water-to-flake study 
demonstrated that improved isoflavone extraction from soy flakes could be achieved at 
increased water-to-flake ratios, but unfortunately this did not translate into increased 
isoflavone concentrations in the protein products. Increased isoflavone extraction did lead to 
increased isoflavones in the whey waste stream, so the whey waste stream may be a viable 
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source for isoflavone recovery. Recovered isoflavones could then be added back to the 
protein products prior to spray drying. 
The physicochemical characteristics of the isoflavones and saponins were observed to be 
quite different with regard to the ability to move into and remain in the aqueous fraction. 
The whey contained a significant quantity of isoflavones but almost no saponins, probably 
due to hydrophobicity characteristics of the saponins and their apparent affinity for the soy 
protein. This affinity was observed again during diafiltration. The P-conglycinin precipitate 
lost 80-85% of its isoflavones to diafiltration but only 10-20% of its saponins. This finding 
presents a useful application for nutritionists wishing to evaluate the impact of isoflavones, 
saponins, and soy protein on serum cholesterol and lipid levels. Isoflavone concentration of 
the protein fractions, or isoflavone to saponin ratio, could be manipulated using diafiltration. 
Diafiltration could prevent the need to ethanol extract isoflavones from protein fractions for 
such studies. Ethanol extraction, as well as the heating process to remove the ethanol, 
denatures the proteins and may diminish the impact that P-conglycinin or other protein 
peptides, recovered through the intestine after digestion, may have on serum cholesterol and 
lipid levels. 
Protein functionality testing did show differences between glycinin, intermediate, and P-
conglycinin fractions. Some differences were observed between a given protein fraction 
produced by the optimized and the control pilot-scale fractionation processes. The effect of 
native state protein on solubility and emulsification was demonstrated. Probably the most 
useful information was provided by the emulsification capacity and gelling studies. Based on 
pH of the system, it may be possible to match a given fractionated protein for a specific 
application. The gelling characteristics of P-conglycinin at pH 3 were especially interesting. 
Future research with the remaining material should include solubility, emulsification, and 
gelling analyses at varied ionic strengths. If more product was available, evaluation of the 
proteins in actual food systems, such as a whipped product or in a meat product, would be 
ideal. 
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Finally, the importance of recovery studies became very clear. It is not useful to be 
frustrated by inaccurate mass balances, such as experienced with the isoflavones and 
saponins, without attempting to understand why those mass balances are inaccurate. The 
recovery study, described in Chapter 3, was very enlightening, demonstrating how very 
different soy matrices can be in their ability to retain phytochemicals. The soy protein 
isolate, and presumably the fractionated proteins that remain to be evaluated, displayed a 
much stronger affinity for the phytochemicals, especially the aglucon isoflavones and 
saponins, than the soy flake starting material. It also was discovered that pH can have a 
dramatic effect on isoflavone and saponin phytochemical extraction from soy products. This 
may be helpful for increasing accurate quantification of these phytochemicals, although 
laboratories may not choose to take the time and absorb the expense to evaluate this effect on 
the samples they analyze. 
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APPENDIX A. ANOVA TABLES FOR CHAPTER 3 TOTAL 
ISOFLAVONE AND SAPONIN CONCENTRATION DATA 
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Soy Protein Isolate Experiment - ANOVA for total isoflavone concentrations for the 
insoluble fraction. 
Degrees of Sum of Mean 
Source freedom squares square F value Pr>F 
Temperature 1 0.627 0.627 22.88 0.0014 
pH 2 4.022 2.011 73.36 <0.0001 
Temp*pH 
Neutralization 1 0.546 0.546 19.90 0.0021 
Temp*Neut 1 0.036 0.037 1.33 0.2821 
pH*Neut 2 0.292 0.146 5.33 0.0338 
Temp*pH*Neut 
Error 8 0.219 0.027 
Soy Protein Isolate Experiment -ANOVA for total isoflavone concentrations for the 
isolate fraction. 
Degrees of Sum of Mean 
Source freedom squares square F value Pr>F 
Temperature 1 0.009 0.009 0.15 0.7063 
PH 2 3.579 1.789 29.96 0.0002 
Temp*pH 
Neutralization 1 1.296 1.296 21.70 0.0016 
Temp*Neut 1 0.349 0.349 5.84 0.0421 
pH*Neut 2 1.003 0.502 8.39 0.0109 
Temp*pH*Neut 
Error 8 0.478 0.060 
Soy Protein Isolate Experiment -ANOVA for total isoflavone concentrations for the 
whey fraction. 
Degrees of Sum of Mean 
Source freedom squares square F value Pr>F 
Temperature 1 1.911 1.911 3.18 0.112 
PH 2 4.069 2.035 3.39 0.086 
Temp*pH 
Neutralization 1 0.029 0.029 0.05 0.832 
Temp*Neut 1 0.285 0.285 0.47 0.510 
pH*Neut 2 0.558 0.279 0.46 0.644 
Temp*pH*Neut 
Error 8 4.802 0.600 
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Soy Protein Isolate Experiment - ANOVA for total saponin concentrations for the 
insoluble fraction. 
Source 
Degrees of 
freedom 
Sum of 
squares 
Mean 
square F value Pr>F 
Temperature 1 0.138 0.138 0.98 0.352 
pH 2 1.598 0.800 5.68 0.029 
Temp*pH 
Neutralization 1 0.403 0.403 2.86 0.129 
Temp*Neut 1 0.086 0.086 0.61 0.457 
pH*Neut 2 0.091 0.046 0.32 0.733 
Temp*pH*Neut 
Error 8 1.127 0.141 
Soy Protein Isolate Experiment - ANOVA for total saponin concentrations for the 
isolate fraction. 
Source 
Degrees of 
freedom 
Sum of 
squares 
Mean 
square F value Pr>F 
Temperature 1 0.769 0.769 0.730 0.419 
pH 2 32.908 16.454 15.570 0.002 
Temp*pH 
Neutralization 1 45.794 45.794 43.330 0.0002 
Temp*Neut 1 0.218 0.218 0.210 0.662 
pH*Neut 2 0.504 0.252 0.240 0.793 
Temp*pH*Neut 
Error 8 8.455 1.057 
Soy Protein Slurry Experiment - ANOVA for total isoflavone concentrations 
Source 
Degrees of 
freedom 
Sum of 
squares 
Mean 
square F value Pr>F 
Temperature 1 2.627 2.627 20.99 0.0006 
PH 2 4.675 2.337 18.68 0.0002 
Temp*pH 2 1.085 0.542 4.33 0.0383 
Neutralization 1 1.804 1.804 14.42 0.0025 
Temp*Neut 1 0.260 0.260 2.08 0.1747 
pH*Neut 2 1.121 0.561 4.48 0.0352 
Temp*pH*Neut 2 0.570 0.285 2.28 0.1449 
Error 12 1.501 0.125 
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Soy Protein Slurry Experiment - ANOVA for 
Degrees of Sum of Mean 
Source freedom squares square F value Pr>F 
Temperature 1 1.445 1.445 4.41 0.0577 
PH 2 0.053 0.026 0.08 0.9232 
Temp*pH 2 0.889 0.444 1.35 0.2948 
Neutralization 1 2.178 2.178 6.64 0.0243 
Temp*Neut 1 0.200 0.200 0.61 0.4503 
pH*Neut 2 0.051 0.026 0.08 0.9250 
Temp*pH*Neut 2 0.953 0.476 1.45 0.2725 
Error 12 3.938 0.328 
otal saponin concentrations 
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APPENDIX B. MICROBIAL LOAD OF DEFATTED SOYBEAN 
FLAKES AND PILOT-SCALE PROCESS FRACTIONS 
Colony forming units on trypticase soy agar aerobic plates for materials from protein fractionation and soy 
protein isolate processes. 
Isolate Rl" Isolate R2 WuRl WuR2 Optimized R1 Optimized R2 
Soy Flakes 2.6 x 107g 2.5 x 107g 2.7 x 107g 6.2 x 107g 5.9 x 107% 3.1 x 107g 
Slurry 1" 1.5 x 107mL 5.8 x 102/mL 7.7 x 107mL 1.9 x 107mL 1.7 x 107mL 6.1 x 107mL 
Slurry 2 2.0 x 107m L 5.3 x 102/mL 1.4 x 104/mL 1.1 x lOVmL 5.9 x 107mL 2.2 x lOVmL 
Glycinin SD >3.0 x 107g 4.6 x 105/g 2.2 x 107/g 8.6 x 107g 
Intermediate SD 8.9 x 107g 8.0 x 104/g 9.3 x 107g 1.3 x 107g 
B-Conglycinin SD 7.5 x 107g 1.6 x 105/g 2.5 x 105/g 3.3 x 107g 
Isolate SD 3.5 x 104/g 7.8 x 104/g 
"Abbreviations: R, replication; SD, spray dried. 
*Slurry 1 was the soy slurry just prior to centrifuging to remove the insoluble fraction. Slurry 2 was the precipitated 
protein fraction that had chilled overnight that, when centrifUged, yielded the soy protein isolate or glycinin fraction. 
Coliform colony forming units on violet red bile agar for materials from protein fractionation and soy protein 
isolate processes. 
Isolate Rl° Isolate R2 WuRl WuR2 Optimized R1 Optimized R2 
Soy Flakes <10/g <10/g <10/g <10/g <10/g <10/g 
Slurry 1° <l/mL <l/mL 10/mL 1.8 x 102/mL 5/mL 4/mL 
Slurry 2 <l/mL 16/mL >250/mL 1.7 x 107mL 1.3 x lOVmL >3.0 x 102/mL 
Glycinin SD 2.2 x 107g 4.0 x lO'/g <10/g 10/g 
Intermediate SD 7.1 x lO'/g A 1
 
<10/g <10/g 
B-Conglycinin SD 4.2 x lO'/g <10/g <10/g <10/g 
Isolate SD <10/g <10/g 
"Abbreviations: R, replication; SD, spray dried. 
^Slurry 1 was the soy slurry just prior to centrifuging to remove the insoluble fraction. Slurry 2 was the precipitated 
protein fraction that had chilled overnight that, when centrifUged, yielded the soy protein isolate or glycinin fraction. 
